"Experiment page name",Study,"Location of subjects","Host species","Body site","UBERON ID",Condition,"EFO ID","Group 0 name","Group 1 name","Group 1 definition","Group 0 sample size","Group 1 sample size","Antibiotics exclusion","Sequencing type","16S variable region","Sequencing platform","Statistical test","Significance threshold","MHT correction","LDA Score above","Matched on","Confounders controlled for",Pielou,Shannon,Chao1,Simpson,"Inverse Simpson",Richness,State,Reviewer
"Experiment 1","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,control,Coli,"Group 1 mice were treated with colistin (2 mg/ml) in sterile drinking water (Coli group).  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",13,14,,16S,4,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 700",Canada,"Homo sapiens",Feces,UBERON:0001988,,,"healthy controls","children with ulcerative colitis","Children hospitalized for intravenous corticosteroid therapy for acute UC",26,27,"1 month",16S,,RT-qPCR,T-Test,0.05,true,,age,,,decreased,,,,,Incomplete,
"Experiment 1","Study 699","United States of America","Homo sapiens",Feces,UBERON:0001988,,,"Healthy controls","Patients with ulcerative colitis","Children aged 7-21 with mild to moderate ulcerative colitis",23,19,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,,Incomplete,
"Experiment 1","Study 698",China,"Homo sapiens",Feces,UBERON:0001988,,,"Healthy controls","Patients with Crohn's disease","Patients with Crohn's disease (11 with as active disease defined by CDAI > 150, 4 with inactive disease)",29,15,"3 months",16S,4,Illumina,Kruskall-Wallis,0.05,true,,"age,sex",,,unchanged,decreased,unchanged,,,Complete,
"Experiment 1","Study 697",China,"Homo sapiens",Feces,UBERON:0001988,,,"Non-responders to Immune checkpoint inhibitors","Responders to Immune checkpoint inhibitors","“Objective response” was defined as complete or partial response per Response
Evaluation Criteria in Solid Tumors (RECIST) v.1.1.",26,10,,16S,"3,4",Illumina,LEfSe,,,3,,,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 658",China,"Homo sapiens",Feces,UBERON:0001988,,,"Non-responders (Progressive Disease)","Responders (Partial Response or Stable Disease)","Patients with histologically confirmed metastatic or unresectable MSS/MSI-L/pMMR colorectal cancer treated with 80 mg, or 120 mg regorafenib, plus toripalimab resulting in stable disease or partial response.",21,11,"Any condition requiring ongoing systemic antibiotic therapy",16S,"3,4",Illumina,LEfSe,0.05,,3,,,,decreased,,,,,Incomplete,
"Experiment 1","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"colorectal cancer patients perioperative placebo","colorectal cancer patients perioperative probiotics","Patients in the PGT group received an encapsulated probiotics preparation (Shanghai Xinyi Pharmaceutical Co., Ltd., Shanghai, China) containing live combined Bifidobacterium longum, Lactobacillus acidophilus and Enterococcus faecalis (1:1:1) with no less than 1.0x107 CFU/g viable cells, three times/day, with a total daily dose of 6.0x107 CFU for five days",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,2,,,,increased,unchanged,increased,,,Complete,
"Experiment 1","Study 567",China,"Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","dietary fiber intake",,"Healthy control group (HC)","Advanced colorectal adenoma group (A-CRA)","Patients with a diagnosis of A-CRA by pathological examination were enrolled in the A-CRA group.",47,47,"6 months

None of the patients had received systemic or oral topical corticosteroids, antibiotics,
aspirin, other nonsteroidal antiinflammatory drugs (16), or health products that regulate intestinal microbiota within 6 mo before enrollment",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,"age,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 563",Afghanistan,"Homo sapiens","1st arch mandibular mesenchyme from head mesenchyme,Buccal salivary gland,abcd","UBERON:0010339,UBERON:0012102","Her2-receptor negative breast cancer,Cancer","MONDO:0000618,EFO:0000311","mild, moderate, and severe dementia","overweight irritable bowel syndrome",,1,2,,16S,,"DNA-DNA Hybridization",ANCOM,,true,,,,,,,,,,Incomplete,
"Experiment 1","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Gegen Qinlian decoction (GQD)",,non-GQD,"low-dose GQD (300 mg/kg)","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were
orally gavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical
traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously
into the left axillary region of each mouse and allowed ~1 week to establish tumours.",20,23,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 693",China,"Homo sapiens",Feces,UBERON:0001988,"hepatocellular carcinoma",EFO:0000182,Non-responders,Responders,"Responders (R, n = 3) were defined by radiographic evidence as complete or partial response, or stable disease lasting for at least six months.",5,3,,WMS,,"BGISEQ-500 Sequencing",LEfSe,0.05,,2,,,,,,,,increased,Complete,Fatima
"Experiment 1","Study 692",China,"Homo sapiens",Feces,UBERON:0001988,Nutraceutical,CHEBI:50733,"colorectal cancer patients who didn't take prebiotics (preoperative fecal sample)","colorectal cancer patients who took prebiotics (preoperative fecal sample)","Patients with radiologic and pathologic diagnosis of CRC (preoperatively). Patients in the intervention group (prebiotic group) received a daily oral dose of 30 g prebiotic supplement (Hangzhou Niuqu Biotech Co., Hainengbo, China) containing fructooligosaccharide (25%), xylooligosaccharide (25%), polydextrose (25%), and resistant dextrin (25%) for 7 d from hospitalization to the day before the operation.",20,18,"no treatment with antibiotics within 6 mo before surgery",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,,Complete,
"Experiment 1","Study 687",China,"Homo sapiens",Feces,UBERON:0001988,"Colorectal adenocarcinoma",EFO:0000365,"healthy controls","colorectal cancer patients","diagnosed of colorectal cancer by colonoscopy and histopathology",20,44,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,4,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 1","Study 691",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,Non-responders,Responders,"Patients with a confirmed response, defined as a complete response, partial response (PR) or stable disease (SD) according to RECIST 12 weeks after start of therapy that was ongoing at the next radiological evaluation, were labelled ‘responder’. In order to include late responders in our analysis, patients with progressive disease (PD) on the first radiological evaluation but a response at the second radiological evaluation compared to baseline were also labelled ‘responder’.",13,12,,WMS,,Illumina,"Fisher's Exact Test",0.05,true,,,"age,antibiotic exposure,body mass index,sex",,unchanged,,,,,Complete,
"Experiment 1","Study 689","United States of America","Homo sapiens",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,Progressive,Responders,"Twenty-four patients showed RECIST response (19, 49%) or stable (5, 13%) disease to ICT, what we classify as responders in this study",16,23,,WMS,,Illumina,LEfSe,0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 680",China,"Homo sapiens",Feces,UBERON:0001988,"Breast cancer",MONDO:0007254,"patients treated with conventional dose","patients treated with metronomic dose of capecitabine","Patients with HER2-negative metastatic breast cancer who receive metronomic capecitabine as maintenance treatment.",16,15,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,unchanged,unchanged,,,,,Complete,Fatima
"Experiment 1","Study 690",Japan,"Homo sapiens",Feces,UBERON:0001988,"non-small cell lung carcinoma",EFO:0003060,Non-responders,Responders,"We defined responder (R) (partial response to ICI treatment) or non-responder (NR) (stable or progressive disease after ICI treatment at the time of first clinical evaluation) according to the RECIST 1.1 evaluation.",11,6,,16S,"1,2",Illumina,LEfSe,0.05,,3,,,,unchanged,,,,,Complete,Fatima
"Experiment 1","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,adenoma,EFO:0000232,controls,"conventional adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,144,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,decreased,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 216",Netherlands,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,80,28,"use of antibiotics between 2 weeks prior to delivery and 2 weeks after delivery, for any reason except for prophylactic use (e.g. cesar- ean section).",16S,,RT-qPCR,,,false,,,,,,,,,,Complete,
"Experiment 1","Study 214","United States of America","Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"milk allergy resolution","children with milk allergy persistence","child with persistent milk allergy",128,98,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 1","Study 218",China,"Homo sapiens",Feces,UBERON:0001988,"hepatocellular carcinoma",EFO:0000182,"healthy controls","non-HBV non-HCV related HCC","HCC patients whose disease is not related to hepatitis B/hepatitis virus",33,22,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,increased,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 217",Finland,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","child with eczema",19,15,,16S,,"Human Intestinal Tract Chip",ANOVA,0.05,false,,,,,,,,increased,,Complete,
"Experiment 1","Study 221",Finland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"healthy controls","urinary tract infection","urinary tract infection",69,37,,16S,"4,5","Ion Torrent",LEfSe,,false,3,"age,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 222",Colombia,"Homo sapiens",Stomach,UBERON:0000945,"Gastric cancer",MONDO:0001056,"low gastric cancer risk patients (Tumaco residents)","high gastric cancer risk patients (Tuquerres residents)","individuals from Tuquerres with high gastric cancer risk",20,20,"30 days",16S,,Illumina,Metastats,0.05,true,,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 10",Brazil,"Homo sapiens",Uterus,UBERON:0000995,"cervical glandular intraepithelial neoplasia",EFO:1000165,"Normal tissue HIV patients","Cervical Intraepithelial Lesion HIV patients","Cases were identified by HIV rapid or ELISA test and subsequent Western blot following recommendations for HIV diagnosis by the Brazilian Ministry of Health.",42,38,,16S,"3,4,5,6",Illumina,LEfSe,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Time 0 days controls","Time 7 days",,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 224","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,baseline,"barley (WGB)","baseline (before fiber supplementation)",28,28,"3 months",16S,"1,2,3",Roche454,ANOVA,0.05,false,,,,,increased,unchanged,increased,,,Complete,
"Experiment 1","Study 225",Sweden,"Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy infant","infant with atopic eczema","infant with atopic eczema",20,20,,16S,"3,4",Roche454,edgeR,0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 166",China,"Homo sapiens",Feces,UBERON:0001988,"chronic kidney disease",EFO:0003884,"healthy controls","chronic kidney disease","patients with chronic kidney disease",24,49,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 226",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy controls","HIV-1 infected patients","HIV-1 diagnosed patients",16,67,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,true,2,"age,body mass index,sex",,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","infant with transient atopic dermatitis","infant with transient atopic dermatitis",84,22,"before sample collection",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 229","South Korea","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"late pectin incubation time",early,"before/early pectin incubation",3,3,"6 months",16S,"1,2",RT-qPCR,"Linear Regression",0.1,true,,,,,,,,,,Complete,
"Experiment 1","Study 230",Japan,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,non-allergy,"infant with food allergy","infant with food allergy",27,14,,16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 228","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"day 6 of PECTIN spike-in","day 3 of PECTIN spike-in","before pectin spike-in",9,9,"6 months",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index",,,,,,,Complete,
"Experiment 1","Study 232","United States of America","Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,HC,"HIV infected cART negative","HIV infected patients not on combined anti-retroviral therapy",20,40,,16S,4,Illumina,Kruskall-Wallis,0.15,true,,,,,unchanged,decreased,,,,Complete,
"Experiment 1","Study 12","South Korea","Homo sapiens",Uterus,UBERON:0000995,"human papilloma virus infection",EFO:0001668,"HPV clearance","HPV persistent","HPV DNA was detected using the Digene HC2 high-risk DNA test (Qiagen, Gaithersburg, MD, USA) with signal amplification and chemiluminescence for 13 types of HR-HPV scored in RLU/PC. A positive result indicated a concentration of 1 pg/ml or higher than the RLU/cutoff ratio (RLU of the specimen/mean RLU of 2 positive controls).",15,16,,16S,,Roche454,LEfSe,0.05,false,2,,"age,contraception,menopause,smoking behavior",,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 233","United States of America","Homo sapiens","Colonic mucosa",UBERON:0000317,"HIV infection",EFO:0000764,"uninfected controls","HIV-infected subjects","Subjects with untreated chronic HIV-1 infection",14,18,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 20",France,"Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,Non-NASH,NASH,"NAFLD was defined as liver steatosis on liver biopsy after exclusion of concomitant steatosis-inducing drugs, excessive alcohol consumption (>210 g/week in men or >140 g/week in women), chronic hepatitis B or C infection, and histological evidence of other concomitant chronic liver disease. NASH was defined as the presence of each of the three following conditions: steatosis grade 1; lobular inflammation grade 1; and ballooning grade 1. “Significant fibrosis” was defined as fibrosis stage F2.",22,35,"2 months",16S,4,Illumina,"Logistic Regression",0.1,false,,,"HDL cholesterol change measurement,blood pressure,body mass index,diabetes mellitus,hypertriglyceridemia,metabolic syndrome",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 27","United States of America","Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"foster mother fat1 pre HFD","foster mother wild-type pre HFD","fat-1 mice: with a balanced tissue n-6/n-3 ratio (~ 1:1) and wild-type (WT) mice: with a high n-6/ n-3 ratio similar to the Western diet (> 10:1).",15,9,,16S,"3,4",Illumina,LEfSe,0.05,true,2.4,age,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 7","United States of America","Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"non-sibling control","severely autistic","Cases were diagnosed with autistic spectrum disorder. Moreover, they were evaluated for autism and their diagnoses were validated based on impairment in social skills, impairment in language skills and verbal communication, sensory disturbances, repetitive stereotypical behaviors, and gastrointestinal disturbances.",8,11,"within preceding month",16S,,Roche454,T-Test,0.05,false,,,,,,increased,,,increased,Complete,Fatima
"Experiment 1","Study 21","United States-Mexico Border","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"Human Microbiome Project samples","Cameron County Hispanic Cohort samples",,213,63,,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.02,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 23","United States of America","Homo sapiens",Feces,UBERON:0001988,"Alzheimer's disease",MONDO:0004975,"Healhty controls",Alzheimer's,,25,25,"6 months",16S,4,Illumina,DESeq2,0.05,true,,"age,sex",,,decreased,decreased,unchanged,unchanged,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 14",Netherlands,"Homo sapiens","Oral gland",UBERON:0010047,halitosis,HP:0100812,Control,"Oral Halitosis","IOH patient group was selected based on an organoleptic score of >= 2 from the mouth and nose =< 1, having a VSC level > 160 ppb, and H2S > 4 nmol/ L (96 ppb) and CH3SH > 0.5 nmol/L (12 ppb) and a DPSI of =< 2",5,10,"3 months",16S,"3,4",Illumina,DESeq2,0.05,true,,,,,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 11",Brazil,"Homo sapiens",Uterus,UBERON:0000995,"cervical glandular intraepithelial neoplasia",EFO:1000165,"HIV pateints with normal tissue at 6 months","HIV patients with lesion at 12 months","Cases were identified by HIV rapid or ELISA test and subsequent Western blot following recommendations for HIV diagnosis by the Brazilian Ministry of Health.",5,5,,16S,"3,4,5,6",Illumina,"Mann-Whitney (Wilcoxon)",0.1,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 18",Denmark,"Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"BL6- Low Fat","Sv129- Low Fat","(BL6): C57BL/6JBomTac mouse strain, (Sv129):  the obesity-resistant mouse strain 129S6/SvEvTac . LF:  (LF)low-fat diet, (HF) high fat diet without indomethacin,  (HFI) high fat diet supplemented with indomethacin.",10,7,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 2","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"head and neck squamous cell carcinoma",EFO:0000181,"normal adjacent tissues","squamous cell carcinoma tissues","Not stated",121,121,,16S,"1,2,3,4",Sanger,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 24",China,"Homo sapiens","Saliva-secreting gland",UBERON:0001044,"chronic fatigue syndrome",EFO:0004540,"Healthy controls","Chronic Fatigue patients",,45,46,"2 months for healthy control only",16S,"3,4",Illumina,LEfSe,0.05,false,3,"age,body mass index,sex",,,unchanged,,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 26",Spain,"Homo sapiens",Feces,UBERON:0001988,"sex design",EFO:0001752,male,female,"three groups according to the BMI: BMI < 30; BMI between 30- 33; and BMI > 33.",39,36,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,age,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 25","United States of America","Homo sapiens","Skin of body",UBERON:0002097,psoriasis,EFO:0000676,Female,"Psoriasis Male","tape stripping method involves the repeated application of adhesive tape to the skin surface, thereby removing stratum corneum layers, it creates a superficial wound showing slight skin irritation (erythema) and loss of barrier function (transepidermal water loss)",6,6,,16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.1,false,,,,,increased,increased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 4",Egypt,"Homo sapiens",Feces,UBERON:0001988,Hepatitis,HP:0012115,"male healthy controls","HCV stage 4 male patients","Not stated",8,6,"3 months",16S,4,Illumina,LEfSe,0.1,false,2,,,,decreased,decreased,decreased,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 22","Russian Federation","Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls",Parkinson's,,66,89,,16S,"3,4",Illumina,T-Test,0.05,true,,,,,,decreased,,,,Complete,Fatima
"Experiment 1","Study 16","United States of America","Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"normal chow diet","high fat diet","Obesity is (BMI ≥ 30kg/m2)",5,5,,16S,"3,4",Illumina,LEfSe,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 9","United States of America","Homo sapiens",Breast,UBERON:0000310,"breast carcinoma",EFO:0000305,Control,"Breast Cancer","Not stated",668,72,,16S,"3,4,5",Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 3","United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,controls,"adenocarcinoma of colon and rectum patients","Not stated",89,42,,16S,"3,4",Roche454,"Logistic Regression",0.05,false,,"body mass index,sex","age,body mass index,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 5","United States of America","Homo sapiens",Lung,UBERON:0002048,"chronic obstructive pulmonary disease",EFO:0000341,controls,"Chronic obstructive pulmonary disease","Not stated",10,22,"2 months",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.1,true,,,age,,unchanged,,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 15",China,"Homo sapiens",Uterus,UBERON:0000995,"gestational diabetes",EFO:0004593,controls,"Gestational diabetes mellitus","GDM was diagnosed when the fasting plasma glucose ≥5.1 mmol/L or 1 h post-OGTT glycemia ≥10.0 mmol/L or 2 h post-OGTT glycemia ≥8.5 mmol/L, according to the criteria set by International Association of Diabetes and Pregnancy Study Groups (IADPSG)",10,10,"9 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,body mass index",,,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 17",China,"Homo sapiens",Feces,UBERON:0001988,"anxiety disorder",EFO:0006788,"healthy controls","treatment active Generalized Anxiety disorder","The active state of GAD was defined as a baseline Hamilton Anxiety Rating Scale HAMA score ≥14 upon admission to the hospital. The remissive state was defined as a HAMA score < 7 after 3 months of treatment.",36,40,"2 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,"age,body mass index,sex",,,unchanged,,unchanged,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 19",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls",Schizophrenia,"The patients were examined and diagnosed according to the ICD-10 by two trained psychiatric physicians.",53,64,"6 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 13",China,"Homo sapiens",Uterus,UBERON:0000995,"cervical glandular intraepithelial neoplasia",EFO:1000165,"Cervical Intraepithelial Neoplasis -1","Cervical Intraepithelial Neoplasis +2",,126,40,,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 6","United States of America","Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"mild/moderate fibrosis","advanced fibrosis","Based on clinical, magnetic resonance, histology assessment; Mild/Moderate NAFLD: fibrosis 0-2. Advanced NAFLD: fibrosis 3-4",72,14,,WMS,,Illumina,"Random Forest Analysis",0.05,true,,,"age,body mass index",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 8",Denmark,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,Control,"Diabetes Type 2","The diabetic group had elevated concentration of plasma glucose as determined by a fasting oral glucose tolerance test (OGTT)",10,10,,16S,4,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 196",China,"Homo sapiens",Feces,UBERON:0001988,"Henoch-Schoenlein purpura",EFO:1000965,controls,"Henoch-Schönlein Purpura","Henoch-Schönlein Purpura in children",70,85,,16S,"1,2",Illumina,LEfSe,0.05,false,3,"age,sex",,,decreased,,,,decreased,Complete,
"Experiment 1","Study 197","United States of America","Homo sapiens","Oral gland",UBERON:0010047,asthma,MONDO:0004979,non-asthma,"severe asthma","severe asthma",11,15,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 167",China,"Homo sapiens",Mouth,UBERON:0000165,"squamous cell carcinoma",EFO:0000707,"healthy controls","Stage 4","OSCC  confirmed by biopsy and pathological findings",51,90,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,increased,unchanged,unchanged,,,Complete,
"Experiment 1","Study 202",Spain,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"children with autism non-mental regression (ANMR)","children with autism mental regression (AMR)","Children between 2-6 years old with an agreed clinical diagnosis of autism per the ICD 10th Edition for ASD and DSM-5 who had development regression during the first two years of life.",30,18,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 213","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high fiber (Q3 and Q4)","low fiber (Q1 and Q2)","lower quartiles (Q1 and Q2) of fiber intake vs control (Q3 and Q4)",76,75,"no ""long term"" antibiotics use",16S,"3,4","Illumina,Roche454",DESeq2,0.05,true,,,"age,body height,body mass index,body weight,race,sex,smoking behavior",,,,,,,Complete,
"Experiment 1","Study 206",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"patients diagnosed with gastritis","patients diagnosed with gastric cancer","Patients with gastric cancer",16,11,,16S,"3,4",Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 126",China,"Homo sapiens",Saliva,UBERON:0001836,"Oral leukoplakia",HP:0002745,"healthy controls","Oral leukoplakia",,19,10,,16S,,Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,increased,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 185",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,controls,"gastric cancer","gastric cancer patients",22,20,"1 month",16S,,Illumina,T-Test,0.05,false,,,,,decreased,increased,unchanged,,increased,Complete,
"Experiment 1","Study 183",Australia,"Homo sapiens",Ileum,UBERON:0002116,"Crohn's disease",EFO:0000384,"crohn disease ASCA negative patients","crohn disease ASCA positive patients","Crohn disease anti-Saccharomyces cerevisiae antibody status",39,38,"3 months",16S,2,"Non-quantitative PCR","Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy controls","HIV infected patients","patients infected with HIV",35,33,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,3,"age,sex",,,decreased,,decreased,,decreased,Complete,Claregrieve1
"Experiment 1","Study 159",China,"Homo sapiens","Dental plaque",UBERON:0016482,"gingival disease",EFO:0009670,before,"1 month after the placement of the brackets","subgingial microbial changes during fixed appliance treatment",10,10,"1 month",16S,"3,4",Illumina,Metastats,0.05,false,,,,,unchanged,unchanged,unchanged,unchanged,unchanged,Complete,
"Experiment 1","Study 188","United Kingdom","Homo sapiens",Vagina,UBERON:0000996,"cervical cerclage",NCIT:C102763,"Vaginal microbiome of asymptomatic women prior to cerclage","Vaginal microbiome of symptomatic women prior ro cerclage",,13,7,,16S,"1,2",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,
"Experiment 1","Study 211","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high fiber (Q3 and Q4)","low fiber (Q1 and Q2)","lower quartiles (Q1 and Q2) of fiber intake vs control (Q3 and Q4)",38,37,"no ""long term"" antibiotics use",16S,"3,4",Roche454,DESeq2,0.05,true,,,"age,body height,body mass index,body weight,race,sex,smoking behavior",,unchanged,,,,,Complete,
"Experiment 1","Study 169",China,"Homo sapiens",Tongue,UBERON:0001723,"gastric cancer",MONDO:0001056,"other coatings","white-thin tongue coating GC patient","gastric cancer with different tongue coatings",90,25,"4 weeks",16S,"3,4,5",RT-qPCR,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 152",Finland,"Homo sapiens",Feces,UBERON:0001988,"cervical cancer",MONDO:0002974,"healthy controls","cervical cancer","pathology confirmed cervical cancer patients",5,8,"2 months",16S,4,Illumina,T-Test,0.05,false,,age,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 122","United States of America","Homo sapiens",Breast,UBERON:0000310,"breast carcinoma",EFO:0000305,"normal tissue","tumor tissue",,20,20,,16S,4,Illumina,T-Test,0.05,false,,,age,,,,,,unchanged,Complete,
"Experiment 1","Study 154",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","colorectal cancer","diagnosed only with colorectal cancer with endoscopy",14,9,"30 days",16S,6,Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,,,,Complete,
"Experiment 1","Study 212","United States of America","Homo sapiens",Feces,UBERON:0001988,Diet,EFO:0002755,"high fiber (Q3 and Q4)","low fiber (Q1 and Q2)","subjects in the lower quartiles (Q1 and Q2) of fiber intake",75,76,"no ""long term"" antibiotics use",16S,"3,4",Illumina,DESeq2,0.05,true,,,"age,body mass index,race,sex,smoking behavior",,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 201","United States of America","Homo sapiens",Feces,UBERON:0001988,leukemia,EFO:0000565,"repeat therapy",induction,"acute leukemia patients undergoing chemotherapy",7,13,,16S,4,Illumina,LEfSe,0.01,true,4,,,,unchanged,,,,,Complete,
"Experiment 1","Study 107","United States of America","Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,"healthy controls",anorexia,,12,16,"2 month",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.1,true,,"age,sex",,,,decreased,,,,Complete,
"Experiment 1","Study 200","United States of America","Homo sapiens","Lower part of vagina",UBERON:0015243,"endometrial cancer",MONDO:0011962,pre,post,"patients undergoing hysterectomy",,,"2 weeks",16S,"3,4,5",Illumina,"Linear Regression",0.1,true,,,"vaginal pH",,decreased,,,,,Complete,
"Experiment 1","Study 237",Germany,"Homo sapiens",Feces,UBERON:0001988,"chronic hepatitis C virus infection",EFO:0004220,"healthy controls","cirrhosis patients","heatitis C patients without cirrhosis",50,38,"3 months",16S,"1,2",Illumina,DESeq2,0.05,false,,,,decreased,decreased,,decreased,,,Complete,
"Experiment 1","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/male caucasian infant",392,36,,16S,,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,
"Experiment 1","Study 247","New Zealand","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"prebiotic (inulin-type fructan)",placebo,"placebo (control for prebiotic intake - representing lower fiber group)",34,33,"6 months",16S,"3,4",Illumina,ANOVA,0.05,false,,"age,body mass index,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 254","United States of America","Homo sapiens",Feces,UBERON:0001988,"nephrolithiasis,urolithiasis","EFO:0004253,MONDO:0024647","healthy control","kidney stone patient","kidney stone",6,23,"2 weeks",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 189",China,"Homo sapiens",Feces,UBERON:0001988,"chronic hepatitis B virus infection",EFO:0004239,"healthy controls","chronic hepatitis B patients","Chronic hepatitis B patients",22,85,"1 month",16S,"3,4",Illumina,LEfSe,0.01,false,2,"body mass index",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 135","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"low animal protein","High animal protein","high protein / low fiber",98,98,"6 months",16S,"1,2",Roche454,ANOVA,0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 102",Germany,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"normoglycemic controls","Women with gestational DM","Gestational Diabetes Mellitus  was diagnosed by a standardized oral glucose tolerance test (OGTT) after the 23rd week of the preceding pregnecy",35,42,"14 days",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 158",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,"healthy volunteers","lung cancer patients","lung cancer patients with a definite postoperative pathological diagnosis",41,41,"12 months",16S,"1,2",Illumina,Metastats,0.05,true,,"age,body mass index,sex",,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 103",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"Healthy Controls","depressed female",,24,24,yes,16S,"3,4,5",Roche454,LEfSe,0.05,false,,demographics,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 173",China,"Homo sapiens",Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"healthy controls","pancreatic cancer","diagnosed according to international guidelines by comprehensive consideration of clinical symptoms",57,85,"8 weeks",16S,"3,4,5",Illumina,LEfSe,0.05,false,,age,,,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 114",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,controls,MDD,,27,27,"6 months",16S,"3,4",Illumina,LEfSe,0.05,false,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 240",Canada,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy control","infant with food sensitization","infant with food sensitization",154,12,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,decreased,,,decreased,Complete,
"Experiment 1","Study 160",Australia,"Homo sapiens",Mouth,UBERON:0000165,"head and neck carcinoma",MONDO:0002038,"High-risk individuals","OCC & OPC","Newly diagnosed OCC(Oral Cavity Cancer) and OPC (Oropharyngeal Cancer)",11,31,,16S,"6,7,8",Illumina,Kruskall-Wallis,0.05,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 262","United States of America","Homo sapiens","nose,Bronchus","UBERON:0000004,UBERON:0002185","atopic asthma",EFO:0010638,"bronchial brush specimens","nasal brush speciments","nasal brush specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,decreased,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 113",Japan,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,controls,MDD,,57,43,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 245",China,"Homo sapiens",Feces,UBERON:0001988,"nephrolithiasis,urolithiasis","EFO:0004253,MONDO:0024647","healthy control","kidney stone group","kidney stones",13,13,"3 months",16S,4,Illumina,LEfSe,0.05,false,3,"age,race",,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 171",Japan,"Homo sapiens",Saliva,UBERON:0001836,"digestive system cancer",MONDO:0002516,controls,"digestive tract cancer patients","patients with digestive tract cancers (tongue/pharynx, esophagus, stomach and/or large intestine)",118,59,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,increased,increased,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 111",China,"Homo sapiens",Feces,UBERON:0001988,"attention deficit hyperactivity disorder",EFO:0003888,"healthy control",ADHD,,32,51,"2 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 191",Japan,"Homo sapiens",Feces,UBERON:0001988,equol,CHEBI:34741,"equol non-producers","equol producers","The equol production status was defined by a urinary log 10 - transformed equol/daidzein ratio of −1.75 or more as described previously",586,458,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,increased,,,,Complete,
"Experiment 1","Study 112",Germany,"Homo sapiens",Feces,UBERON:0001988,"attention deficit hyperactivity disorder",EFO:0003888,controls,"ADHD males",,17,14,,16S,"1,2",Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,,,,Complete,
"Experiment 1","Study 105","United States of America","Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"healthy controls",bipolar,,64,115,,16S,4,Illumina,"Logistic Regression",0.05,true,,,age,,,,,,,Complete,
"Experiment 1","Study 144",China,"Homo sapiens",Throat,UBERON:0000341,"air pollution",ENVO:02500037,"lightly poluuted region (A)","moderately polluted region (B)","paticipants lived in any of those regions for more than 2 years. region A: (lightly polluted region of PM 2.5), region B: (moderately polluted region of PM 2.5) and region C: (heavily polluted region of PM 2.5)",35,40,"3 months",16S,3,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,"vital capacity",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 162",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,"healthy control","lung cancer group","newly diagnosed lung cancer patients by histopathology and computed tomography",16,30,"1 month",16S,4,Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,decreased,,unchanged,Complete,
"Experiment 1","Study 265",Finland,"Homo sapiens",Mouth,UBERON:0000165,"human papilloma virus infection",EFO:0001668,"at birth","two months","HPV infection",13,22,,16S,4,Illumina,LEfSe,0.05,false,3,,,,unchanged,increased,,,increased,Complete,
"Experiment 1","Study 277",Spain,"Homo sapiens",Feces,UBERON:0001988,"Crohn's disease",EFO:0000384,"healthy control","crohn's disease","new-onset adult crohn's disease (CD) patients",16,13,"10 weeks",16S,"1,2,3",Illumina,Chi-Square,0.05,false,,"age,sex",,,decreased,,,,,Complete,Fatima
"Experiment 1","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,"non-current H.pylori infection","current H.pylori infection","patients with H.pylori infection (bacteria were histologically detected in any one of the biopsies or it was positively indicated by C-UBT)",23,24,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 242",China,"Homo sapiens","Dental plaque",UBERON:0016482,"Iron deficiency anemia",HP:0001891,"healthy control","iron deficiency anemia","patients with iron deficiency anemia",24,24,"2 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,sex",,,decreased,unchanged,decreased,,,Complete,
"Experiment 1","Study 151",China,"Homo sapiens",Feces,UBERON:0001988,"breast cancer",MONDO:0007254,controls,"Postmenopausal breast cancer patients","Postmenopausal breast cancer patients",46,44,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,increased,,,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 139","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"head and neck squamous cell carcinoma",EFO:0000181,controls,HNSCC,"histologically confirmed incident HNSCC including oral cavity, pharynx and larynx. (excluding salivary glands & nasopharynx)",254,129,,16S,"3,4",Roche454,DESeq2,0.1,true,,"age,ethnic group,sex","age,sex,smoking status",,,,,unchanged,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 109",Germany,"Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,"normal weight participants","anorexia patients before weight gain",,55,55,"8 weeks",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.15,true,,,"age,sex",,unchanged,unchanged,,,,Complete,Lwaldron
"Experiment 1","Study 231","United Kingdom","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"renatta canada apple - at 10 hr",cellulose,"poorly fermentable fiber (cellulose)",3,3,"3 months",16S,"3,4",Illumina,ANOVA,0.05,true,,,,,increased,increased,,,increased,Complete,
"Experiment 1","Study 187","United States of America","Homo sapiens",Vagina,UBERON:0000996,"medroxyprogesterone acetate",CHEBI:6716,"depot medroxyprogesterone acetate vaginal microbiome (visit 2) among black participants","naive black participants (baseline visit)","participants who had not yet been given the medroxyprogesterone acetate treatment at baseline",16,16,"before sample collection",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.2,true,,,,,,,,,,Complete,
"Experiment 1","Study 219","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"higher fiber (almonds) - interaction by time","lower fiber (cracker)","students eating crackers",35,38,,16S,"4,5",Illumina,ANCOM,0.05,true,,,,,decreased,decreased,unchanged,,decreased,Complete,
"Experiment 1","Study 145","United States of America","Homo sapiens",Saliva,UBERON:0001836,"oral squamous cell carcinoma",EFO:0000199,Controls,"oral squamous cell carcinoma (OSCC)","disgnosed oral squamous cell carcinoma via biopsy, age 18 years or older and immunocompetent",229,45,"3 months",,,"DNA-DNA Hybridization","Mann-Whitney (Wilcoxon)",0.001,true,,"age,sex,smoking behavior",,,,,,,,Complete,"Rimsha Azhar"
"Experiment 1","Study 259","United States of America","Homo sapiens","Skin of cheek",UBERON:0008803,"atopic eczema",EFO:0000274,"no emollient use","emollient use","infant randomized to emollient therapy",9,10,"during study",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,increased,,,increased,Complete,
"Experiment 1","Study 288",Italy,"Homo sapiens",Feces,UBERON:0001988,Phenylketonuria,MONDO:0009861,"mild hyperphenylalaninemic with unrestricted diet","phenylketonuric with Phe-restricted diet","phenylketonuric patients with restricted (phenylalanine-free) diets",21,21,"3 months",16S,"2,3",RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex",,,,,,,,Complete,
"Experiment 1","Study 275","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"healthy sibling control","ALL patient","before chemotherapy adminstration in pediatric and adolescent Acute Lymphoblastic Leukemia at time of disease diagnosis",23,28,,16S,"1,2,3",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 268",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"after loop electrosurgical excision procedure",before,"Cervical intraepithelial neoplasia 2/3 patients who underwent Loop electrosurgical excision procedure(LEEP)",26,26,"6 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,unchanged,increased,Complete,"Fatima Zohra"
"Experiment 1","Study 148",China,"Homo sapiens",Feces,UBERON:0001988,"polycystic ovary syndrome",EFO:0000660,HC,NIR-PCOS,"diagnosed if two of the following were present: olig-/amenorrhea, clinical and/or biochemical hyperandrogenish, or polycystic ovaries",8,8,"administration of antibiotics",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 165",China,"Homo sapiens",Feces,UBERON:0001988,"chronic kidney disease",EFO:0003884,"healthy controls","chronic kidney disease patients","individuals diagnosed with chronic kidney disease because they exhibited an effective glomerular filtration rate of <60mL/min for a 3 month period",22,50,"3 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 177",Sweden,"Homo sapiens",Mucosa,UBERON:0000344,"colorectal cancer",EFO:0005842,control,mucosa,"patients diagnosed with stage I-III colon cancer",14,12,recent,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,increased,Complete,
"Experiment 1","Study 234","Finland,Germany,United Kingdom","Homo sapiens","Skin of body",UBERON:0002097,"atopic eczema",EFO:0000274,"healthy control","adult with atopic dermatitis","adult with atopic dermatitis",115,82,"2 weeks",16S,,Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 296",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy control","multiple myeloma patients","newly diagnosed multiple myeloma patients",18,19,,16S,"1,2",RT-qPCR,DESeq2,0.05,true,,"age,sex",,,increased,,,,,Complete,Claregrieve1
"Experiment 1","Study 178",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,normal,"gastric cancer peritumor group","gastric cancer",60,61,"1 month",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,decreased,,decreased,,decreased,Complete,
"Experiment 1","Study 264",Nigeria,"Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,HPV-/HIV-,HPV+/HIV-,"HR-HPV+ confirmed by medical records and HPV genotyping test",99,12,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"Multiple sclerosis",MONDO:0005301,"healthy controls","multiple sclerosis","multiple sclerosis patients",43,60,"6 months",16S,4,Illumina,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 301","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV infection through PCR confirmation",9,9,"6 months",16S,"2,3",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 306",Italy,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"pre- allogeneic hematopoietic stem cell transplant","post- allogeneic hematopoietic stem cell transplant","children between 3 and 10 years of age that has undergone allogeneic hematopoeitic stem cell transplantation and hospitalized at Institute for Maternal and Child Health of Trieste",5,5,,16S,"1,2,3","Ion Torrent",T-Test,,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 270",Italy,"Homo sapiens","Vaginal fluid",UBERON:0036243,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+  determined through HR-HC2 assay",17,55,"3 days",16S,"3,4,5",Roche454,LEfSe,0.05,false,2,age,,,unchanged,unchanged,,,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 172","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Cannabis use",EFO:0007585,"controls (lateral border of tongue)","marijuana usage group","using marijuana on 20 or more days in the past month associated with a distinct oral microbiota at the most common sites of HNSCC, the lateral border of the tongue",19,20,"1 month",16S,"1,2,3",Illumina,LEfSe,,false,,"age,sex",,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 208",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy controls","infants with food allergies","infant with food allergy",45,34,"1 month",16S,"1,2,3",Roche454,Metastats,0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 182",Japan,"Homo sapiens",Mouth,UBERON:0000165,acetaldehyde,CHEBI:15343,"low acetaldehyde concentration group","high acetaldehyde concentration group","The Sensor Gas Chromatograph SGEA-P2 (FIS Inc., Itami, Japan) was used to measure acetaldehyde concentrations in mouth air.",6,6,"current use",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 285","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,"healthy controls","pediatric multiple sclerosis","early pediatric multiple sclerosis",16,18,"2 months",16S,4,Illumina,,0.05,true,,,,,,,,,unchanged,Complete,
"Experiment 1","Study 282",China,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"Grades 0-I (non-acute graft-host disease)","Grades II-IV (acute graft-host-disease)","patients diagnoised with acute graft-versus-host disease (aGVHD)",49,32,,16S,4,Illumina,LEfSe,0.05,false,,,,,decreased,,,decreased,decreased,Complete,
"Experiment 1","Study 294","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,baseline,"post-induction therapy","6 weeks of remission induction therapy",112,97,,16S,"1,2,3",Illumina,,0.05,true,,,,,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 261",Japan,"Homo sapiens",Feces,UBERON:0001988,"Chronic pancreatitis",EFO:0000342,"chronic pancreatitis","autoimmune pancreatitis type 1","autoimmune pancreatitis type 1",8,12,,16S,"4,5",Illumina,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 314","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"CIN regression","CIN non-regression","histology proven CIN2, no regression after 12 months",42,45,,16S,"1,2",Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"premature birth",EFO:0003917,"2-day old Full-term infants(born after uncomplicated pregnancy)","2-day old Pre-term","born at gestational ages between 24 and 32 weeks",13,27,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 207",China,"Homo sapiens",Vagina,UBERON:0000996,vulvovaginitis,EFO:1001240,"Normal controls","Women with BV","BV assessment with a gram-stain score => 7",30,10,"1 month",16S,6,Illumina,LEfSe,0.05,false,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 1","Study 147",China,"Homo sapiens",Throat,UBERON:0000341,"squamous cell carcinoma",EFO:0000707,controls,"laryngeal squamous cell carcinoma (LSCC)","histopathological confirmation of Laryngeal squamous cell carcinoma and underwent total laryngectomy",28,27,"3 months",16S,"1,2",Roche454,T-Test,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ determined by the Linear Array HPV Genotyping Tests",20,31,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 215",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control infants","infants with eczema","infants with eczema",51,50,,16S,"3,4",Roche454,Metastats,1.0e-5,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 299",Denmark,"Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"no induction chemotherapy","induction chemotherapy","children (ages 1-18 years old) newly diagnosed with Acute Lymphoblastic Leukemia and undergoing induction chemotherapy according to the Nordic Society of Paediatric Haematology and Oncology (NOPHO)",19,51,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,,Complete,
"Experiment 1","Study 278",Canada,"Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"healthy control","non alcoholic fatty liver disease","biopsy proved steatosis and non alcoholic steatohepatitis",28,39,"6 monts",16S,,RT-qPCR,Metastats,0.05,true,,,,,,,unchanged,,,Complete,
"Experiment 1","Study 31","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,controls,"CFS/ME patients","Cases met the 1994 CDC Fukuda and the 2003 Canadian consensus criteria for ME/CFS",50,50,"3 months for controls only",WMS,,Illumina,LEfSe,0.2,true,2,"age,ethnic group,geographic area,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 266",Thailand,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"healthy non-vegetarian","healthy vegetarian","healthy vegetarians",36,36,"1 month",16S,"6,7,8",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 127",Norway,"Homo sapiens",Feces,UBERON:0001988,"alcohol drinking",EFO:0004329,controls,"alcohol overconsumers","subjects with ongoing or recent history of alcohol overconsumption of more than 20 or 40 g of alcohol per day",18,24,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 291",China,"Homo sapiens",Feces,UBERON:0001988,"Graves disease",EFO:0004237,"healthy controls","graves disease","graves' disease patients",11,27,"2 months",16S,"3,4",Illumina,T-Test,0.05,false,,age,,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 1","Study 203",China,"Homo sapiens",Feces,UBERON:0001988,Syncope,HP:0001279,"healthy children","children with vasovagal syncope",,20,20,"8 weeks",16S,4,Illumina,LEfSe,0.05,false,4,"age,sex",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 305","United States of America","Homo sapiens",Vagina,UBERON:0000996,"Genital neoplasm, female",EFO:1001331,"healthy controls","women with gynecological cancer","postmenopausal women (naturally or due to hysterectomy) with endometrial or cervical cancer treated with radiotherapy with or without surgery and/or chemotherapy",69,65,"course of the study",16S,4,Illumina,LEfSe,0.05,true,3,,,unchanged,increased,increased,,,increased,Complete,Claregrieve1
"Experiment 1","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","Postnatal antibiotic group (2-day old infant)","Term, vaginally delivered infants",47,29,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 309","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,CIN1,CIN2+,"patients with CIN2+ confirmed by colposcopy",90,340,,16S,4,Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 251","United States of America","Mus musculus",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"healthy control","cows milk allergy","cows milk allergy",8,9,,16S,4,Illumina,LEfSe,0.05,false,2,"age,sex",,unchanged,unchanged,,,,,Complete,
"Experiment 1","Study 29",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"Healthy Controls","Active Major Depressive Disorder","The A-MDD group was defined as having an HAMDS score P20. The patients in the R-MDD group were defined as those with a baseline HAMDS scores P20 upon admission to the hospi- tal.",30,29,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,2,,,,increased,,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 210",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy controls","children with food sensitization","child with food sensitization",22,23,"1 week",16S,"3,4,5",Roche454,T-Test,0.01,false,2,age,,,decreased,decreased,,,decreased,Complete,
"Experiment 1","Study 302","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,asthma,MONDO:0004979,"healthy control","exacerbated asthma","physician-diagnosed current asthma presenting with an encounter diagnosis of asthma exacerbation",21,20,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 1","Study 204",Canada,"Homo sapiens",Vagina,UBERON:0000996,"premature birth",EFO:0003917,"mothers whose newborns were delivered at ≥37 getastional weeks","mothers whose newborns were delivered at <34 gestational week",,365,17,,16S,4,Illumina,NLMIXED,0.05,true,,,"body mass index,ethnic group,maternal age,parity,smoking behavior",,,,,,,Complete,
"Experiment 1","Study 304",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"or placebo (microcrystalline cellulose)","oral intake of vancomycin (directed against Gram-positive bacteria)","low-active (<3 hr organized sports activities per week), weight-stable (<2 kg body weight change 3 months prior to inclusion) overweight/obese (BMI 25–35 kg/m2) Caucasian men, between 35 and 70 years with impaired glucose metabolism (either fasting glucose >5.6 mmol/l, and/or 2 hr glucose between 7.8–11 mmol/l) and insulin resistant (homeostasis model assessment for insulin resistance; HOMA-IR > 2.2).",37,38,"3 months",16S,,"Human Intestinal Tract Chip","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,decreased,,Complete,"Rimsha Azhar"
"Experiment 1","Study 303",France,"Homo sapiens",Feces,UBERON:0001988,"non-Hodgkins lymphoma",EFO:0005952,pre-chemotherapy,post-chemotherapy,"non-Hodgkin's lymphoma patients post myeloablative conditiong regimen (chemotherapy) fecal sampling for 5 consecutive days of high-dose Carmustine, Etoposide, Aracytine and Melphalan and with no antibiotics treatment after starting regimen",28,15,"1 month",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 100","Russian Federation","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low BMI","High BMI",,69,23,"3 months",16S,"3,4",Illumina,"Linear Regression",0.05,true,,,"age,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 146",China,"Homo sapiens",Saliva,UBERON:0001836,"oral squamous cell carcinoma",EFO:0000199,Controls,"oral squamous cell carcinoma (OSCC)","subjects with oral squamous cell carcinoma and did not have detectable periodontal inflammation, visible carious lesions, oral mucosa disease or any sever systemic disorders such as diabetes, immune compromise or genetic diseases",40,40,"2 weeks",16S,"4,5",Illumina,LEfSe,0.05,false,,,,,increased,unchanged,unchanged,,,Complete,"Rimsha Azhar"
"Experiment 1","Study 283","United States of America","Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ confirmed using Roche Linear Array HPV Genotyping Test",13,26,"30 days",16S,"1,2,3",Roche454,LEfSe,0.05,true,2,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"children who did not experience asthma exacerbation","Children who experienced exacerbation","children who experienced exacerbation of their asthma (physician-prescribed use of systemic corticosteroids for asthma symptoms, hospitalization for asthma, or both)",346,67,,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,age,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 198",China,"Homo sapiens",Mouth,UBERON:0000165,"Henoch-Schoenlein purpura",EFO:1000965,controls,"Henoch-Schönlein Purpura","Henoch-Schönlein Purpura in children",66,98,"4 weeks",16S,"1,2",Illumina,LEfSe,0.05,false,3.5,"age,sex",,,increased,,,,increased,Complete,
"Experiment 1","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,age,EFO:0000246,"2-12 years","18-62 years","adult age 18-62",13,45,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 1","Study 330",Finland,"Homo sapiens",Placenta,UBERON:0001987,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ placenta sample determined by PCR and genotyped with Multimetrix",26,13,,16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 295",China,"Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,"negative control","low risk HPV","LR-HPV+ according to results of screening",20,42,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,increased,,increased,,,Complete,"Fatima Zohra"
"Experiment 1","Study 327",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control(no treatment)","infants received short-term(<3days) antibiotic treatment","infants born between 32-42 weeks of gestation and admitted to the hospital level III neonatal intesive care or level II neonatal ward",28,22,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,,unchanged,,,,Complete,
"Experiment 1","Study 205",China,"Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,"HPV negative women","HPV positive women","women positive for HPV infection",38,32,"1 month",16S,"2,3",,Chi-Square,0.05,false,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 1","Study 170",China,"Homo sapiens",Lung,UBERON:0002048,"lung cancer",MONDO:0008903,controls,"cancerous site","diagnosis of lung cancer established by histological confirmation",18,24,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,decreased,,decreased,,,Complete,
"Experiment 1","Study 84",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean controls","after surgery","Roux-en-Y gastric-bypass operation were recruited according to the S3 guidelines of the German Society for Obesity",6,,"3 weeks",WMS,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 396","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"Atopic eczema",EFO:0000274,"healthy control","atopic dermatitis","child between the age of 3 months-5 years with moderate to severe atopic dermatitis defined as an investigator’s global assessment (IGA) score of 3 or 4 (0–4 scale)",11,21,"2 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 133",Japan,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Equol producer (""healhtier"" diet)","Equol NON producer (""unhealthier"" diet)","cross sectional",45,13,,16S,3,Illumina,"Linear Regression",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 360","United States of America","Mus musculus","Small intestine",UBERON:0002108,"air pollution",ENVO:02500037,"mice exposed to Filtered Air","mice exposed to MVE","male ApoE−/- mice exposed to  mixed diesel and gasoline engine emissions (MVE) or Wood Smoke (WS)",20,20,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,decreased,,,decreased,Complete,
"Experiment 1","Study 96",Japan,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,obese,,10,10,,16S,"3,4",Illumina,T-Test,0.05,false,,,,,decreased,,,,,Complete,Fatima
"Experiment 1","Study 405",Denmark,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma at 5 years old","child with asthma at 5 years old","child with physician diagnosed asthma based on verified diary recordings of five episodes of troublesome lung symptoms within 6 months, exercise-induced symptoms, prolonged nocturnal cough, and/or persistent cough outside of common colds, need for intermittent rescue use of inhaled β2-agonist, response to a 3-month course of inhaled corticosteroids andrelapse upon ending treatment",531,58,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 80",Mexico,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,controls,"Type I diabetic children at onset","T1D diagnose as established according to the American Diabetes Association criteria1, a positive anti-GAD and/or anti-IA-2 auto- antibodies result, HbA1C levels , 8%",8,8,"3 months",16S,4,Roche454,ANOVA,0.05,false,,,,,,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 85",Gabon,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery","two-day aged babies c-section",,7,8,,16S,3,Roche454,"Linear Regression",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 321","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"10 d old 2 day treatment infants","10 d old 7-10 day treatment infants","born at gestational ages less than 32 weeks",15,12,,16S,"1,2,3",Roche454,,,false,,,"delivery procedure",,decreased,,,,unchanged,Complete,
"Experiment 1","Study 287","Costa Rica","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"HPV (clearance)","Visit 1 HPV (progression)","HPV progression to CIN2+ lesion diagnosis",70,33,,16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 91",China,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,"the first-pass meconium stools from within 24 h of delivery",8,10,"None of VD mothers received antibiotics during delivery. CSD mothers recieved prophylactic antibiotics after delivery.",WMS,,Illumina,LEfSe,0.05,false,3.5,,,,unchanged,,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 326",France,"Homo sapiens",Feces,UBERON:0001988,"non-small cell lung carcinoma,renal cell carcinoma","EFO:0003060,EFO:0000681",Non-Responders,Responders,"non-small cell lung carcinoma or renal carcinoma patients (all samples regardless of ampicillin, colistin, and streptomycin (ATB) anitbiotic treatment) that have been treated with PD-1 blockage with partial response or stable disease",36,42,,WMS,,"Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 372",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice exposed to FRA","Diesel exhaust particle (DEP) exposed mice","mice exposed to Diesel exhaust particles (DEP)",30,37,,16S,"3,4",Illumina,LEfSe,0.05,true,4,,,,,,,,,Complete,
"Experiment 1","Study 284",China,"Homo sapiens",Gingiva,UBERON:0001828,"chronic kidney disease",EFO:0003884,"healthy controls","Chronic kidney disease","chronic kidney disease patients undergoing hemodialysis",30,30,"30 days",16S,"3,4",Illumina,Metastats,0.05,false,,"age,sex,smoking behavior",,,decreased,decreased,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 289",China,"Homo sapiens",Feces,UBERON:0001988,"health trait",EFO:0007652,"healthy controls","suboptimal health status","subjects with SHSQ-25 (SHS score >= 35)",50,50,"2 months",16S,4,Illumina,LEfSe,0.05,false,2,"age,body mass index,sex",,,increased,unchanged,increased,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 78","United States of America","Rattus norvegicus",Feces,UBERON:0001988,"stimulus or stress design",EFO:0001762,controls,"limited nesting stress","pups exposed to limited nesting stress",23,23,,16S,4,Illumina,DESeq2,0.05,true,,,sex,,decreased,decreased,,,,Complete,Claregrieve1
"Experiment 1","Study 393",Spain,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"infant with non-IgE-mediated cow's milk allergy non-tolerant to cow's milk protein","infant with non-IgE-mediated cow's milk allergy tolerant to cow's milk protein","infant with non-IgE mediated cow's milk allergy tolerant to cow's milk after a period of six months dairy-free diet",3,14,"4 weeks",16S,"3,4",Illumina,Metastats,0.05,true,,age,,,,,,,,Complete,
"Experiment 1","Study 411","United States of America","Homo sapiens",Rectum,UBERON:0001052,"HIV/AIDS pre-exposure prophylaxis",GSSO:001787,"HIV-negative MSM not on PrEP","HIV-negative MSM on PrEP","HIV-negative Men who have sex with men (MSM) on HIV pre-exposure prophylaxis (PrEP)",37,37,,16S,4,Illumina,,0.1,true,,"age,anal intercourse,ethnic group,marijuana,nicotine dependence,obesity,race",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 415","United States of America","Homo sapiens",Saliva,UBERON:0001836,"HIV infection",EFO:0000764,"Age-matched HIV-uninfected women","HIV-positive women who have been taking ART for more than 1 year","HIV-positive women who have been taking antiretroviral therapy (ART) for more than 1 year",3,3,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,,Complete,
"Experiment 1","Study 66",China,"Homo sapiens",Meconium,UBERON:0007109,"neonatal jaundice",EFO:1000739,control,"cesarean infants with jaundice",,160,141,"among all the participants,11 mothers used antibiotics during pregnancy and 4 infants used antibiotics after birth.",16S,3,Illumina,LEfSe,0.05,false,2.5,,"birth weight,gestational age,maternal age,sex,smoking behavior",,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 354",Sweden,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control (BMI at normal range)",overweight/obese,"pre-school children",20,20,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,unchanged,,,Complete,
"Experiment 1","Study 52",China,"Homo sapiens",Feces,UBERON:0001988,"substance-related disorder",MONDO:0002494,"Healthy controls","Substance use disorder patients",,45,48,"3 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,,unchanged,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 153",China,"Homo sapiens","Prostate gland secretion",UBERON:0004796,"prostate cancer",MONDO:0008315,controls,"prostate cancer","Prostate cancer",27,32,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,increased,,unchanged,Complete,
"Experiment 1","Study 83",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"after surgery","before surgery","Roux-en-Y gastric-bypass operation were recruited according to the S3 guidelines of the German Society for Obesity",6,6,"3 weeks",WMS,,Illumina,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 392",Italy,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"healthy controls","non-IgE mediated cow's milk allergy","diagnosis of non-IgE mediated cow's milk allergy based on clinical history, negative result of skin prick test, and/or negative level of IgE serum-specific anti-cow's milk proteins",23,23,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 315",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Infants to mothers didn't receive IAP","Infants to mothers received IAP","Full-term (gestational ages >37 weeks) vaginally delivered infants born after an uncomplicated pregnancy",22,18,"During pregnancy or postnatal period (Mothers); during the study period (infants)",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 134",Denmark,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"before Average Danish Diet","6 months after Average Danish Diet","the dietary intervention study of the NND compared to the ADD was performed as a 6-month, nonblinded, parallel, randomized, controlled, ad libitum dietary intervention trial and was carried out between October 2010 and July 2011.",26,26,,16S,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 324",China,"Homo sapiens",Feces,UBERON:0001988,"thyroid carcinoma",EFO:0002892,"healthy controls","patients with thyroid carcinoma","at least one solid lesion identified by thyroid ultrasonagraphy",35,30,,16S,"3,4",Illumina,LEfSe,0.05,true,3,"age,body mass index,sex",,,increased,increased,,,increased,Complete,Claregrieve1
"Experiment 1","Study 350",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"children aged 7-10 years old",7,10,"3 months",16S,4,Illumina,LEfSe,0.05,false,1,"age,sex",,,unchanged,,,,increased,Complete,
"Experiment 1","Study 137",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,controls,CRC,"CRC positive during colonoscopy",104,62,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.01,false,,,,,,,,,increased,Complete,
"Experiment 1","Study 76",China,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,controls,"type I diabetes mellitus children","type 1 diabetes mellitus",15,15,"3 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,breastfeeding duration,delivery procedure,race,sex",,,unchanged,decreased,,,decreased,Complete,"Rimsha Azhar"
"Experiment 1","Study 42",China,"Homo sapiens",Feces,UBERON:0001988,"extrahepatic cholestasis",EFO:1000933,"healthy infants","cholestasis infants",,37,43,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 70",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"pediatric normal weight","pediatric obese","Obesity was defined as body mass index (BMI) ≥95th percentile, whereas NW was de- fined as BMI between the 15th and 75th percentiles for age and gender based on Centers for Disease Control and Prevention (CDC) reference data",67,71,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 412","United States of America","Homo sapiens",Rectum,UBERON:0001052,"HIV infection,methamphetamine dependence","EFO:0000764,EFO:0004701","HIV-positive non-MA users","HIV-positive MA users","HIV-positive Men who have sex with men (MSM) who self-reported methamphetamine (MA) use in the past six months",81,101,,16S,4,Illumina,,0.1,true,,,"age,alcohol drinking,cannabis use,ethnic group,smoking behavior",,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 343","United States of America","Homo sapiens",Feces,UBERON:0001988,leukemia,EFO:0000565,"Allogeneic Hematopoeitic Stem Cell Transplant",Antileukemic,"Intensive chemotherapy (involving induction and re-induction.salvage) was defined as any regimen requiring a planned hospitalization of approximately 4 weeks. patients can not be enrolled twice in the same study with exception of 3 patients that went into allogeneic hematopoeitic stem cell transplant study",20,20,,16S,4,Illumina,LEfSe,0.01,true,4,,,,unchanged,,,,,Complete,
"Experiment 1","Study 408",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"healthy controls","asthma at 3 months","physician diagnosis of asthma by 4 years of age or was prescribed inhaled asthma medications (inhaled corticosteroids or bronchodilators) from 3 to 4 years of age",37,39,,16S,3,Illumina,DESeq2,0.05,true,,"antibiotic exposure,feeding practices,sex",,,unchanged,,,,,Complete,
"Experiment 1","Study 391",China,"Homo sapiens",Feces,UBERON:0001988,"neuromyelitis optica",EFO:0004256,"healthy controls","neuromyelitis optica spectrum disorder","Each patient met the 2015 international diagnostic criteria for NMOSD and tested positive for serum AQP4-IgG using cell-based assays",20,20,"currently taking antibiotics",16S,"3,4",Illumina,LEfSe,0.05,true,3,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 395","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic kidney disease,stage 5 chronic kidney disease","EFO:0003884,EFO:0009909","healthy controls","peritoneal dialysis","4 groups of pediatric patients (age 2-18), hemodialysis, peritoneal dialysis, kidney transplant, healthy controls",13,8,"1 month",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,age,,,,decreased,,,decreased,Complete,
"Experiment 1","Study 417","United States of America","Homo sapiens",Feces,UBERON:0001988,"diabetes mellitus,HIV infection","EFO:0000400,EFO:0000764","Women without diabetes","Women with diabetes","Women with or at high risk for HIV infection who have diabetes",26,22,,16S,4,Illumina,"Linear Regression",0.1,true,,,"HIV infection,age",,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 51",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"postoperation patients","Carcinoma patients","The adenoma and carcinoma patients were diagnosed by colonoscopic examination and histopathological review of biopsies. Postoperative patients were classified as having NDA or CIT by follow-up surveillance colonoscopy and biopsies",47,15,"3 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.1,true,,"age,body mass index,sex",,,,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 369","Cyprus,Estonia,Germany,Hungary,Sweden","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"children aged 2-9 years",34,36,"14 days",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,unchanged,Complete,
"Experiment 1","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m2",211,142,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,unchanged,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 374","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"Cervical glandular intraepithelial neoplasia",EFO:1000165,"normal controls","cervical intraepithelial neoplasia cases","women with histology proven CIN2/3",18,17,,WMS,,Illumina,LEfSe,0.05,true,2.5,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0-3 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,T-Test,0.05,false,,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 1","Study 385",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric adenocarcinoma",EFO:0000503,"superficial gastritis (SG)","gastric adenocarcinoma (GC)","SG patients with mild to moderate epigastric discomfort. The disgnosis of malignancy was based on patological analysis of tissue biopsies",5,6,"6 months",WMS,,Illumina,LEfSe,0.05,true,2,"age,body mass index,sex",,,unchanged,,,,decreased,Complete,
"Experiment 1","Study 176",Malaysia,"Homo sapiens",Caecum,UBERON:0001153,leukemia,EFO:0000565,controls,"survivors of acute lymphoblastic leukemia","adult surviors of childhood leukemia",61,73,,16S,4,Illumina,LEfSe,0.05,true,4,,,,,decreased,,,,Complete,
"Experiment 1","Study 92","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"healthy controls","obese without non-alcoholic fatty liver disease","clinical diagnosis of NAFLD based on ultrasound findings and elevated transaminases.  BMI for obese children with and without clinical NAFLD were greater than the 95% for age",26,11,"6 months",16S,,"Ion Torrent",ANOVA,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 49",China,"Homo sapiens","Oral gland",UBERON:0010047,obesity,EFO:0001073,controls,"Obesity group","obesity group (BMI ≥30)",29,33,"3 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,decreased,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group before procedure","women with suspected high grade cervical dysplasia planning for their first Loop Electrosurgical Excision Procedure",100,89,"long-term antibiotic use",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 186",China,"Homo sapiens","Prostate gland secretion",UBERON:0004796,"prostate cancer",MONDO:0008315,"non prostrate cancer","prostrate cancer","pathology after prostate biopsy",27,32,"4 week",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,increased,,,Complete,
"Experiment 1","Study 60",China,"Homo sapiens",Blood,UBERON:0000178,"type II diabetes mellitus",MONDO:0005148,controls,"Type-2 DM cases",,100,50,"2 months",16S,"5,6",Illumina,T-Test,0.05,false,,"age,sex","blood pressure,body mass index,smoking behavior,total cholesterol measurement",,unchanged,unchanged,unchanged,,,Complete,Fatima
"Experiment 1","Study 399","United States of America","Homo sapiens",Saliva,UBERON:0001836,age,EFO:0000246,"healthy aging (HA)","non-healthy aging (NHA)","participants aged 70–82 who had a medical history linked to one or more of the following major disease categories: cancer, acute or chronic cardiovascular disease, acute or chronic pulmonary disease, chronic liver disease, diabetes and diabetic complications, and stroke or neurodegenerative disorder.",33,32,"6 weeks",16S,"1,2,3",Illumina,DESeq2,0.05,true,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 257",Morocco,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy control","colorectal cancer","colorectal cancer",12,11,"3 months",16S,"1,2",Illumina,Kruskall-Wallis,0.05,true,,"age,diet,region","body mass index,family history of cancer,sex",,,,,,unchanged,Complete,
"Experiment 1","Study 348",Brazil,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean children","obese children","Healthy children with obesity based on z-score of >+2",30,30,"3 months",16S,,RT-qPCR,Kruskall-Wallis,0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 419",Denmark,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,baseline,"combination antiretroviral therapy treated individuals after taking LGG probiotic for 8 weeks","Persons with HIV",27,27,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 1","Study 72",China,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"typically developing controls",autism,"diagnosed with autistic spectrum disorder according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders-5th Edition)",6,35,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 340","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"non-overweight/non-obese children",obese/overweight,"Children who participated in the VDAART clinical trial-a a two arm, double-blind, placebo controlled, randomized, clinical trial of vitamin D supplementation in the pregnant mother to prevent asthma and allergy in childhood in three clinical centers across the United States",356,146,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 380","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"patients post allogenic hematopoietic cell transplant/pre Fecal Microbiota Transplant","patients preallogenic hematopoietic cell transplant","patients who received Fecal Microbiome Transplant",5,13,"48 hours",16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,"HLA match,acute graft vs. host disease,age,transplant conditioning",,,,,increased,,Complete,"Rimsha Azhar"
"Experiment 1","Study 260","Estonia,Sweden","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,nonallergic,allergic,"child with allergy",35,27,,,,,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 357",China,"Homo sapiens",Mucosa,UBERON:0000344,"air pollution",ENVO:02500037,"pre-smog swabs","post-smog swabs","Vendors in an open-air farer's market who worked in the same place and were exposed to smog over the same business hours",83,83,,16S,"3,4",Illumina,LEfSe,0.001,true,4,,,,unchanged,increased,unchanged,,increased,Complete,
"Experiment 1","Study 56","United States of America","Homo sapiens",Meconium,UBERON:0007109,"type II diabetes mellitus",MONDO:0005148,"adult stool","Healthy baby meconium",,9,13,"9 months",16S,"3,4","PacBio RS","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 77","United States of America","Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"non users","atypical antipsychotic users","Medication group was defined by the use of an Atypical Antipsychotics at the time of fecal sample collection",68,49,,16S,4,Illumina,"Linear Regression",0.05,false,,,"age,body mass index,sex",,,,,decreased,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 28","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,"Healthy controls","CFS cases","Subjects with ME/CFS were established patients of a ME/ CFS specialist, Susan Levine, M.D. and fit the Fukuda diag- nostic criteria",39,48,,16S,4,Illumina,LEfSe,0.05,true,2,,,,decreased,decreased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 156",China,"Homo sapiens",Feces,UBERON:0001988,"gastric adenocarcinoma",EFO:0000503,"healthy controls","Gastric cancer","gastric carcinoma confirmed by pathological examination",88,116,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 313",France,"Homo sapiens",Feces,UBERON:0001988,"non-Hodgkins lymphoma",EFO:0005952,"non-bloodstream infection","bloodstream infection","participants had blood stream infection, diagnosis with non-Hodgkins lymphoma (NHL), undergone hematopoeitic stem cell transplant and chemotherapy that did not had a history of inflammatory bowel disease, no exposure to probiotics, prebiotics or broad-soectrium antibiotics, no administered nasal-tube feeding or parenteral nutrition in a month prior to initiation of the study",17,11,,16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.15,true,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 359","United States of America","Homo sapiens",Mouth,UBERON:0000165,"Smoking behavior",EFO:0004318,"former smoker","current smoker","participants who developed head and neck or pancreatic cancer at any point after collection of the oral wash samples",521,112,,16S,"3,4",Roche454,Kruskall-Wallis,0.05,true,,"age,sex",,,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 98","United States of America","Homo sapiens",Blood,UBERON:0000178,"chronic kidney disease",EFO:0003884,controls,CKD,,20,20,"current use",16S,"3,4",Illumina,LEfSe,0.05,true,,age,"age,body mass index,hyperlipidemia,hypertension,immunosuppressant use measurement,leukocyte",,,decreased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 377","United States of America","Homo sapiens",Mouth,UBERON:0000165,"smoking behavior",EFO:0004318,"E-cigarette smoker","never smoker","participants who were 21 years or older, healthy, diagnosed with periodontal disease, and current smokers, non-smokers, or e-cigarette users",39,40,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,increased,Complete,
"Experiment 1","Study 53","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,"healthy controls","chronic fatigue syndrome patients","patients met the ME/CFS case definition criteria established by Fukuda et al in 1994",10,10,"current use",16S,,Roche454,"Kolmogorov-Smirnov Test",0.05,false,,"age,body mass index,sex",,,,,,,,Complete,Fatima
"Experiment 1","Study 401",China,"Homo sapiens",Throat,UBERON:0000341,asthma,MONDO:0004979,"healthy control",asthma,"child age 3-5 diagnosed as ever having asthma with the occurrence of recurrent wheeze in the last 12 months, or current use of asthma medication",32,32,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 379","United States of America","Homo sapiens",Mouth,UBERON:0000165,obesity,EFO:0001073,obese,non-obese,"participants who were selected for four nested case-control studies to investigate the oral microbiome and those diagnosed after mouth rinse sample colection with type 2 diabetes, lung cancer, upper aero-digestive tract cancer, and colorectal cancer",647,969,"1 year",16S,4,Illumina,"Logistic Regression",0.05,true,,"age,race,sex,smoking behavior","age,race,sex,smoking behavior",,unchanged,,unchanged,,unchanged,Complete,
"Experiment 1","Study 312",Italy,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants born by mothers negative to GBS","Infants born by mothers positive to GBS and received IAP","Infants of Mothers positive to Streptococcus (GBS) and received intrapartum antibiotic prophylaxis (IAP)",10,10,"perinatal antibiotics",16S,"2,3,4,5,6,7,8,9","Ion Torrent",ANOVA,0.05,false,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 238","United States of America","Homo sapiens",Feces,UBERON:0001988,"cervical cancer",MONDO:0002974,"healthy controls","cervical cancer patient","patients with biopsy-proven carcinoma of the cervix",46,42,"1 month- controls only",16S,4,Illumina,LEfSe,0.05,false,3,,,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 47","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"high dietary fiber",low,"BMI ≥ 30.0 kg/m2 was considered obese",68,68,"2-3 months",16S,4,Illumina,LEfSe,0.05,false,,,,,,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 422",India,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"uninfected age-matched controls","Perinatally HIV-infected children","Perinatally HIV-infected children",14,29,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,2.5,age,,,decreased,,decreased,,,Complete,
"Experiment 1","Study 410",Nigeria,"Homo sapiens",Rectum,UBERON:0001052,"HIV infection",EFO:0000764,"HIV-uninfected MSM","ART-treated HIV infected MSM","Men who have sex with men (MSM) with HIV that has been treated with antiretroviral therapy (ART)",55,34,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"normal tissues","peritumoral tissues","gastric cancer",230,247,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,decreased,decreased,decreased,,decreased,Complete,Claregrieve1
"Experiment 1","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic free group (postnatal day 3)","combination of penicillin and moxalactam group (postnatal day 3)","pre-term neonates given a treatment regimen of penicillin (10U kg-1, twice a day) combined with moxalactam (40 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,unchanged,,,,,Complete,Chloe
"Experiment 1","Study 341",Australia,"Homo sapiens","Small intestine",UBERON:0002108,"nicotine dependence",EFO:0003768,"never smoked","patients with FD, ID,or CD who currently smoked","patient with FD,ID or CD with who previously or currently smokes",41,61,"2 months",16S,"6,7,8",Illumina,Kruskall-Wallis,0.05,true,,,,,,unchanged,,,,Complete,
"Experiment 1","Study 323","United States of America","Homo sapiens","feces,Mucosa of small intestine","UBERON:0001988,UBERON:0001204","necrotizing enterocolitis",EFO:0003928,non-NEC,NEC,"infants who underwent intestinal resection at <180 days of age",14,10,,16S,"1,2,3",Roche454,DESeq2,0.1,true,,,,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 1","Study 54",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,placenta,meconium,,15,15,"prior to or during c-section",16S,"1,2,3",Roche454,LEfSe,0.05,true,3,,,,increased,decreased,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 345",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,normal,obese,"unrelated children between 9 and 11 years",10,10,,WMS,,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 418",Spain,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,baseline,"immunological non-responders assigned to treatment for 12 weeks","HIV-infected immunological non-responders (INR) who received S. boulardii probiotic",11,11,"2 months",16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 249","United States of America","Homo sapiens",Blood,UBERON:0000178,"Hepatitis, Alcoholic",EFO:1001345,NAC,alcoholics,"alcoholic hepatitis",20,56,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,
"Experiment 1","Study 423",China,"Homo sapiens",Feces,UBERON:0001988,"amyotrophic lateral sclerosis",MONDO:0004976,"Healthy controls","ALS patients","Patients clinically diagnosed with probably or definite ALS according to the revised El Escorial criteria in the neurology department.",20,20,,16S,4,Illumina,LEfSe,0.05,true,4,age,age,,increased,increased,,,increased,Complete,
"Experiment 1","Study 269",Malaysia,"Homo sapiens",Feces,UBERON:0001988,leukemia,EFO:0000565,"healthy control","Acute Lymphoblastic Leukemia diagnosis and Pre- Chemotherapy treatment","children (ages 2-6 years old) diagnosed with and treated for Acute Lymphoblastic Leukemia",7,7,,16S,4,Illumina,DESeq2,0.1,true,,"ethnic group",,,,,,,,Complete,
"Experiment 1","Study 339","United States of America","Mus musculus",Caecum,UBERON:0001153,"Air pollution",ENVO:02500037,"vehicle control","mice exposed to UFP","C57BL/6 mice exposed to UFP (Ultrafine particles)",11,12,,16S,4,Illumina,ANOVA,0.05,false,,,,,decreased,decreased,,,,Complete,Claregrieve1
"Experiment 1","Study 81",Denmark,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,baseline,"3 Months after Roux-en-Y gastric bypass surgery",,13,12,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 106",Denmark,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"healthy controls",bipolar,,116,113,,16S,"3,4",Illumina,"Fisher's Exact Test",0.05,true,,,"age,physical activity,sex,smoking behavior,waist circumference",,unchanged,,,,,Complete,
"Experiment 1","Study 104",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"healthy controls","major depressive disoreder (visit 1)","The patients were assessed with the major depressive disorder criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV- TR) and 17-items HAM-D scales ≥23.Three visits occurred on day 1, day 15 and day 29.",10,10,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.01,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 382",Italy,"Homo sapiens",Endocervix,UBERON:0000458,"Chlamydia trachomatis infectious disease",EFO:0007205,"healthy control","patient with chlamydia infection","patient with Chlamydia infection",7,7,Current,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 64",China,"Homo sapiens","Oral gland",UBERON:0010047,periodontitis,EFO:0000649,"No Periodontitis within negative diabetic background only",periodnotitis,"Periodontitis was defined by the following criteria: at least 30% of sites with probing depth and attachment loss, and more than four with probing depth >=4 mm and clinical attachment loss >=2 mm. Subjects with type 2 diabetes had been diagnosed for at least one year with HbA1c >= 6.5%, fasting plasma glucose test >=7.0 mmol/L, or OGTT 2 hour glucose test >=11.1 mmol/L",5,6,"3 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 331",China,"Homo sapiens",Feces,UBERON:0001988,"Hashimoto's thyroiditis",EFO:0003779,"healthy controls","hashimoto's thyroiditis patients","presence of euthyroidism, free thyroxine, and thyrotropin without hormonal therapy",27,50,"3 months",16S,"3,4",Illumina,LEfSe,0.05,true,3,"age,body mass index,sex",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 286",China,"Homo sapiens",Feces,UBERON:0001988,"Graves ophthalmopathy",EFO:1001466,"Healthy controls","graves orbitopathy","The diagnosis of GO was established according to the EUGOGO Guidelines. The active GO was defined by a clinical activity score (CAS)≥3/7, and the severe GO was defined by NOSPECS score≥IV. CT or MRI was used to exclude any orbital space-occupying disease such as tumor or extraocular myositis.",32,33,"4 weeks",16S,4,"Ion Torrent",Metastats,0.05,false,,"age,sex",,,decreased,unchanged,decreased,,unchanged,Complete,Fatima
"Experiment 1","Study 338",China,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"normal weight children","obese children","volunteers between the ages of 6-11 years old who were determined to be obese by BMI",23,28,"4 weeks",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,decreased,decreased,,decreased,Complete,Claregrieve1
"Experiment 1","Study 71","United States of America","Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,"the study groups are devided into two groups acc to the gestational age. 1) gestational age < 33 weeks. 2) gestational age >/= 33 weeks",19,33,,16S,4,"Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,"birth weight,chorioamnionitis,sex",,increased,increased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 95","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control babies at the age of 3","overweight/obese babies",,356,146,"7 days",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"education level",,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 194",China,"Homo sapiens",Uterus,UBERON:0000995,"ovarian cancer",MONDO:0008170,"normal tissue","ovarian cancer","women diagnosed with high grade ovarian cancer",25,25,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,decreased,,unchanged,,,Complete,
"Experiment 1","Study 258","Canada,United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy control",carcinoma,carcinoma,30,30,,16S,4,Illumina,LEfSe,0.05,false,2.5,,,,,,,,,Complete,
"Experiment 1","Study 40",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"attention deficit hyperactivity disorder",EFO:0003888,Controls,ADHD,"cases were diagnosed based on DSM-IV symptoms using the Schedule for Affective Disorders and Schizophrenia for School-Age Children",77,19,,16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.1,false,,,,,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 319",China,"Mus musculus",Feces,UBERON:0001988,"air pollution",ENVO:02500037,"mice exposed to PM 2.5 (CAP)","mice exposed to filtered air (FA)","male C57Bl/6 J mice exposed to PM2.5 (CAP)",10,10,,16S,4,Illumina,ANOVA,0.05,false,,,,,increased,increased,increased,,unchanged,Complete,
"Experiment 1","Study 400",China,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"healthy control",asthma,"child age 4-7 years with physician diagnosed asthma",24,34,"4 weeks",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 55",Denmark,"Mus musculus",Caecum,UBERON:0001153,"stimulus or stress design",EFO:0001762,control,"grid floor induced stress","cases were exposed to a stress factor which is a grid floor exposure for two weeks. this implies that the use of grid floor is a sufficient stressor for inducing a depression-like behavioral state in the TST.",14,14,,16S,4,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 420","Norway,Sweden","Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,baseline,"HIV-infected on antiretroviral therapy allocated to probiotic intervention","HIV-infected patients receiving antiretroviral therapy (ART) with HIV-RNA < 50 copies per milliliter for at least 6 months and CD4 count < 500 cell per microliter",11,11,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 310",France,"Homo sapiens",Feces,UBERON:0001988,"non-Hodgkins lymphoma",EFO:0005952,pre-chemotherapy,post-chemotherapy,"patients ages 40 to 60 years old diagnosis with non-Hodgkin's lymphoma undergoing post-chemotherapy high-dose carmustine, etoposide, aracytin and melphalan",8,8,"all antibiotics after starting chemotherapy",16S,"5,6",Roche454,T-Test,0.05,true,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 334",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"prenatal antibiotic free group (PAF group)","infants(14-d old) exposed to prenatal antibiotic therapy (PAT group)","Pre-term infants",12,12,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,unchanged,,,Complete,
"Experiment 1","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery at day 3",c-section,"meconium samples were collected at day 1 after delivery",6,3,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,increased,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 38",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"child head","teen head","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 386",China,"Homo sapiens",Feces,UBERON:0001988,"pulmonary tuberculosis",EFO:1000049,"healthy controls","Tuberculosis (TB) patients","patients diagnosed with TB by assessing symptoms, including the results of acid-fast bacilli (AFB) smear microscopy, culture, the T-SPOT.TB test and a chest radiograph.",31,30,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,decreased,Complete,
"Experiment 1","Study 346","United States of America","Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"mild depression","severe depression","psychiatric inpatients diagnosed by DSM-IV Disorders, SCID-I and SCID-II interviews, CSSR-S, SLEQ and GAD-7",,,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 1","Study 398",Ireland,"Homo sapiens","Skin of forearm",UBERON:0003403,"atopic eczema",EFO:0000274,"healthy control","atopic dermatitis","child with atopic dermatis at month 12 diagnosed by experienced health care personnel using the UK Working Party Diagnostic Criteria",10,10,,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 407",China,"Homo sapiens",Saliva,UBERON:0001836,"peptic esophagitis",EFO:1001095,"healthy controls","reflux esophagus patients","symptoms such as heartburn and regurgitation were in accordance with the endoscopic criteria of Los Angeles Grade and taken no drugs as treatment",51,55,"6 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,"age,sex",,,unchanged,,unchanged,,,Complete,
"Experiment 1","Study 90",Brazil,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"mecomium in vaginal delivery","transitional stool","cases are delivery or an elective C-section delivery between 38 and 42 weeks of gestation (confirmed by an ultrasound taken before the 20th week of pregnancy).",10,10,"oral antibiotics in the third trimester of pregnancy",16S,4,Illumina,LEfSe,,false,3,,,,,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 347",China,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,controls,"obese children","School children meeting WHO diagnostic criteria for obesity",38,39,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,decreased,increased,,decreased,Complete,Claregrieve1
"Experiment 1","Study 373",Estonia,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight children",overweight,"Children and adults",9,9,,16S,"3,4",Illumina,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 311",Italy,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"pre- engraftment","post- engraftment","malignant or non-malignant disease patients from four transplantation centers (Bologna, Pavia, Rome and Verona) that underwent allogeneic hematopoietic stem cell transplant with or without myeloablative conditioning regimen, who did not develop acute graft-versus-host disease post- enrichment",17,17,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 394",Denmark,"Homo sapiens",Hypopharynx,UBERON:0001051,asthma,MONDO:0004979,"healthy control","child with asthma at age 6","asthma at age 6 years diagnosed using a pre-defined validated quantitative symptom algorithm based on parental registration of troublesome lung symptoms on structured daily diary cards from birth, verified by study pediatricians at each clinic visit",438,135,,16S,4,Illumina,"Cox Proportional-Hazards Regression",0.05,true,,,,,increased,,,,increased,Complete,
"Experiment 1","Study 365","United States of America","Mus musculus",Feces,UBERON:0001988,"Methionine measurement",EFO:0009771,"mice fed control rodent diet.","mice fed American Diet","C57BL/6J mice fed an American diet (AD), which contained higher amounts of fat and fiber",6,5,,16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 337","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"3-month old infants not exposed to antibiotics during the second trimester","3-month-old infants exposed to antibiotics in the second trimester","infants born after 28 weeks gestation with no congenital abnormalities who were exposed to antibiotics during the second trimester",56,12,,16S,4,Illumina,"Beta Binomial Regression",0.05,true,,,"body mass index,education level,household income,marital status,maternal age,race,smoking behavior",,,,,,,Complete,Claregrieve1
"Experiment 1","Study 424",Israel,,Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"Healthy control",PC,"Patients presenting with pancreatic cancer. The diagnosis was verified by histological samples obtained by EUS or by postoperative pathological assessment.",13,30,"8 weeks",16S,,Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,
"Experiment 1","Study 65",Brazil,"Homo sapiens","Oral gland",UBERON:0010047,"type II diabetes mellitus",MONDO:0005148,Non-diabetic,Diabetic,"chronic periodontitis, according to the criteria of the 1999 International Classification; the presence of at least 15 teeth; >= 30% of the sites and at least nine teeth pre-senting a probing pocket depth of >= 5 mm with bleeding on probing (with two or more of these teeth having a probing pocket depth of >= 7 mm); uncontrolled type-2 DM, determined by a glycated hemoglobin (HbA1c) concentration of > 8%",11,12,"3 months",16S,,Illumina,T-Test,0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 370","United States of America","Homo sapiens","Buccal mucosa",UBERON:0006956,"air pollution",ENVO:02500037,"non-farmworker exposure","farmworker exposure","self-identified Hispanic farmworkers in apple and pear orchads and Hispanic non-farmworker community members",,101,,16S,"5,6","Ion Torrent","Mann-Whitney (Wilcoxon)",0.01,true,,,,,,unchanged,,,unchanged,Complete,
"Experiment 1","Study 82",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean controls","before surgery","Roux-en-Y gastric-bypass operation were recruited according to the S3 guidelines of the German Society for Obesity",6,,"3 weeks",WMS,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 409",Italy,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"healthy controls","IgE mediated cow's milk allergy","diagnosis of IgE mediated cow's milk allergy based on clinical history and level of IgE serum-specific anti-cow's milk proteins",20,19,"4 weeks",16S,4,Illumina,"Welch's T-Test",0.05,true,,"age,body weight,sex",,increased,increased,,,,,Complete,
"Experiment 1","Study 389","United States of America","Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls",schizophrenia,"patients met DSM-IV criteria for schizophrenia, mania participants with symptoms of mania or hypermania could have diagnosis of Bipolar I disorder, single manic episode, most recent episode, mixed Bipolar II episode, most recent episode mixed,or Schizoaffective disorder., bipolar type (manic, hypomanic or mixed state)",85,121,,16S,"3,4",Illumina,"Wald Test",0.05,true,,,"age,body mass index,nicotine dependence,race,sex",,,,,,,Complete,
"Experiment 1","Study 333",Japan,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"without (non-Abx) use of maternal antimicrobial agents at delivery","infants with (Abx)","Healthy infants",14,19,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,unchanged,,,,Complete,
"Experiment 1","Study 317","United States of America","Homo sapiens",Meconium,UBERON:0007109,"antimicrobial agent",CHEBI:33281,"without prenatal antibiotics usages","infants delivered to mothers with","infants delivered to mothers given prenatal antibiotics (antibiotics given to mother from conception to 2 days prior to delivery)",88,17,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,unchanged,,unchanged,Complete,
"Experiment 1","Study 69",China,"Homo sapiens",Feces,UBERON:0001988,"sex design",EFO:0001752,male,female,,259,292,"2 months",16S,"3,4",Illumina,DESeq2,0.05,true,,,,,increased,,unchanged,unchanged,increased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 328","United States of America","Homo sapiens",Feces,UBERON:0001988,"psoriatic arthritis",EFO:0003778,"healthy controls","psoriatic arthiritis","patients fulfilling the criteria of the Classification of Psoriatic arthritis (CASPAR)",17,16,"3 months",16S,"1,2",Roche454,LEfSe,0.2,true,2,"age,ethnic group,sex",,,decreased,,,,,Complete,
"Experiment 1","Study 179",China,"Homo sapiens",Saliva,UBERON:0001836,"esophageal squamous cell carcinoma",EFO:0005922,"Healthy controls","Oesophageal cancer","oesophageal cancer",21,20,"1 month",16S,"3,4",Illumina,Metastats,0.05,false,3,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 184","United States of America","Homo sapiens",Urine,UBERON:0001088,"prostate cancer",MONDO:0008315,controls,"prostate cancer patients","the association of urinary and fecal microbiota with prostate cancer diagnosis",16,14,"28 days",16S,"3,4,5",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 193","South Korea","Homo sapiens","Mucosa of stomach",UBERON:0001199,"gastric cancer",MONDO:0001056,"chronic gastritis and intestinal metaplasia","gastric cancer","diagnosis confirmed by hisotpathology",21,10,"6 months",16S,5,Roche454,,0.05,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 241",Lithuania,"Homo sapiens",Feces,UBERON:0001988,"Iron deficiency anemia",HP:0001891,"healthy control","iron deficiency anemia","infants and young children with iron deficiency anemia",10,10,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,,,,,Complete,
"Experiment 1","Study 50",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","Colrectal cancer patients","All patients were categorized according to histopathological features by TNM classification of malignant tumors after surgery",56,46,"3 months",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 43",Turkey,"Homo sapiens","Oral gland",UBERON:0010047,"Behcet's syndrome",EFO:0003780,controls,"behcet's disease",,15,31,"6 months",16S,4,Illumina,LEfSe,0.05,false,,,,,,,,decreased,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 253","South Korea","Homo sapiens",Nasopharynx,UBERON:0001728,asthma,MONDO:0004979,"healthy control",asthma,asthma,31,31,"3 months",16S,"1,2,3",Roche454,"Dunn's test",0.1,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 308","United States of America","Mus musculus","Small intestine",UBERON:0002108,"air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,increased,increased,,,increased,Complete,
"Experiment 1","Study 307",France,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Negative control group (CLT)","moxifloxacin treated group (MXF)","healthy male and female volunteers aged >18 years",8,14,"3 months",WMS,,"Mass spectrometry","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,decreased,Complete,
"Experiment 1","Study 62",Japan,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,134,17,"No information about pre-delivey duration. 3 Vaginally-delivered infants have been exposed to antibiotics (birth to sampling)",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 252",China,"Homo sapiens",Feces,UBERON:0001988,"pemphigus vulgaris",EFO:0004719,"healthy control","pemphigus vulgaris","pemphigus vulgaris",14,18,"6 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,"age,sex",,,unchanged,,unchanged,,,Complete,Chloe
"Experiment 1","Study 168",China,"Homo sapiens",Tongue,UBERON:0001723,"Chronic hepatitis B virus infection",EFO:0004239,"healthy controls","chronic hepatitis B yellow tongue coating patients","patients diagnosed with chronic hepatitis B per ""The Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2010 version)"" with a yellow tongue coating",22,28,"3 months",16S,3,"Ion Torrent",Metastats,0.05,false,,"age,sex",,,unchanged,unchanged,,,,Complete,Claregrieve1
"Experiment 1","Study 320","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants (6-weeks) to mothers unexposed to  intrapartum antibiotic","infants(6-weeks) to mothers exposed to intrapartum antibiotic","vaginally delivered at full-term (>37 weeks of gestation)",179,87,,16S,"4,5",Illumina,PERMANOVA,0.05,false,,,,,decreased,,decreased,,,Complete,
"Experiment 1","Study 75","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"smoking behavior",EFO:0004318,"right oropharynx of nonsmokers","right oropharynx of smokers","Smokers were defined as current smoking of .2 cigarettes daily for more than 6 months, and nonsmokers were defined as less than 100 cigarettes lifetime.",33,29,"3 months",16S,"1,2",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 358","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia,cervical cancer","EFO:1000165,MONDO:0002974","Healthy controls",CIN2/3-CC,"patients diagnosed with CIN2/3 or cervical cancer during screening of the cervical tract",50,42,"antibiotic therapy within 3 months",16S,,Roche454,LEfSe,0.05,false,2,,,,unchanged,increased,unchanged,,increased,Complete,
"Experiment 1","Study 390",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls","acute schizphrenia","patients who complied with diagnostic criteria for SCZ in the Diagnostic and Statistical Manual of Mental DIsorders Fourth Edition, Positive and negative syndrome scale, PANSS<60; No change in antipsychotic regimen (within two weeks)",29,29,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,age,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 88","United States of America","Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"non-psychiatric controls",schizophrenia,"type 1 diabetes was diagnosed according to the criteria of the American Diabetes Association and the positivity of at least two persistent, confirmed anti-islet autoantibodies (anti-insulin autoantibodies, GAD autoantibodies, or tyrosine phosphatase autoantibodies). MODY2 children were diagnosed by suggestive clinical history, negative anti-islet autoantibodies, and positive genetic testing. Healthy control subjects were children with negative anti-islet autoantibodies,",25,25,,16S,4,Illumina,Kruskall-Wallis,0.01,true,,demographics,"age,antimicrobial agent,body mass index,race,sex",,unchanged,,,,,Complete,
"Experiment 1","Study 118",China,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal born children","cesarean born","cesarean delivery",60,34,,16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,"Rimsha Azhar"
"Experiment 1","Study 363",Japan,"Homo sapiens",Tongue,UBERON:0001723,"smoking behavior",EFO:0004318,"never smokers","current smokers","participants who underwent tongue-coating analysis in 2016 and 2017",384,144,,16S,"3,4",Illumina,DESeq2,0.05,true,,,"age,alcohol drinking,body mass index,dental caries,number of teeth measurement,peridontal microbiome,sex",,decreased,,decreased,,decreased,Complete,
"Experiment 1","Study 236",Germany,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"after walnut diet","before walnut diet","before walnut consumption",135,135,"excluded those on ""antibiotic therapy""",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,"age,body mass index,smoking behavior,triglycerides",,unchanged,,unchanged,,unchanged,Complete,
"Experiment 1","Study 335",Canada,"Mus musculus",Feces,UBERON:0001988,"air pollution",ENVO:02500037,"healthy mice","wild type mice fed mouse chow with PM10","Wild-type 129/SvEv mice in chronic treatement group were  fed mouse chow ± PM10 (0.09 gm/kg) for 35 days",7,8,,16S,,"Non-quantitative PCR","PLS-DA (Partial least square discriminant analysis)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 421",Spain,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"uninfected siblings or children born to HIV-infected mothers","Vertically HIV-infected children","Vertically HIV-infected children",10,23,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 361",Canada,"Mus musculus",Caecum,UBERON:0001153,"Air pollution",ENVO:02500037,"all other mice","male mice exposed to cigarette smoke","male mice exposed to smoke",50,8,,16S,4,Illumina,LEfSe,0.05,true,3.5,,,decreased,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 367",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"Unrelated children, 9–11 years old",81,80,"3 months",16S,3,"Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 366",Canada,"Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"healthy controls","nonalcoholic fatty liver disease","Obese patients with a body mass index (BMI) greater than 30 kg/m2 and clinically suspected non-alcoholic fatty liver disease",30,30,"3 months",16S,,"Mass spectrometry",Metastats,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 352","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia,human papilloma virus infection","EFO:1000165,EFO:0001668","Atypical Squamous Cells of Undetermined Significance","Low Grade Squamous Intraepithelial Lesion","low grade squamous intraepithelial lesion",6,18,"2 months",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control adolescent","obese adolescent","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 381","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"healthy volunteers","hematopoietic stem cell transplant recipients","patients undergoing T cell repleted allogeneic hematopoietic stem cell transplantation",18,50,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,decreased,Complete,"Fatima Zohra"
"Experiment 1","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Hypertensive at Low Altitude (LHH)","Tibetan Hypertensive at High Altitude (HTH)","Tibetan participants with hypertension living at high altitudes.",34,38,"3 months",16S,"3,4",Illumina,T-Test,0.05,false,,"age,sex",,,increased,,,,,Complete,Fatima
"Experiment 1","Study 383","United States of America","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"no food sensitization","child with food sensitization","child with serum-specific IgE to milk, egg, peanut, soy, wheat, and walnut greater than 0.35 kU/L at age 3",131,85,"1 week",16S,"3,4,5",Roche454,,0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 121",China,"Homo sapiens","Oral gland",UBERON:0010047,gingivitis,MONDO:0002508,"healthy controls",gingivitis,,12,54,"3 months",16S,"3,4",Illumina,ANOSIM,0.05,false,,,,,increased,increased,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"Minimal Residual Disease- (positivity) with Allogenic Stem Cell Transplant","Minimal Residual Disease- (negativity) with Allogenic Stem Cell Transplant","Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,LEfSe,0.05,true,2,,,,,,,unchanged,,Complete,
"Experiment 1","Study 292",Japan,"Homo sapiens",Tongue,UBERON:0001723,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"community-dwelling controls","allogeneic-hematopoietic stem cell transplant","patient ages 36-69 years old undergoing allogeneic- hematopoietic stem cell transplantation",164,45,,16S,"1,2","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,true,,age,,,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 46",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,"pediatric obese",,33,28,"previous month",16S,"2,3",RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 59",China,"Rattus norvegicus",Feces,UBERON:0001988,"titanium dioxide nanoparticle",CHEBI:51050,"control pregnant rats at gestational day 10","pregnant rats exposed to titanium dioxide nanoparticles","The female rats were daily gavage administrated with 5 mg/kg bw/day of TiO2 NPs from the 5th to 18th day after pregnancy.",4,4,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 414",Sweden,"Homo sapiens",Feces,UBERON:0001988,epilepsy,EFO:0000474,"after keto diet","before keto diet","children with therapy resistent inoperabe epilepsy or a diagnosis of a neorometablic disorder in which KD is recommended",12,12,"3 months",WMS,,Illumina,LEfSe,0.05,true,4,,,,,,,,,Complete,
"Experiment 1","Study 41",Finland,"Homo sapiens",Feces,UBERON:0001988,psychosis,EFO:0005407,Controls,"FIrst episode Psychosis",,16,28,"3 months",16S,,Illumina,LEfSe,0.05,false,2,"age,region of residence,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 89",Brazil,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery in transitional stools","C-section delivery","cases are delivery or an elective C-section delivery between 38 and 42 weeks of gestation (confirmed by an ultrasound taken before the 20th week of pregnancy).",10,40,"oral antibiotics in the third trimester of pregnancy",16S,4,Illumina,LEfSe,,false,3,,,,,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 44",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,"pediatric obese",,36,42,"6 months",16S,,Illumina,"Linear Regression",0.05,true,,,"age,sex",,unchanged,unchanged,,unchanged,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 371",France,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"anorexic, lean, and overweight subjects","obese subjects","patients who were obese by BMI (BMI>30 kg m−2)",128,134,"6 months",WMS,,RT-qPCR,Chi-Square,0.05,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 388",China,"Homo sapiens","skin of cheek,tongue,gingiva,oropharynx,Mouth","UBERON:0000165,UBERON:0008803,UBERON:0001723,UBERON:0001828,UBERON:0001729","oral squamous cell carcinoma",EFO:0000199,"paracancerous tissues","cancerous  lesions","patients at different stages of OSCC were enrolled in the study",24,24,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,true,3,,,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 192","United States of America","Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"healthy controls","diarrhea-predominant irritable bowel syndrome","Diarrhea-Predominant irritable bowel syndrome",23,23,"2 months",16S,"1,2,3",Roche454,T-Test,0.05,false,,,,,,,,,decreased,Complete,
"Experiment 1","Study 364",Turkey,"Homo sapiens","Buccal mucosa",UBERON:0006956,"smoking behavior",EFO:0004318,non-smokers,smokers,"Participants who smoke cigarettes that fulfilled the inclusion criteria for good health: no use of antibiotics in the past 3 months, no respiratory infections, no oral aphthous lesions on buccal mucosa, and absence of dental problems",20,20,"3 months",16S,"2,3,4,5,6,7,8,9","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 37",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"Healthy controls","CRC patients",,20,19,"3 months",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,body mass index,sex",,,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 272",Botswana,"Homo sapiens",Nasopharynx,UBERON:0001728,pneumonia,EFO:0003106,negative,"S.pneumoniae positive","clinical pneumonnia",74,96,,16S,3,Illumina,"Logistic Regression",0.05,false,,"date,primary care clinic",age,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 416",Zimbabwe,"Homo sapiens",Feces,UBERON:0001988,"HIV infection,cotrimoxazole",EFO:0000764,"stop cotrimoxazole prophylaxis","continue cotrimoxazole prophylaxis","HIV-positive and antiretroviral therapy (ART) treated children who were randomized to continue taking cotrimoxazole prophylaxis",36,36,,WMS,,Illumina,"Zero-Inflated Beta Regression",0.05,true,,,,unchanged,unchanged,,,,,Complete,
"Experiment 1","Study 57","United States of America","Homo sapiens","Buccal mucosa",UBERON:0006956,"irritable bowel syndrome",EFO:0000555,control,"irritable bowel syndrome","IBS are who suffered from chronic visceral pain and altered bowel habits for more than 6 months for which no organic cause had been identified",20,9,,16S,,PhyloChip,"Welch's T-Test",0.05,false,,"age,body weight,race,sex",,,,,,,,Complete,Fatima
"Experiment 1","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,Controls,"Bipolar disorder","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",10,32,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 164",China,"Homo sapiens",Tongue,UBERON:0001723,"gastric cancer",MONDO:0001056,controls,"gastric cancer","gastric cancer",16,34,"2 months",16S,"2,3,4",Illumina,T-Test,0.05,false,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 375",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"both sexes aged between 18 to 25 years",32,32,"4 weeks",WMS,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 61",Finland,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"infants of normal weight mother at age 1 month","infants of overweight mothers","mothers whose prepregnancy body mass index (BMI; in kg/m2) was >25",26,16,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 280","United Kingdom","Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"cervical glandular intraepithelial neoplasia",EFO:1000165,"low grade squamus intraepithelial lesion","high grade squamus intraepithelial lesion","high grade squamus intraepithelial lesion confirmed by histology or cytology",52,92,"14 days",16S,"1,2",Illumina,LEfSe,0.05,true,,,,,unchanged,,,unchanged,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 99",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,obese,,79,72,"1 month",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,sex",,,decreased,,,,,Complete,
"Experiment 1","Study 132","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,mushroom,Meat,,16,16,"3 months",16S,"1,2,3",Illumina,"Linear Regression",0.004,true,,,"age,body mass index,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 413",Canada,"Homo sapiens",Feces,UBERON:0001988,"obsessive-compulsive disorder",EFO:0004242,"healthy controls",OCD,"non-depressed medication free individuals or individuals with mild depressive symptoms (MADRS score<16) with a primary DSM-5 diagnosis of OCD as per the MINI or at least moderate OCD (Y-BOCS score >= 20)",22,21,"8 weeks",16S,3,Illumina,ANCOM,0.05,true,,"age,sex",,,unchanged,unchanged,,decreased,unchanged,Complete,Fatima
"Experiment 1","Study 404","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","patient with atopic dermatitis","patient age <1 year diagnosed with atopic dermatitis based on the SCORAD scoring system",5,15,"6 months",16S,"1,2",Roche454,"Random Forest Analysis",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 45",Australia,"Rattus norvegicus",Feces,UBERON:0001988,obesity,EFO:0001073,"control rats","Rats fed  HFHS",,8,8,,16S,"3,4",Illumina,DESeq2,0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 378",France,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"non acute graft-versus-host-disease","Severe acute graft-versus-host-disease","patients who are diagnosis with mild gut acute graft- versus-host disease (less than or equal 2) or severe gut acute graft- versus-host disease (between standard stage greater or equal to 2 and less than or equal to 4)",35,35,,16S,"3,4",Illumina,LEfSe,0.01,true,4,,,,,decreased,decreased,,decreased,Complete,
"Experiment 1","Study 281","United States of America","Mus musculus","Small intestine",UBERON:0002108,"acute lymphoblastic leukemia",EFO:0000220,"Fecal bacterial composition in small intestines of control mice","Fecal bacterial composition in small intestines of leukemia mice","three-week old female mice induced leukemia using lymphomblasts from pediatric acture lymphocytic leukemia patients from ATCC",8,8,,16S,4,Illumina,T-Test,0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 1","Study 322",Sweden,"Homo sapiens","buccal mucosa,lower lip","UBERON:0006956,UBERON:0001835","oral mucositis",EFO:1001904,reference,"newly diagnosis maligancies","patients that are newly diagnosed with malignancies (before chemotherapy treatment) that are between ages 4 and 18 years old that are treated with cytostatic drug and has a national population registration number (Sweden)",38,37,,16S,,Roche454,T-Test,0.05,true,,"age,sex",,,decreased,,,,,Complete,
"Experiment 1","Study 32",Italy,"Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,Controls,"Aonerxia Nervosa patients","The severity of eating disorder and psychopathology tests were assessed by means of the Symptom Checklist 90 (general psychopathology), Eating Disorder Inventory 2 (eating disorder), State Trait Anxiety Inventory (anxiety disorder) and Beck Depression Inventory (depressive symptoms). Psychologists and psychiatrists (all extensively trained in the use of the instruments) conducted clinical evaluations.",15,15,"1 month",16S,,Illumina,T-Test,0.05,true,,"age,sex",,,,,,,,Complete,Fatima
"Experiment 1","Study 73",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,"the guidelines from the American Heart Association was used to diagnose metabolic syndrome, which must adhere to at least three of the five following parameters; 1. Elevated waist circumference: waist circumference of ≥80, 2. Elevated Triglycerides ≥150 mg/dL, 3. Reduced HDL- Cholesterol <50 mg/dL, 4. Elevated Blood pressure; systolic ≥130 mm Hg and/or diastolic ≥85 mm Hg and 5. Elevated Fasting blood glucose ≥100 mg/dL. On the other hand, the women with just OB were identified using body mass index (BMI) as follows: normal rank was considered 18.5–24.99 kg/m2, the rank for obese class I was 30–34.99 kg/m2, obese class II 35–39.99 kg/m2, and obese class III greater than or equal to 40 kg/m2.",25,17,"3 months",16S,3,"Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,increased,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 161",China,"Homo sapiens",Saliva,UBERON:0001836,"lung cancer",MONDO:0008903,"healthy controls",NSCLC,"newly diagnosed NSCLC (non small cell lung cancer) patients",20,39,"6 months",16S,"1,2",Illumina,Metastats,0.05,false,,"age,sex",,,increased,unchanged,increased,,,Complete,
"Experiment 1","Study 149",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,Obese,obesity,10,10,,WMS,,Illumina,LEfSe,0.05,false,,,,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 1","Study 138",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,controls,"lung cancer",,30,30,"3 months",16S,"3,4",Illumina,"Linear Regression",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 163",Austria,"Homo sapiens",Saliva,UBERON:0001836,"squamous cell carcinoma",EFO:0000707,"Healthy Controls","Oropharyngeal Squamous Cell Carcinoma","diagnosed with OSCC and SCC of the oral cavity",11,11,"1 month",16S,4,Illumina,DESeq2,0.05,false,,,,,unchanged,,,unchanged,,Complete,
"Experiment 1","Study 129","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,"healthy controls","multiple sclerosis",,36,31,current,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,sex",,,unchanged,,,,,Complete,
"Experiment 1","Study 239","United States of America","Homo sapiens",Feces,UBERON:0001988,"egg allergy",EFO:0007248,"healthy control","infant with egg allergy","infant with egg allergy",75,66,,16S,4,Illumina,"LEfSe,Logistic Regression",0.05,false,2,,"age,antibiotic,atopic eczema,breast feeding",,increased,increased,,,increased,Complete,
"Experiment 1","Study 199",China,"Homo sapiens",Uterus,UBERON:0000995,"ovarian cancer",MONDO:0008170,controls,"ovarian cancer","preliminary diagnosis of suspected ovarian cancer and undergoing laparotomy",10,6,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 116",Spain,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,"healthy controls","children with type 1 diabetes","Type 1 diabetes was diagnosed following the criteria of the American Diabetes Association and the appearance of at least two persistent, confirmed anti-islet autoantibodies (insulin autoantibodies, glutamic acid decarboxylase autoantibodies or tyrosine phosphatase autoantibodies)",16,16,"3 months",16S,"2,3",RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,breastfeeding duration,delivery procedure,race,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 119","United States of America","Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Metaformin negative among Opoid negative","Metaformin positive","Opioid use was defined as “Yes” if during review of medical record two parameters were present: 1) the participant was under care of psychiatric care professional, and 2) psychiatric care professional established the diagnosis of opioid use disorder as official diagnosis in medical record",34,21,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 117",Netherlands,"Homo sapiens","Oral gland",UBERON:0010047,pneumonia,EFO:0003106,"elderly controls","elderly pneumonia patients",,91,100,"3 months",16S,"5,6,7",Roche454,T-Test,0.05,true,,,"age,comorbidity,smoking behavior",,increased,,,,decreased,Complete,
"Experiment 1","Study 175","United States of America","Homo sapiens",Mouth,UBERON:0000165,"pancreatic carcinoma",EFO:0002618,controls,"pancreatic cancer cases","subjects from the two cohorts with incident primary pancreatic adenocarcinoma",371,361,,16S,"3,4",Roche454,"Logistic Regression",0.05,false,,"age,sex",,,,,,,,Complete,
"Experiment 1","Study 220",France,"Homo sapiens","Skin of body",UBERON:0002097,age,EFO:0000246,"younger age","older age European women",aging,17,17,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,increased,unchanged,,,unchanged,Complete,
"Experiment 1","Study 141","United Kingdom","Homo sapiens",Vagina,UBERON:0000996,"preterm premature rupture of the membranes",MONDO:0012511,controls,PPROM,"(PPROM) preterm premature rupture of the membranes",36,60,"9 months",16S,"1,2",Illumina,LEfSe,0.05,false,,"body mass index,ethnic group,gestational age,maternal age",,,,,,unchanged,,Complete,
"Experiment 1","Study 276",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy control","Multiple Myeloma patient","patient diagnosis with multiple myeloma and no other disease validated to affect intestinal microbial including digestive disease like liver cirrhosis, liver cancer, inflammatory bowel disease, and irritable bowel syndrome; systemic disease like diabetes and hypertension and thyroid disease; no treatment including antibiotics, chemotherapy, plasma exchange or bone marrow transplant; no cold, fever or other infections within 3 months before sampling with administrated antibacterial drugs, gastrointestinal motility drugs or micro-ecological conditioning agents like eating and living habit change 1 week before sampling",17,40,"3 months",16S,"3,4",Illumina,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 125",Japan,"Homo sapiens",Saliva,UBERON:0001836,"squamous cell carcinoma",EFO:0000707,"noncancer individuals","Oral Squamous Cell Cancer patients","All diagnoses of oral squamous cell carcinoma were confirmed by biopsy and pathological findings.The control group was defined as individuals without any diagnosed mucosal diseases and other cancers and these individuals were over the age of 40.",80,60,"28 days",16S,"3,4",Illumina,T-Test,0.05,false,,,,,unchanged,increased,unchanged,,increased,Complete,Fatima
"Experiment 1","Study 142","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"oral squamous cell carcinoma",EFO:0000199,Controls,HNSCC,"histopathologically confirmed HNSCC (Head & Neck Squamous Cell Cancer) and had atleast one post-treatment salivary sample",25,17,,16S,"3,4,5",Roche454,LEfSe,0.05,false,,,,,,decreased,,,decreased,Complete,"Rimsha Azhar"
"Experiment 1","Study 108",Japan,"Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,"healthy controls","anorexia nervosa patients",,21,25,"3 months",16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.002,true,,,age,,,,,,,Complete,
"Experiment 1","Study 101",France,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean controls",obese,"Obese patients, as defined by a BMI>=30 kg/m2",47,68,"less than one month before stool collection",16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,age,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 263",Canada,"Homo sapiens",Feces,UBERON:0001988,"Crohn's disease",EFO:0000384,"healthy controls","chron's disease","patients with immune-mediated inflammatory disease (IMID)",23,20,"8 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 1","Study 180",Portugal,"Homo sapiens",Stomach,UBERON:0000945,"gastric carcinoma",EFO:0000178,"chronic gastritis","gastric carcinoma","gastric carcinoma",23,23,,16S,"5,6","Ion Torrent",LEfSe,0.05,true,4,age,,,decreased,unchanged,,,,Complete,
"Experiment 1","Study 298","United States of America","Homo sapiens","Feces,Mouth","UBERON:0001988,UBERON:0000165","acute myeloid leukemia",EFO:0000222,oral,stool,"stool samples collected from 59 patients with acute myeloid leukemia after induction chemotherapy",483,365,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 273",Canada,"Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"non-infectious complications (NIC)","Infectious complications (IC)","Infectious complications (IC) in the past 6 months of Acute Lymphoblastic Leukemia treatment",7,9,"Prophylactic Septra which was prescribed ubiquitously to patients throughout the study, as per standard of care.",WMS,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,decreased,Complete,
"Experiment 1","Study 279","United States of America","Homo sapiens",Mouth,UBERON:0000165,"acute myeloid leukemia",EFO:0000222,"Low Intensity Chemotherapy","High Intensity Chemotherapy","Acute Myeloid Leukemia patients with receiving low- intensity remission induction chemotherapy",11,28,,16S,4,Illumina,ANOVA,0.05,false,,,,,increased,,,,,Complete,
"Experiment 1","Study 402",Australia,"Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","IgE associated eczema","Infants with typical skin lesions responsive to topical steroids diagnosed with eczema and with severity determined using the SCORAD index",8,6,,16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,"delivery procedure,medical procedure",,unchanged,unchanged,,,,,Complete,
"Experiment 1","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"healthy control","atopic asthma","atopic asthma",21,42,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 344",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice exposed suspension from extracts of “blank” filter","mice exposed to Pm 2.5 suspension","exposed to PM2.5 suspension",12,12,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,2,,,,increased,decreased,increased,,increased,Complete,
"Experiment 1","Study 387",Sweden,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before ciprofloxacin exposure","after ciprofloxacin exposure","""healthy"" adults between the ages of 18-45 years old with normal medical histories and physical examinations who were given ciprofloxacin",9,9,"3 months",16S,"5,6,7",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 368","Saudi Arabia","Homo sapiens",Tongue,UBERON:0001723,"smoking behavior",EFO:0004318,"non-shammah users","shammah users","participants who used shammah daily for at least one year without a period of cessation and those who had no history of shammah use",23,29,"3 months",16S,"1,2,3",Illumina,LEfSe,0.015,true,,sex,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 297",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"human papilloma virus infection",EFO:0001668,"non pregnant no HPV","non pregnant high risk HPV","non pregnant high risk HPV confirmed using HPV genotyping kit",30,19,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,increased,increased,,,increased,Complete,"Fatima Zohra"
"Experiment 1","Study 87",Spain,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,"maturity-onset diabetes of the young 2 (MODY2) and healthy Controls","Type I Diabetics","type 1 diabetes was diagnosed according to the criteria of the American Diabetes Association and the positivity of at least two persistent, confirmed anti-islet autoantibodies (anti-insulin autoantibodies, GAD autoantibodies, or tyrosine phosphatase autoantibodies). MODY2 children were diagnosed by suggestive clinical history, negative anti-islet autoantibodies, and positive genetic testing. Healthy control subjects were children with negative anti-islet autoantibodies,",28,15,"3 months",16S,"2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,delivery procedure,race,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 35",China,"Homo sapiens","Oral gland",UBERON:0010047,"Sjogren syndrome",EFO:0000699,Control,PSS,,23,22,,16S,"3,4",Illumina,LEfSe,0.05,false,4,"age,sex",,decreased,decreased,unchanged,,decreased,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 325",Israel,"Homo sapiens",Feces,UBERON:0001988,psoriasis,EFO:0000676,"healthy controls",psoriasis,"patients with active psoriatic disease diagnosed by a senior dermatologist",22,24,"3 months",16S,4,Illumina,LEfSe,0.05,true,,"age,comorbidity,sex",,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 362",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight children",obese,"School-aged children",56,16,"4 months",16S,,RT-qPCR,ANOVA,0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 94",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"baseline participants","3 months","A threshold of 10% weight loss and maintenance of it over one year has been proposed as definition for successful weight loss maintenance",16,16,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 406",China,"Homo sapiens",Saliva,UBERON:0001836,"lung cancer",MONDO:0008903,"healthy controls","non-smoking female lung cancer patients","female and have confirmed diagnosis of non-small-cell lung cancer",172,75,,16S,"1,2",Illumina,LEfSe,0.05,false,3,age,,,decreased,,,,decreased,Complete,
"Experiment 1","Study 79",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"Laparoscopic sleeve gastrectomy after 3 months and 6 Months combined","Laparoscopic sleeve gastrectomy baseline",,3,3,"3 months",WMS,,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 67",Italy,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,neurotypical,autistic,"cases were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.",40,40,"3 months",16S,"3,4,5",Roche454,"Welch's T-Test",0.05,true,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 1","Study 332",China,"Homo sapiens",Feces,UBERON:0001988,"Hashimoto's thyroiditis",EFO:0003779,"healthy controls","hashimoto's thyroiditis patients","The Thyroid stimulating hormone(TSH) was higher than 5 μIU/ml, T4 was lower than 4.2 μg/dl, T3 was lower than 0.78 ng/ml, anti-thyroid peroxidase antibodies level was higher than 15 IU/ml, and anti-thyroglobulin antibodies was more than 30%",12,29,"60 days",16S,"3,4",Illumina,T-Test,0.05,false,,,,,unchanged,increased,unchanged,,unchanged,Complete,
"Experiment 1","Study 58","United States of America","Homo sapiens",Meconium,UBERON:0007109,"high fat diet",EFO:0002757,"nebowrns of maternal control","newborns of maternal high-fat diet","To determine maternal dietary intake during pregnancy, each mother was asked by trained personnel at each sample collection time point to answer the Dietary Screener Questionnaire (DSQ), which was developed and validated by the National Health and Examination Survey (NHANES) program (2009–2010)",13,13,,16S,"3,4,5",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 290",Netherlands,"Homo sapiens",Mouth,UBERON:0000165,"oral mucositis",EFO:1001904,"no ulcerative oral mucositis","ulcerative oral mucositis","patient developed uclerative oral mucositis",31,20,,16S,4,RT-qPCR,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 1","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control adult","obese adolescent",,25,12,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,decreased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 353",India,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,non-obese,obese,"(Private) School Children",13,15,"1 month",16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,"class/grade level",,,,,,,,Complete,
"Experiment 1","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","youth underarm before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",30,30,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 97",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"healthy controls","obese patients prior to Sleeve gastrectomy SG0","obese patients had a body mass index (BMI) of >28 kg/m2.",20,19,"3 months",16S,4,"Ion Torrent",Kruskall-Wallis,0.05,false,4,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 376",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before antibiotic exposure","patients that took amoxiclav","took amoxiclav for 7 days",7,7,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,decreased,,,decreased,Complete,
"Experiment 1","Study 355",Belgium,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control (lean/normal weight)","obese (obese/overweight/morbidly obese)",Children,27,26,"1 month",16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 33",Japan,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,controls,obese,"BMI ≥25 kg/m2",4,6,"current use",16S,"3,4",Illumina,"Welch's T-Test",0.05,false,,,,,increased,,,,,Complete,Fatima
"Experiment 1","Study 30",Belgium,"Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,"Belgian controls","Norweigan controls","Patients were diagnosed for CFS according to the clinical criteria of Fukuda et al",19,17,"4 weeks",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 3","ICR male mice exposed to PM 2.5","ICR mice exposed to PM 2.5 air",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 1","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"Baseline HPV-","Baseline HPV+","HPV+ confirmed by HPV assay and genotyping",43,90,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,decreased,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 63",Japan,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery after 7 days of delivery","C-section delivery",,134,17,"No information about pre-delivey duration. 3 Vaginally-delivered infants have been exposed to antibiotics (birth to sampling)",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 318",Japan,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"non-acute graft-versus-host disease","acute graft-versus-host disease","participants that developed acute graft-versus-host disease after allogeneic hematopoeitic transplant and graded accordinly to pattern of organ involvement and clinical performance status using a system introduced by Glucksberg et al. (Severity Index), which includes late-onset of acute graft-versus-host disease (more than 100 days after transplantation)",,107,,16S,"1,2",Roche454,T-Test,0.01,false,,,,,,,,,,Complete,
"Experiment 1","Study 74",Netherlands,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,non-obese,obese,"obesity: BMI 30.5-60.3 kg/m2",13,15,"6 months",16S,,"Human Intestinal Tract Chip","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 248","South Africa","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"low risk hpv","high risk hpv","High risk HPV infection confirmed through HPV genotyping test",57,30,,16S,"3,4",Illumina,LEfSe,0.2,true,2,,,,unchanged,,unchanged,,,Complete,"Fatima Zohra"
"Experiment 1","Study 93",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,172,40,"newborns administerated antibiotics during delivery: Cefuroxime (n= 31), penicillin (n= 28), piperacillin-tazobactam (n=2)",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 384",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls",FSCZ,"first-episode drug naive schizophrenia (FSCZ) diagnosed according to the DSM IV criteria and PANSS having illness duration <=12 months and no treatment with antipsychotic medications before",69,40,"1 month",16S,4,Illumina,DESeq2,0.05,true,,demographics,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 250","United States of America","Homo sapiens",Tongue,UBERON:0001723,"severe aplastic anemia",EFO:0006927,baseline,"hematopoietic stem cell transplantation engraftment","In HSCT patients, The first sample was obtained before transplant conditioning treatment. The second specimen was collected at engraftment, defined as two absolute neutrophil counts of greater than 500 per microliter for at least 2 days. The final specimen collection occurred at the participant’s scheduled clinic visit approximately 100 days following transplant.",4,4,,16S,"2,3,4,5,6,7,8","Ion Torrent",LEfSe,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 397",China,"Homo sapiens","Skin of body",UBERON:0002097,"atopic eczema",EFO:0000274,"healthy control","severe atopic dermatitis","child with severe atopic dermatitis based on eczema area and severity index (EASI) local rating method",20,20,"1 month",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,decreased,increased,,decreased,Complete,
"Experiment 1","Study 351","Trinidad and Tobago","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,normal,overweight/obesity,"school aged children (6-14 years)",30,21,"3 months",16S,,Illumina,ANOVA,0.05,false,,,,,,,,,decreased,Complete,
"Experiment 1","Study 255","United Republic of Tanzania","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"negative for intraepithelial lesion or malignancy","high-grade squamous intraepithelial lesions","high-grade squamous intraepithelial lesions (HSIL) comfirmed by Pap smear",23,45,,16S,4,Illumina,LEfSe,0.1,true,,,,,,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 1","Study 115",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,controls,MDD,,30,31,"1 month",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,decreased,,unchanged,,Complete,
"Experiment 1","Study 143",Ireland,"Homo sapiens","Mesenteric lymph node",UBERON:0002509,"inflammatory bowel disease",EFO:0003767,"Ulcerative colitis","Crohn's disease","histopathologivally diagnosed ulcerative colitis and crohn's disease",8,5,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,increased,,,increased,Complete,"Rimsha Azhar"
"Experiment 1","Study 120",Spain,"Rattus norvegicus",Feces,UBERON:0001988,"physical activity",EFO:0003940,"exercise group","Activity Based Anorexia group","(a) Activity based anorexia (ABA) group: rats starved by restricting food access to 23 hours per day and confined to running wheels except during a 60 min meal per day, (b) Control ABA group: rats submitted to the same food restriction schedule as ABA with no wheel access exercise, (c) Exercise group: rats feed ad libitum with free access to the activity wheel and (d) Ad libitum group: rats feed ad libitum but without access to the activity wheel.",10,10,,16S,"2,3",RT-qPCR,Kruskall-Wallis,0.05,true,,"body weight",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 190",Norway,"Homo sapiens",Feces,UBERON:0001988,"breast milk measurement",EFO:0009092,"one-month age infants exposed to low chemical breast milk","one-month age infants exposed to high chemical breast milk","low chemical exposure is < 20th percentile breast milk toxicant exposure and high chemical exposure is ≥ 80th percentile breast milk toxicant exposure.",,,"more than two weeks prior sampling",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"gestational age",,increased,,,,,Complete,
"Experiment 1","Study 195",China,"Homo sapiens","Dental plaque",UBERON:0016482,"chronic hepatitis B virus infection",EFO:0004239,"healthy controls","chronic hepatitis B","chronic hepatitis B",10,10,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,2,,,,decreased,decreased,increased,,decreased,Complete,
"Experiment 1","Study 123","United States of America","Rattus norvegicus",Feces,UBERON:0001988,diet,EFO:0002755,"low fat diet","high fat diet","High fat diet rats were fed (20% protein, 35% carbohydrate, 45% fat by calories).  Controls or low fat diet were fed (20% protein, 70% carbohydrate, 10% fat by calories) for eight weeks.",6,6,,16S,,Roche454,ANOVA,0.05,false,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 155","United States of America","Homo sapiens",Mouth,UBERON:0000165,"esophageal cancer",MONDO:0007576,controls,"Esophageal Adenocarcinoma (EAC)","diagnosed with easophageal cancer anytime after oral wash sample collection",160,81,,16S,4,Illumina,"Logistic Regression",0.05,false,,"age,race,sex","alcohol drinking,body mass index,smoking behavior",,unchanged,,,,unchanged,Complete,"Fatima Zohra"
"Experiment 1","Study 136","Russian Federation","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high vegetable, fruit, grain","Low vegetable, fruit, grains,","low fiber",215,215,,16S,4,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,
"Experiment 1","Study 235","United States of America","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy control","child with food allergy","child with food allergy",21,22,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex",,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"low Southern European Atlantic Diet","high Southern European Atlantic Diet","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",3,7,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 110",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls",schizophrenia,,41,41,"1 month",16S,,RT-qPCR,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 124","South Korea","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"distance runners (high carb)","body builders (high protein)",,15,15,"6 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 1","Study 150",China,"Homo sapiens",Saliva,UBERON:0001836,"head and neck carcinoma",MONDO:0002038,"Healthy controls","Throat cancer","throat cancer including cancer of oropharynx, hypopharynx, nasopharynx and larynx",29,32,"6 months",16S,3,Illumina,LEfSe,0.05,false,4,,,,decreased,decreased,decreased,,,Complete,"Fatima Zohra"
"Experiment 1","Study 209","United States of America","Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,"meconium defined as the first stool passed, other than meconium staining of amniotic fluid.",62,43,"Mothers of infants born by CS received significantly more peripartum antibiotics than those born by VD (43/43 (100%) in CS vs. 19/62 (31%) in VD, p < 0.001).",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,increased,,unchanged,Complete,
"Experiment 1","Study 128",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"intestinal metaplasia","gastric cancer",,37,17,"2 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,helicobacter pylori,sex",,,decreased,,,decreased,Complete,
"Experiment 1","Study 157",China,"Homo sapiens",Saliva,UBERON:0001836,"esophageal cancer",MONDO:0007576,Dysplasia,"Esophageal Squamous cell carcinoma (ESCC)","Histopathological confirmation, complete questionnaire with saliva sample",63,87,"1 month",16S,"3,4",Roche454,T-Test,0.05,true,,"age,sex",,,decreased,unchanged,,,,Complete,
"Experiment 1","Study 300","United States of America","Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"non- graft- versus- host disease","acute graft- versus- host disease","individual's receiving Hematopoietic cell transplantation (HCT) and having a grade 1-4 for acute graft-versus-host-disease",14,52,,16S,"3,4",Illumina,T-Test,0.05,true,,,,,,,,decreased,,Complete,
"Experiment 1","Study 174",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"paired adjacent non-cacerous tissue","cacerous tissue","gastric cancer patients who underwent subtotal gastrectomy",62,62,"1 month",16S,"4,5",Illumina,LEfSe,0.05,true,3,,,,increased,increased,,,increased,Complete,
"Experiment 1","Study 426",China,"Homo sapiens",Feces,UBERON:0001988,"Autoimmune Hepatitis",EFO:0005676,"healthy controls","autoimmune hepatits cases","The diagnosis of AIH was made if patients conformed with (1) 1999 revised International Autoimmune Hepatitis Group (IAIHG) score ≥10 and/or (2) 2008 IAIHG simplified AIH score ≥6 and/or (3) histological features indicative of AIH.",98,91,,16S,"3,4",Illumina,LEfSe,0.05,false,2,"age,body mass index,sex",,,decreased,,,,decreased,Complete,
"Experiment 1","Study 427",Italy,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,vegetarians,omnivores,,51,51,"3 months",16S,"1,2,3",Roche454,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",,true,,,,,,,,,unchanged,Complete,
"Experiment 1","Study 429","South Korea","Homo sapiens",Feces,UBERON:0001988,"Gastric cancer",MONDO:0001056,"healthy controls","gastric cancer patients","patients with histologically confirmed early gastric cancer (invasive carcinoma confined to the mucosa, regardless of lymph node metastasis status) within the preceding 3 months",288,268,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,decreased,decreased,,,,increased,Complete,Claregrieve1
"Experiment 1","Study 430",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Patients with low-to-none SARS CoV-2 infectivity","Patients with high SARS CoV-2 infectivity","SARS CoV-2 infection confirmed by two consecutive RT-OCR tests. High SARS-CoV2 infectivity defined as higher 3' vs 5' end coverage of SARS CoV-2 genome in fecal viral RNA metagenome.",15,15,,WMS,,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,Fatima
"Experiment 1","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"persistent HPV+ with LSIL","persistent HPV+ with HSIL","persistent HPV+ infection ( same HPV subtype has infected for >12 months) with high grade squamus intraepithelial lesion",,,,16S,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 432",China,"Homo sapiens",Vagina,UBERON:0000996,"Human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ confirmed by Hybrid Capture II assay",30,30,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 433","South Korea","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"healthy controls","CIN 2+","Patients with cervical intraepithelial neoplasia 2 or higher",7,8,,16S,3,"Ion Torrent",LEfSe,0.05,false,7,,,,increased,,increased,,increased,Complete,
"Experiment 1","Study 434",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"human papilloma virus infection",EFO:0001668,"healthy control","HPV +","HPV-infected women without CIN confirmed by HPV genotyping test and examination",68,78,"14 days",16S,"3,4",Illumina,LEfSe,0.05,true,4,,,,increased,increased,,,,Complete,
"Experiment 1","Study 435",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,"HPV+ persistence","HPV infection of the same type that lasts for more than 12 months",5,6,"1 month",16S,4,"Ion Torrent",LEfSe,0.05,true,4,,,,increased,,,,increased,Complete,
"Experiment 1","Study 436","South Korea","Homo sapiens","Vaginal fluid",UBERON:0036243,"Cervical glandular intraepithelial neoplasia",EFO:1000165,"healthy controls","CIN2+/cervical cancer","patients with cervical intraepithelial neoplasia 2+ or cervical cancer confirmed by biopsy",10,20,,16S,"3,4",Illumina,Chi-Square,0.05,false,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 437",China,"Homo sapiens","Cervicovaginal secretion,Posterior fornix of vagina",UBERON:0016486,"human papilloma virus infection",EFO:0001668,"healthy control",HPV-16+,"Patients with HPV-16 confirmed by HPV genotyping assay",25,27,"1 month",WMS,,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,
"Experiment 1","Study 428",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 cases","Laboratory-confirmed SARS-CoV-2 positive by quantitative reverse transcription PCR performed on nasopharyngeal swabs",78,87,,WMS,,Illumina,LEfSe,0.05,false,,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 1","Study 439",Nigeria,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus; The definition of T2D was based on the American Diabetes Association (ADA) criteria: a fasting plasma glucose concentration (FPG) ≥ 126 mg/dl (7.0 mmol/l) or a 2-h post-load value in the oral glucose tolerance test ≥ 200 mg/dl (11.1 mmol/l) on more than one occasion. Alternatively, a diagnosis of T2D was accepted if an individual was on pharmacological treatment for T2D, and a review of clinical records indicated adequate justification for that therapy.",193,98,,16S,4,Illumina,Kruskall-Wallis,0.05,false,,,,,increased,,,,increased,Complete,
"Experiment 1","Study 440","United States of America","Homo sapiens","Nose,Skin of cheek","UBERON:0000004,UBERON:0008803",rosacea,EFO:1000760,"Healthy controls","Participants with papulopustular rosacea (PPR)","Participants with rosacea included individuals with diagnosed papulopustular rosacea (PPR): severity of rosacea assessed using the National Rosacea Society clinical grading system ranged from mild to moderate",19,19,"4 weeks for topical antibiotics, corticosteroids, and other anti-inflammatory medications, within 8 weeks for systemic antibiotics, corticosteroids, and other immunosuppressive agents",16S,"3,4",Illumina,Metastats,0.05,true,,"age,race,sex",,,,,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 441",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 cases","viral COVID-19 infections confirmed by real-time reverse-transcription polymerase chain reaction",30,30,"4 weeks",16S,"3,4",Illumina,LEfSe,0.05,true,3.5,"age,body mass index,sex",,,decreased,decreased,,,,Complete,Fatima
"Experiment 1","Study 443",India,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Health Control",IBS,"Patients with IBS diagnosed using Rome III. Patients were classified into three sub-types
using Rome III criteria: constipation predominant IBS (IBS-C), diarrhea predominant (IBS-D), and un-subtyped (IBS-U). All participants.",30,47,"Patients who had prior history of gastrointestinal surgery, inflammatory bowel disease, and celiac disease were excluded. Patients with IBS who used antibiotics, probiotics, or prokinetics within last 4 weeks of inclusion into the study were also excluded.",16S,,RT-qPCR,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 445",Italy,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative patients","COVID-19 cases","Diagnosis with COVID-19 based on SARS-CoV-2 RNA detection using real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay",22,18,,16S,"5,6",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,unchanged,unchanged,Complete,
"Experiment 1","Study 442","South Korea","Homo sapiens","Skin of sole of pes,Interdigital space","UBERON:0013778,UBERON:0036252","type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Type 2 Diabetes Mellitus patients diagnosed by an endocrinologist at Konkuk University Medical Center, Seoul, Korea",18,17,"concomitant systemic (within four weeks of enrolment) or topical (within two weeks of enrolment) treatments",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,unchanged,,decreased,Complete,
"Experiment 1","Study 446","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","COVID-19 cases","Positive for SaRS-CoV-2 by diagnostic RT-PCR",10,40,,WMS,,Nanopore,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 447",China,"Homo sapiens",Feces,UBERON:0001988,"gestational diabetes",EFO:0004593,"Healthy controls","Individuals with gestational diabetes","Individuals with gestational diabetes at third trimester during pregnancy;",31,30,"2 weeks",16S,"3,4",Illumina,"LEfSe,Mann-Whitney (Wilcoxon)",0.05,false,2,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 448",China,"Homo sapiens",Throat,UBERON:0000341,"influenza A (H1N1)",EFO:1001488,"Pneumonia patients without any influenza A infection","Pneumonia patients with pH1N1 infection","Positive lab test (real-time PCR or cell culture) and criteria for pneumonia simultaneously met, with pH1N1 infection",11,11,,WMS,,Illumina,DESeq2,0.05,,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 449","China,Switzerland","Homo sapiens",Lung,UBERON:0002048,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 cases","COVID-19 infected patients",23,19,,WMS,,,DESeq2,1.0e-11,true,,,,,increased,,,,,Complete,
"Experiment 1","Study 450","United Kingdom","Mus musculus",Feces,UBERON:0001988,"viral pneumonia",EFO:0007541,"Day 0","Day 7","Mice assessed 7 days after infection",,,,16S,4,Illumina,"ANOVA,DESeq2",0.05,true,,,,,unchanged,,,unchanged,,Complete,
"Experiment 1","Study 451",Portugal,"Homo sapiens",Saliva,UBERON:0001836,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Medicated Type II Diabetes individuals","Medicated Type II Diabetes individuals",24,22,"2 months",16S,"3,4",Illumina,"ANCOM,Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,Chloe
"Experiment 1","Study 452",China,"Homo sapiens",Placenta,UBERON:0001987,"gestational diabetes",EFO:0004593,"euglycemic (control) singleton pregnant women","Pregnant women with Gestational Diabetes Mellitus","Pregnant women with Gestational Diabetes Mellitus (GDM) who had prenatal care at Xinhua Hospital, a tertiary hospital in Shanghai, and were admitted to the hospital for cesarean deliveries",7,8,"Women who were treated with any antibiotics during pregnancy",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,increased,,,increased,Complete,
"Experiment 1","Study 453","United States of America","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Non-infected patients with unrelated respiratory medical conditions","SARS-CoV-2 infected patients",">age 18, positive nasopharyngeal swab for SARS-CoV-2 by PCR, COVID-19 related symptoms present, weight > 110 pounds",34,50,,16S,"1,2,3",Illumina,edgeR,0.05,true,,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 1","Study 455",Singapore,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,pregnancy,EFO:0002950,"non pregnant women without gingivitis","pregnant women without gingivitis","Pregnant women sampled between 21 to 24 wk of gestation without gingivitis",10,10,"6 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,increased,,decreased,increased,Complete,Fatima
"Experiment 1","Study 456",China,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Patients with Type 2 Diabetes who were admitted to the First Affiliated Hospital of Zhengzhou University from October 2018 to October 2019;  The diagnostic criteria of diabetes mellitus were as follows: (1) twice fasting plasma glucose ðFPGÞ ≥ 7:0 mmol/L, (2) twice oral glucose tolerance test (OGTT ≥ 11:1 mmol/L), and (3) diabetic symptoms (polyuria, thirst, drinking more water, and unexplained weight loss) accompanied with twice random blood glucose ≥ 11:1 mmol/L.",179,137,"long-term antibiotic application",16S,"3,4",Illumina,"LEfSe,Mann-Whitney (Wilcoxon)",0.05,,2,"age,sex",,,decreased,,,,,Complete,
"Experiment 1","Study 457",China,"Homo sapiens",Saliva,UBERON:0001836,periodontitis,EFO:0000649,"Healthy controls","Individuals diagnosed with Periodontitis","Individuals with Peridontitis; Periodontal disease was assessed by determining the PD, CAL, BI, GI, and PLI, which were measured at six sites (i.e., mesiobuccal, buccal, distobuccal, distolingual, lingual, and mesiolingual) according to the Community Periodontal Index by an experienced dentist. Periodontitis patients had a PD of ≥ 5 mm and a CAL of ≥ 3 mm.",27,31,"patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,increased,,,Complete,Claregrieve1
"Experiment 1","Study 458",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Non-intubated patients with non-incubation viral pneumonia or non-incubation non-infectious diseases","COVID-19 patients","Intubated patients with critically severe COVID-19 infection",54,50,,WMS,,"BGISEQ-500 Sequencing",PERMANOVA,0.05,false,,,,,decreased,,,,,Complete,Fatima
"Experiment 1","Study 459","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","COVID-19 positive patients","Patients who are COVID-19 positive by RT-PCR",10,9,,16S,4,Illumina,DESeq2,0.05,false,,,,unchanged,unchanged,,unchanged,,unchanged,Complete,Chloe
"Experiment 1","Study 460",Israel,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative patients","COVID-19 positive patients","SARS-CoV-2 presence by RT-PCR",29,26,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,,,,,Complete,
"Experiment 1","Study 462",Poland,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,"Healthy controls","Individuals diagnosed with Type 1 Diabetes Mellitus","Individuals diagnosed with Type 1 Diabetes Mellitus in 2012–2015 at the Department of Metabolic Diseases, University Hospital, Krakow, Poland",26,24,"30 days",16S,,Illumina,ANOVA,0.05,true,,,,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 463",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Patients 6 months post-COVID-19 infection",30,30,"Any antibiotic or prebiotic use in previous months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,body mass index,sex",,,,decreased,,,,Complete,
"Experiment 1","Study 464",China,"Homo sapiens",Tongue,UBERON:0001723,COVID-19,MONDO:0100096,"Healthy controls","Confirmed COVID-19 patients","Suspected COVID-19 cases with one of the following etiological or serological evidence:
(1) Fluorescence RT-PCR detects the positive of the COVID-19 virus nucleic acid.
(2) Viral gene sequencing finds highly homologous to COVID-19 virus",100,48,"Receipt of antibiotics and/or probiotics within 8 weeks prior to enrollment",16S,"3,4,5",Illumina,LEfSe,0.05,false,2,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 1","Study 465",China,"Homo sapiens",Feces,UBERON:0001988,"diabetic neuropathy",EFO:1000783,"Healthy controls","Individuals diagnosed with peripheral neuropathy associated with type 2 diabetes","Individuals diagnosed with peripheral neuropathy associated with type 2 diabetes; The criteria for DPN were as follows: spontaneous limb pain, symmetrical or unilateral limb numbness, sensation of dullness and body tension, muscle weakness, weakened or absent tendon reflexes, and significant decreases in sensory and motor nerve conduction velocities as revealed via electromyography indicating the positive involvement of two or more nerves and normal arterial pulses in the foot and back.",14,45,"3 months",16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","HER2 Positive Breast Carcinoma",EFO:1000294,"Her2 negative tumor","Her2 positive tumor","Breast cancer patients with Her2 positive tumors (human epidermal growth factor receptive 2 positive)",25,12,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,age,,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 468",Turkey,"Homo sapiens",Vagina,UBERON:0000996,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","All women in the endometriosis group had moderate to severe (stage 3–4) endometriosis according to American Fertility Society Revised Classification. 

Diagnosis of endometriosis was verified through histology.",14,14,"Participants were excluded if they had taken antibiotics within the past 8 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 469",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Non-COVID-19 controls","COVID-19 patients","Positive for infection with SARS-CoV-2 by nucleic acid testing",3,6,,WMS,,Illumina,LEfSe,0.05,false,3,"age,sex",,,unchanged,,,,,Complete,Fatima
"Experiment 1","Study 470","Austria,China,France,Germany,Italy,Japan,United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,controls,"colorectal cancer","Colorectal cancer cases from eight independent studies",392,386,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,Lwaldron
"Experiment 1","Study 471","Austria,Canada,China,France,Italy,United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,controls,"colorectal cancer cases","colorectal cancer cases",308,313,,WMS,,Illumina,"Linear Regression",0.05,true,,,,,,,,,increased,Complete,
"Experiment 1","Study 473",Italy,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","COVID-19 positive patients","Symptomatic COVID-19 positive patients",12,18,,16S,"1,2,3",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 474","Bangladesh,China,United Kingdom,United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Non-COVID patients with URTI or COPD","COVID-19 patients","Confirmed COVID-19 diagnosis by RT-qPCR",10,11,,WMS,,Illumina,Kruskall-Wallis,0.05,false,,,,,increased,,,,increased,Complete,Fatima
"Experiment 1","Study 475",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls (Group H)","Non-COVID-19 patients (Group NP)","6 COVID-19 patients, 10 non-COVID-19 patients, 2 healthy controls",13,18,,16S,4,Illumina,ANOSIM,0.05,true,,,,unchanged,,,,,decreased,Complete,
"Experiment 1","Study 476",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 patients","Patients between 25-45 years of age with documented recovery from COVID-19, detailed medical records during hospitalization and discharge certificate",7,7,"Participants instructed to avoid any drugs affecting gastrointestinal function before sampling",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,unchanged,decreased,decreased,,,Complete,Fatima
"Experiment 1","Study 477",Spain,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","Severe COVID-19 patients","Patients with confirmed COVID-19 infection and severe symptoms; required hospital admission",18,18,,16S,"3,4",Illumina,"Linear Regression",0.25,true,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 1","Study 472",China,"Homo sapiens",Feces,UBERON:0001988,"gestational diabetes",EFO:0004593,"Pregnant individuals who are normal glucose tolerance (NGT)]","Pregnant individuals with gestational diabetes","Pregnant individuals with gestational diabetes",18,15,"1 month",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 478",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Confirmed COVID-19 cases",28,31,,WMS,,MGISEQ-2000,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 1","Study 479",Italy,"Homo sapiens","oropharynx,Nasopharynx","UBERON:0001729,UBERON:0001728",COVID-19,MONDO:0100096,"Healthy controls","ICU COVID-19 patients","COVID-19 patients admitted to intensive care unit",10,10,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,decreased,decreased,,,,Complete,
"Experiment 1","Study 480",Brazil,"Homo sapiens",Vagina,UBERON:0000996,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign conditions","Confirmed endometriosis patients","Patients were assigned to the endometriosis group after endometriosis was confirmed via laparoscopic surgery and histology.",11,10,"within 30 days prior to sample collection",16S,"3,4",Illumina,DESeq2,0,false,,,,,unchanged,,unchanged,,unchanged,Complete,
"Experiment 1","Study 481",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Patients with COVID-19",5,13,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 482",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Mild COVID-19 patients","Severe COVID-19 patients","COVID-19 infected patients admitted to the ICU and requiring mechanical ventilation",8,15,,WMS,,DNBSEQ-T7,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,decreased,Complete,Fatima
"Experiment 1","Study 483",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Uninfected controls, pneumonia patients, antibiotics treated COVID-19 patients","Antibiotic-naive COVID-19 patients","COVID-19 patients hospitalized with SARS-CoV-2 infection confirmed by 2 consecutive RT-PCR tests, not treated with antibiotics",29,7,,WMS,,Illumina,"Linear Regression",0.05,true,,,"age,antibiotic exposure,comorbidity,sex",,,,,,,Complete,Chloe
"Experiment 1","Study 484",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative patients with fever and cough","COVID-19 positive patients","COVID-19 positive patients with fever and cough symptoms",11,11,,WMS,,MGISEQ-2000,ANOVA,0.05,false,,,,decreased,unchanged,,,,unchanged,Complete,Fatima
"Experiment 1","Study 485",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"COVID-19 patients without fever","COVID-19 patients with fever","Symptomatic patients with confirmed COVID-19 (positive for COVID-19 nucleic acid by real-time RT-PCR from throat swab specimens) and fever (axillary temperature > 37.3 degrees Celsius)",11,20,,WMS,,MGISEQ-2000,LEfSe,0.05,false,2,,,,unchanged,unchanged,,,,Complete,Fatima
"Experiment 1","Study 486",India,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Asymptomatic COVID-19 patients","Asymptomatic COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with no symptoms",10,10,,16S,"3,4",,LEfSe,0.05,false,2,,,,,,,,,Complete,Fatima
"Experiment 1","Study 487","South Korea","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Infected COVID-19 samples (respiratory positive)","Recovered COVID-19 samples (respiratory negative)","Samples from symptomatic/mild COVID-19 patients collected on or after negative conversion for SARS-CoV-2 RNA from the respiratory tract",12,12,"No history of antibiotics or probiotics",16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,increased,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 488",China,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"Aged from 20 to 64; and staple food of all participants were collected,
Inclusion criteria met the Rome IV diagnostic criteria [19] for IBS-D. Gender, age, BMI and staple food of all participants were collected",30,30,"Exclusion criteria for all subjects included: (1) taking antibiotics, probiotics, or other treatments, within 4 weeks; (2) inflammatory bowel disease, peptic ulcer, diverticulitis or infectious gastroenteritis; (3) pregnant, menstruating and lactating women; (4) any psychiatric comorbidity; (5) excessive physical exercise.",16S,4,Illumina,"Mann-Whitney (Wilcoxon),T-Test",0.05,false,4,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 489",Italy,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"Pneumonia control patients (COVID-negative)","COVID-positive patients admitted to ICU (i-COVID-19)","COVID-19 patients with nasopharyngeal swab positive for SARS-CoV-2, > 18 years of age admitted in ICU",8,6,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",DESeq2,0.05,true,,,,,unchanged,decreased,,,,Complete,Fatima
"Experiment 1","Study 490",Japan,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS,"All patients were diagnosed with IBS after conducting a medical interview based on Rome II criteria and positive judgment by a Rome II modular questionnaire retrospectively and positively fulfilling Rome III criteria. According to Rome II criteria related to bowel habits, 11 subjects had constipation-predominant IBS (IBS-C), eight had diarrhoea-predominant IBS (IBS-D) and seven had mixed IBS (IBS-M).",26,26,"In the previous study, agents containing probiotics were administered to humans and stopped thereafter. On day 10 after stopping the administration of probiotics, levels of these bacteria returned to the levels before administration of probiotics. No subject received antibiotics during the abstention period.",WMS,,RT-qPCR,"ANOVA,Chi-Square,Mann-Whitney (Wilcoxon),Spearman Correlation,T-Test",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 491","United States of America","Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS,"Participants met Pediatric Rome III criteria for IBS7 (Table 1). Subtyping of IBS was based on previous recommendations for IBS in adults because no Pediatric Rome subtype criteria exist for children.",22,22,"Exclusion criteria included use of antibiotics, probiotics, or steroids (oral or nasal [inhaled]) within 6 months of sampling. Four children withdrew from the study (2 children declined after the home visit; 1 child consumed an antibiotic; 1 child took a probiotic).",16S,"1,2,3,4,5","PhyloChip,Roche454","Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 492",India,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals having Type 2 Diabetes Mellitus without Diabetic Retinopathy","Individuals having Type 2 Diabetes Mellitus without Diabetic Retinopathy (T2D group); the T2DM cohort included subjects (a) positive for at least one of the three biochemical tests (HbA1c > 7%, fasting blood sugar > 120 mg% and post-prandial blood sugar > 200 mg%); (b) had history of taking anti-diabetic medications (Metformin or combinations of Metformin and / or Insulin) and (c) had no clinical signs of DR",30,24,"3 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,diet,region,sex",,,increased,increased,unchanged,,increased,Complete,Claregrieve1
"Experiment 1","Study 494",China,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus; T2D subjects were required to meet the following inclusion criteria: (i) fasting blood glucose test (FBG) 7 mmol/L or greater and/or 2-h fasting oral glucose tolerance test (OGTT) 11.1 mmol/L or greater35; (ii) no previously received pharmacologic treatment; and (iii) body mass index (BMI) > 18.0 kg/m2.",40,20,"2 months",16S,"4,5",Illumina,,0.05,true,,,,,unchanged,decreased,unchanged,,,Complete,
"Experiment 1","Study 495",China,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus; Participants with T2DM were required to meet the following inclusion criteria: (i) fasting blood glucose test (FBG) ≥7 mmol/L and/or 2-h fasting oral glucose tolerance test (OGTT) ≥11.1 mmol/L; and (ii) all cases of T2DM were newly diagnosed.",60,60,"2 months",16S,"4,5",Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 496",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Patients with COVID-19",40,62,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,decreased,,,,Complete,Fatima
"Experiment 1","Study 498","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Asymptomatic uninfected controls","COVID-19 patients","Confirmed symptomatic mild to moderate COVID-19 patients > age 18, nonhospitalized",21,38,"2 weeks",16S,4,Illumina,DESeq2,0.05,true,,,"age,sex",,unchanged,,,unchanged,increased,Complete,
"Experiment 1","Study 493",China,"Homo sapiens","Skin of body",UBERON:0002097,Vitiligo,EFO:0004208,"Vitiligo patients before narrowband UV (NBUVB) light irradiation in normal skin (NF group)","Vitiligo patients after NBUVB irradiation on normal skin (NB group)","Vitiligo patients after NBUVB irradiation on normal skin (NB group); Vitiligo patients recruited from Weifang Medical University Hospital, Shandong, China, from February 2018 to January 2019.",15,15,"6 months",16S,"3,4",Illumina,T-Test,0.05,true,,,,,unchanged,increased,unchanged,,,Complete,
"Experiment 1","Study 500",Italy,"Homo sapiens",Lung,UBERON:0002048,COVID-19,MONDO:0100096,"Non-COVID-19 pneumonia patients","COVID-19 patients","Patients positive for SARS-CoV-2 by RT-PCR on nasopharyngeal swabs or lower respiratory tract samples",24,24,,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,,unchanged,unchanged,Complete,
"Experiment 1","Study 499",Finland,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-A,"IBS patients fulfilled the Rome II criteria. Alternating IBS (IBS-A)",46,19,,16S,,"Human Intestinal Tract Chip",T-Test,0.05,true,,,,,,,,,,Complete,Lwaldron
"Experiment 1","Study 501","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Women scheduled for laparoscopic surgery for benign uterine/ ovarian conditions as well as women with Stage I or Stage II endometriosis","One (1) Stage III Endometriosis patient","One (1) Stage III Endometriosis patient was diagnosed via laparoscopic surgery and categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",17,1,None,16S,"3,4,5",Illumina,PERMANOVA,0.05,false,,,,,,,,,increased,Complete,
"Experiment 1","Study 502",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS,"Fulfilled the Rome III criteria for the diagnosis of IBS.",24,19,"Exclusion criteria included pregnancy or lactation, chronic intestinal disease (i.e., inflammatory bowel disease or celiac disease) or severe systemic disorders, lactose intolerance or food allergies. Patients who in the 2 mo prior to study entry had taken medication, such as antibiotics, corticosteroids or functional foods containing pre or probiotics, were also excluded from the study.",16S,,HTF-Microbi.Array,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 505",Netherlands,"Homo sapiens","mucosa of small intestine,Feces","UBERON:0001988,UBERON:0001204","irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS,"Twelve male and 29 female IBS patients included in this study fulfilled the Rome II criteria for IBS and were categorized as diarrhea predominant (IBS-D), constipation predominant (IBS-C) or alternating IBS subgroup (IBS-A)",26,41,"Subjects taking medication known to influence bacterial composition and gastrointestinal motility, especially antimicrobial medications and/or probiotics were excluded from the study.",,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 1","Study 506",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"The diagnosis of IBS-D was defined by the Rome 3 criteria",18,14,"Patients with lactose intolerance and organic diseases, including inflammatory
bowel diseases, liver disease, pregnancy, and significant systemic diseases, were excluded.
Patients were free of any previous treatment, including probiotics, antibiotics, steroids, immunosuppressors, transit modulators, and antipsychotics, during the 3 months preceding inclusion.",,,RT-qPCR,"Mann-Whitney (Wilcoxon),T-Test",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 503",Switzerland,"Homo sapiens",Saliva,UBERON:0001836,"otitis media with effusion",EFO:0007415,"not treated with amoxicillin (end of treatment)","treated with amoxicillin (end of treatment)","The amoxicillin group was patients/children aged from 12 to 72 months with clinically diagnosed AOM whose care providers prescribed amoxicillin treatment. Excluded criteria contained pharyngitis.",15,18,"6 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,"antimicrobial agent",,,increased,,,,increased,Incomplete,
"Experiment 1","Study 507",Italy,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Patients before Rifaximin treatment","Patients after Rifaximin treatment","Patients affected by ulcerative colitis, Chron's disease, Irritable Bowel Syndrome, diverticular disease, and liver cirrhosis with hepatic encephalopathy consecutively treated with 1,200 mg of Rifaximin daily for 10 days.",20,20,"1 month",16S,"1,2,3",Roche454,metagenomeSeq,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 1","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,neoplasm,EFO:0000616,"BNH with TNBC normal tissue","BNH with TNBC tumor tissue","Tumor tissue from black non-hispanic patients with triple negative breast cancer",7,7,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,Chloe
"Experiment 1","Study 510",Brazil,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,periodontitis,EFO:0000649,"patients with no rheumatoid arthritis","patients with rheumatoid arthritis","patients with rheumatoid arthritis",20,21,"3 months",16S,4,Illumina,LEfSe,0.05,true,,"age,sex",,,increased,,increased,,increased,Complete,Fatima
"Experiment 1","Study 511",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Patients with confirmed COVID-19 infection per 2 sequential positive RT-PCR tests",44,140,"No antibiotics or probiotics within 8 weeks prior to COVID-19 infection (also true for controls)",16S,"3,4",Illumina,"LEfSe,Linear Regression",0.05,true,2,"age,sex",,,,,,,decreased,Complete,Fatima
"Experiment 1","Study 512","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls and healthcare workers","COVID-19 positive patients","Patients positive for SARS-CoV-2",66,68,,16S,4,Illumina,LEfSe,0.05,true,2,,,,unchanged,,,,,Complete,
"Experiment 1","Study 513","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","COVID-19 positive patients","Patients who were confirmed PCR positive for SARS-CoV-2",20,79,,WMS,,Illumina,"Fisher's Exact Test",0.05,false,,,,,unchanged,,,unchanged,unchanged,Complete,
"Experiment 1","Study 514",Japan,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Women scheduled for laparoscopic surgery for benign uterine/ ovarian conditions","Stage 3/4 endometriosis patients","Women were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",39,30,"No antibiotics were taken 6 months prior to sample collection",16S,"5,6","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,unchanged,Complete,
"Experiment 1","Study 515",China,"Homo sapiens","Uterovesical pouch",UBERON:0011049,endometriosis,EFO:0001065,"Non-endometriosis patients with infertility","Endometriosis patients with infertility","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",30,55,None,16S,"4,5","Ion Torrent",T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 516",China,"Mus musculus",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy mice","Mice who were injected with endometrial tissues","Researchers induced endometriosis models by intraperitoneal injection of endometrial tissues to mimic endometriosis formation in humans.",8,,N/A,16S,4,Illumina,T-Test,0.05,,,,,,unchanged,unchanged,unchanged,,,Complete,Fatima
"Experiment 1","Study 517",Japan,"Homo sapiens",Endometrium,UBERON:0001295,endometriosis,EFO:0001065,"Fertile women being operated on for other gynecological issues","Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM). 16 of the control patients and 16 of the endometriosis patients received GnRHa (gonadotropin releasing hormone agonist) treatment for 4-6 months.",32,32,None,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 518",China,"Homo sapiens",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","Women were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",12,12,None,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,unchanged,,decreased,Complete,
"Experiment 1","Study 519","United States of America","Mus musculus",Feces,UBERON:0001988,Endometriosis,EFO:0001065,"Non-endo mice","Endo mice","Uterine tissue was transplanted onto the peritoneal wall in order to induce endometriosis in these mice.",5,5,"Mice had never been given antibiotics prior to the start of the experiment",16S,,Illumina,T-Test,0.05,false,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 1","Study 520",Brazil,"Homo sapiens",Vagina,UBERON:0000996,endometriosis,EFO:0001065,"Stage 1/2 Endometriosis patients","Stage 3/4 Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM). This study was comparing patients with different stages of endometriosis to each other.",21,14,"Participants were excluded if they had taken antibiotics within the past 3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",,false,,,,,,,,,,Complete,
"Experiment 1","Study 521","South Korea","Homo sapiens","Uterovesical pouch",UBERON:0011049,Endometriosis,EFO:0001065,"Surgical controls","Stage 3/4 endometriosis patients","Stage 3/4 endometriosis patients that were diagnosed with endometriosis via laparoscopic surgery; stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",45,45,"Patients were excluded if they had taken antibiotics 12 weeks prior to sample collection",16S,"3,4",Illumina,PERMANOVA,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 522",China,"Homo sapiens","Lower part of vagina",UBERON:0015243,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign tumors","Endometriosis patients","This experiment only curates unknown species up to the genus level so it needs to be deleted.",14,36,"This experiment only curates unknown species up to the genus level so it needs to be deleted.",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 523",China,"Mus musculus",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Non-endo mice","Endo mice","Endometriosis was induced in female mice via transplantation of endometrial fragments.",6,6,N/A,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 1","Study 524","United Kingdom","Homo sapiens",Feces,UBERON:0001988,"non-alcoholic steatohepatitis",EFO:1001249,"Healthy controls","Individuals diagnosed with  Nonalcoholic steatohepatitis (without cirrhosis)","Individuals diagnosed with  Nonalcoholic steatohepatitis (without cirrhosis); The Fatty Liver Inhibition of Progression (FLIP) Consortium algorithm was used as a diagnostic indicator where the histological diagnosis of NASH requires the presence of steatosis, ballooning, and lobular inflammation",76,40,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,"age,body mass index,sex",,,decreased,,,,,Complete,
"Experiment 1","Study 525",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,endometriosis,EFO:0001065,"Women without CPPS presenting for routine examinations","Women with EM-associated CPPS","Thirty-seven women with endometriosis-associated chronic pelvic pain syndrome (CPPS) confirmed  by exploratory laparoscopy or surgical pathology",66,37,"Patients were excluded if they had taken antibiotics within 14 days prior to sampling",16S,4,Illumina,T-Test,0.05,false,,age,,,,,,,increased,Complete,
"Experiment 1","Study 526",China,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Endometriosis patients","Endometriosis/ adenomyosis patients","All participants were diagnosed with endometriosis and/or adenomyosis (a condition where endometrial tissue grows into the uterine wall) through laparoscopic surgery",25,14,"No antibiotic use within 30 days",16S,,Illumina,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 527",Sweden,"Homo sapiens",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy controls taken from a larger cohort study","Endometriosis patients","Patients with a diagnosis of endometriosis, confirmed by laparoscopy or laparotomy.",198,66,,16S,"1,2,3",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,sex,smoking status",,,decreased,,,,,Complete,Claregrieve1
"Experiment 1","Study 528","United States of America","Mus musculus",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Non-endo mice","Endo mice","Endometrial tissue was transplanted into the peritoneal cavity to simulate endometriosis",8,8,"None were given prior to the start of the experiment. It should be noted that this experiment found no significant differences of any of the taxa examined on both the genus and family level. Thus, there are no relevant signatures to report.",16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 529",China,"Homo sapiens",Saliva,UBERON:0001836,"rheumatoid arthritis,osteoarthritis","EFO:0000685,MONDO:0005178","healthy controls","arthritis patient",arthritis,155,177,,16S,,Illumina,LEfSe,0.05,true,2,,,,increased,,,,increased,Complete,Chloe
"Experiment 1","Study 531",China,"Homo sapiens",Saliva,UBERON:0001836,"rheumatoid arthritis",EFO:0000685,"healthy controls","rheumatoid arthritis patient","rheumatoid arthritis patient",23,27,"Individuals having a history of antibiotics treatment or surgery in the last 3 months were excluded",16S,"3,4",Illumina,LEfSe,0.05,true,3,"age,ethnic group,sex",,,unchanged,,,,,Incomplete,
"Experiment 1","Study 532","United States of America","Homo sapiens",Feces,UBERON:0001988,"rheumatoid arthritis",EFO:0000685,"healthy controls","rheumatoid arthritis patients","rheumatoid arthritis patients",32,40,"Any patient or control on antibiotics, consuming probiotics, or having a known history of inflammatory bowel disease or other autoimmune diseases like diabetes and multiple sclerosis were excluded.",16S,"3,4,5",Illumina,LEfSe,0.05,true,2,"age,sex",,,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 535",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic untreated","Antibiotic treated","subjects receiving antibiotics within 1 month prior to visiting an ELDERMET Clinic",143,42,,16S,4,Roche454,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,true,,age,,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 536",Denmark,"Homo sapiens",Feces,UBERON:0001988,azithromycin,CHEBI:2955,"The group given a placebo","The group given an azithromycin oral solution","1-3-year-olds diagnosed with recurrent asthma-like symptoms from the COPSAC2010 cohort. Exclusion criteria included macrolide allergy, heart, liver, neurological, kidney disease, and or one or more clinical signs of pneumonia. Participants were prescribed a 3-day course of oral azithromycin solution of 10mg/kg per day.",33,39,"none mentioned",16S,4,Illumina,"Linear Regression",0.05,false,,,,,decreased,,,,decreased,Complete,
"Experiment 1","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"Antimicrobial agent",CHEBI:33281,"baseline of the ciprofloxacin treated","ciprofloxacin treated","UTI patients treated with ciprofloxacin 500mg twice daily",10,10,"2 months",16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with idiopathic parkinson's disease","Patients with idiopathic parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,193,"1 month",16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,increased,,,increased,Complete,Fatima
"Experiment 1","Study 541",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls","Schizophrenic patients (ARSCZ, FESCZ)","Only acutely relapsed schizophrenic (ARSCZ) and first-episode schizophrenic (FESCZ) patients were recruited in this study. The current episode of ARSCZ patients was required to happen in the last three months. ARSCZ patients were free of treatment for at least six months. The current episode of FESCZ patients was required to happen in the last year. FESCZ patients did not take any antipsychotics, or their accumulative dosages of antipsychotics intake were much less than the effective dosage (generally less than 100 mg chlorpromazine equivalents in the last two weeks based on the transformation method).",81,90,,WMS,,"BGISEQ-500 Sequencing,Illumina","Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,diet,sex",,,increased,,,,increased,Complete,
"Experiment 1","Study 542","United States of America","Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,,"Antibiotic treated","Healthy adults who had not taken any antibiotics within the previous year were recruited to donate stool samples before, during, and after a short course of ciprofloxacin (Cp) (500 mg twice a day for 5 d).",,3,"1 year",16S,"3,4,5,6",Roche454,,0.05,,,,,,decreased,,,,decreased,Incomplete,
"Experiment 1","Study 545","United States of America","Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"7 week old (young) mice before antibiotic treatment","7 week old (young) mice 10 days after antibiotic treatments","7-week old mice (young mice) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.",5,5,"Mice were not previously given antibiotics before the study",16S,,Illumina,DESeq2,0.05,true,,,sex,,decreased,,decreased,,,Complete,
"Experiment 1","Study 546",India,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Non-infected controls","COVID-19 cases","COVID-19 infected individuals",26,63,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 1","Study 547",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 patients","Health-care workers who recovered from COVID-19 and were discharged from the hospital between May and July 2020",14,15,"3 months prior",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,unchanged,,,unchanged,Complete,
"Experiment 1","Study 548",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 cases","Confirmed COVID-19 cases by RT-PCR",48,94,,16S,"3,4",Illumina,LEfSe,0.05,false,2.5,"age,body mass index,sex",,,decreased,,decreased,,,Complete,
"Experiment 1","Study 550",Norway,"Homo sapiens",Saliva,UBERON:0001836,"juvenile idiopathic arthritis",EFO:0002609,"healthy controls","JIA patients","children with juvenile idiopathic arthritis",34,59,"Patients on antibiotics prior to sampling were excluded.",16S,"1,2,3",Illumina,LEfSe,0.1,true,2.5,"age,sex",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 549",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,Control,"HIV Positive patients","HIV-infected participants from the HIV outpatient clinic.",,,"None of the respondents included in the final analysis reported antibiotics usage at the time of the study visit at which time fecal samples were collected.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,sex",,,decreased,,,,decreased,Incomplete,
"Experiment 1","Study 438",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Untreated controls (week 4)","Antibiotic treated (week 4)","Had received parenteral antibiotic treatment with a combination of ampicillin and gentamicin within 48 hours of birth",9,9,"excluded if they required oral antibiotics (no time frame given)",16S,4,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,decreased,decreased,,,,Complete,Chloe
"Experiment 1","Study 551","United States of America","Mus musculus",Feces,UBERON:0001988,"high fat diet",EFO:0002757,"high fiber","low fiber","Mice fed high-fat diet with 50g cellulose (vs. high-fat diet with 200g inulin for high fiber group)",,,None,16S,4,Illumina,T-Test,0.05,false,,,,,,,,,,Incomplete,
"Experiment 1","Study 553","United Kingdom","Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"spontaneous abortion",EFO:1001255,"Viable control pregnancy","First or second-trimester miscarriage",,81,77,,16S,"1,2",Illumina,Chi-Square,0.05,,,"age,body mass index,gestational age",,,,,,increased,increased,Complete,Fatima
"Experiment 1","Study 555",China,"Homo sapiens",Feces,UBERON:0001988,"rheumatoid arthritis",EFO:0000685,"healthy controls","rheumatoid arthritis patient","rheumatoid arthritis patient",20,30,"Potential volunteer enrolees (including patients and or healthy individuals) were excluded from this study if having: (1) ingested antibiotics in the last 6 months,",16S,"3,4",Illumina,LEfSe,0.05,true,2,"age,sex",,,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 554",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with parkinson's disease","Diagnosed with PD according to the diagnostic criteria proposed by the International Parkinson Disease and Movement Disorder Society in 2015 (Postuma et al., 2015) in the First Hospital of Jilin University.",48,51,"No antibiotic use for at least 3 months prior to the study. 

Subjects with a history of using medications that have been shown to affect gut microbiota, including COMT inhibitors, anticholinergics, anti-secretory drugs, or cardiological drugs within the 3 months before the start of the study were excluded.",16S,4,Illumina,T-Test,0.05,,4,age,,,increased,increased,increased,,decreased,Complete,
"Experiment 1","Study 552","United States of America","Homo sapiens",Vagina,UBERON:0000996,"gestational age",EFO:0005112,"Week 24","Week 36","gestational age of 36 weeks",56,57,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 1","Study 557","United States of America","Homo sapiens",,,,,,,"two or more of the following clinical signs and symptoms with onset ≤72 h at screening: dysuria, frequency, urgency, or lower abdominal pain They were required to have pyuria (≥10 white blood cells/mm3 or the presence of leukocyte esterase) and/or nitrite from a pretreatment urine sample.",22,22,"Participants who had any preexisting condition that may have impacted gepotidacin absorption, distribution, metabolism, or excretion were excluded.",,,,,,,,,,,,,,,,Incomplete,
"Experiment 1","Study 558","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"received oral-i.v.-administered GSK1322322 (prestudy)","received oral-i.v.-administered GSK1322322 (end-of-study)","received oral-i.v.-administered GSK1322322",38,38,,16S,4,Roche454,ANOVA,0.05,true,,,,,,decreased,,,,Complete,
"Experiment 1","Study 559","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"regular fiber omnivore diet","no fiber liquid omnivore diet","omnivores randomized to an enteral liquid nutrition diet devoid of any fiber (but similar in profile to regular food omnivore group)",10,10,"6 months",16S,,Illumina,"Linear Regression",0.05,true,,,age,,unchanged,,,,,Complete,Chloe
"Experiment 1","Study 560",Germany,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy men without Parkinsons's Disease.","Men with Parkinson's Disease.","Only early stage PD men who were naïve to L-DOPA therapy as diagnosed according to the UK Brain Bank criteria.",28,30,"The use of antibiotics in the past three months in principle was an exclusion criterion. However, we included three PD patients and three controls despite the intake of antibiotics for one to three days in a period of 28–34 days prior to feces sampling as the omission of those cases from the analyses did not change any result",16S,,Illumina,Kruskall-Wallis,0.1,true,,"age,sex",,,,,,,,Incomplete,
"Experiment 1","Study 561","United States of America","Homo sapiens","Major salivary gland",UBERON:0001829,"Parkinson's disease",MONDO:0005180,"Healthy age-sex matched controls without Parkinson's disease.","Participants with early stage Parkinson's Disease.","Subjects included in the Parkinson’s disease (PD) group had been previously diagnosed by a neurologist and met the general diagnostic criteria for early PD.",36,48,"None of the participants underwent antibiotic use in the past month prior to sample collection.",16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,age,,,unchanged,,,,,Complete,
"Experiment 1","Study 562","Italy,Luxembourg,United States of America","Homo sapiens",Vagina,UBERON:0000996,healthy,,,"healthy adult vagina 50% up",,,96,No,WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 1","Study 564",Italy,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Control group (@7 days)","IAP group (@7 days)","infants born to GBS-positive mothers who had received IAP. According to the institutional treatment protocol for GBS prophylaxis (derived from the Centers for Disease Control and Prevention guidelines (13)), intravenous ampicillin was given every 4 hours until delivery (first dose 2 g, following doses 1 g each).",49,35,"The mother had received any antibiotic other than IAP in the 4 weeks before delivery.
Maternal IAP was performed with antibiotics other than ampicillin, such as erythromycin.",16S,,,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 566",Italy,"Homo sapiens",Feces,UBERON:0001988,"juvenile idiopathic arthritis",EFO:0002609,HLAB27-,HLAB27+,"enthesitis-related arthritis (JIA-ERA) patients with HLA-B27 allele",10,9,"3 months",16S,"5,6",Roche454,LEfSe,0.05,true,2,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 568",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","NPD group: patients suffering with suffering with with PD for less than 1 year and before treatment.","New Parkinson's disease patients: patients suffering with with PD for less than 1 year and before treatment.",68,13,"The use of any antibiotics or probiotics within 90 days before collection of the samples.",16S,,Illumina,Metastats,0.05,false,,"age,life style",,,unchanged,unchanged,unchanged,,,Complete,Rimsha
"Experiment 1","Study 569",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","colorectal cancer patients","diagnosed with primary early-stage CRC (aged 46-75 years old) between January 2011 and March 2012",45,53,"1 month",16S,,RT-qPCR,T-Test,0.05,,,"age,body mass index,sex",,,,,,,,Complete,Fatima
"Experiment 1","Study 570","South Korea","Homo sapiens",,,,,"female healthy control","female with early RA","female early rheumatoid arthritis patients",25,29,"People using antibiotics, probiotics, or prebiotics at the time of sample collection were excluded
from subject selection.",16S,,Illumina,LEfSe,0.1,true,3,,,,increased,,,,increased,Complete,
"Experiment 1","Study 571",,"Homo sapiens",Feces,UBERON:0001988,"osteoarthritis, knee",EFO:0004616,"Normal Vitamin D status","Knee osteroarthritis","Knee osteoarthritis",6,4,"excluded if antibiotics for last 12 weeks",16S,"3,4",Illumina,LEfSe,0.05,,2,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 1","Study 572","United States of America","Homo sapiens",,,,,"healthy controls","new-onset rheumatoid arthritis","new-onset rheumatoid arthritis",44,28,"recent (<3 months prior) use of any antibiotic therapy",16S,"1,2",,LEfSe,0.05,true,2,,,,,,,decreased,,Incomplete,
"Experiment 1","Study 573",China,"Homo sapiens",Feces,UBERON:0001988,,,"Healthy Controls (HC)","Colorectal Cancer (CC)","Patients who visited the department of gastroenterology of Tianyou hospital of Wuhan from January 2017 to December 2017 and received colonoscopy and histopathological examination were recruited to the study. Patients with colorectal adenocarcinoma were recorded as the colorectal cancer (CC) group.",42,51,"2 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,decreased,,,decreased,Complete,Fatima
"Experiment 1","Study 574","Russian Federation","Homo sapiens",Feces,UBERON:0001988,"Antimicrobial agent",CHEBI:33281,"azithromycin-lactulose treated (day 0)","azithromycin-lactulose treated (day 18)","administered a single daily dosage of 10 mg/kg body weight azithromycin in addition with 20 mg/kg body weight lactulose per day, as powder for oral suspension.",42,42,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,age,,,increased,,,,unchanged,Complete,
"Experiment 1","Study 575",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Control group","perinatal antibiotics","postnatal antibiotics during the first week of life, or to any maternal antibiotics within 1 week before delivery, the IAP group received only IAP (n=27), the postnatal group was exposed to empirical postnatal intravenous antibiotics within 24 h after birth (n=24), and the IAP + postnatal group received both IAP and postnatal intravenous antibiotics (n=22)",27,73,,16S,,"Ion Torrent",T-Test,0.05,,,,,unchanged,unchanged,,,,,Complete,
"Experiment 1","Study 576","United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"contemporaneous patients awaiting elective surgery for nononcologic conditions",adenocarcinoma,"newly diagnosed, histologically confirmed adenocarcinoma of the colon or rectum",94,47,"1 year",16S,"3,4",,"Mann-Whitney (Wilcoxon),T-Test",0.05,true,,"body mass index,sex",,,,,,,,Complete,
"Experiment 1","Study 578","Belgium,Poland","Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"Control group","Antibiotic treated","receiving nitrofurantoin treatment (100 mg three times daily for 3–15 days)",5,8,"2 months",16S,"3,4,5",Roche454,"Linear Regression",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 577","United States of America","Homo sapiens",Sputum,UBERON:0007311,Asthma,MONDO:0004979,Female,Male,"Male participants",32,15,"1 month",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 1","Study 580","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Human immunodeficiency virus",NCBITAXON:12721,"HIV-uninfected individuals","HIV+ individuals","People with HIV",93,75,"5 days",16S,4,Illumina,LEfSe,0.05,false,2,,,,decreased,,,,,Complete,Claregrieve1
"Experiment 1","Study 581",China,"Homo sapiens",Feces,UBERON:0001988,epilepsy,EFO:0000474,"Drug sensitive epilepsy","Drug resistant epilepsy","Drug resistant epilepsy patients were defined according to the 2015 International League Against Epilepsy (ILAE)",49,42,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,increased,increased,increased,,,Complete,Lwaldron
"Experiment 1","Study 582",Spain,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy controls","CRC patients","patients with gastrointestinal symptoms referred for colonoscopy",77,89,none,16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,Rimsha
"Experiment 1","Study 583","United States of America","Homo sapiens",,,"HIV infection",EFO:0000764,,,,,,,16S,,,,,,,,,,,,,,,Incomplete,
"Experiment 1","Study 584",China,"Homo sapiens",Feces,UBERON:0001988,"precancerous colorectal adenoma",,"normal participants","cra patients","patients with precancerous colorectal adenoma",24,20,none,16S,"3,4",Illumina,"Linear Regression,Mann-Whitney (Wilcoxon)",0.03,false,,sex,,,,,,,,Complete,
"Experiment 1","Study 585","China,Germany,Ireland,Malaysia,Netherlands,Spain,United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","CRC patients","patients diagnosed with colorectal cancer",,,,16S,,"Illumina,Roche454",,,,,,,,,,,,,Incomplete,
"Experiment 1","Study 587",Bangladesh,"Homo sapiens","Pair of lungs",UBERON:0000170,"nicotine dependence,smoking behavior","EFO:0003768,EFO:0004318","Non smoker","Current Smoker","The relative abundance of bacterial taxa along the Erysipelotrichi-to-Catenibacterium lineage was significantly higher in current smokers compared to never-smokers.",151,62,"1 month.",16S,"3,4",Illumina,"Beta Binomial Regression,Chi-Square,Logistic Regression",0.05,true,,"age,body mass index,sex",,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 588",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy subjects","colorectal cancer patients","persons aged 25–95 years old with cancerous large intestine tumor symptoms",17,21,"1 month",16S,"3,4",Illumina,,0.05,true,2,,,,increased,increased,increased,,,Complete,
"Experiment 1","Study 586",Italy,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"Healthy Controls","CRC Patients","Italian patients aged 71-95 with colorectal adenocarcinoma confirmed by histological analysis undergoing surgical resections",10,10,"3 months",16S,"3,4",Illumina,"ANOSIM,T-Test",,,,,,,increased,increased,decreased,,,Complete,
"Experiment 1","Study 589","United States of America","Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy control","CRC patients","recently diagnosed colon cancer patients prior to surgery for colonic resection",11,10,"2 months",16S,4,Roche454,,0.01,false,,,,,,,,,,Complete,
"Experiment 1","Study 590",Mozambique,"Homo sapiens",Feces,UBERON:0001988,"Human immunodeficiency virus",NCBITAXON:12721,"HIV-1-negative individuals","Recently HIV-1 infected individuals","Individuals with recent HIV infection (RHI), defined as a negative or indeterminate rapid test serology (first test negative or first test positive and second test negative) and positive HIV-1 viremia",54,49,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,body mass index",,,unchanged,unchanged,unchanged,,increased,Complete,Claregrieve1
"Experiment 1","Study 592",Japan,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"Healthy controls","HIV Patients","Patients with HIV infection",61,71,,16S,"3,4",Illumina,LEfSe,0.05,false,3,"age,body mass index,sex",,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 595",France,"Homo sapiens",Feces,UBERON:0001988,"colorectal carcinoma",EFO:1001951,"tumor-free controls","CRC patients","patients referred for colonoscopy that had cancerous tumors",53,61,none,16S,"3,4",Illumina,"Fisher's Exact Test,Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.01,false,,,"age,body mass index,sex",,,,,,,Complete,
"Experiment 1","Study 594","United States of America","Homo sapiens","Dental plaque,Internal cheek pouch,Major salivary gland","UBERON:0016482,UBERON:0013640,UBERON:0001829",periodontitis,EFO:0000649,HIV–,HIV+,"Participants who were positive for HIV-1 infection, as verified by ELISA and confirmed by Western blot.",10,40,,16S,4,Illumina,"Wald Test",0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 1","Study 596",Canada,"Homo sapiens",Semen,UBERON:0001968,"HIV infection",EFO:0000764,"HIV-uninfected men","HIV-infected men","MSM with HIV infection",22,27,"6 months.",16S,"3,4,5,6",Roche454,ANOVA,0.05,false,,age,,,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 1","Study 597","United States of America","Homo sapiens",HIV,,,,,,,16,20,"12 months.",16S,"3,4",,,0.05,,4,,,,unchanged,,,,unchanged,Incomplete,
"Experiment 1","Study 598",Uganda,"Homo sapiens","Skin of penis",UBERON:0001331,"HIV infection",EFO:0000764,"HIV seronegative","HIV seroconverted","HIV-infected trial participants who were randomized to the delayed circumcision arm of the trial and remained uncircumcised who seroconverted during the trial",136,46,"24 months.",16S,"3,4",Illumina,PERMANOVA,0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 599","United States of America","Homo sapiens",Vagina,UBERON:0000996,"Human immunodeficiency virus",NCBITAXON:12721,"Healthy females who recieved universal placebo","Healthy females who recieved two vaginal HIV microbicidal gels","Healthy females were treated with two gels twice daily over 13.5 days.",10,25,,16S,"5,6",,,,,,,,,,,,,,Complete,
"Experiment 1","Study 600",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls","Participants with Parkinson's Disease","All PD patients eligible for this study were diagnosed with PD according to the UK Brain Bank criteria. Patients with IBS were excluded.",45,45,"Participants taking antibiotics or probiotic supplements within the three months prior to sample collection.",16S,"3,4",Illumina,LEfSe,0.05,false,2,,"age,body mass index,sex",,increased,increased,increased,,,Complete,Claregrieve1
"Experiment 1","Study 602","United States of America","Homo sapiens","Feces,Colonic mucosa","UBERON:0001988,UBERON:0000317","irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"Studied 16 patients that met the Rome III criteria for D-IBS.",21,16,"Individuals were excluded if they had a history of treatment with antibiotics or anti-inflammatory agents, including aspirin or nonsteroidal anti-inflammatory drugs (or steroids), or if they had intentionally consumed probiotics 2 mo prior to the study.",,,,,,,,,,,,,,,,Incomplete,
"Experiment 1","Study 543","United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,Complete,
"Experiment 1","Study 544",China,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy controls","CRC patients","patients diagnosed with colorectal cancer",130,130,"6 months",16S,"3,4",Illumina,"Zero-Inflated Beta Regression",0.05,true,,"age,sex","age,alcohol drinking,body mass index,sex,smoking status",,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 603",,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"non disease controls","CRC patients","patients diagnosed with colorectal cancer",632,354,,16S,,,"Chi-Square,Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,false,,,"age,body mass index,sex",,,,,,,Complete,
"Experiment 1","Study 604","United States of America","Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls free of neurological disease","Participants with Parkinson's Disease","Dataset 1. Participants with Parkinson's Disease, diagnosed by a movement disorder specialist using UK Brain Bank criteria.",136,212,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,"age,alcohol drinking,body mass index,sex",,,,,,,Complete,Claregrieve1
"Experiment 1","Study 605",Japan,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls without Parkinson's disease","Participants with Parkinson's Disease","PD was diagnosed according to the United Kingdom PD Society Brain Bank clinical diagnostic criteria.",77,80,"Individuals currently taking antibiotics or probiotic supplements within 3 months of sample collection",16S,"3,4",Illumina,LEfSe,0.05,,2,"age,sex","age,diet,sex",,increased,unchanged,,,increased,Complete,Rimsha
"Experiment 1","Study 606",Australia,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls","Participants with idiopathic Parkinson's Disease and mild symptoms.","All patients were confirmed to have idiopathic Parkinson’s disease by a movement disorders neurologist, in accordance with the United Kingdom Brain Bank criteria and mild symptoms.",7,7,"No history of antibiotic or non-steroidal anti-inflammatory drug use in the previous 3 months.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 607",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls","Participants with typical PD","PD patients were defined as typical PD, according to the inclusion criteria by the United Kingdom Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria.",162,147,"Excluded control persons who took dopaminergic medications (n = 5; intake for a different than anti-PD indication) and individuals who reported to have taken antibiotics in the last 6 months (controls: n = 20, PD: n = 13).",16S,"3,4",Illumina,"Linear Regression",0.05,,,,age,,unchanged,,,,increased,Complete,
"Experiment 1","Study 608","Italy,United States of America","Homo sapiens",oral,,healthy,,none,"healthy child oral 50% up",,,81,,16S,,Illumina,,,,,,,,,,,,,Complete,
"Experiment 1","Study 454",Ireland,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","CRC patients","patients undergoing surgery for CRC",56,59,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon),T-Test",0.05,false,,age,,,,,,,,Complete,
"Experiment 1","Study 609",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"Healthy Controls (HC)",CRC,"Patients with colorectal neoplastic lesions where tumors were removed and pathologically diagnosed with adenomatous polyp or colorectal adenocarcinoma; ages of participants ranged from 18-80.",38,79,"4 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,"age,body mass index,sex",,,,unchanged,,,,Complete,Chloe
"Experiment 1","Study 610",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowl syndrome",,"Healthy Control",constipated-IBS,"The 14 women IBS patients (age range: 36–59, mean age: 48) included in this study fulfilled the Rome II criteria for IBS. They were classified as IBS with constipation (C-IBS) by a questionnaire following the Rome II subgrouping criteria which have been recognized as valid also in the Rome III criteria.",12,14,"Exclusion criteria included organic intestinal disease, other systemic disease, previous abdominal surgery, lactation, pregnancy, dementia or inadequate cooperative capability and antibiotic therapy during the previous 2 months.",16S,,,T-Test,0.05,false,,sex,,,,,,,,Complete,Lwaldron
"Experiment 1","Study 611",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"healthy controls","CRC patients","patients diagnosed with colorectal cancer",50,50,"2 months",16S,"3,4",Illumina,"Chi-Square,Fisher's Exact Test",0.05,,,,,,decreased,decreased,,,,Incomplete,
"Experiment 1","Study 612","France,United States of America","Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"control subjects","CRC cases","pre treatment colorectal cancer cases",94,47,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"body mass index,sex","age,body mass index,sex",,,,,,,Complete,Claregrieve1
"Experiment 1","Study 613",China,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy individuals","CRC patients","patients diagnosed with colorectal cancer",33,31,,16S,"4,5",Illumina,PERMANOVA,0.001,false,,,,,,,,,,Complete,Rimsha
"Experiment 1","Study 614",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"Healthy Controls",CRC,"The CRC patients were selected according to the criteria of no other health complications, no family history of CRC or recurrence of CRC, and no radiotherapy and chemotherapy prior to surgical resection. Patients were then classified according to postoperative clinical data using the tumor-node-metastasis (TNM) staging system for malignant tumors.",30,67,"3 months",16S,"3,4",Illumina,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex",,,increased,unchanged,increased,,,Complete,Rimsha
"Experiment 1","Study 616",Finland,"Homo sapiens",,,,,"Healthy controls-without polyps","Patients with chronic rhinosinusitis","There were 3 treatment arms: oral steroid, tropical steroid, and oral antibiotic",50,50,"Patients on any oral steroid, topical steroid or oral antibiotic in a 
6-weeks period prior to enrolment, below the age of 18, had a history of  
sinus surgery, documented doxycycline or steroid allergy, 
using CYP450 inhibitors, immunosuppression, uncontrolled 
diabetes.",16S,"3,4",,,0.05,,,,,,,,,,,Incomplete,
"Experiment 1","Study 619",,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,,,,16S,2,Roche454,ANOSIM,0.001,false,,,,,,,,,,Complete,
"Experiment 1","Study 617","United States of America","Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,105,52,,16S,"3,4,5",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 1","Study 618",Austria,"Homo sapiens",,,,,"Control, mild, and moderate dementia","Severe dementia","MMSE 0-9: The Mini-Mental State Examination [19] and the clock drawing test [20] were used to quantify cognitive function. We classified cognitive dysfunction according to the German S3-guideline on Dementia 2016 as MMSE 0–9: severe; MMSE 10–19: moderate; MMSE 20–26: mild; MMSE 27–30: no dementia [21].",,,"4 weeks",16S,"1,2",Illumina,LEfSe,0.05,false,,"age,sex",,,,unchanged,unchanged,,,Complete,Lwaldron
"Experiment 1","Study 620",Japan,"Homo sapiens",Colon,UBERON:0001155,"Colorectal cancer",EFO:0005842,"Early cancer group","Invasive cancer group","Patients undergoing ESD procedure for colorectal cancer",11,14,,16S,"3,4",Illumina,"Welch's T-Test",0.05,,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 621","United States of America","Homo sapiens",Colon,UBERON:0001155,"Colorectal cancer",EFO:0005842,Placebo,Aspirin,"Experimental group took 325 mg daily aspirin over six weeks, with additional six weeks of washout",20,30,"3 months",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,Fatima
"Experiment 1","Study 622",China,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Negative control group","CRA and CRC groups","Patients with CRA (colorectal adenoma) or CRC (colorectal carcinoma) confirmed by colonoscopy and pathological examination",52,89,"6 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 623",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Patients without CRC recurrence","Patients with CRC recurrence","Patient tissues with colorectal cancer recurrence",16,15,"6 months",16S,"1,2,3",Roche454,LEfSe,,,3.5,,,,,,,,,Complete,Fatima
"Experiment 1","Study 624",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Healthy Individuals","Patients with CRC","Healthy controls and patients with CRC verified disease state via colonoscopy",384,380,"1 Month",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 625","United States of America","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,,"High SES","588 Metagenomics from infants and children of high and low socioeconomic families as continuous variables.",,,"2 weeks",WMS,,Illumina,,0.05,,,,"age,delivery procedure,race,sex",,unchanged,,,,,Complete,
"Experiment 1","Study 626","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,"White (W)","East Asian (EA)","A balanced distribution of both lean and obese adults who identified as East Asians residing within the Bay area of San Fransisco.",24,22,Unspecified,16S,"1,2,3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,decreased,,,,decreased,Complete,
"Experiment 1","Study 627","United Kingdom","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Higher SES (income= > £25,000)","lower SES (income<£25,000)","Lower socioeconomic status(SES) with higher deprivation by income <£25,000",457,342,Unspecified,16S,"1,2,3,4",Illumina,edgeR,0.05,true,,,"age,body mass index,diet",,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 628","United States of America","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"High SES","Low SES","44 healthy participants from low-income neighborhoods with a median annual income of $20,100 and a 35% unemployment rate and neighborhoods at the high end, with a median income of $129,570 and an unemployment rate under 5%).
(Income level as a continuous variable.)",44,,"3 months",16S,,Roche454,"Linear Regression,Spearman Correlation",0.05,,,,"age,alcohol drinking,body mass index,race,sex,smoking status",,decreased,,,,,Complete,
"Experiment 1","Study 629","United States of America","Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Tumor Tissue of Colorectal Cancer Cases","Adjacent Non-Tumor Tissue of Colorectal Cancer Cases","Both colon and rectal carcinomas were included on the basis of the colorectal continuum model. Patients were followed up until death or the end of follow-up.",558,558,None,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.013,true,,,"age,family history of cancer,sex",,,,,,,Complete,
"Experiment 1","Study 630",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy control (normal and a few polyps)","stage I/II (SI/II)","stage I and II CRCs",251,111,"None specified",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.005,,,,,,,,,,,Complete,
"Experiment 1","Study 631",Austria,"Homo sapiens",Feces,UBERON:0001988,"Colorectal adenoma",EFO:0005406,"Healthy Controls","Advanced Colorectal Adenoma","colorectal adenoma patients

The study was conducted both in participants of a health screening programme according to national screening recommendations for CRC49 as well as in patients with suspected CRC undergoing colonoscopy as part of the clinical workup at the Department of Internal Medicine,
Oberndorf Hospital.",55,42,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 1","Study 632","United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,"Caucasian + other races neonates by maternal profiles","African American neonate by maternal profile","Gut bacterial composition among neonates by maternal profiles. Microbiome Associated Maternal Profile (MMP3) as the most racially diverse was used for contrast.",83,92,unspecified.,16S,3,Illumina,PERMANOVA,0.05,true,,,"age,breast feeding,delivery procedure,education level,household income,marital status,smoking status",increased,,,,,increased,Complete,
"Experiment 1","Study 579",China,"Homo sapiens",Feces,UBERON:0001988,"major depressive disorder",MONDO:0002009,"Healthy controls (age 18-29)","MDD patients (age 18-29)","Subjects with major depressive disorder between the ages of 18 and 29",27,25,,16S,"3,4,5",Roche454,LEfSe,0.05,false,2,,,,,unchanged,,,,Complete,
"Experiment 1","Study 637",China,"Homo sapiens","Oral cavity",UBERON:0000167,"Colorectal cancer",EFO:0005842,"Healthy Individuals",CRC,"Patients with colorectal cancer",58,161,"Not specified",16S,"3,4",Illumina,"Welch's T-Test",0.05,,,,"age,smoking status",,increased,unchanged,increased,,,Complete,
"Experiment 1","Study 639",China,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,,"underdeveloped cities vs developed cities","7009 Individuals' fecal samples from underdeveloped cities with GDP/capita of 22.1K to 25.3K CNY, and those from developed cities with GDP/capita of 149.5K to 136.1K CNY. (continuous variables)",,"7,009",Unspecified.,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,unchanged,,,,,Complete,
"Experiment 1","Study 643",China,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,yControl,yCRC,"young-onset CRC patients (<50 years old)",148,144,"1 month",16S,"3,4",Illumina,LEfSe,0.05,,2,age,"age,sex",,increased,,,,,Complete,
"Experiment 1","Study 642",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Chinese Children (High SES, household income>RM500)","Malays Children (Moderate SES. house income=<RM500)","Gut microbiota from fecal samples of 24 Malays children whose household income =<RM500.

Note: Poverty line = RM 764($254).",17,24,unspecified,16S,"3,4,5",,PERMANOVA,0.05,true,,,,unchanged,increased,,,unchanged,increased,Complete,Fatima
"Experiment 1","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"healthy controls","colorectal adenoma","histology-proven adenoma",61,47,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,unchanged,,,Complete,
"Experiment 1","Study 645","United States of America","Homo sapiens",Feces,UBERON:0001988,"mother's own milk,donor's milk",,"DM (Donor's Milk)","MOM (Mother's own milk)","Mother's own milk group consists of infants who drank at least >50% of mother's own milk. Any less and they were placed in the other cohort.",43,74,"No antibiotic exclusions were listed as infants were at a vulnerable stage in their lives.",16S,4,Illumina,"Logistic Regression",0.05,false,,,,,unchanged,,,,increased,Complete,
"Experiment 1","Study 646","United States of America","Homo sapiens",Feces,UBERON:0001988,"Colorectal adenoma",EFO:0005406,Non-Adenoma,Adenoma,"Patients with colorectal adenoma as identified during a screening colonoscopy. Fecal
samples from patients in which at least one adenoma > 1 cm was identified were included in the “adenoma” group.",547,233,"None specified",16S,"3,4,5",Illumina,"Linear Regression",0.2,,,,,,unchanged,,,,unchanged,Complete,
"Experiment 1","Study 647","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,"White Women","Black Women","Healthy non-Hispanic black females (age ≥19 years)",33,47,"90 days",16S,4,Illumina,PERMANOVA,0.05,true,,,"age,body mass index,diet,waist circumference",,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 1","Study 648","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,"Gut microbiome of European American children (EA)","Gut microbiome of African American children (AA)","Gut microbiome of 30 African American children (18 female, 12 male; age 6 - 10 years)",30,30,unspecified,16S,"3,4,5",Illumina,PERMANOVA,0.05,true,,,"age,body mass index,education level,household income,sex",,increased,,,increased,increased,Complete,
"Experiment 1","Study 651",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Healthy volunteers (swc)","CRC patients (swp)","37-88 years of age, diagnosed with colorectal cancer (swp = gut swab)",34,32,"1 month",16S,"1,2,3",Sanger,"Mann-Whitney (Wilcoxon)",0.05,,,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 1","Study 652",Japan,"Homo sapiens",Intestine,UBERON:0000160,"intramucosal CRC",,Healthy,"Intramucosal CRC","Intramucosal CRC is in its earliest stage (stage 0) and is also known as carcinoma in situ or intramucosal carcinoma. Intramucosal CRC has not yet grown beyond the inner mucosal layer of the colorectum",10,24,"None Specified",16S,"3,4",Illumina,LEfSe,0.05,,3,,,,unchanged,,,,,Complete,
"Experiment 1","Study 653",Ireland,"Homo sapiens","Oral cavity",UBERON:0000167,"Colorectal cancer",EFO:0005842,"Healthy Controls","Individuals with CRC","Individuals diagnosed with CRC",103,99,"None specified",16S,"3,4",Illumina,ANCOM,0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 650",Indonesia,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"74 children of high SES","66 children of low SES","66 School children whose parents are low-educated and work in low-skilled labor jobs.",74,66,NA,16S,"3,4",Illumina,PERMANOVA,0.05,true,,,"age,body mass index,diet,sex",,increased,,,,unchanged,Complete,
"Experiment 1","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Caucasians,"Asian Pacific","Asian Pacific sampled from the American Gut Project (AGP) data set","1,237",88,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,decreased,decreased,decreased,,,Complete,
"Experiment 1","Study 655","United States of America","Homo sapiens","Oral opening",UBERON:0000166,"Ethnic group",EFO:0001799,"European Americans (EA)","African Americans (AA)","Mouth rinse samples of 1,058 African Americans, with about 57% population with low SES of annual household income < $15,000.",558,"1,058","12 Months",16S,"1,2,3,4",Illumina,"Logistic Regression",0.05,true,,,"age,alcohol drinking,body mass index,household income,sex,smoking status",,,,,,increased,Complete,
"Experiment 1","Study 656",Brazil,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Private school children (High SES)","Children living in slum (Low SES)","Children between 5 and 11 years old living in slums in Sao Paulo State, Brazil.",30,100,"1 month",16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 663",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Chinese,Malay,"Malay ethnic group living in the  Segamat Malaysian community.",65,46,,16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,unchanged,unchanged,,,,,Complete,Fatima
"Experiment 1","Study 634","China,France,United States of America","Homo sapiens","fecal samples,gut microbiome",,"Melanoma,Colitis,non-small cell lung carcinoma,Hepatocellular Carcinoma,GI Toxicity","EFO:0000756,EFO:0003872,EFO:0003060,EFO:0000182",Non-responders,Responders,"Those cancer patients who responded to ICI",,,,16S,"1,2,3,4",,,0.05,,,,,,,,,,,Incomplete,
"Experiment 1","Study 666","Finland,Malawi","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"High-Income country (Finland)","Low-income country (Malawi)","44 healthy 6-month-old rural infants from Malawi",31,44,"6 months",WMS,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 1","Study 665",France,"Homo sapiens",Feces,UBERON:0001988,Melanoma,EFO:0000756,"No collitis",Collitis,"MM patients that developed an immune-mediated colitis following ipilimumab treatment",19,7,,16S,"3,4",Illumina,LEfSe,0.05,,3.5,,,,decreased,,,,,Complete,Fatima
"Experiment 1","Study 662","Papua New Guinea","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"High SES (low land region)","Low SES (high land region)","Participants living a subsistence lifestyle in the high-land rural areas of Papua New Guinea",29,86,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 1","Study 667",China,"Homo sapiens","Buccal gland,Feces","UBERON:0017654,UBERON:0001988","Hepatocellular carcinoma",EFO:0000182,Non-responders,Responders,"Patients who were diagnosed with uveal HCC or who received ICIs in combination with targeted agents or with adoptive T cell transfer therapy",,,,16S,4,Illumina,LEfSe,0.05,,,,,,increased,,,,,Complete,Fatima
"Experiment 1","Study 669","Burkina Faso,Italy","Homo sapiens",Feces,UBERON:0001988,"ethnic group,socioeconomic status",EFO:0001799,"European Children in Italy","Rural African Children in Burkina Faso","14 healthy children (nine male and six female) living in the rural village
of Boulpon district of Nanoro, Boulkiemde province, Burkina Faso.",15,14,"6 months",16S,"5,6",Roche454,"ANOVA,Kruskall-Wallis",0.05,,,,,increased,increased,,,,,Complete,
"Experiment 1","Study 670","Bangladesh,United States of America","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status,ethnic group",EFO:0001799,"US children","Bangladesh Children (Household income < $61)","Fecal specimens from 6 Bangladeshi children (ages 8–13), in low socioeconomic conditions with an average monthly income per family of,5,000 takas (the U.S. $61).",4,6,"3 months",16S,"1,2,3",Roche454,ANOSIM,0.1,true,,,"age,sex",,increased,increased,,,,Complete,
"Experiment 1","Study 671",Malawi,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"18 months exposure (maternal education as proxy)","30 Months exposure (maternal education as proxy)","Microbiota data  from 579  participants at 30 months",631,579,NA,16S,"1,2,3,4",,PERMANOVA,0.05,true,,,"antibiotic exposure,delivery procedure,education level,marital status,maternal age,sex",,increased,,,,,Complete,
"Experiment 1","Study 672","New Zealand","Homo sapiens",fecal,,,,,,,,,,16S,3,Illumina,"Chi-Square,Fisher's Exact Test",,,,,,,,,,,,Incomplete,
"Experiment 1","Study 673","Colombia,Denmark,France,Japan,South Korea,Spain,United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,"USA data","Colombia data","30 healthy Colombia adults of both genders from the general population living in Medellin, Colombia South America.",54,30,"4 months",16S,"1,2,3",,ANOSIM,0.05,,,,"age,sex,waist circumference",,,,,,,Complete,
"Experiment 1","Study 674",Israel,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"High SES","Low SES","SES score below median score of 6.4 based on (a) residential SES rank; (b) the number of paternal schooling years; and (c) household crowding index.",70,69,NA,16S,"1,2,3,4",Illumina,"Linear Regression,PERMANOVA",0.05,true,,,"age,body mass index,diet,sex",,unchanged,,,,,Complete,
"Experiment 1","Study 675",Mexico,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"75th Percentile of 926 participants (monthly household  income=>$15,250.)","25th Percentile of 926 participants (monthly household income=<$7000.)","25th percentile of 926 children from 6 to 12 y old, representing a sub-cohort who participated in the Obesity Research Study of Mexican Children (ORSMEC) cohort which has been extensively phenotyped for a variety of metabolic and metabolomic parameters.
(Income analyzed as a continuous variable)",,,unspecified.,16S,"1,2,3,4",Illumina,PERMANOVA,0.05,true,,,"age,antibiotic exposure,body mass index,sex",,unchanged,unchanged,,,,Complete,
"Experiment 1","Study 676",China,"Homo sapiens",Feces,UBERON:0001988,"non-small cell lung carcinoma",EFO:0003060,Non-responders,Responders,"Patients in this study were defined as responder (R) (with partial response or stable disease)",14,23,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,,,,,,increased,,,increased,,Complete,Fatima
"Experiment 1","Study 681","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Colorectal cancer",EFO:0005842,controls,"Colorectal cancer","colorectal cancer; 24% of the colorectal cancer cases were current smokers. 16% habitual alcohol drinkers",122,68,"None specified",16S,"3,4",Illumina,"Zero-Inflated Beta Regression",0.05,,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 1","Study 679","United States of America","Homo sapiens",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,Non-responders,Responders,,26,16,,16S,4,Illumina,T-Test,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 1","Study 682",China,"Homo sapiens","Small intestine",UBERON:0002108,"irritable bowel syndrome",EFO:0000555,IBS.sibo-,IBS.sibo+,"typical clinical symptoms and normal colonoscopy presentation fulfilling the Rome III diagnostic criteria with SIBO",33,24,"3 months; also includes probiotics and proton-pump inhibitors",16S,"1,2,3",Roche454,LEfSe,0.05,,2,,,,,,,,,Complete,
"Experiment 1","Study 683",Netherlands,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"non-adenoma group","adenoma group","Patients with a successful polypectomy. A total of 9 patients had advanced adenomas and 10 patients had non-advanced adenoma (NA), with a median size of the largest adenoma being 0.7 cm [IQR 0.5–0.8].
PRIOR to polypectomy.",32,32,"3 months prior to study inclusion and 3 months prior to second sample",16S,4,Illumina,LEfSe,0.05,,2,,,,,,,,unchanged,Complete,
"Experiment 1","Study 685",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,Control,CRC,"Tumor specimens taken from patients with colorectal cancer",19,19,"None specified",16S,"3,4",Illumina,T-Test,0.05,,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 1","Study 686",Italy,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,controls,CRC,"Patients diagnosed with CRC",24,29,"None specified",WMS,,Illumina,,0.05,,,,,,,,,,,Complete,
"Experiment 1","Study 649",,,,,"Huntington disease",MONDO:0007739,,,,,,,,,,,,,,,,,,,,,,Incomplete,
"Experiment 2","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,"Hyperplastic Polyp",EFO:1000299,controls,"hyperplastic polyp cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,40,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 218",China,"Homo sapiens",Feces,UBERON:0001988,"hepatocellular carcinoma",EFO:0000182,"healthy controls","HBV-related HCC patients","HBV-related HCC patients",33,35,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 10",Brazil,"Homo sapiens",Uterus,UBERON:0000995,"cervical glandular intraepithelial neoplasia",EFO:1000165,"Normal tissue HIV patients","Cervical Intraepithelial Lesion HIV patients","Cases were identified by HIV rapid or ELISA test and subsequent Western blot following recommendations for HIV diagnosis by the Brazilian Ministry of Health.",42,38,,16S,"3,4,5,6",Illumina,LEfSe,0.1,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Time 0 days Cara Cara","Time 7 days",,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy controls","infants with persistent atopic dermatitis","infant with persistent atopic dermatitis",84,26,"before sample collection",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 228","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"day 6 of INULIN spike-in","day 3 of INULIN spike-in","before pectin spike-in",9,9,"6 months",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index",,,,,,,Complete,
"Experiment 2","Study 26",Spain,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,male,"BMI >33 female","three groups according to the BMI: BMI < 30; BMI between 30- 33; and BMI > 33.",13,13,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,age,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 13",China,"Homo sapiens",Uterus,UBERON:0000995,"cervical glandular intraepithelial neoplasia",EFO:1000165,"HPV -ve among pateints with Cervical Intraepithelial Neoplasia different severity status","HPV +ve",,130,36,,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 16","United States of America","Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"high fat diet","high fat diet + melatonin","Obesity is (BMI ≥ 30kg/m2)",5,5,,16S,"3,4",Illumina,LEfSe,0.05,true,,,,,decreased,decreased,increased,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 18",Denmark,"Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"BL6-High Fat without enomithacin","Sv129-High Fat without enomithacin","(BL6): C57BL/6JBomTac mouse strain, (Sv129):  the obesity-resistant mouse strain 129S6/SvEvTac . LF:  (LF)low-fat diet, (HF) high fat diet without indomethacin,  (HFI) high fat diet supplemented with indomethacin.",10,8,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 5","United States of America","Homo sapiens",Lung,UBERON:0002048,"chronic obstructive pulmonary disease",EFO:0000341,"moderate Chronic obstructive pulmonary disease",Severe,"Not stated",8,14,"2 months",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.1,true,,,age,,unchanged,,unchanged,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 12","South Korea","Homo sapiens",Uterus,UBERON:0000995,"human papilloma virus infection",EFO:0001668,"HPV negative","HPV clearance","HPV DNA was detected using the Digene HC2 high-risk DNA test (Qiagen, Gaithersburg, MD, USA) with signal amplification and chemiluminescence for 13 types of HR-HPV scored in RLU/PC. A positive result indicated a concentration of 1 pg/ml or higher than the RLU/cutoff ratio (RLU of the specimen/mean RLU of 2 positive controls).",10,15,,16S,,Roche454,LEfSe,0.05,false,2,,"age,contraception,menopause,smoking behavior",,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 20",France,"Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"mild fibrosis (F 0-1)","significant fibrosis (F>2)","NAFLD was defined as liver steatosis on liver biopsy after exclusion of concomitant steatosis-inducing drugs, excessive alcohol consumption (>210 g/week in men or >140 g/week in women), chronic hepatitis B or C infection, and histological evidence of other concomitant chronic liver disease. NASH was defined as the presence of each of the three following conditions: steatosis grade 1; lobular nflammation grade 1; and ballooning grade 1. “Significant fibrosis” was defined as fibrosis stage F2.",30,27,"2 months",16S,4,Illumina,"Logistic Regression",0.05,false,,,"blood pressure,body mass index",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 17",China,"Homo sapiens",Feces,UBERON:0001988,"anxiety disorder",EFO:0006788,"healthy controls","treatment naiive Generalized Anxiety disorder","The active state of GAD was defined as a baseline Hamilton Anxiety Rating Scale HAMA score ≥14 upon admission to the hospital. The remissive state was defined as a HAMA score < 7 after 3 months of treatment.",17,12,"2 months",16S,"3,4",Illumina,LEfSe,0.05,true,2,"age,body mass index,sex",,,decreased,decreased,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 2","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"head and neck squamous cell carcinoma",EFO:0000181,"T0-T2 low tumor stages patients","T3-T4 high tumor stages patients","Not stated",,,,16S,"1,2,3,4",Sanger,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 171",China,"Homo sapiens",Saliva,UBERON:0001836,"tongue neoplasm",EFO:0003871,controls,"tongue/pharyngeal cancer patients","patients with tongue/pharyngeal cancer",26,13,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,increased,increased,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 173",China,"Homo sapiens",Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"without cancer","pancreatic head cancer with obstruction","pancreatic head cancer with obstruction of common bile duct",32,22,"8 weeks",16S,"3,4,5",Illumina,LEfSe,0.05,false,,age,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 208",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy controls","infants with food allergies","infant with food allergy",45,34,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 235","United States of America","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy sibling","child with food allergy","child with food allergy",25,22,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 100","Russian Federation","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"non-abdominal obesity","Abdominal obesity",,39,53,"3 months",16S,"3,4",Illumina,"Linear Regression",0.05,true,,,"age,sex",,,,,,,Complete,LGeistlinger
"Experiment 2","Study 158",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,"healthy volunteers","lung cancer patients","lung cancer patients with a definite postoperative pathological diagnosis",41,41,"12 months",16S,"1,2",Illumina,LEfSe,0.05,true,4,"age,body mass index,sex",,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 193","South Korea","Homo sapiens","Mucosa of stomach",UBERON:0001199,"gastric cancer",MONDO:0001056,"H. pylori negative","H. pylori postive","by conventional laboratory method including rapid urease test and histopathology",3,7,"6 months",16S,5,Roche454,,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 109",Germany,"Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,HC,"anorexia patients after weight gain",,55,44,"8 weeks",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.15,true,,,"age,sex",,increased,unchanged,,,,Complete,Lwaldron
"Experiment 2","Study 103",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"Healthy Controls","depressed male",,20,20,yes,16S,"3,4,5",Roche454,LEfSe,0.05,false,,demographics,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 136","Russian Federation","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"before dietary intervention","two weeks after a dietry intervention",,215,215,,16S,4,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 248","South Africa","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"no HPV",HPV,"HPV infection confirmed through HPV genotyping test",50,37,,16S,"3,4",Illumina,LEfSe,0.2,true,2,,,,unchanged,,unchanged,,,Complete,"Fatima Zohra"
"Experiment 2","Study 219","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,baseline,"week 8","students eating crackers",35,38,,16S,"4,5",Illumina,ANCOM,0.05,true,,,,,,,,,,Complete,
"Experiment 2","Study 133",Japan,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Equol producer (""healhtier"" diet)","Equol NON producer (""unhealthier"" diet)","cross sectional",45,13,,16S,3,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 2","Study 159",China,"Homo sapiens","Dental plaque",UBERON:0016482,"gingival disease",EFO:0009670,before,"3 months after the placement of the brackets","subgingial microbial changes during fixed appliance treatment",10,10,"1 month",16S,"3,4",Illumina,Metastats,0.05,false,,,,,unchanged,unchanged,unchanged,unchanged,unchanged,Complete,
"Experiment 2","Study 239","United States of America","Homo sapiens",Feces,UBERON:0001988,"egg allergy",EFO:0007248,"healthy control","infant with egg sensitization","infant with egg sensitization",40,101,,16S,4,Illumina,"LEfSe,Logistic Regression",0.05,false,2,,"age,race",,increased,increased,,,increased,Complete,
"Experiment 2","Study 157",China,"Homo sapiens",Saliva,UBERON:0001836,"esophageal cancer",MONDO:0007576,controls,"Esophageal Squamous cell carcinoma (ESCC)","Histopathological confirmation, complete questionnaire with saliva sample",85,87,"1 month",16S,"3,4",Roche454,T-Test,0.05,true,,"age,sex",,,decreased,decreased,,,,Complete,
"Experiment 2","Study 162",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,others,"CEA group","newly diagnosed lung cancer patients by histopathology and computed tomography",16,30,"1 month",16S,4,Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,decreased,,unchanged,Complete,
"Experiment 2","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"atopic eczema",EFO:0000274,"non-lesional skin","lesional skin","atopic dermatitis lesional skin",59,59,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 2","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/female caucasian infant",329,38,,16S,,Illumina,LEfSe,0.05,true,2,,,,,,,,,Complete,
"Experiment 2","Study 282",China,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"standard conditioning","intensified conditioning","patients diagnoised with grade II to IV acute graft-versus-host disease (aGVHD) undergoing intense conditioning",19,13,,16S,4,Illumina,,0.05,false,,,,,,,,increased,,Complete,
"Experiment 2","Study 263",Canada,"Homo sapiens",Feces,UBERON:0001988,"ulcerative colitis",EFO:0000729,"healthy controls","ulcerative colitis","patients with immune-mediated inflammatory disease (IMID)",23,19,"8 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 2","Study 237",Germany,"Homo sapiens",Feces,UBERON:0001988,"chronic hepatitis C virus infection",EFO:0004220,"no cirrhosis","cirrhosis patients","heatitis C patients with cirrhosis",38,57,"3 months",16S,"1,2",Illumina,DESeq2,0.05,false,,,,unchanged,unchanged,,unchanged,,,Complete,
"Experiment 2","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,"past H.pylori infection","current H.pylori infection patients","patients with H.pylori infection (bacteria were histologically detected in any one of the biopsies or it was positively indicated by C-UBT)",8,24,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 117",Netherlands,"Homo sapiens","Oral gland",UBERON:0010047,pneumonia,EFO:0003106,"adult controls","adult pneumonia patients",,187,27,"3 months",16S,"5,6,7",Roche454,T-Test,0.05,true,,,"age,comorbidity,smoking behavior",,,,,,,Complete,
"Experiment 2","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"peritumoral tissues","tumoral tissues","gastric cancer",247,229,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,increased,decreased,increased,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"low grade dysplasia","low grade dysplasia confirmed by histology of colonoscopy-directed biopsy",20,12,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 30",Belgium,"Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,"Norweigan controls","Norweigan CFS/ME patients","Patients were diagnosed for CFS according to the clinical criteria of Fukuda et al",17,25,"4 weeks",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 301","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ through PCR confirmation",26,19,"6 months",16S,"2,3",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 290",Netherlands,"Homo sapiens",Mouth,UBERON:0000165,"oral mucositis",EFO:1001904,"one and two weeks after stem cell transplant","pre- and three month after auto stem cell transplant","patient developed uclerative oral mucositis",31,20,,16S,4,RT-qPCR,PERMANOVA,0.05,false,,,,,increased,,,,,Complete,
"Experiment 2","Study 168",China,"Homo sapiens",Tongue,UBERON:0001723,"Chronic hepatitis B virus infection",EFO:0004239,"chronic hepatitis B white tongue coating patients","chronic hepatitis B yellow tongue coating patients","patients diagnosed with chronic hepatitis B per ""The Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2010 version)"" with a yellow tongue coating",25,28,"3 months",16S,3,"Ion Torrent",Metastats,0.05,false,,"age,sex",,,unchanged,unchanged,,,,Complete,Claregrieve1
"Experiment 2","Study 285","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,"IMD naive cases","IMD exposure multiple sclerosis cases",,9,9,"2 months",16S,4,Illumina,,0.05,true,,,,,,,,,unchanged,Complete,
"Experiment 2","Study 120",Spain,"Rattus norvegicus",Feces,UBERON:0001988,"physical activity",EFO:0003940,"exercise group","Ad libitum group","(a) Activity based anorexia (ABA) group: rats starved by restricting food access to 23 hours per day and confined to running wheels except during a 60 min meal per day, (b) Control ABA group: rats submitted to the same food restriction schedule as ABA with no wheel access exercise, (c) Exercise group: rats feed ad libitum with free access to the activity wheel and (d) Ad libitum group: rats feed ad libitum but without access to the activity wheel.",10,10,,16S,"2,3",RT-qPCR,Kruskall-Wallis,0.05,true,,"body weight",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 317","United States of America","Homo sapiens",Meconium,UBERON:0007109,"antimicrobial agent",CHEBI:33281,"without peripartum antibiotics usages","infants delivered to mothers with","infants delivered to mothers given preipartum antibiotics (antibiotics given to mother 2 days prior to delivery to during delivery)",43,62,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,increased,,unchanged,Complete,
"Experiment 2","Study 311",Italy,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"pre- engraftment","post- engraftment","malignant or non-malignant disease patients from four transplantation centers (Bologna, Pavia, Rome and Verona) that underwent allogeneic hematopoietic stem cell transplant with or without myeloablative conditioning regimen, who developed skin acute graft-versus-host disease post- enrichment",13,13,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 2","Study 170",China,"Homo sapiens",Lung,UBERON:0002048,"Lung cancer",MONDO:0008903,controls,"paired contralateral non-cancerous site in lung cancer patients","patients with diagnosis of lung cancer established by histological confirmation",18,24,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 126",China,"Homo sapiens",Saliva,UBERON:0001836,"oral squamous cell carcinoma",EFO:0000199,"healthy controls","Oral Squamous Cell Cancer patients",,19,16,,16S,,Illumina,Kruskall-Wallis,0.05,false,,,,,increased,unchanged,increased,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 338",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight children","obese children","volunteers between the ages of 6-11 years old who were determined to be obese by BMI",23,28,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,,decreased,decreased,,decreased,Complete,Claregrieve1
"Experiment 2","Study 115",China,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"healthy controls",bipolar,,30,30,"1 month",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,unchanged,,Complete,
"Experiment 2","Study 160",Australia,"Homo sapiens",Mouth,UBERON:0000165,"head and neck carcinoma",MONDO:0002038,"Normal Healthy Controls","OCC & OPC","Newly diagnosed OCC(Oral Cavity Cancer) and OPC (Oropharyngeal Cancer)",20,31,,16S,"6,7,8",Illumina,Kruskall-Wallis,0.05,false,,,,,decreased,,,,,Complete,
"Experiment 2","Study 250","United States of America","Homo sapiens",Tongue,UBERON:0001723,"severe aplastic anemia",EFO:0006927,baseline,"hematopoietic stem cell transplantation engraftment","In HSCT patients, The first sample was obtained before transplant conditioning treatment. The second specimen was collected at engraftment, defined as two absolute neutrophil counts of greater than 500 per microliter for at least 2 days. The final specimen collection occurred at the participant’s scheduled clinic visit approximately 100 days following transplant.",4,4,,16S,"3,4,5,6,7,8,9","Ion Torrent",LEfSe,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 318",Japan,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"non-acute graft-versus-host disease","acute graft-versus-host disease","participants that developed acute graft-versus-host disease after allogeneic hematopoeitic transplant and graded accordinly to pattern of organ involvement and clinical performance status using a system introduced by Glucksberg et al. (Severity Index), which includes late-onset of acute graft-versus-host disease (more than 100 days after transplantation)",,107,,16S,"1,2",Roche454,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 279","United States of America","Homo sapiens",Mouth,UBERON:0000165,"acute myeloid leukemia",EFO:0000222,"No bacterial infections","bacterial infections","Acute Myeloid Leukemia patients that experience microbiologically defined bacterial infections during remission induction chemotherapy",30,9,,16S,4,Illumina,LEfSe,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 273",Canada,"Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"non-infectious complications (NIC)","Infectious complications (IC)","Infectious complications (IC) in the past 6 months of Acute Lymphoblastic Leukemia treatment",7,9,"Prophylactic Septra which was prescribed ubiquitously to patients throughout the study, as per standard of care.",WMS,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,unchanged,Complete,
"Experiment 2","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"Multiple sclerosis",MONDO:0005301,controls,"multiple sclerosis patients","patients with multiple sclerosis",43,60,"6 months",16S,"3,4,5",Roche454,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 418",Spain,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,baseline,"immunological responders assigned to treatment for 12 weeks","HIV-infected immunological responders (IR) who received S. boulardii probiotic",11,11,"2 months",16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 287","Costa Rica","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"HPV (clearance)","Visit 2 HPV (progression)","HPV progression to CIN2+ lesion diagnosis",69,33,,16S,4,Illumina,LEfSe,0.05,false,2,,,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 395","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic kidney disease,stage 5 chronic kidney disease","EFO:0003884,EFO:0009909","healthy controls",hemodialysis,"4 groups of pediatric patients (age 2-18), hemodialysis, peritoneal dialysis, kidney transplant, healthy controls",13,8,"1 month",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,age,,,,unchanged,,,unchanged,Complete,
"Experiment 2","Study 376",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before antibiotic exposure","patients that took levofloxacin/Metronidazole","took levofloxacin/Metronidazole for 7 days",9,9,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,decreased,,,decreased,Complete,
"Experiment 2","Study 41",Finland,"Homo sapiens",Feces,UBERON:0001988,psychosis,EFO:0005407,Controls,"FIrst episode Psychosis (physically active)",,16,15,"3 months",16S,,Illumina,LEfSe,0.05,false,2,"age,region of residence,sex",,,,,,,,Complete,
"Experiment 2","Study 127",Norway,"Homo sapiens",Feces,UBERON:0001988,"alcohol drinking",EFO:0004329,controls,"alcohol overconsumers",,18,24,"4 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 2","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group before procedure","women with suspected high grade cervical dysplasia planning for their first Loop Electrosurgical Excision Procedure",99,89,"long-term antibiotic use",16S,,RT-qPCR,"Logistic Regression",0.05,false,,,"age,contraception,marital status,smoking behavior",,,,,,,Complete,Claregrieve1
"Experiment 2","Study 156",China,"Homo sapiens",Feces,UBERON:0001988,"gastric adenocarcinoma",EFO:0000503,"healthy controls","Gastric cancer","gastric carcinoma confirmed by pathological examination",48,48,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,"age,sex",,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 352","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia,human papilloma virus infection","EFO:1000165,EFO:0001668","Low risk-HPV","High risk-HPV","High risk-HPV",3,27,"2 months",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,,,unchanged,Complete,Fatima
"Experiment 2","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","youth Neck before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",30,30,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 51",China,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,"CIT(cleain intestine)","NDA(new dev. adenoma)","The adenoma and carcinoma patients were diagnosed by colonoscopic examination and histopathological review of biopsies. Postoperative patients were classified as having NDA or CIT by follow-up surveillance colonoscopy and biopsies",26,21,"3 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2.5,"age,body mass index,sex",,,,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 27","United States of America","Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"foster mother fat1 post HFD","foster mother wild-type post HFD","fat-1 mice: with a balanced tissue n-6/n-3 ratio (~ 1:1) and wild-type (WT) mice: with a high n-6/ n-3 ratio similar to the Western diet (> 10:1).",15,9,,16S,"3,4",Illumina,LEfSe,0.05,true,2.4,age,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 56","United States of America","Homo sapiens",Meconium,UBERON:0007109,"gestational diabetes",EFO:0004593,"Healthy baby meconium","Baby meconium with GDM mothers",,13,5,"9 months",16S,"3,4","PacBio RS","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 399","United States of America","Homo sapiens",Feces,UBERON:0001988,age,EFO:0000246,"healthy aging (HA)","non-healthy aging (NHA)","participants aged 70–82 who had a medical history linked to one or more of the following major disease categories: cancer, acute or chronic cardiovascular disease, acute or chronic pulmonary disease, chronic liver disease, diabetes and diabetic complications, and stroke or neurodegenerative disorder.",33,32,"6 weeks",16S,"1,2,3",Illumina,DESeq2,0.05,true,,,,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 148",China,"Homo sapiens",Feces,UBERON:0001988,"polycystic ovary syndrome",EFO:0000660,HC,IR-PCOS,"diagnosed if two of the following were present: olig-/amenorrhea, clinical and/or biochemical hyperandrogenish, or polycystic ovaries",8,9,"administration of antibiotics",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 296",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy controls","multiple myeloma patients","newly diagnosed multiple myeloma patients",18,19,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,"age,sex",,,increased,,,,,Complete,Claregrieve1
"Experiment 2","Study 38",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"child neck","teen neck","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 405",Denmark,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma at 5 years old","child with asthma at 5 years old among mothers with asthma","child with physician diagnosed asthma based on verified diary recordings of five episodes of troublesome lung symptoms within 6 months, exercise-induced symptoms, prolonged nocturnal cough, and/or persistent cough outside of common colds, need for intermittent rescue use of inhaled β2-agonist, response to a 3-month course of inhaled corticosteroids andrelapse upon ending treatment and mother with asthma",122,25,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 67",Italy,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,neurotypical,autistic,"cases were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.",40,40,"3 months",16S,"3,4,5",Roche454,LEfSe,0.01,false,2,,"age,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 71","United States of America","Homo sapiens",Meconium,UBERON:0007109,"premature birth",EFO:0003917,">/=33 weeks","infants <33 weeks gestational age","the study groups are devided into two groups acc to the gestational age. 1) gestational age < 33 weeks. 2) gestational age >/= 33 weeks",17,35,,16S,4,"Ion Torrent","Spearman Correlation",0.05,false,,,"birth weight,chorioamnionitis,sex",,unchanged,unchanged,,,unchanged,Complete,Fatima
"Experiment 2","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",overweight,"Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m2",211,246,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 52",China,"Homo sapiens",Feces,UBERON:0001988,"substance-related disorder",MONDO:0002494,"adjusted Healthy controls","Substance use disorder patients",,28,29,"3 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low IL-6","Bipolar patients with high IL-6","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 340","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"non-overweight/non-obese children",obese/overweight,"Children who participated in the VDAART clinical trial-a a two arm, double-blind, placebo controlled, randomized, clinical trial of vitamin D supplementation in the pregnant mother to prevent asthma and allergy in childhood in three clinical centers across the United States",356,146,,16S,4,Illumina,"Logistic Regression",0.05,true,,,"education level",,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 314","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"CIN regression","CIN non-regression","histology proven CIN2, no regression after 12 months",42,45,,16S,"1,2",Illumina,"Welch's T-Test",0.05,false,,,,,,,,unchanged,increased,Complete,Fatima
"Experiment 2","Study 64",China,"Homo sapiens","Oral gland",UBERON:0010047,"type II diabetes mellitus",MONDO:0005148,"Non-diabetic within negative  periodnotitis",Diabetic,"Periodontitis was defined by the following criteria: at least 30% of sites with probing depth and attachment loss, and more than four with probing depth >=4 mm and clinical attachment loss >=2 mm. Subjects with type 2 diabetes had been diagnosed for at least one year with HbA1c >= 6.5%, fasting plasma glucose test >=7.0 mmol/L, or OGTT 2 hour glucose test >=11.1 mmol/L",5,8,"3 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 381","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"low fecal butyrate levels","high fecal butyrate levels","patients undergoing T cell repleted allogeneic hematopoietic stem cell transplantation",50,50,,16S,4,Illumina,LEfSe,0.05,false,4,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 408",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"healthy controls","asthma at 1 year","physician diagnosis of asthma by 4 years of age or was prescribed inhaled asthma medications (inhaled corticosteroids or bronchodilators) from 3 to 4 years of age",37,39,,16S,3,Illumina,DESeq2,0.05,true,,"antibiotic exposure,feeding practices,sex",,,unchanged,,,,,Complete,
"Experiment 2","Study 54",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,placenta,colostrum,,15,15,"prior to or during c-section",16S,"1,2,3",Roche454,LEfSe,0.05,true,3,,,,increased,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 383","United States of America","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"no food allergy","child with food allergy","child with healthcare provider-diagnosed allergy to milk, egg, peanut, wheat, soy, or other nut allergy prior to age 3 years with evidence of IgE sensitization to that food (>0.1 kU/L) at age 3 years",202,14,"1 week",16S,"3,4,5",Roche454,,0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 87",Spain,"Homo sapiens",Feces,UBERON:0001988,"type I diabetes mellitus",MONDO:0005147,"healthy Controls","Type I Diabetics and maturity-onset diabetes of the young 2 (MODY2)","type 1 diabetes was diagnosed according to the criteria of the American Diabetes Association and the positivity of at least two persistent, confirmed anti-islet autoantibodies (anti-insulin autoantibodies, GAD autoantibodies, or tyrosine phosphatase autoantibodies). MODY2 children were diagnosed by suggestive clinical history, negative anti-islet autoantibodies, and positive genetic testing. Healthy control subjects were children with negative anti-islet autoantibodies,",13,30,"3 months",16S,"2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,delivery procedure,race,sex",,,decreased,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 81",Denmark,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,baseline,"one year after Roux-en-Y gastric bypass surgery",,13,8,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","IAP group (4-day old infant)","Term, vaginally delivered infants",47,44,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 61",Finland,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"infants of normal weight mother at age 6 month","infants of overweight mothers","mothers whose prepregnancy body mass index (BMI; in kg/m2) was >25",26,16,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 236",Germany,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"replace both","carbohydrate replacement (with walnuts)","before walnut consumption",135,135,"excluded those on ""antibiotic therapy""",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,"age,body mass index,smoking behavior,triglycerides",,,,,,,Complete,
"Experiment 2","Study 43",Turkey,"Homo sapiens","Oral gland",UBERON:0010047,"Behcet's syndrome",EFO:0003780,"non-immunosuppressent users among behcet's patients","immunosuppressant users",,19,12,"6 months",16S,4,Illumina,LEfSe,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 29",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"Healthy Controls","Responded Major Depressive Disorder","The A-MDD group was defined as having an HAMDS score P20. The patients in the R-MDD group were defined as those with a baseline HAMDS scores P20 upon admission to the hospi- tal.",30,17,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,2,,,,unchanged,,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 341",Australia,"Homo sapiens","Small intestine",UBERON:0002108,"nicotine dependence",EFO:0003768,"never smoked","patients with FD, ID,or CD who currently smokes","patient with FD,ID or CD with who previously or currently smokes",41,61,"2 months",16S,"6,7,8",Illumina,Kruskall-Wallis,0.05,true,,,,,,unchanged,,,,Complete,
"Experiment 2","Study 404","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","patient with atopic dermatitis","patient age 1-6 years diagnosed with atopic dermatitis based on the SCORAD scoring system",15,58,"6 months",16S,"1,2",Roche454,"Random Forest Analysis",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 94",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"3 months participants","6 months","A threshold of 10% weight loss and maintenance of it over one year has been proposed as definition for successful weight loss maintenance",16,16,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 387",Sweden,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Before clindamycin exposure","after clindamycin exposure","""healthy"" adults between the ages of 18-45 years old with normal medical histories and physical examinations who were exporsed to clindamycin",9,9,"3 months",16S,"5,6,7",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,decreased,Complete,Claregrieve1
"Experiment 2","Study 320","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants (1-year) to mothers unexposed to  intrapartum antibiotic","infants(1-year) to mothers exposed to intrapartum antibiotic","vaginally delivered at full-term (>37 weeks of gestation)",179,87,,16S,"4,5",Illumina,PERMANOVA,0.05,false,,,,,decreased,,decreased,,,Complete,
"Experiment 2","Study 240",Canada,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy control","infant with food sensitization","infant with food sensitization",154,12,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 47","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"hight moderate to vigrous physical activity",low,"BMI ≥ 30.0 kg/m2 was considered obese",68,68,"2-3 months",16S,4,Illumina,LEfSe,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low BMI zscores","high BMI zscore","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Spearman Correlation",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 2","Study 249","United States of America","Homo sapiens",Blood,UBERON:0000178,"Hepatitis, Alcoholic",EFO:1001345,NAC,HDC,"alcoholic hepatitis",20,19,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,
"Experiment 2","Study 79",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"very low calorie diet after 3 months and 6 months","Very low calorie diet baseline",,3,3,"3 months",WMS,,Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 172","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Cannabis use",EFO:0007585,"controls (oral pharynx)","marijuana usage group","using marijuana on 20 or more days in the past month associated with a distinct oral microbiota at the most common sites of HNSCC, the oral pharynx.",19,20,"1 month",16S,"1,2,3",Illumina,LEfSe,,false,,"age,sex",,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 90",Brazil,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"mecomium in C-section delivery","transitional stool","cases are delivery or an elective C-section delivery between 38 and 42 weeks of gestation (confirmed by an ultrasound taken before the 20th week of pregnancy).",40,40,"oral antibiotics in the third trimester of pregnancy",16S,4,Illumina,LEfSe,,false,3,,,,,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 85",Congo,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery","two-day aged babies c-section",,7,8,,16S,3,Roche454,"Linear Regression",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 74",Netherlands,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"Nonobese microbiota cluster",obese,"obesity: BMI 30.5-60.3 kg/m3",13,15,"6 months",16S,,"Human Intestinal Tract Chip","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,decreased,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery at day 5",c-section,"meconium samples were collected at day 1 after delivery",7,5,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,unchanged,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 326",France,"Homo sapiens",Feces,UBERON:0001988,"non-small cell lung carcinoma,renal cell carcinoma","EFO:0003060,EFO:0000681","Progressive- Free- Survival more less than 30 days","Progressive -Free- Survival more than 30 days","non-small cell lung carcinoma or renal carcinoma patients (excluding ampicillin, colistin, and streptomycin (ATB) anitbiotic treatment) that have been treated with PD-1 blockage with partial response or stable disease that are Progressive- Free- Survival greater than 3 months",,,"ampicillin, colistin, and streptomycin",WMS,,"Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 382",Italy,"Homo sapiens",Endocervix,UBERON:0000458,"human papilloma virus infection,Chlamydophila infectious disease","EFO:0001668,EFO:1000863","HPV positive women","patient with chlamydia infection","patient with Chlamydia infection",7,8,Current,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 75","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"smoking behavior",EFO:0004318,"left oropharynx of nonsmokers","left oropharynx of smokers","Smokers were defined as current smoking of .2 cigarettes daily for more than 6 months, and nonsmokers were defined as less than 100 cigarettes lifetime.",33,29,"3 months",16S,"1,2",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 58","United States of America","Homo sapiens",Feces,UBERON:0001988,"high fat diet",EFO:0002757,"6 months babies control","6 months babies of maternal high-fat diet","To determine maternal dietary intake during pregnancy, each mother was asked by trained personnel at each sample collection time point to answer the Dietary Screener Questionnaire (DSQ), which was developed and validated by the National Health and Examination Survey (NHANES) program (2009–2010)",75,75,,16S,"3,4,5",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 163",Austria,"Homo sapiens",Saliva,UBERON:0001836,"squamous cell carcinoma",EFO:0000707,"Healthy Controls","Oropharyngeal Squamous Cell Carcinoma","diagnosed with OSCC and SCC of the oral cavity",11,11,"1 month",16S,4,Illumina,LEfSe,0.05,false,,,,,unchanged,,,unchanged,,Complete,
"Experiment 2","Study 374","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"Cervical cancer",MONDO:0002974,"normal control","cervical cancer","histology proven cervical cancer",18,12,,WMS,,Illumina,LEfSe,0.05,true,2.5,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 66",China,"Homo sapiens",Meconium,UBERON:0007109,"neonatal jaundice",EFO:1000739,control,"infants with jaundice",,160,141,"among all the participants,11 mothers used antibiotics during pregnancy and 4 infants used antibiotics after birth.",16S,3,Illumina,LEfSe,0.05,false,2.5,,"birth weight,gestational age,maternal age,sex,smoking behavior",,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 384",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls",TSCZ,"first-episode drug naive schizophrenia(FSCZ) diagnosed according to the DSM IV criteria and PANSS having illness duration <=12 months and no treatment with antipsycotic medications before, anti-psycotic treated schizophrenia (TSCZ) having illness duration >12 months and received antipsychotic treatment for at least past 3 months",69,85,"1 month",16S,4,Illumina,DESeq2,0.05,true,,demographics,,,decreased,decreased,,,decreased,Complete,
"Experiment 2","Study 70",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"female pediatric normal weight","female pediatric obese","Obesity was defined as body mass index (BMI) ≥95th percentile, whereas NW was de- fined as BMI between the 15th and 75th percentiles for age and gender based on Centers for Disease Control and Prevention (CDC) reference data",29,29,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 119","United States of America","Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Metaformin negative among Opoid positive","Metaformin positive","Opioid use was defined as “Yes” if during review of medical record two parameters were present: 1) the participant was under care of psychiatric care professional, and 2) psychiatric care professional established the diagnosis of opioid use disorder as official diagnosis in medical record",35,9,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 392",Italy,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"infant with non-IgE-mediated cow's milk allergy at diagnosis","infant with non-IgE-mediated cow's milk allergy treated with EHCF","infant with non-IgE mediated cow's milk allergy treated with EHCF",23,9,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 128",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"atrophic gastric","gastric cancer",,37,74,"2 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,helicobacter pylori,sex",,,unchanged,,,unchanged,Complete,
"Experiment 2","Study 60",China,"Homo sapiens",Blood,UBERON:0000178,"type II diabetes mellitus",MONDO:0005148,"carier of pathogens controls","Type-2 DM cariers of pathogens","The non-carrier meant that the individual did not have sequence read for the specific pathogen.",,,"2 months",16S,"5,6",Illumina,T-Test,0.05,false,,"age,sex","blood pressure,body mass index,smoking behavior,total cholesterol measurement",,,,,,,Complete,Fatima
"Experiment 2","Study 402",Australia,"Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"mothers whose infants remained non-allergic","Mothers whose infants developed IgE associated eczema","Mothers whose infants developed typical skin lesions responsive to topical steroids diagnosed with eczema and with severity determined using the SCORAD index",10,9,,16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,"delivery procedure,medical procedure",,unchanged,unchanged,,,,,Complete,
"Experiment 2","Study 421",Spain,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"uninfected siblings or children born to HIV-infected mothers","Vertically HIV-infected children","Vertically HIV-infected children",12,12,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 377","United States of America","Homo sapiens",Mouth,UBERON:0000165,"smoking behavior",EFO:0004318,"cigarette smoker","never smoker","participants who were 21 years or older, healthy, diagnosed with periodontal disease, and current smokers, non-smokers, or e-cigarette users",39,40,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,increased,Complete,
"Experiment 2","Study 424",Israel,,Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"Healthy control",PC,"Patients presenting with pancreatic cancer. The diagnosis was verified by histological samples obtained by EUS or by postoperative pathological assessment.",13,30,"Individuals who were exposed to antibiotics up to 8 weeks before sampling were excluded from the analysis.",16S,,Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,
"Experiment 2","Study 245",China,"Homo sapiens",Feces,UBERON:0001988,"nephrolithiasis,urolithiasis","EFO:0004253,MONDO:0024647","healthy control","kidney stone group","kidney stones",13,13,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,race",,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"contorl adolescent","obese adult",,20,12,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,decreased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 179",China,"Homo sapiens",Saliva,UBERON:0001836,"esophageal squamous cell carcinoma",EFO:0005922,"Healthy controls","Oesophageal cancer","oesophageal cancer",21,20,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 393",Spain,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"healthy control","infant with non-IgE-mediated cow's milk allergy","infant with cow's milk protein allergy confirmed by a negative skin prick test, values lower than 0.35 kU/L cow’s milk-specific IgE determined in their blood, and a clear positive standardized oral challenge (SOC), performed under medical supervision",10,17,"4 weeks",16S,"3,4",Illumina,Metastats,0.05,true,,age,,,,,,,,Complete,
"Experiment 2","Study 169",China,"Homo sapiens",Tongue,UBERON:0001723,"gastric cancer",MONDO:0001056,"other coatings","white-thick tongue coating GC patient","gastric cancer with different tongue coatings",72,43,"4 weeks",16S,"3,4,5",RT-qPCR,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 238","United States of America","Homo sapiens",Feces,UBERON:0001988,"cervical cancer",MONDO:0002974,"healthy controls","cervical cancer patient","patients with biopsy-proven carcinoma of the cervix",46,42,"1 month- controls only",16S,4,Illumina,LEfSe,0.05,false,3,,age,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 63",Japan,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery after 3 months of delivery","C-section delivery",,134,17,"No information about pre-delivey duration. 3 Vaginally-delivered infants have been exposed to antibiotics (birth to sampling)",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 411","United States of America","Homo sapiens",Rectum,UBERON:0001052,"HIV/AIDS pre-exposure prophylaxis",GSSO:001787,"HIV-negative MSM not on PrEP","HIV-negative MSM on PrEP","HIV-negative Men who have sex with men (MSM) on HIV pre-exposure prophylaxis (PrEP)",37,37,,16S,4,Illumina,,0.05,true,,"age,anal intercourse,ethnic group,marijuana,nicotine dependence,obesity,race",,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 330",Finland,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ cervical sample determined by PCR and genotyped with Multimetrix",30,9,,16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 73",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight","obese + metabolic syndrome","the guidelines from the American Heart Association was used to diagnose metabolic syndrome, which must adhere to at least three of the five following parameters; 1. Elevated waist circumference: waist circumference of ≥80, 2. Elevated Triglycerides ≥150 mg/dL, 3. Reduced HDL- Cholesterol <50 mg/dL, 4. Elevated Blood pressure; systolic ≥130 mm Hg and/or diastolic ≥85 mm Hg and 5. Elevated Fasting blood glucose ≥100 mg/dL. On the other hand, the women with just OB were identified using body mass index (BMI) as follows: normal rank was considered 18.5–24.99 kg/m2, the rank for obese class I was 30–34.99 kg/m2, obese class II 35–39.99 kg/m2, and obese class III greater than or equal to 40 kg/m2.",25,25,"3 months",16S,3,"Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,increased,unchanged,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 380","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"post fecal mircobiota day 180","post allogenic hematopoietic cell transplant/ pre Fecal microbiota transplant","patients who received Fecal Microbiome Transplant",5,13,"48 hours",16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,"HLA match,acute graft vs. host disease,age,transplant conditioning",,,,,unchanged,,Complete,"Rimsha Azhar"
"Experiment 2","Study 124","South Korea","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,control,"body builders (high protein)",,15,15,"6 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 315",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"breast-fed Infants to mothers didn't receive IAP","Breast-fed Infants to mothers received IAP","Full-term (gestational ages >37 weeks) vaginally delivered infants born after an uncomplicated pregnancy",18,11,"During pregnancy or postnatal period (Mothers); during the study period (infants)",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0-3 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,LEfSe,0.05,false,4,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 2","Study 134",Denmark,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"before  New Nordic Diet","6 months after  New Nordic Diet","the dietary intervention study of the NND compared to the ADD was performed as a 6-month, nonblinded, parallel, randomized, controlled, ad libitum dietary intervention trial and was carried out between October 2010 and July 2011.",36,36,,16S,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 118",China,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"cesarean born and breastfed","cesarean born and mixed-fed","cesarean delivery and mixed-fed",24,10,,16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,"Rimsha Azhar"
"Experiment 2","Study 161",China,"Homo sapiens",Saliva,UBERON:0001836,"lung cancer",MONDO:0008903,"healthy controls",NSCLC,"newly diagnosed NSCLC (non small cell lung cancer) patients",20,39,"6 months",16S,"1,2",Illumina,LEfSe,0.05,false,4,"age,sex",,,increased,unchanged,increased,,,Complete,
"Experiment 2","Study 276",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy control","Multiple Myeloma patient","patient diagnosis with multiple myeloma and no other disease validated to affect intestinal microbial including digestive disease like liver cirrhosis, liver cancer, inflammatory bowel disease, and irritable bowel syndrome; systemic disease like diabetes and hypertension and thyroid disease; no treatment including antibiotics, chemotherapy, plasma exchange or bone marrow transplant; no cold, fever or other infections within 3 months before sampling with administrated antibacterial drugs, gastrointestinal motility drugs or micro-ecological conditioning agents like eating and living habit change 1 week before sampling",17,40,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,decreased,unchanged,,,,Complete,
"Experiment 2","Study 297",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"human papilloma virus infection",EFO:0001668,"pregnant no HPV","pregnant high risk HPV","pregnant high risk HPV confirmed using HPV genotyping kit",48,38,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,unchanged,unchanged,,,unchanged,Complete,"Fatima Zohra"
"Experiment 2","Study 31","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,controls,"CFS/ME patients with IBS","Cases met the 1994 CDC Fukuda and the 2003 Canadian consensus criteria for ME/CFS",50,21,"3 months for controls only",WMS,,Illumina,LEfSe,0.2,true,2,"age,ethnic group,geographic area,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"no new acquisition of HPV within a year","new acquisition of HPV within a year","New HPV-type acquisition confirmed by HPV assay and genotyping",109,24,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 2","Study 312",Italy,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants born by mothers negative to GBS","Infants born by mothers positive to GBS and received IAP","Infants of Mothers positive to Streptococcus (GBS) and received intrapartum antibiotic prophylaxis (IAP)",10,10,"perinatal antibiotics",16S,"2,3,4,5,6,7,8,9","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,decreased,,,,Complete,
"Experiment 2","Study 178",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,peritumor,"gastric cancer tumor group","gastric cancer",61,59,"1 month",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,increased,,increased,,unchanged,Complete,
"Experiment 2","Study 323","United States of America","Homo sapiens","Mucosa of small intestine,Feces","UBERON:0001988,UBERON:0001204","necrotizing enterocolitis",EFO:0003928,non-NEC,NEC,"infants who underwent intestinal resection at <180 days of age",14,10,,16S,"1,2,3,4",Roche454,DESeq2,0.1,true,,,,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 2","Study 270",Italy,"Homo sapiens","Vaginal fluid",UBERON:0036243,"human papilloma virus infection",EFO:0001668,"HPV+ (clearance)","HPV+ (persistance)","HR-HPV+ persistence confirmed by HPV genotyping after 1 year",27,28,"3 days",16S,"3,4,5",Roche454,LEfSe,0.05,false,2,,,,unchanged,unchanged,,,unchanged,Complete,"Fatima Zohra"
"Experiment 2","Study 390",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls","scizophrenia during remission","patients who complied with diagnostic criteria for SCZ in the Diagnostic and Statistical Manual of Mental DIsorders Fourth Edition, Positive and negative syndrome scale, PANSS<60; No change in antipsychotic regimen (within two weeks)",29,29,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,age,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 104",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"healthy controls","major depressive disoreder (visit 2)","The patients were assessed with the major depressive disorder criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV- TR) and 17-items HAM-D scales ≥23.Three visits occurred on day 1, day 15 and day 29.",10,10,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.01,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 415","United States of America","Homo sapiens",Saliva,UBERON:0001836,"HIV infection,oral candidiasis","EFO:0000764,EFO:0007406","Age-matched HIV-uninfected womenn","HIV-positive women with oral candidiasis","HIV-positive women with oral candidiasis",3,3,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,,Complete,
"Experiment 2","Study 69",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"female normal weight","female obese",,168,20,"2 months",16S,"3,4",Illumina,DESeq2,0.05,true,,,,,unchanged,,unchanged,unchanged,increased,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 92","United States of America","Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"healthy controls","non-alcoholic fatty liver disease patients","clinical diagnosis of NAFLD based on ultrasound findings and elevated transaminases.  BMI for obese children with and without clinical NAFLD were greater than the 95% for age",26,13,"6 months",16S,,"Ion Torrent",ANOVA,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 396","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"Atopic eczema",EFO:0000274,baseline,"atopic dermatitis after treatment with TCS + Bleach","child with moderate to severe atopic dermatitis after treatment with TCS + bleach",9,9,"2 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 2","Study 57","United States of America","Homo sapiens","Buccal mucosa",UBERON:0006956,"irritable bowel syndrome",EFO:0000555,control,"overweight irritable bowel syndrome","IBS are who suffered from chronic visceral pain and altered bowel habits for more than 6 months for which no organic cause had been identified",20,11,,16S,,PhyloChip,"Welch's T-Test",0.05,false,,"age,body weight,race,sex",,,,,,,,Complete,Fatima
"Experiment 2","Study 379","United States of America","Homo sapiens",Mouth,UBERON:0000165,obesity,EFO:0001073,non-obese,obese,"participants who were selected for four nested case-control studies to investigate the oral microbiome and those diagnosed after mouth rinse sample colection with type 2 diabetes, lung cancer, upper aero-digestive tract cancer, and colorectal cancer",969,647,"1 year",16S,4,Illumina,"Logistic Regression",0.05,true,,"age,race,sex,smoking behavior","age,race,sex,smoking behavior",,unchanged,,unchanged,,unchanged,Complete,
"Experiment 2","Study 97",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"healthy controls","Roux-en-Y gastric bypass (RYGB)","obese patients had a body mass index (BMI) of >28 kg/m2.",20,7,"3 months",16S,4,"Ion Torrent",Kruskall-Wallis,0.05,false,4,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 93",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,no,"Antimicrobials use during delivery yes",,151,61,"newborns administerated antibiotics during delivery: Cefuroxime (n= 31), penicillin (n= 28), piperacillin-tazobactam (n=2)",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 224","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,baseline,"brown rice (BR)","baseline (before fiber supplementation)",28,28,"3 months",16S,"1,2,3",Roche454,ANOVA,0.05,false,,,,,increased,unchanged,increased,,,Complete,
"Experiment 2","Study 185",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,"healthy gastric cancer","gastric cancer","gastric cancer patients",22,20,"1 month",16S,,Illumina,LEfSe,,false,3.5,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 144",China,"Homo sapiens",Throat,UBERON:0000341,"air pollution",ENVO:02500037,"lightly poluuted region (A)","heavily polluted region (C)","paticipants lived in any of those regions for more than 2 years. region A: (lightly polluted region of PM 2.5), region B: (moderately polluted region of PM 2.5) and region C: (heavily polluted region of PM 2.5)",35,39,"3 months",16S,3,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,"vital capacity",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"low Southern European Atlantic Diet","intermediate Southern European Atlantic Diet","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",3,21,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 2","Study 143",Ireland,"Homo sapiens","Mesenteric lymph node",UBERON:0002509,"inflammatory bowel disease",EFO:0003767,"Ulcerative colitis","Crohn's disease","histopathologivally diagnosed ulcerative colitis and crohn's disease",8,5,,16S,"3,4",Illumina,T-Test,0.05,false,,,,,decreased,increased,,,increased,Complete,Fatima
"Experiment 2","Study 107","United States of America","Homo sapiens",Feces,UBERON:0001988,"anorexia nervosa",EFO:0004215,"healthy controls",anorexia,,12,10,"2 month",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.1,true,,"age,sex",,,,decreased,,,,Complete,
"Experiment 2","Study 247","New Zealand","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"prebiotic (inulin-type fructan) - in participants with low dietary fiber",placebo,"placebo (control for prebiotic intake - representing lower fiber group)",34,33,"6 months",16S,"3,4",Illumina,ANOVA,0.05,false,,"age,body mass index,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 426",China,"Homo sapiens",Feces,UBERON:0001988,"Autoimmune Hepatitis",EFO:0005676,"healthy controls","autoimmune hepatits cases","The diagnosis of AIH was made if patients conformed with (1) 1999 revised International Autoimmune Hepatitis Group (IAIHG) score ≥10 and/or (2) 2008 IAIHG simplified AIH score ≥6 and/or (3) histological features indicative of AIH.",98,91,,16S,"3,4",Illumina,"Logistic Regression",0.05,false,,"age,body mass index,sex","age,body mass index,sex",,decreased,,,,decreased,Complete,
"Experiment 2","Study 427",Italy,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,vegans,omnivores,,51,51,"3 months",16S,"1,2,3",Roche454,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",,true,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 428",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 cases","Recovered following negative quantitative reverse transcription PCR (RT-qPCR) tests for SARS-CoV-2 RNA in nasopharyngeal swabs",78,13,"Patients whose COVID-19 treatment included antibiotics were excluded",WMS,,Illumina,LEfSe,0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 253","South Korea","Homo sapiens",Nasopharynx,UBERON:0001728,asthma,MONDO:0004979,"healthy control","asthma remission","asthma remission",31,30,"3 months",16S,"1,2,3",Roche454,"Dunn's test",0.1,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 192","United States of America","Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"healthy controls","diarrhea-predominant irritable bowel syndrome","Diarrhea-Predominant irritable bowel syndrome",23,23,"2 months",16S,6,Roche454,T-Test,0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 2","Study 177",Sweden,"Homo sapiens",Colon,UBERON:0001155,"colorectal cancer",EFO:0005842,control,tumor,"patients diagnosed with stage I-III colon cancer",14,12,recent,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,increased,Complete,
"Experiment 2","Study 327",Netherlands,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control(no treatment)","infants received long-term(>5days) antibiotic treatment","infants born between 32-42 weeks of gestation and admitted to the hospital level III neonatal intesive care or level II neonatal ward",28,13,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,,unchanged,,,,Complete,
"Experiment 2","Study 360","United States of America","Mus musculus","Small intestine",UBERON:0002108,"air pollution",ENVO:02500037,"mice exposed to Filtered Air","mice exposed to WS","male ApoE−/- mice exposed to  mixed diesel and gasoline engine emissions (MVE) or Wood Smoke (WS)",20,20,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,decreased,,,decreased,Complete,
"Experiment 2","Study 202",Spain,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"healthy controls","children with autism non-mental regression (ANMR)","Children between 2-6 years old with an agreed clinical diagnosis of autism per the ICD 10th Edition for ASD and DSM-5 who did not have development regression during the first two years of life.",57,30,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 298","United States of America","Homo sapiens","buccal mucosa",UBERON:0006956,"acute myeloid leukemia",EFO:0000222,"no infection",infection,"acute myeloid leukemia patients that were microbiologically documented with infection during induction chemotherapy before neutrophil recovery",30,15,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,,,,Complete,
"Experiment 2","Study 361",Canada,"Mus musculus",Caecum,UBERON:0001153,"Air pollution",ENVO:02500037,"all other mice","female mice exposed to cigarette smoke","female mice exposed to cigarette smoke",48,10,,16S,4,Illumina,LEfSe,0.05,true,3.5,,,decreased,increased,,,,increased,Complete,Claregrieve1
"Experiment 2","Study 389","United States of America","Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"healthy controls",schizophrenia,"patients met DSM-IV criteria for schizophrenia, mania participants with symptoms of mania or hypermania could have diagnosis of Bipolar I disorder, single manic episode, most recent episode, mixed Bipolar II episode, most recent episode mixed,or Schizoaffective disorder., bipolar type (manic, hypomanic or mixed state)",85,62,,16S,"3,4",Illumina,"Wald Test",0.05,true,,,"age,body mass index,nicotine dependence,race,sex",,,,,,,Complete,
"Experiment 2","Study 187","United States of America","Homo sapiens",Vagina,UBERON:0000996,"medroxyprogesterone acetate",CHEBI:6716,"black naive vaginal microbiome (baseline visit )","white naiive vaginal microbiome (baseline)","white participants at baseline",16,9,"before sample collection",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.2,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 378",France,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"non acute graft-versus-host-disease","Severe acute graft-versus-host-disease","patients who are diagnosis with severe gut acute graft- versus-host disease (between standard stage greater or equal to 2 and less than or equal to 3)",35,15,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,4,,,,,decreased,decreased,,decreased,Complete,
"Experiment 2","Study 150",China,"Homo sapiens",Saliva,UBERON:0001836,"head and neck carcinoma",MONDO:0002038,"Vocal cord polyp",Cancer,"throat cancer including cancer of oropharynx, hypopharynx, nasopharynx and larynx",9,32,"6 months",16S,3,Illumina,LEfSe,0.05,false,4,,,,unchanged,unchanged,unchanged,,,Complete,"Fatima Zohra"
"Experiment 2","Study 371",France,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"lean and anorexic subjects","obese and overweight subjects","patients who were overweight or obese by BMI",91,171,"6 months",WMS,,RT-qPCR,Chi-Square,0.05,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 155","United States of America","Homo sapiens",Mouth,UBERON:0000165,"esophageal cancer",MONDO:0007576,controls,"Esophageal Squamous cell carcinoma (ESCC)","diagnosed with easophageal cancer anytime after oral wash sample collection",50,25,,16S,4,Illumina,"Logistic Regression",0.05,false,,"age,race,sex","alcohol drinking,body mass index,smoking behavior",,unchanged,,,,unchanged,Complete,"Fatima Zohra"
"Experiment 2","Study 328","United States of America","Homo sapiens",Feces,UBERON:0001988,"psoriatic arthritis",EFO:0003778,"healthy controls","skin psoriasis","patients fulfilling the criteria of the Classification of Psoriatic arthritis (CASPAR)",17,15,"3 months",16S,"1,2",Roche454,LEfSe,0.2,true,2,"age,ethnic group,sex",,,decreased,,,,,Complete,
"Experiment 2","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic free group (postnatal day 3)","piperacillin-tazobactam group (postnatal day 3)","pre-term neonates receiving piperacillin-tazobactam (75 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,unchanged,,,,,Complete,Chloe
"Experiment 2","Study 302","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,asthma,MONDO:0004979,"healthy control","non-exacerbated asthma","physician-diagnosed current asthma presenting for routine, non-urgent, asthma followup care.",21,31,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 2","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy controls","HIV infected patients who are homosexual","homosexual patients infected with HIV",35,4,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,3,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 255","United Republic of Tanzania","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"negative for intraepithelial lesion or malignancy","high-grade squamous intraepithelial lesions","high-grade squamous intraepithelial lesions (HSIL) comfirmed by Pap smear",4,4,,16S,4,Illumina,LEfSe,0.1,true,,age,,,,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 226",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"HAART-naive HIV-1 patients","HAART-treated HIV-1 patients","HIV-1 diagnosed patients",35,32,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,true,2,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 373",Estonia,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight adult",overweight,"Children and adults",9,7,,16S,"3,4",Illumina,T-Test,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 322",Sweden,"Homo sapiens","Buccal mucosa,Lower lip","UBERON:0006956,UBERON:0001835","oral mucositis",EFO:1001904,"no oral mucositis","oral mucositis","patients that are newly diagnosed with malignancies (before chemotherapy treatment) that are between ages 4 and 18 years old that are treated with cytostatic drug and has a national population registration number (Sweden) that has later developed oral mucositis (graded by the World Health Organization)",12,25,,16S,,Roche454,T-Test,0.05,true,,"age,sex",,,increased,,,,,Complete,
"Experiment 2","Study 419",Denmark,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,baseline,"combination antiretroviral therapy naive individuals after taking LGG probiotic for 8 weeks","Persons with HIV",13,13,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 2","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"healthy control","atopic no asthma","atopic no asthma",21,21,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 369","Cyprus,Estonia,Germany,Hungary,Sweden","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"before onset of obesity","after onset of obesity","children aged 2-9 years",36,36,"14 days",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,unchanged,Complete,
"Experiment 2","Study 334",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants exposed to antibiotic <=7day (L group)","infants exposed to antibiotic >7day (H group)","Pre-term infants",11,11,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,unchanged,,,Complete,
"Experiment 2","Study 234","Finland,Germany,United Kingdom","Homo sapiens","Skin of body",UBERON:0002097,psoriasis,EFO:0000676,"healthy control","adult with psoriasis","adult with psoriasis",115,119,"2 weeks",16S,,Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 152",Finland,"Homo sapiens",Feces,UBERON:0001988,"Cervical cancer",MONDO:0002974,"healthy controls","cervical cancer patients","pathology confirmed cervical cancer patients",5,8,"2 months",16S,4,Illumina,LEfSe,0.05,false,4,age,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 294","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,baseline,"post-consolidation therapy","8 weeks of consolidation",112,107,,16S,"1,2,3",Illumina,,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 346","United States of America","Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"mild depression","moderate depression","psychiatric inpatients diagnosed by DSM-IV Disorders, SCID-I and SCID-II interviews, CSSR-S, SLEQ and GAD-7",,,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 2","Study 308","United States of America","Mus musculus",Feces,UBERON:0001988,"air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,increased,increased,,,increased,Complete,
"Experiment 2","Study 309","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"<=38.8% 8-OHdG-positive cervical cells",">38.8% 8-OHdG-positive cervical cells","patients with >38.8% of 8-OHdG-positive cervical cells",,,,16S,4,Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 367",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",overweight,"Unrelated children, 9–11 years old",81,29,"3 months",16S,3,"Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 142","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"oral squamous cell carcinoma",EFO:0000199,"HPV -","HPV +","histopathologically confirmed HNSCC (Head & Neck Squamous Cell Cancer) and had atleast one post-treatment salivary sample",4,7,,16S,"3,4,5",Roche454,LEfSe,0.05,false,,,,,,decreased,,,decreased,Complete,"Rimsha Azhar"
"Experiment 2","Study 231","United Kingdom","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"golden delicious apple - at 10 hr",cellulose,"poorly fermentable fiber (cellulose)",3,3,"3 months",16S,"3,4",Illumina,ANOVA,0.05,true,,,,,increased,increased,,,increased,Complete,
"Experiment 2","Study 147",China,"Homo sapiens",Saliva,UBERON:0001836,"squamous cell carcinoma",EFO:0000707,"Site 2 (site below the epiglottis in the throat)","Site 1 (upper portion of throat near the epiglottis)","histopathological confirmation of Laryngeal squamous cell carcinoma and underwent total laryngectomy",28,27,"3 months",16S,"1,2",Roche454,T-Test,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 400",China,"Homo sapiens",Feces,UBERON:0001988,"allergic rhinitis",EFO:0005854,"healthy control","allergic rhinitis","child age 4-7 years with physician diagnosed allergic rhinitis",24,27,"4 weeks",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 401",China,"Homo sapiens",Throat,UBERON:0000341,"allergic rhinitis",EFO:0005854,"healthy control","allergic rhinitis","child age 3-5 diagnosed as having symptoms such as sneezing, nasal congestion, itching, and rhinorrhea in the last 12 months",32,23,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"premature birth",EFO:0003917,"10-day old Full-term infants(born after uncomplicated pregnancy)","10-day old Pre-term","born at gestational ages between 24 and 32 weeks",13,27,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 184","United States of America","Homo sapiens",Feces,UBERON:0001988,"prostate cancer",MONDO:0008315,controls,"prostate cancer patients","the association of urinary and fecal microbiota with prostate cancer diagnosis",16,14,"28 days",16S,"3,4,5",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"Minimal Residual Disease- (positivity) with Allogenic Stem Cell Transplant","Minimal Residual Disease- (negativity) with Allogenic Stem Cell Transplant","Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,LEfSe,0.05,true,2,,,,,,,,increased,Complete,
"Experiment 2","Study 135","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high fiber","Low fiber","high protein / low fiber",98,98,"6 months",16S,"1,2",Roche454,ANOVA,0.05,true,,,,,,,,,,Complete,
"Experiment 2","Study 200","United States of America","Homo sapiens","Lower part of vagina",UBERON:0015243,"endometrial cancer",MONDO:0011962,benign,"endometrial cancer","patients undergoing hysterectomy for endometrial cancer",75,66,"2 weeks",16S,"3,4,5",Illumina,"Linear Regression",0.1,true,,,"vaginal pH",,unchanged,,,,,Complete,
"Experiment 2","Study 410",Nigeria,"Homo sapiens",Rectum,UBERON:0001052,gonorrhea,,"MSM with no gonorrhea","MSM with gonorrhea","Men who have sex with men (MSM)",95,35,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 139","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"squamous cell carcinoma",EFO:0000707,controls,"Larynx cancer cases","histologically confirmed incident HNSCC including oral cavity, pharynx and larynx. (excluding salivary glands & nasopharynx)",254,58,,16S,"3,4",Roche454,DESeq2,0.1,true,,"ethnic group,sex","age,sex,smoking status",,,,,,,Complete,"Fatima Zohra"
"Experiment 2","Study 175","United States of America","Homo sapiens",Mouth,UBERON:0000165,"pancreatic carcinoma",EFO:0002618,controls,"pancreatic cancer cases","subjects from the CPSII cohorts with incident primary pancreatic adenocarcinoma",170,170,,16S,"3,4",Roche454,"Logistic Regression",0.05,false,,"age,sex",,,,,,,,Complete,
"Experiment 2","Study 412","United States of America","Homo sapiens",Rectum,UBERON:0001052,"methamphetamine dependence",EFO:0004701,non-users,"Methamphetamine users","MSM who self-reported methamphetamine (MA) use in the past six months",225,156,,16S,4,Illumina,,0.1,true,,,"age,alcohol drinking,cannabis use,ethnic group,smoking behavior",,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"Samples with no rhinovirus infection","Samples with any rhinovirus infection","Samples with rhinovirus infection assessed by using quantitative PCR and partial sequencing to identify viral strain type","1,883","1,239",,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,age,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 286",China,"Homo sapiens",Feces,UBERON:0001988,"Graves ophthalmopathy",EFO:1001466,"healthy controls","graves orbitopathy","severe and active graves' orbitopathy",32,33,"4 weeks",16S,4,"Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,decreased,unchanged,decreased,,unchanged,Complete,Fatima
"Experiment 2","Study 265",Finland,"Homo sapiens",Mouth,UBERON:0000165,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV infection",21,14,,16S,4,Illumina,LEfSe,0.05,false,4,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 2","Study 420","Norway,Sweden","Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"nonprobiotic intervention","HIV-infected on antiretroviral therapy allocated to probiotic intervention","HIV-infected patients receiving antiretroviral therapy (ART) with HIV-RNA < 50 copies per milliliter for at least 6 months and CD4 count < 500 cell per microliter",13,11,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 262","United States of America","Homo sapiens","Bronchus,Mouth","UBERON:0000165,UBERON:0002185","atopic asthma",EFO:0010638,"bronchial brush specimens","oral wash specimens","oral wash specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,unchanged,increased,,,,increased,Complete,Claregrieve1
"Experiment 2","Study 217",Finland,"Homo sapiens",Feces,UBERON:0001988,age,EFO:0000246,"infant at 6 months","infant at 18 months","infant 18 months of age",34,34,,16S,,"Human Intestinal Tract Chip",ANOVA,0.05,false,,,,,,,,increased,,Complete,
"Experiment 2","Study 167",China,"Homo sapiens",Mouth,UBERON:0000165,"squamous cell carcinoma",EFO:0000707,"healthy controls","Stage 1","OSCC  confirmed by biopsy and pathological findings",51,41,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,increased,unchanged,unchanged,,,Complete,
"Experiment 2","Study 284",China,"Homo sapiens",Gingiva,UBERON:0001828,"chronic kidney disease",EFO:0003884,"healthy controls","Chronic kidney disease","chronic kidney disease patients undergoing hemodialysis",30,30,"30 days",16S,"3,4,5",Illumina,LEfSe,0.05,false,2,"age,sex,smoking behavior",,,decreased,decreased,,,decreased,Complete,Claregrieve1
"Experiment 2","Study 350",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight","obesity with metabolic syndrome","children aged 7-10 years old",7,10,"3 months",16S,4,Illumina,LEfSe,0.05,false,1,"age,sex",,,unchanged,,,,increased,Complete,
"Experiment 2","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 10","ICR male mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 2","Study 207",China,"Homo sapiens",Vagina,UBERON:0000996,vulvovaginitis,EFO:1001240,"Normal controls","Women with BV and VVC","Women infected with both BV and VVC",30,16,"1 month",16S,6,Illumina,LEfSe,0.05,false,,,,,increased,,,,,Complete,Claregrieve1
"Experiment 2","Study 335",Canada,"Mus musculus",Feces,UBERON:0001988,"air pollution",ENVO:02500037,"healthy mice","IL-10−/−  mice fed mouse chow with PM10","IL-10−/−  mice in chronic treatement group were  fed mouse chow ± PM10 (0.09 gm/kg) for 35 days",9,7,,16S,,"Non-quantitative PCR","PLS-DA (Partial least square discriminant analysis)",0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 195",China,"Homo sapiens","Dental plaque",UBERON:0016482,"chronic hepatitis B virus infection",EFO:0004239,"liver cirrhosis","chronic hepatitis B","chronic hepatitis B",10,10,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 242",China,"Homo sapiens","Dental plaque",UBERON:0016482,"Iron deficiency anemia",HP:0001891,"healthy control","iron deficiency anemia","patients with iron deficiency anemia",24,24,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,true,3.5,"age,sex",,,decreased,unchanged,decreased,,,Complete,
"Experiment 2","Study 213","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high fiber from FRUITS/VEGETABLES (Q3 and Q4)","low fiber from FRUITS/VEGETABLES (Q1 and Q2)","lower quartiles (Q1 and Q2) of FRUIT/VEGETABLE fiber intake vs control (Q3 and Q4)",76,75,"no ""long term"" antibiotics use",16S,"3,4","Illumina,Roche454",DESeq2,0.05,true,,,"age,body height,body mass index,body weight,race,sex,smoking behavior",,,,,,,Complete,
"Experiment 2","Study 210",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy controls","children with food sensitization","child with food sensitization",22,23,"1 week",16S,"3,4,5",Roche454,LEfSe,0.05,false,2,age,,,decreased,decreased,,,decreased,Complete,
"Experiment 2","Study 307",France,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"moxifloxacin treated group (MXF)","DAV132+moxifloxacin treated group (MXF+DAV132)","healthy male and female volunteers aged >18 years",14,14,"3 months",WMS,,"Mass spectrometry","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,increased,Complete,
"Experiment 2","Study 348",Brazil,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"lean children","overweight children","Healthy children who are considered overweight based on z-score of ≥ +1 and < +2",30,24,"3 months",16S,,RT-qPCR,Kruskall-Wallis,0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 259","United States of America","Homo sapiens","Skin of forearm",UBERON:0003403,"atopic eczema",EFO:0000274,"no emollient use","emollient use","infant randomized to emollient therapy",9,10,"during study",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,increased,,,increased,Complete,
"Experiment 2","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Hypertensive at Middle Altitude (MHH)","Tibetan Hypertensive at High Altitude (HTH)","Tibetan participants with hypertension living at high altitudes.",49,38,"3 months",16S,"3,4",Illumina,T-Test,0.05,,,"age,sex",,,increased,,,,,Complete,Fatima
"Experiment 2","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"transient HPV+ with LSIL","transient HPV+ with HSIL","high-risk HPV transient infection (HPV has regressed within 1 year) with high grade squamus intraepithelial lesion",,,,16S,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 433","South Korea","Homo sapiens",Vagina,UBERON:0000996,"cervical cancer",MONDO:0002974,"healthy controls","cervical cancer","Patients with cervical cancer",7,8,,16S,3,"Ion Torrent",LEfSe,0.05,false,7,,,,unchanged,,unchanged,,increased,Complete,
"Experiment 2","Study 434",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"cervical glandular intraepithelial neoplasia",EFO:1000165,"healthy control",LSIL,"women with low-grade squamous intraepithelial lesions confirmed by biopsy",78,51,"14 days",16S,"3,4",Illumina,LEfSe,0.05,true,4,,,,unchanged,increased,,,,Complete,
"Experiment 2","Study 435",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,"HPV+ transient","HPV infection cleared within 12 months",5,4,"1 month",16S,4,"Ion Torrent",LEfSe,0.05,true,4,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 440","United States of America","Homo sapiens","Nose,Skin of cheek","UBERON:0000004,UBERON:0008803",rosacea,EFO:1000760,"Healthy controls","Participants with erythematotelangiectatic rosacea","Participants with rosacea included individuals with diagnosed erythematotelangiectatic rosacea (ETR): severity of rosacea assessed using the National Rosacea Society clinical grading system ranged from mild to moderate",19,19,"4 weeks for topical antibiotics, corticosteroids, and other anti-inflammatory medications, within 8 weeks for systemic antibiotics, corticosteroids, and other immunosuppressive agents",16S,"3,4",Illumina,Metastats,0.05,true,,"age,race,sex",,,,,,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 441",China,"Homo sapiens",Feces,UBERON:0001988,"influenza A (H1N1)",EFO:1001488,"Healthy controls","H1N1 cases","H1N1 patients with viral infection confirmed by real-time reverse-transcription polymerase chain reaction hospitalized between January 2018 and March 2019 with severe disease at time of admission",30,24,"4 weeks",16S,"3,4",Illumina,LEfSe,0.05,true,3.5,"age,body mass index,sex",,,decreased,decreased,,,,Complete,Fatima
"Experiment 2","Study 447",China,"Homo sapiens",Saliva,UBERON:0001836,"gestational diabetes",EFO:0004593,"Healthy controls","Individuals with gestational diabetes","Individuals with gestational diabetes at third trimester during pregnancy",31,30,"2 weeks",16S,"3,4",Illumina,"LEfSe,Mann-Whitney (Wilcoxon)",0.05,false,2,,,,unchanged,decreased,unchanged,,,Complete,
"Experiment 2","Study 442","South Korea","Homo sapiens","Skin of sole of pes,Interdigital space","UBERON:0013778,UBERON:0036252","type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Type 2 Diabetes Mellitus patients diagnosed by an endocrinologist at Konkuk University Medical Center, Seoul, Korea",18,17,"concomitant systemic (within four weeks of enrolment) or topical (within two weeks of enrolment) treatments",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,unchanged,,decreased,Complete,
"Experiment 2","Study 450","United Kingdom","Mus musculus",Feces,UBERON:0001988,"viral pneumonia",EFO:0007541,"Day 0","Day 7","Day 7 of infection for mice infected with influenza virus (H1N1)",,,,16S,4,Illumina,"ANOVA,DESeq2",0.05,true,,,,,unchanged,,,unchanged,,Complete,
"Experiment 2","Study 453","United States of America","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"SARS-CoV-2 infected patients","SARS-CoV-2 recovered individuals",">age 18, more than 2 weeks post-COVID-19 infection that was confirmed by positive PCR for SARS-CoV-2",50,9,,16S,"1,2,3",Illumina,edgeR,0.05,true,,,,,unchanged,,,,unchanged,Complete,Lwaldron
"Experiment 2","Study 455",Singapore,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,gingivitis,MONDO:0002508,"pregnant women without gingivitis","pregnant women with gingivitis",,10,10,"6 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,unchanged,unchanged,Complete,Fatima
"Experiment 2","Study 457",China,"Homo sapiens",Saliva,UBERON:0001836,periodontitis,EFO:0000649,"Healthy controls","Individuals diagnosed with Periodontitis and Type 2 Diabetes Mellitus (DAP)","Individuals diagnosed with Periodontitis and Type 2 Diabetes Mellitus (DAP); Patients were classified into the DAP group when both periodontitis and T2DM were present.",27,46,"patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,increased,,,Complete,Claregrieve1
"Experiment 2","Study 458",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Inbutation non-covid","critically severe covid","Intubated patients with critically severe COVID-19 infection",20,50,,WMS,,"BGISEQ-500 Sequencing",PERMANOVA,0.05,false,,,,,unchanged,,,,,Complete,Fatima
"Experiment 2","Study 462",Poland,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 1 Diabetes Mellitus in 2012–2015 at the Department of Metabolic Diseases, University Hospital, Krakow, Poland",26,26,"30 days",16S,,Illumina,ANOVA,0.05,true,,,,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 463",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients in convalescence","Sample from COVID-19 convalescence period (from viral clearance to 2 weeks after hospital discharge)",30,30,"Any antibiotic or prebiotic use in previous months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,body mass index,sex",,,,decreased,,,,Complete,
"Experiment 2","Study 464",China,"Homo sapiens",Tongue,UBERON:0001723,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 patients","Confirmed COVID-19 patients who recovered",150,22,"Receipt of antibiotics and/or probiotics within 8 weeks prior to enrollment",16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,2,,,,decreased,,,,,Complete,
"Experiment 2","Study 465",China,"Homo sapiens",Feces,UBERON:0001988,"diabetic neuropathy",EFO:1000783,"Individuals diagnosed with type 2 diabetes Mellitus","Individuals diagnosed with peripheral neuropathy associated with type 2 diabetes","Patients with peripheral neuropathy associated with type 2 diabetes; the criteria for DPN were as follows: spontaneous limb pain, symmetrical or unilateral limb numbness, sensation of dullness and body tension, muscle weakness, weakened or absent tendon reflexes, and significant decreases in sensory and motor nerve conduction velocities as revealed via electromyography indicating the positive involvement of two or more nerves and normal arterial pulses in the foot and back.",21,45,"3 months",16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,increased,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 468",Turkey,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","All women in the endometriosis group had moderate to severe (stage 3–4) endometriosis according to American Fertility Society Revised Classification. Diagnosis of endometriosis was verified through histology.",14,14,"Participants were excluded if they had taken antibiotics within the past 8 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 475",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls (Group H)","Community Type I Patients","16 COVID-19 patients, 2 healthy controls",13,18,,16S,4,Illumina,ANOSIM,0.05,true,,,,increased,,,,,unchanged,Complete,
"Experiment 2","Study 477",Spain,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","Severe COVID-19 patients requiring ICU","Patients with confirmed COVID-19 infection and severe symptoms who were admitted into the intensive care unit",18,19,,16S,"3,4",Illumina,"Linear Regression",0.25,true,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 2","Study 479",Italy,"Homo sapiens","Nasopharynx,Oropharynx","UBERON:0001729,UBERON:0001728",COVID-19,MONDO:0100096,"Healthy controls","Mild-moderate COVID-19 patients","COVID-19 patients with mild to moderate symptoms that were not admitted to an intensive care unit",10,11,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,decreased,,,,Complete,
"Experiment 2","Study 480",Brazil,"Homo sapiens",Endometrium,UBERON:0001295,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign conditions","Confirmed endometriosis patients","Patients were assigned to the endometriosis group after endometriosis was confirmed via laparoscopic surgery and histology.",11,10,"within 30 days prior to sample collection",16S,"3,4",Illumina,DESeq2,0,false,,,,,unchanged,,unchanged,,unchanged,Complete,
"Experiment 2","Study 481",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Antibiotic-naive COVID-19 patients","Antibiotic-treated COVID-19 patients","Patients with COVID-19 treated with antibiotics",8,5,,WMS,,Illumina,"Linear Regression",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 2","Study 482",China,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"Mild COVID-19 patients","Severe COVID-19 patients","COVID-19 infected patients admitted to the ICU and requiring mechanical ventilation",7,15,,WMS,,DNBSEQ-T7,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 483",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Antibiotic-naive COVID-19 patients, pneumonia patients, uninfected controls","Antibiotic-treated COVID-19 patients","COVID-19 patients hospitalized with SARS-CoV-2 infection confirmed by 2 consecutive RT-PCR tests, treated with antibiotics",28,8,,WMS,,Illumina,"Linear Regression",0.05,true,,,"age,antibiotic exposure,comorbidity,sex",,,,,,,Complete,Chloe
"Experiment 2","Study 484",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 positive patients","COVID-19 positive patients with fever and cough symptoms",7,11,,WMS,,MGISEQ-2000,ANOVA,0.05,false,,,,decreased,decreased,,,,decreased,Complete,Fatima
"Experiment 2","Study 485",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"COVID-19 patients without fever","COVID-19 patients with fever","Symptomatic patients with confirmed COVID-19 (positive for COVID-19 nucleic acid by real-time RT-PCR from throat swab specimens) and fever (axillary temperature > 37.3 degrees Celsius)",11,20,,WMS,,MGISEQ-2000,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,unchanged,,,,Complete,Fatima
"Experiment 2","Study 486",India,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Asymptomatic COVID-19 patients","COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with mild symptoms and no requirement of oxygen support/ventilator",10,10,,16S,"3,4",,LEfSe,0.05,false,2,,,,,,,,,Complete,Fatima
"Experiment 2","Study 487","South Korea","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 samples (respiratory negative)","Samples from symptomatic/mild COVID-19 patients collected on or after negative conversion for SARS-CoV-2 RNA from the respiratory tract",36,12,"No history of antibiotics or probiotics",16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,decreased,unchanged,,,,increased,Complete,
"Experiment 2","Study 489",Italy,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"COVID-positive patients admitted to infectious disease ward (w-COVID-19)","COVID-positive patients admitted to ICU (i-COVID-19)","COVID-19 patients with nasopharyngeal swab positive for SARS-CoV-2, > 18 years of age admitted in ICU",9,6,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",DESeq2,0.05,true,,,,,unchanged,decreased,,,,Complete,Fatima
"Experiment 2","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","age at menarche",EFO:0004703,"early age at menarche (≤11)","later age at menarche (≥12)","breast cancer patients with age at menarche being over 12 years old",11,26,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,increased,,,,Complete,
"Experiment 2","Study 492",India,"Homo sapiens",Feces,UBERON:0001988,"diabetic retinopathy",EFO:0003770,"Healthy controls","Individuals diagnosed with Type 2 Diabetes and clinically manifest Diabetic Retinopathy (DR)","Individuals diagnosed with Type 2 Diabetes and clinically manifest Diabetic Retinopathy (DR); Subjects confirmed to having DR based on the fundus examination/photograph followed by fundus fluorescein angiography (FFA) and optical coherence tomography (OCT).",30,28,"3 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,diet,region,sex",,,increased,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 2","Study 495",China,"Homo sapiens",Feces,UBERON:0001988,"prediabetes syndrome",EFO:1001121,"Healthy controls","Individuals with Prediabetes (PreDM)","Individuals with Prediabetes (PreDM); PreDM was defined as FBG of 6.1–7.0 mmol/L or HbA1c levels of 6.0%–6.5%.",60,60,"2 months",16S,"4,5",Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 2","Study 496",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Seasonal flu patients","COVID-19 patients","Patients with COVID-19",33,62,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,decreased,,,,Complete,Fatima
"Experiment 2","Study 498","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 patients with low viral load","COVID-19 patients with high viral load","Confirmed symptomatic mild to moderate COVID-19 patients > age 18, nonhospitalized,  with high viral load (quantitative reverse transcription PCR cycle threshold value
below the median for the detection of SARS-CoV-2 nucleocapside gene region 1)",,,"2 weeks",16S,4,Illumina,DESeq2,0.05,true,,,"age,sex",,unchanged,,,unchanged,unchanged,Complete,
"Experiment 2","Study 493",China,"Homo sapiens","Skin of body",UBERON:0002097,Vitiligo,EFO:0004208,"Normal skin of Vitiligo patients before narrowband UV (NBUVB) light irradiation (NF group)","Lesional skin of Vitiligo patients after NBUVB irradiation (DB group)","Lesional skin of Vitiligo patients after NBUVB irradiation (DB group); Vitiligo patients recruited from Weifang Medical University Hospital, Shandong, China, from February 2018 to January 2019.",15,15,"6 months",16S,"3,4",Illumina,T-Test,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 478",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Flu patients","COVID-19 patients","Confirmed COVID-19 cases",29,31,,WMS,,MGISEQ-2000,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 2","Study 499",Finland,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-C,"IBS patients fulfilled the Rome II criteria. Constipation-predominant IBS (IBS-C)",46,18,,16S,,"Human Intestinal Tract Chip",T-Test,0.05,true,,,,,,,,,,Complete,Lwaldron
"Experiment 2","Study 502",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-C,"Fulfilled the Rome III criteria for the diagnosis of IBS. Constipation IBS (IBS-C)",24,4,"Exclusion criteria included pregnancy or lactation, chronic intestinal disease (i.e., inflammatory bowel disease or celiac disease) or severe systemic disorders, lactose intolerance or food allergies. Patients who in the 2 mo prior to study entry had taken medication, such as antibiotics, corticosteroids or functional foods containing pre or probiotics, were also excluded from the study.",16S,,HTF-Microbi.Array,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 2","Study 443",India,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Health Control",IBS-C,"Patients with IBS diagnosed using Rome III. Patients were classified into three sub-types
using Rome III criteria: constipation predominant IBS (IBS-C).",30,20,"Patients who had prior history of gastrointestinal surgery, inflammatory bowel disease, and celiac disease were excluded. Patients with IBS who used antibiotics, probiotics, or prokinetics within last 4 weeks of inclusion into the study were also excluded.",16S,,RT-qPCR,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,
"Experiment 2","Study 505",Netherlands,"Homo sapiens","Feces,Mucosa of small intestine","UBERON:0001988,UBERON:0001204","irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"IBS patients included in this study fulfilled the Rome II criteria for IBS and were categorized as diarrhea predominant (IBS-D)",26,14,"Subjects taking medication known to influence bacterial composition and gastrointestinal motility, especially antimicrobial medications and/or probiotics were excluded from the study.",,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 2","Study 503",,,,,,,"Pre-amoxicillin treatment",End-of-treatment,,,,,,,,,,,,,,,,,,,,Incomplete,
"Experiment 2","Study 507",Italy,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Patients before Rifaximin treatment","Patients 1 month after Rifaximin treatment","Patients 1 month after Rifaximin treatment affected by ulcerative colitis, Chron's disease, Irritable Bowel Syndrome, diverticular disease, and liver cirrhosis with hepatic encephalopathy consecutively.",20,20,"1 month prior to Rifaximin treatment.",16S,"1,2,3",Roche454,metagenomeSeq,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 2","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,neoplasm,EFO:0000616,"WNH with TNBC normal tissue","WNH with TNBC normal tissue","Tumor tissue from white non-hispanic patients with triple negative breast cancer",6,6,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",,false,,,,,increased,,,,,Complete,Chloe
"Experiment 2","Study 510",Brazil,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,"rheumatoid arthritis",EFO:0000685,"patients with no rheumatoid arthritis","patients with rheumatoid arthritis","patients with rheumatoid arthritis",27,21,"3 months",16S,4,Illumina,LEfSe,0.05,true,,"age,sex",,,increased,,increased,,increased,Complete,
"Experiment 2","Study 511",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"COVID-19 patients (mild/moderate)","COVID-19 patients (severe/critical)","Patients with confirmed COVID-19 infection per 2 sequential positive RT-PCR tests deemed to have severe/critical disease",30,22,"No antibiotics or probiotics within 8 weeks prior to COVID-19 infection (also true for controls)",16S,"3,4",Illumina,"LEfSe,Linear Regression",0.05,true,2,"age,sex",,,,,,,decreased,Complete,Fatima
"Experiment 2","Study 512","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative controls","COVID-19 positive patients","Patients positive for SARS-CoV-2",21,68,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,increased,Complete,
"Experiment 2","Study 513","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 positive patients without breathing assistance","COVID-19 positive patients with breathing assistance","Patients who were confirmed PCR positive for SARS-CoV-2 and had treatment with oxygen mask, non-rebreather mask, nasal cannula, BiPAP, CPAP, or ventilator",67,12,,WMS,,Illumina,"Fisher's Exact Test",0.05,false,,,,,unchanged,,,unchanged,unchanged,Complete,
"Experiment 2","Study 517",Japan,"Homo sapiens",Endometrium,UBERON:0001295,endometriosis,EFO:0001065,"Endometriosis patients not treated with GnRHa","Endometriosis patients treated with GnRHa","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM). 16 of the 32 endometriosis patients received GnRHa (gonadotropin releasing hormone agonist) treatment for 4-6 months.",16,16,None,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 522",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign tumors","Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",14,36,"Patients were excluded if they had taken antibiotics within 6 months before the study",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 2","Study 524","United Kingdom","Homo sapiens",Feces,UBERON:0001988,"non-alcoholic steatohepatitis",EFO:1001249,"Healthy controls","Individuals diagnosed with Nonalcoholic steatohepatitis (NASH) with cirrhosis","Individuals diagnosed with Nonalcoholic steatohepatitis (NASH) with cirrhosis; The Fatty Liver Inhibition of Progression (FLIP) Consortium algorithm was used as a diagnostic indicator where the histological diagnosis of NASH requires the presence of steatosis, ballooning, and lobular inflammation; Fibrosis was scored following the CRN grading system54 by a single pathologist.",76,25,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,"age,body mass index,sex",,,decreased,,,,,Complete,
"Experiment 2","Study 525",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,endometriosis,EFO:0001065,"Women without CPPS presenting for routine examinations","Women with EM-associated CPPS","Thirty-seven women with endometriosis-associated chronic pelvic pain syndrome (CPPS) confirmed  by exploratory laparoscopy or surgical pathology",66,37,"Patients were excluded if they had taken antibiotics within 14 days prior to sampling",16S,4,Illumina,LEfSe,0.05,false,4,age,,,,,,,increased,Complete,
"Experiment 2","Study 526",China,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Patients without endometriosis","Endometriosis/ adenomyosis patients","All participants were diagnosed with endometriosis and/or adenomyosis (a condition where endometrial tissue grows into the uterine wall) through laparoscopic surgery",67,14,"No antibiotic use within 30 days",16S,,Illumina,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 527",Sweden,"Homo sapiens",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy controls taken from a larger cohort study","Endometriosis patients","Patients with a diagnosis of endometriosis, confirmed by laparoscopy or laparotomy.",198,66,"6 months",16S,"1,2,3",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,sex,smoking status",,,decreased,,,,,Complete,Claregrieve1
"Experiment 2","Study 529",China,"Homo sapiens",Saliva,UBERON:0001836,"rheumatoid arthritis,osteoarthritis","EFO:0000685,MONDO:0005178",Osteoarthritis,"rheumatoid arthritis","patient with rheumatoid arthritis",67,110,,16S,,Illumina,LEfSe,0.05,true,2,,,,unchanged,,,,unchanged,Complete,Chloe
"Experiment 2","Study 535",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic untreated subjects in day hospital","Antibiotic treated subjects in day hospital","subjects who were antibiotic-treated in a day hospital",33,7,,16S,4,Roche454,"Chi-Square,Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,true,,age,,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","the trend over Parkinson's disease progression","Patients with idiopathic Parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,193,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,,,,,Complete,
"Experiment 2","Study 541",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls","Schizophrenic patients (ARSCZ, FESCZ)","Only acutely relapsed schizophrenic (ARSCZ) and first-episode schizophrenic (FESCZ) patients were recruited in this study. The current episode of ARSCZ patients was required to happen in the last three months. ARSCZ patients were free of treatment for at least six months. The current episode of FESCZ patients was required to happen in the last year. FESCZ patients did not take any antipsychotics, or their accumulative dosages of antipsychotics intake were much less than the effective dosage (generally less than 100 mg chlorpromazine equivalents in the last two weeks based on the transformation method).",81,90,,,,,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 2","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,,,"Baseline of the Nitrofurantoin treated","Nitrofurantoin treated","UTI patients treated with nitrofurantoin macrocrystals 100mg twice daily",10,10,"2 months",16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 2","Study 550",Norway,"Homo sapiens",Saliva,UBERON:0001836,"temporomandibular joint disorder",EFO:0005279,"JIA patients without TMJ","JIA patients with TMJ","children with juvenile idiopathic arthritis",15,44,"Patients on antibiotics on the day of sampling were excluded, but previous antibiotic use were not recorded.",16S,"1,2,3",Illumina,LEfSe,0.1,true,2.5,"age,sex",,,,,,,,Complete,
"Experiment 2","Study 545","United States of America","Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"7 week old (young) mice before antibiotic treatment","7 week old (young) mice 6 months after antibiotic treatments","7-week old mice (young mice) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.",5,5,"Mice were not previously given antibiotics before the study",16S,,Illumina,DESeq2,0.05,true,,,sex,,decreased,,decreased,,,Complete,
"Experiment 2","Study 438",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Untreated controls (week 8)","Antibiotic treated (week 8)","Received parenteral antibiotic treatment with a combination of ampicillin and gentamicin within 48 hours of birth",9,9,"excluded if they required oral antibiotics (no time frame given)",16S,4,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,decreased,decreased,,,,Complete,Chloe
"Experiment 2","Study 553","United Kingdom","Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"spontaneous abortion",EFO:1001255,"Viable control pregnancy","First trimester miscarriage",,81,64,,,,,,,,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 554",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease, with Wexner scores < 3 using Wilcoxon rank sum test.","patients with Parkinson's disease with Wexner scores < 3","Patients with Parkinson's disease with Wexner scores < 3.",25,13,"No antibiotic use for at least 3 months prior to the study. 

Subjects with a history of using medications that have been shown to affect gut microbiota, including COMT inhibitors, anticholinergics, anti-secretory drugs, or cardiological drugs within the 3 months before the start of the study were excluded.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.01,,4,age,,,,decreased,,,,Complete,
"Experiment 2","Study 552","United States of America","Homo sapiens",Vagina,UBERON:0000996,"gestational age",EFO:0005112,36,Birth,"birth timepoint",57,57,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 2","Study 560",Germany,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy men without Parkinson's Disease.","Men with Parkinson's Disease.","Only early stage PD men who were naïve to L-DOPA therapy as diagnosed according to the UK Brain Bank criteria.",28,30,"The use of antibiotics in the past three months in principle was an exclusion criterion. However, we included three PD patients and three controls despite the intake of antibiotics for one to three days in a period of 28–34 days prior to feces sampling as the omission of those cases from the analyses did not change any result",16S,,Illumina,Kruskall-Wallis,0.1,true,,"age,sex",,,,,,,,Incomplete,
"Experiment 2","Study 568",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","NPD group: patients suffering with PD for less than 1 year and 5 days after treatment.","New Parkinson's disease patients: patients suffering with PD for less than 1 year and samples taken 5 days after treatment.",68,13,"The use of any antibiotics or probiotics within 90 days before collection of the samples.",16S,,Illumina,Metastats,0.01,,,age,,,increased,unchanged,increased,,,Complete,Rimsha
"Experiment 2","Study 566",Italy,"Homo sapiens",Feces,UBERON:0001988,"juvenile idiopathic arthritis",EFO:0002609,"JIA patients with active disease","JIA patients in remission","JIA patients with enthesitis-related arthritis who are in remission",8,21,"3 months",16S,"5,6",Roche454,LEfSe,0.05,true,2,,,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 574","Russian Federation","Homo sapiens",Feces,UBERON:0001988,"Antimicrobial agent",CHEBI:33281,"azithromycin treated (day 0)","azithromycin treated (day 18)","administered 10 mg/kg body weight per day of azithromycin, as powder for oral suspension.",42,42,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,age,,,,,,,,Complete,
"Experiment 2","Study 562","China,India,Italy,Malaysia,Singapore,United States of America","Homo sapiens","Skin of body",UBERON:0002097,healthy,,none,"healthy adult skin 50% up",,,362,"All records NA",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 2","Study 580","United States of America","Homo sapiens",Saliva,UBERON:0001836,"nicotine dependence,smoking behavior","EFO:0003768,EFO:0004318","HIV+ non-smokers","HIV+ smokers","People with HIV who currently smoke cigarettes",26,23,"5 days",16S,4,Illumina,LEfSe,0.05,false,2,,,,decreased,,,,,Complete,Claregrieve1
"Experiment 2","Study 581",China,"Homo sapiens",Feces,UBERON:0001988,epilepsy,EFO:0000474,"Healthy controls","Drug resistant epilepsy","Drug sensitive epilepsy patients were defined according to the 2015 International League Against Epilepsy (ILAE)",65,49,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,,Complete,Lwaldron
"Experiment 2","Study 558","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"received oral-i.v.-administered GSK1322322 (prestudy)","received oral-i.v.-administered GSK1322322 (end-of-study)","received oral-i.v.-administered GSK1322322",38,38,,16S,4,Roche454,,0.05,,,,,,,decreased,,,,Complete,
"Experiment 2","Study 578","Belgium,Poland","Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"Antibiotic treated (day 1)","Antibiotic treated (day 5-15)","receiving nitrofurantoin treatment (100 mg three times daily for 3–15 days)",8,8,"2 months",16S,"3,4,5",Roche454,"Linear Regression",0.05,,,,,,,,,,,Complete,
"Experiment 2","Study 601",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls without any form of Parkinson's Disease","Participants with idiopathic Parkinson's Disease","All Parkinson’s disease patients eligible for this study were diagnosed with idiopathic Parkinson’s disease according to the UK Brain Bank criteria.",75,78,"Antibiotic use within 3 months prior to sample collection.",16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,age,,,increased,,,,increased,Incomplete,
"Experiment 2","Study 586",Italy,"Homo sapiens",Saliva,UBERON:0001836,"colorectal cancer",EFO:0005842,"Healthy Controls","CRC Patients","Italian patients aged 71-95 with colorectal adenocarcinoma confirmed by histological analysis undergoing surgical resections.",10,10,"3 months",16S,"3,4",Illumina,ANOSIM,,,,,,,decreased,decreased,,decreased,,Complete,
"Experiment 2","Study 604","United States of America","Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy control free of neurological disease.","Participants with Parkinson's Disease","Dataset 2. PD was diagnosed by a movement disorder specialist using UK Brain Bank criteria",184,323,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,"age,body mass index,sex",,,,,,,Complete,Claregrieve1
"Experiment 2","Study 605",Japan,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Participants with Parkinson's Disease with non-tremor subtypes","Participants with Parkinson's Disease with tremor subtypes","Participants with Parkinson's Disease with tremor subtypes.",33,47,"Individuals currently taking antibiotics or probiotic supplements within 3 months of sample collection",16S,"3,4",Illumina,LEfSe,0.05,,2,"age,sex","age,diet,sex",,increased,,,,increased,Complete,Rimsha
"Experiment 2","Study 606",Australia,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Participants with mild PD","Participants with severe PD","All patients were confirmed to have idiopathic Parkinson’s disease by a movement disorders neurologist, in accordance with the United Kingdom Brain Bank criteria and severe symptoms.",7,7,"No history of antibiotic or non-steroidal anti-inflammatory drug use in the previous 3 months.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 2","Study 607",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy controls","Participants with typical PD","PD patients were defined as typical PD, according to the inclusion criteria by the United Kingdom Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria.",162,147,"Excluded control persons who took dopaminergic medications (n = 5; intake for a different than anti-PD indication) and individuals who reported to have taken antibiotics in the last 6 months (controls: n = 20, PD: n = 13).",16S,"3,4",Illumina,"Linear Regression",0.05,,,,age,,unchanged,,,,increased,Complete,
"Experiment 2","Study 608","Bangladesh,China,Estonia,Finland,Germany,India,Ireland,Italy,Luxembourg,Netherlands,Russian Federation,Spain,Sweden,United Kingdom,United Republic of Tanzania,United States of America","Homo sapiens",Feces,UBERON:0001988,healthy,,none,"healthy child stool 50% up",,,"3,375",,16S,,Illumina,,,,,,,,,,,,,Complete,
"Experiment 2","Study 618",Austria,"Homo sapiens",Feces,UBERON:0001988,Dementia,MONDO:0001627,"Controls without cognitive impairments","Patients with dementia","Participants with any level of dementia (mild, moderate, severe).",18,23,"4 weeks",16S,"1,2",Illumina,LEfSe,0.05,false,,"age,sex",,,,unchanged,unchanged,,,Complete,Lwaldron
"Experiment 2","Study 89",Brazil,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,13,46,"oral antibiotics in the third trimester of pregnancy",16S,4,Illumina,LEfSe,,false,3,,,,,,,,unchanged,Complete,
"Experiment 2","Study 571",,"Homo sapiens",Feces,UBERON:0001988,"osteoarthritis, knee",EFO:0004616,"Vitamin D deficiency","Knee osteroarthritis with vit D deficiency","Knee osteoarthritis",7,7,"excluded if antibiotics for last 12 weeks",16S,"3,4",Illumina,LEfSe,0.05,,2,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 2","Study 516",China,"Mus musculus",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy mice","Mice who were injected with endometrial tissues","Researchers induced endometriosis models by intraperitoneal injection of endometrial tissues to mimic endometriosis formation in humans.",8,,N/A,16S,4,Illumina,LEfSe,0.05,,4,,,,unchanged,unchanged,unchanged,,,Complete,Fatima
"Experiment 2","Study 582",Spain,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"adenoma patients","CRC patients","patients with gastrointestinal symptoms referred for colonoscopy",65,89,none,16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,Rimsha
"Experiment 2","Study 621","United States of America","Homo sapiens",Colon,UBERON:0001155,"Colorectal cancer",EFO:0005842,Placebo,Aspirin,"Experimental group took 325 mg daily aspirin over six weeks, with additional six weeks of washout",20,30,"3 months",16S,4,Illumina,"Mixed-Effects Regression",0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 622",China,"Mus musculus",Intestine,UBERON:0000160,,,"Control (male C57BL/6-APCMin/+ and male wild-type C57BL/6)","C57BL/6-APCMin/+: F. nucleatum (Fn), E. coli (Ec); wild-type C57BL/6: DMH, Fn, Fn+DMH, Ec, Ec+DMH","DMH was injected subcutaneous at a dose of 20 mg/kg once weekly. 

All treatments were performed for 8 weeks to ensure aberrant crypt foci (ACF) formation or 20 weeks to ensure tumor formation.",20,70,None,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 2","Study 624",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Healthy Individuals","Patients with early CRC","Patients with early colorectal cancer",129,136,"1 Month",16S,"1,2",Illumina,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 2","Study 630",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy control (normal and a few polyps)","stage III/IV (SIII/IV)","stage III and IV CRCs",251,74,"None specified",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.005,,,,,,,,,,,Complete,
"Experiment 2","Study 632","United States of America","Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Infants in household income =>$80,000.","Infants in household income <$80,000.","Gut bacterial composition among infants by maternal profiles. Microbiome Associated Maternal Profile (MMP3) 
 19.8% of the analytical sample(N =168)",52,33,unspecified.,16S,3,Illumina,PERMANOVA,0.05,true,,,"age,breast feeding,delivery procedure,education level,marital status,race,smoking status",decreased,,,,,decreased,Complete,
"Experiment 2","Study 631",Austria,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Healthy Controls","Colorectal Cancer","colorectal cancer patients

The study was conducted both in participants of a health screening programme according to national screening recommendations for CRC49 as well as in patients with suspected CRC undergoing colonoscopy as part of the clinical workup at the Department of Internal Medicine,
Oberndorf Hospital.",55,41,"3 months",WMS,,,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,,,,increased,Complete,Fatima
"Experiment 2","Study 637",China,"Homo sapiens","Oral cavity",UBERON:0000167,"Colorectal adenoma",EFO:0005406,"Healthy Individuals",CRA,"Patients with colorectal adenoma",58,34,"Not specified",16S,"3,4",Illumina,"Welch's T-Test",0.05,,,,"age,smoking status",,increased,unchanged,increased,,,Complete,
"Experiment 2","Study 643",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,oControls,oCRC,"old-onset CRC patients (greater than or equal to 50 years old)",203,233,"1 month",16S,"3,4",Illumina,LEfSe,0.05,,2,age,"age,sex",,increased,,,,,Complete,
"Experiment 2","Study 642",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Chinese Children (High SES, household income >RM500)","Orang Asli Children (low SES, household income<RM500)","Gut microbiota from fecal samples of 20 Orang Asli children whose household income <RM500.

45% of the households earn < RM500

Note: Poverty line = RM 764($254).",17,20,unspecified,16S,"3,4,5",,PERMANOVA,0.05,true,,,,increased,increased,,,increased,increased,Complete,
"Experiment 2","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"healthy controls","colorectal cancer","subjects with invasive adenocarcinoma",61,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,unchanged,,,Complete,
"Experiment 2","Study 648","United States of America","Homo sapiens","Oral opening",UBERON:0000166,"Ethnic group",EFO:0001799,"Oral microbiota of European American children (EA)","Oral microbiota of African American children (AA)","Oral microbiota of 30 African American children (18 female, 12 male; age 6 - 10 years)",30,30,unspecified,16S,"3,4,5",Illumina,PERMANOVA,0.05,true,,,"age,body mass index,education level,household income,sex",,unchanged,,,unchanged,unchanged,Complete,
"Experiment 2","Study 651",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"paracancerous tissue (pa10t)","cancerous tissue (cat)","37-88 years of age, colorectal cancer tissue

Note: group 0 = paracancerous tissue 10-20 cm from cancerous tissue",27,27,"1 month",16S,"1,2,3",Sanger,"Mann-Whitney (Wilcoxon)",0.05,,,,,,decreased,unchanged,,,unchanged,Complete,
"Experiment 2","Study 652",Japan,"Homo sapiens",Intestine,UBERON:0000160,"intramucosal CRC",,"CRA (colorectal adenoma)","Intramucosal CRC","Intramucosal CRC is in its earliest stage (stage 0) and is also known as carcinoma in situ or intramucosal carcinoma. Intramucosal CRC has not yet grown beyond the inner mucosal layer of the colorectum",47,24,"None Specified",16S,"3,4",Illumina,LEfSe,0.05,,3,,,,unchanged,,,,,Complete,
"Experiment 2","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Caucasians,Hispanic,"Hispanics sampled from the American Gut Project (AGP) data set","1,237",37,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,increased,increased,increased,,,Complete,
"Experiment 2","Study 663",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Chinese,India,"India ethnic group living in the  Segamat Malaysian community.",65,49,,16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,unchanged,unchanged,,,,,Complete,Fatima
"Experiment 2","Study 673","Colombia,Denmark,France,Japan,South Korea,Spain,United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,"USA data","Europe data","The European dataset consisted of the subset of 13 healthy volunteers (three women and 10 men) among Spanish, French, and Danish inhabitants whose microbiomes were published by the MetaHIT Consortium",54,13,"4 months",16S,"1,2,3",,ANOSIM,0.05,,,,"age,sex,waist circumference",,,,,,,Complete,
"Experiment 2","Study 681","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Colorectal cancer",EFO:0005842,controls,"Colorectal cancer","colorectal cancer; 24% of the colorectal cancer cases were current smokers. 16% habitual alcohol drinkers",122,68,"None specified",16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 2","Study 682",China,"Homo sapiens","duodenal mucosa",UBERON:0000320,"small intestine enteropathy",EFO:0009705,IBS.sibo-,IBS.sibo+,"Patients with typical clinical symptoms and normal colonoscopy presentation fulfilling the Rome III diagnostic criteria; with SIBO",33,24,"3 months; also includes probiotics and proton-pump inhibitors",16S,"1,2,3",Roche454,LEfSe,0.05,,2,,,,,increased,,,,Complete,
"Experiment 2","Study 683",Netherlands,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"non-adenoma group","adenoma group","Patients with a successful polypectomy. A total of 9 patients had advanced adenomas and 10 patients had non-advanced adenoma (NA), with a median size of the largest adenoma being 0.7 cm [IQR 0.5–0.8].",19,19,"3 months prior to study inclusion and 3 months prior to second sample",16S,4,Illumina,LEfSe,0.05,,2,"smoking status",,,,,,,unchanged,Complete,
"Experiment 2","Study 686",Italy,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,controls,adenomas,"Patients diagnosed with colorectal adenomas",24,27,"None specified",WMS,,Illumina,,0.05,,,,,,,,,,,Complete,
"Experiment 2","Study 687",China,"Homo sapiens",Tissue,UBERON:0000479,"Colorectal adenocarcinoma",EFO:0000365,"colorectal cancer patients without KRAS mutation","colorectal cancer patients with KRAS mutation","diagnosed of colorectal cancer by colonoscopy and histopathology",21,18,"No antibiotics for one month prior to surgery (fecal sample was taken the night before surgery)",16S,"3,4",Illumina,LEfSe,0.05,false,4,,,,,,,,,Complete,Fatima
"Experiment 2","Study 698",China,"Homo sapiens",Feces,UBERON:0001988,,,"Healthy controls","Patients with ulcerative colitis","Patients with ulcerative colitis",29,14,"3 months",16S,4,Illumina,Kruskall-Wallis,0.05,true,,"age,sex",,,unchanged,decreased,unchanged,,decreased,Complete,
"Experiment 2","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,non-GQD,"low-dose GQD (300 mg/kg)","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were
orally lavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical
traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously
into the left axillary region of each mouse and allowed ~1 week to establish tumours.",20,23,,16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 697",China,"Homo sapiens",Feces,UBERON:0001988,,,"Disease control with Immune checkpoint inhibitors","Disease control with Immune checkpoint inhibitors","“disease control” was defined as objective response or stable disease lasting =16 weeks.” Objective response was defined as complete or partial response per Response Evaluation Criteria in Solid Tumors (RECIST) v.1.1.",17,19,,16S,"3,4",Illumina,LEfSe,,,3,,,,unchanged,unchanged,,,,Complete,
"Experiment 2","Study 688","United States of America","Homo sapiens",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,Non-responders,Responders,"Patients were classified as R if they achieved an objective response (complete or partial response or stable disease lasting at least 6 months)",35,54,,16S,,Illumina,LEfSe,0.05,,3,,,,,,,increased,,Complete,Fatima
"Experiment 2","Study 679","United States of America","Homo sapiens",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,Non-responders,Responders,,26,16,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 2","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,control,Vanc,"Group 1 mice were treated with vancomycin alone (0.25 mg/ml) in sterile drinking
water (Vanc group).  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",13,14,,16S,4,Illumina,ANOVA,,,,,,,,,,,,Complete,
"Experiment 2","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"Healthy controls","colorectal cancer patients perioperative probiotics","Patients in the PGT group received an encapsulated probiotics preparation (Shanghai Xinyi Pharmaceutical Co., Ltd., Shanghai, China) containing live combined Bifidobacterium longum, Lactobacillus acidophilus and Enterococcus faecalis (1:1:1) with no less than 1.0x107 CFU/g viable cells, three times/day, with a total daily dose of 6.0x107 CFU for five days",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,2,,,,,increased,,,,Complete,
"Experiment 2","Study 692",China,"Homo sapiens",Feces,UBERON:0001988,Nutraceutical,CHEBI:50733,"colorectal cancer patients non-prebiotic (preoperative)","colorectal cancer patients non-prebiotic (postoperative)","Patients with radiologic and pathologic diagnosis of CRC who underwent radical resection (post-operative samples) and did not take prebiotics pre-surgery.",20,20,"no treatment with antibiotics within 6 mo before surgery",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 2","Study 577","United States of America","Homo sapiens",Sputum,UBERON:0007311,Asthma,MONDO:0004979,"Female normal controls","Female participants with asthma","Females participants with asthma",17,15,"1 month",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,Claregrieve1
"Experiment 2","Study 563",Afghanistan,"Homo sapiens","1st arch mandibular mesenchyme from head mesenchyme,Buccal salivary gland,abcd","UBERON:0010339,UBERON:0012102","Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome,Her2-receptor negative breast cancer,Breast cancer,breast cancer,Lung cancer","MONDO:0013806,MONDO:0000618,MONDO:0007254,MONDO:0008903","mild, moderate, and severe dementia","overweight irritable bowel syndrome",,1,2,,WMS,,"DNA-DNA Hybridization",ANCOM,,true,,,,,,,,,,Incomplete,
"Experiment 3","Study 697",China,"Homo sapiens",Feces,UBERON:0001988,,,"Non-responders to Immune checkpoint inhibitors","Responders to Immune checkpoint inhibitors","“Objective response” was defined as complete or partial response per Response
Evaluation Criteria in Solid Tumors (RECIST) v.1.1.",12,6,,WMS,,Illumina,LEfSe,,,2,,,,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 698",China,"Homo sapiens",Feces,UBERON:0001988,,,"Patients with ulcerative colitis","Patients with Crohn's disease","Patients with Crohn's disease",14,15,"3 months",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,
"Experiment 3","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"Healthy controls","colorectal cancer patients perioperative placebo","Patients in the CGT group received encapsulated maltodextrin (Haiyan Liuhe Pharmaceutical Industry Co., Ltd., Jiangsu, China) three times a day. During the study period, no parenteral or enteral nutritional",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,2,,,,decreased,unchanged,decreased,,,Complete,
"Experiment 3","Study 679","United States of America","Mus musculus",Feces,UBERON:0001988,"metastatic melanoma",EFO:0002617,"Group B Non-responders","Group A Responders","Mouse with 16.SIY melanoma tumor growth",3,3,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 3","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,Coli,Vanc,"Group 1 mice were treated with vancomycin alone (0.25 mg/ml) in sterile drinking
water (Vanc group).  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",14,14,,16S,4,Illumina,ANOVA,,,,,,,,,,,,Complete,
"Experiment 3","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Gegen Qinlian decoction (GQD)",,control,"low-dose GQD (300 mg/kg) + PD-1","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were orally gavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously into the left axillary region of each mouse and allowed ~1 week to establish tumours.  When the tumours reached a size of 50mm3, the mice were intraperitoneally (i.p.) injected with 250 μg of anti-mouse PD-1 mAb.  The mice in the control group were administered the same volume of PBS. All mice were injected five times at 3-day intervals with antimouse PD-1 mAb or PBS",11,12,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 687",China,"Homo sapiens",Tissue,UBERON:0000479,"Colorectal adenocarcinoma",EFO:0000365,"colorectal cancer patients without TP53 mutation","colorectal cancer patients with TP53 mutation","diagnosed of colorectal cancer by colonoscopy and histopathology",11,28,"No antibiotics for one month prior to surgery (fecal sample was taken the night before surgery)",16S,"3,4",Illumina,LEfSe,0.05,false,4,,,,decreased,,decreased,,,Complete,
"Experiment 3","Study 692",China,"Homo sapiens",Feces,UBERON:0001988,Nutraceutical,CHEBI:50733,"colorectal cancer patients who took prebiotics (preoperative fecal sample)","colorectal cancer patients who took prebiotics (postoperative fecal sample)","Patients with radiologic and pathologic diagnosis of CRC who underwent radical resection (post-operative samples) and took prebiotics pre-surgery.",18,18,"no treatment with antibiotics within 6 mo before surgery",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,,,,,Complete,
"Experiment 3","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,"Colon Sessile Serrated Adenoma/Polyp",EFO:1000189,controls,"Sessile serrated adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,33,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 218",China,"Homo sapiens",Feces,UBERON:0001988,"hepatocellular carcinoma",EFO:0000182,"HBV related HCC patients","non-HBV non-HCV patients","HCC patients whose disease is not related to hepatitis B/hepatitis virus",35,22,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 3","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"transient atopic dermatitis","infants with persistent atopic dermatitis","infant with persistent atopic dermatitis",22,26,"before sample collection",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 18",Denmark,"Mus musculus",Feces,UBERON:0001988,obesity,EFO:0001073,"BL6-High Fat with enomithacin","Sv129-High Fat with enomithacin","(BL6): C57BL/6JBomTac mouse strain, (Sv129):  the obesity-resistant mouse strain 129S6/SvEvTac . LF:  (LF)low-fat diet, (HF) high fat diet without indomethacin,  (HFI) high fat diet supplemented with indomethacin.",10,9,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 12","South Korea","Homo sapiens",Uterus,UBERON:0000995,"human papilloma virus infection",EFO:0001668,"HPV presistent and clearance","HPV negative","HPV DNA was detected using the Digene HC2 high-risk DNA test (Qiagen, Gaithersburg, MD, USA) with signal amplification and chemiluminescence for 13 types of HR-HPV scored in RLU/PC. A positive result indicated a concentration of 1 pg/ml or higher than the RLU/cutoff ratio (RLU of the specimen/mean RLU of 2 positive controls).",31,10,,16S,,Roche454,LEfSe,0.05,false,2,,"age,contraception,menopause,smoking behavior",,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 2","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"head and neck squamous cell carcinoma",EFO:0000181,"T0-T2 stages patients","T3-T4 stages patients","Not stated",,,,16S,"1,2,3,4",Sanger,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 126",China,"Homo sapiens",Saliva,UBERON:0001836,"Oral leukoplakia",HP:0002745,"Oral Squamous Cell Cancer patients","Oral leukoplakia",,16,10,,16S,,Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,unchanged,increased,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 169",China,"Homo sapiens",Tongue,UBERON:0001723,"gastric cancer",MONDO:0001056,"other coatings","yellow-thick tongue coating GC patient","gastric cancer with different tongue coatings",95,20,"4 weeks",16S,"3,4,5",RT-qPCR,LEfSe,0.05,false,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 3","Study 224","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,baseline,"brown rice + barley (BR + WGB)","baseline (before fiber supplementation)",28,28,"3 months",16S,"1,2,3",Roche454,ANOVA,0.05,false,,,,,increased,unchanged,increased,,,Complete,
"Experiment 3","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"<20 years participants","> 30 years participants","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",5,11,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 124","South Korea","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,control,"distance runners (high carb)",,15,15,"6 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 168",China,"Homo sapiens",Tongue,UBERON:0001723,"Chronic hepatitis B virus infection",EFO:0004239,"healthy controls","chronic hepatitis B white tongue coating patients","patients diagnosed with chronic hepatitis B per ""The Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2010 version)"" with a white tongue coating",22,25,"3 months",16S,3,"Ion Torrent",Metastats,0.05,false,,"age,sex",,,unchanged,unchanged,,,,Complete,Claregrieve1
"Experiment 3","Study 104",China,"Homo sapiens",Feces,UBERON:0001988,"unipolar depression",EFO:0003761,"healthy controls","major depressive disoreder (visit 3)","The patients were assessed with the major depressive disorder criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV- TR) and 17-items HAM-D scales ≥23.Three visits occurred on day 1, day 15 and day 29.",10,10,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.01,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 219","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"higher fiber (almonds)","lower fiber (cracker)","students eating crackers",35,38,,16S,"4,5",Illumina,ANCOM,0.05,true,,,,,,,,,,Complete,
"Experiment 3","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,controls,"untreated multiple sclerosis","untreated multiple sclerosis",43,28,"6 months",16S,4,Illumina,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 3","Study 250","United States of America","Homo sapiens",Tongue,UBERON:0001723,"severe aplastic anemia",EFO:0006927,engraftment,"hematopoietic stem cell transplantation 100 days after the transplant","In HSCT patients, The first sample was obtained before transplant conditioning treatment. The second specimen was collected at engraftment, defined as two absolute neutrophil counts of greater than 500 per microliter for at least 2 days. The final specimen collection occurred at the participant’s scheduled clinic visit approximately 100 days following transplant.",4,4,,16S,"2,3,4,5,6,7,8","Ion Torrent",LEfSe,0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 237",Germany,"Homo sapiens",Feces,UBERON:0001988,"chronic hepatitis C virus infection",EFO:0004220,"healthy controls","hepatitis C patients","hepatitic C patients",50,95,"3 months",16S,"1,2",Illumina,DESeq2,0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 238","United States of America","Homo sapiens",Feces,UBERON:0001988,"cervical cancer",MONDO:0002974,"healthy controls","cervical cancer patient","patients with biopsy-proven carcinoma of the cervix",46,42,"1 month- controls only",16S,4,Illumina,LEfSe,0.05,false,3,,race,,increased,,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 172","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Cannabis use",EFO:0007585,"controls (lateral border of tongue)","marijuana usage group","using marijuana on 20 or more days in the past month associated with a distinct oral microbiota at the most common sites of HNSCC, the oral pharynx.",19,20,"2 month",16S,"1,2,3",Illumina,DESeq2,,true,,"age,sex",,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 170",China,"Homo sapiens",Lung,UBERON:0002048,"Lung cancer",MONDO:0008903,"paired contralateral non-cancerous site","cancerous site","patients with diagnosis of lung cancer established by histological confirmation",24,24,"3 months",16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 3","Study 30",Belgium,"Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,"Belgian controls","Belgian CFS/ME patients","Patients were diagnosed for CFS according to the clinical criteria of Fukuda et al",19,18,"4 weeks",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 326",France,"Homo sapiens",Feces,UBERON:0001988,"non-small cell lung carcinoma,renal cell carcinoma","EFO:0003060,EFO:0000681",Non-Responders,Responders,"non-small cell lung carcinoma or renal carcinoma patients (all samples regardless of ampicillin, colistin, and streptomycin (ATB) anitbiotic treatment) that have been treated with PD-1 blockage with partial response or stable disease",16,16,,WMS,,"Mass spectrometry","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Time 0 days Bahia","Time 7 days",,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","Children underarm before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight men","obese men","Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m2",80,70,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 285","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,"healthy controls","IMD naive cases multiple sclerosis",,16,9,"2 months",16S,4,Illumina,,0.05,true,,,,,,,,,unchanged,Complete,
"Experiment 3","Study 395","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic kidney disease,stage 5 chronic kidney disease","EFO:0003884,EFO:0009909","peritoneal dialysis",hemodialysis,"4 groups of pediatric patients (age 2-18), hemodialysis, peritoneal dialysis, kidney transplant, healthy controls",8,8,"1 month",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,age,,,,increased,,,increased,Complete,
"Experiment 3","Study 85",Gabon,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery","seven-day aged babies c-section",,7,8,,16S,3,Roche454,"Linear Regression",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 74",Netherlands,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low BMI","high BMI","obesity: BMI 30.5-60.3 kg/m4",13,15,"6 months",16S,,"Human Intestinal Tract Chip","Spearman Correlation",0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 3","Study 63",Japan,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery after 6 months of delivery","C-section delivery",,134,17,"No information about pre-delivey duration. 3 Vaginally-delivered infants have been exposed to antibiotics (birth to sampling)",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 93",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,no,"Maternal consumption of probiotics yes",,151,61,"newborns administerated antibiotics during delivery: Cefuroxime (n= 31), penicillin (n= 28), piperacillin-tazobactam (n=2)",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 352","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia,human papilloma virus infection","EFO:1000165,EFO:0001668","Atypical Squamous Cells of Undetermined Significance","Low Grade Squamous Intraepithelial Lesion","low grade squamus intraepithelial lesion",6,18,"2 months",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,unchanged,Complete,"Fatima Zohra"
"Experiment 3","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"high grade dysplasia","high grade dysplasia confirmed by histology of colonoscopy-directed biopsy",20,27,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 56","United States of America","Homo sapiens",Meconium,UBERON:0007109,"type II diabetes mellitus",MONDO:0005148,"Healthy baby meconium","Baby meconium with DM mothers",,13,5,"9 months",16S,"3,4","PacBio RS","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 64",China,"Homo sapiens","Oral gland",UBERON:0010047,"type II diabetes mellitus",MONDO:0005148,"Non-diabetic within positive  periodnotitis",Diabetic,"Periodontitis was defined by the following criteria: at least 30% of sites with probing depth and attachment loss, and more than four with probing depth >=4 mm and clinical attachment loss >=2 mm. Subjects with type 2 diabetes had been diagnosed for at least one year with HbA1c >= 6.5%, fasting plasma glucose test >=7.0 mmol/L, or OGTT 2 hour glucose test >=11.1 mmol/L",6,12,"3 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 340","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"non-overweight/non-obese children",obese/overweight,"Children who participated in the VDAART clinical trial-a a two arm, double-blind, placebo controlled, randomized, clinical trial of vitamin D supplementation in the pregnant mother to prevent asthma and allergy in childhood in three clinical centers across the United States",356,146,,16S,4,Illumina,"Logistic Regression",0.05,true,,,"antibiotic therapy,body mass index,breast feeding,delivery procedure,education level,formula feeding,marital status,race,watching tv",,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 75","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,"smoking behavior",EFO:0004318,"right nasopharynx of nonsmokers","right nasopharynx of smokers","Smokers were defined as current smoking of .2 cigarettes daily for more than 6 months, and nonsmokers were defined as less than 100 cigarettes lifetime.",33,29,"3 months",16S,"1,2",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","IAP group (6-month old infant)","Term, vaginally delivered infants",47,44,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 3","Study 61",Finland,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"infants of normal maternal weight gain mothers at age 1 month","infants of excessive maternal weight gain mothers","Weight gain >16.0 kg in women with BMI (in kg/m2) <25 and >11.5 kg in women with BMI >25 was considered excessive",20,22,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 69",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"male normal weight","male obese",,93,38,"2 months",16S,"3,4",Illumina,DESeq2,0.05,true,,,,,unchanged,,unchanged,unchanged,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 38",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"child underarm","teen underarm","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 67",Italy,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"non constipated autistic","constipated autistic","cases were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.",29,5,"3 months",16S,"3,4,5",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 92","United States of America","Homo sapiens",Feces,UBERON:0001988,"non-alcoholic fatty liver disease",EFO:0003095,"obese without non-alcoholic fatty liver disease","non-alcoholic fatty liver disease patients","clinical diagnosis of NAFLD based on ultrasound findings and elevated transaminases.  BMI for obese children with and without clinical NAFLD were greater than the 95% for age",11,13,"6 months",16S,,"Ion Torrent",ANOVA,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 247","New Zealand","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"prebiotic (inulin-type fructan) - in participants with high dietary fiber",placebo,"placebo (control for prebiotic intake - representing lower fiber group)",34,33,"6 months",16S,"3,4",Illumina,ANOVA,0.05,false,,"age,body mass index,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"with at least one HPV type cleared in a year","without any HPV type cleared","No HPV-type cleared confirmed by HPV assay and genotyping",75,15,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 3","Study 323","United States of America","Homo sapiens","Mucosa of small intestine,Feces","UBERON:0001988,UBERON:0001204","necrotizing enterocolitis",EFO:0003928,non-NEC,NEC,"infants who underwent intestinal resection at <180 days of age",14,10,,16S,"1,2,3,4",Roche454,DESeq2,0.1,true,,,,,,,,,,Complete,
"Experiment 3","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control adult","control adolescent",,12,12,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,increased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 171",China,"Homo sapiens",Saliva,UBERON:0001836,"Esophageal cancer",MONDO:0007576,controls,"esophageal cancer patients","patients with esophageal cancer",24,12,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,increased,increased,increased,,,Complete,Claregrieve1
"Experiment 3","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,"H.pylori negative","past H.pylori infection","subjects with evidence of past H.pylori infection but no current infection",15,8,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 3","Study 128",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"superficial gastric","gastric cancer",,37,77,"2 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,helicobacter pylori,sex",,,decreased,,,decreased,Complete,
"Experiment 3","Study 97",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"obese patients prior to Sleeve gastrectomy SG0","obese patients three months after Sleeve gastrectomy SG3","obese patients had a body mass index (BMI) of >28 kg/m2.",19,8,"3 months",16S,4,"Ion Torrent",Kruskall-Wallis,0.05,false,4,"age,sex",,,increased,increased,,,increased,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 301","South Korea","Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,HR-HPV+,"HR-HPV+ through PCR confirmation, HPV genotype 16, 18, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66",26,13,"6 months",16S,"2,3",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 415","United States of America","Homo sapiens",Saliva,UBERON:0001836,age,EFO:0000246,"HIV uninfected women who are less than 35 years of age","HIV uninfected women who are 50 years of age or older","HIV-negative women who are 50 years of age or older",4,4,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,,Complete,
"Experiment 3","Study 178",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,normal,"gastric cancer tumor group","gastric cancer",60,59,"1 month",16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,unchanged,,unchanged,,decreased,Complete,
"Experiment 3","Study 263",Canada,"Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,"healthy controls","multiple sceloris","patients with immune-mediated inflammatory disease (IMID)",23,19,"8 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 3","Study 31","United States of America","Homo sapiens",Feces,UBERON:0001988,"chronic fatigue syndrome",EFO:0004540,controls,"CFS/ME patients without IBS","Cases met the 1994 CDC Fukuda and the 2003 Canadian consensus criteria for ME/CFS",50,29,"3 months for controls only",WMS,,Illumina,LEfSe,0.2,true,2,"age,ethnic group,geographic area,sex",,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 119","United States of America","Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"opoid negative among Metaformin negative","Opoid positive","Opioid use was defined as “Yes” if during review of medical record two parameters were present: 1) the participant was under care of psychiatric care professional, and 2) psychiatric care professional established the diagnosis of opioid use disorder as official diagnosis in medical record",34,35,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 70",Mexico,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"male pediatric normal weight","male pediatric obese","Obesity was defined as body mass index (BMI) ≥95th percentile, whereas NW was de- fined as BMI between the 15th and 75th percentiles for age and gender based on Centers for Disease Control and Prevention (CDC) reference data",38,42,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low total cholesterol","Bipolar patients with high total cholesterol","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 380","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"post fecal mircobiota day 7","post allogenic hematopoietic cell transplant/ pre Fecal microbiota transplant","patients who received Fecal Microbiome Transplant",5,13,"48 hours",16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,"HLA match,acute graft vs. host disease,age,transplant conditioning",,,,,decreased,,Complete,"Rimsha Azhar"
"Experiment 3","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low triglycerides","high triglycerides","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Spearman Correlation",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 3","Study 94",Germany,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"6 months participants","24 months","A threshold of 10% weight loss and maintenance of it over one year has been proposed as definition for successful weight loss maintenance",16,16,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"normal tissues","tumoral tissues","gastric cancer",230,229,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,decreased,decreased,decreased,,decreased,Complete,Claregrieve1
"Experiment 3","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery at day 28",c-section,"meconium samples were collected at day 1 after delivery",7,6,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,decreased,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group before procedure (age <46)","women <46 years old with suspected high grade cervical dysplasia planning for their first Loop Electrosurgical Excision Procedure",48,75,"long-term antibiotic use",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,age,EFO:0000246,"2-12 years","13-62 years","teenager/adult age 13-62",59,69,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 3","Study 236",Germany,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"fat replacement (with walnuts)","replace both","before walnut consumption",135,135,"excluded those on ""antibiotic therapy""",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,"age,body mass index,smoking behavior,triglycerides",,,,,,,Complete,
"Experiment 3","Study 427",Italy,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,vegans,vegetarians,,51,51,"3 months",16S,"1,2,3",Roche454,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",,true,,,,,unchanged,,,,,Complete,
"Experiment 3","Study 249","United States of America","Homo sapiens",Blood,UBERON:0000178,"Hepatitis, Alcoholic",EFO:1001345,NAC,MAH,"alcoholic hepatitis",20,18,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,
"Experiment 3","Study 322",Sweden,"Homo sapiens","Buccal mucosa,Lower lip","UBERON:0006956,UBERON:0001835","oral mucositis",EFO:1001904,"at malignancy diagnosis","during chemotherapy","patients that are newly diagnosed with malignancies that are between ages 4 and 18 years old that are treated with cytostatic drug and has a national population registration number (Sweden) that has later developed oral mucositis (graded by the World Health Organization) during chemotherapy treatment",12,12,,16S,,Roche454,T-Test,0.05,true,,"age,sex",,,,,,,,Complete,
"Experiment 3","Study 371",France,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"lean subjects","obese subjects","obese patients defined by BMI  (BMI>30 kg m−2)",64,108,"6 months",WMS,,RT-qPCR,Chi-Square,0.05,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"Minimal Residual Disease- (positivity) with Allogenic Stem Cell Transplant","Minimal Residual Disease- (negativity) with Allogenic Stem Cell Transplant","Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,,,,,increased,Complete,
"Experiment 3","Study 361",Canada,"Mus musculus",Caecum,UBERON:0001153,"Air pollution",ENVO:02500037,"all other mice","ovariectomized female mice exposed to cigarette smoke","ovariectomized female mice exposed to smoke",48,10,,16S,4,Illumina,LEfSe,0.05,true,3.5,,,decreased,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 3","Study 377","United States of America","Homo sapiens",Mouth,UBERON:0000165,"smoking behavior",EFO:0004318,"cigarette smoker","E-cigarette smoker","participants who were 21 years or older, healthy, diagnosed with periodontal disease, and current smokers, non-smokers, or e-cigarette users",40,40,"1 month",16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,increased,Complete,
"Experiment 3","Study 144",China,"Homo sapiens",Throat,UBERON:0000341,"air pollution",ENVO:02500037,"moderately poluuted region (B)","heavily polluted region (C)","paticipants lived in any of those regions for more than 2 years. region A: (lightly polluted region of PM 2.5), region B: (moderately polluted region of PM 2.5) and region C: (heavily polluted region of PM 2.5)",40,39,"3 months",16S,3,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,"vital capacity",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 3","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma",934,87,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 3","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 21","ICR male mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 3","Study 337","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"12-month-old infants not exposed to antibiotics during the second trimester","12-month-old infants exposed to antibiotics during the second trimester","infants born after 28 weeks gestation with no congenital abnormalities who were exposed to antibiotics during the second trimester",40,10,,16S,4,Illumina,"Beta Binomial Regression",0.05,true,,,"body mass index,education level,household income,marital status,maternal age,race,smoking behavior",,,,,,,Complete,Claregrieve1
"Experiment 3","Study 376",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before antibiotic exposure","patients that took Piperacilin/Tazobactam","took Piperacilin/Tazobactam for 7 days",1,1,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,decreased,,,decreased,Complete,
"Experiment 3","Study 235","United States of America","Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"healthy control","healthy sibling","sibling with no food allergy",21,25,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 187","United States of America","Homo sapiens",Vagina,UBERON:0000996,"medroxyprogesterone acetate",CHEBI:6716,"black participants after using depot medroxyprogesterone (visit 2)","white participants after using depot medroxyprogesterone (visit 2)","white participants at visit 2",16,9,"before sample collection",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.2,true,,,,,decreased,unchanged,,,decreased,Complete,Claregrieve1
"Experiment 3","Study 315",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Formula-fed Infants to mothers didn't receive IAP","Formula-fed Infants to mothers received IAP","Full-term (gestational ages >37 weeks) vaginally delivered infants born after an uncomplicated pregnancy",4,7,"During pregnancy or postnatal period (Mothers); during the study period (infants)",16S,"3,4",Illumina,Kruskall-Wallis,0.05,false,,,,,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 392",Italy,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"infant with non-IgE-mediated cow's milk allergy at diagnosis","infant with non-IgE-mediated cow's milk allergy treated with EHCF+LGG","infant with non-IgE mediated cow's milk allergy treated with EHCF+LGG",23,14,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 3","Study 390",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"symptomatic remission","acute schizphrenia","patients who complied with diagnostic criteria for SCZ in the Diagnostic and Statistical Manual of Mental DIsorders Fourth Edition, Positive and negative syndrome scale, PANSS<60; No change in antipsychotic regimen (within two weeks)",29,29,"4 weeks",16S,"3,4",Illumina,LEfSe,0.05,false,2,age,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 3","Study 162",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,others,"NSE group","newly diagnosed lung cancer patients by histopathology and computed tomography",16,30,"1 month",16S,4,Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,decreased,,unchanged,Complete,
"Experiment 3","Study 282",China,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"no b-lactum antibiotics","b-lactum antibiotics","patients diagnoised with grade II to IV acute graft-versus-host disease (aGVHD) undergoing intense conditioning treated with b-lactum (include carbapenem, cephalosporin, and b-lactam-b-lactamase combinations.)",48,31,,16S,4,Illumina,,0.05,false,,,,,,,,decreased,,Complete,
"Experiment 3","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"premature birth",EFO:0003917,"30-day old Full-term infants(born after uncomplicated pregnancy)","30-day old Pre-term","born at gestational ages between 24 and 32 weeks",13,27,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 402",Australia,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginally delivered infant","caesarean delivered infant","infant born by caesarean section",7,7,,16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,unchanged,unchanged,,,,,Complete,
"Experiment 3","Study 265",Finland,"Homo sapiens",Mouth,UBERON:0000165,"human papilloma virus infection",EFO:0001668,"HPV- at two months",HPV+,"HPV infection",17,5,,16S,4,Illumina,LEfSe,0.05,false,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 3","Study 175","United States of America","Homo sapiens",Mouth,UBERON:0000165,"pancreatic carcinoma",EFO:0002618,controls,"pancreatic cancer cases","subjects from the PLCO cohorts with incident primary pancreatic adenocarcinoma",201,191,,16S,"3,4",Roche454,"Logistic Regression",0.05,false,,"age,sex",,,,,,,,Complete,
"Experiment 3","Study 262","United States of America","Homo sapiens","Nose,Sputum","UBERON:0000004,UBERON:0007311","atopic asthma",EFO:0010638,"nasal brush specimens","induced sputum specimens","induced sputum specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,increased,increased,,,,increased,Complete,Claregrieve1
"Experiment 3","Study 396","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"Atopic eczema",EFO:0000274,baseline,"atopic dermatitis after treatment with TCS only","child with moderate to severe atopic dermatitis after treatment with TCS only",9,9,"2 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,increased,,,,,Complete,
"Experiment 3","Study 177",Sweden,"Homo sapiens",Feces,UBERON:0001988,"colorectal cancer",EFO:0005842,control,fecal,"patients diagnosed with stage I-III colon cancer",21,14,recent,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 3","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"Samples that were RV-A negative-","Samples with rhinovirus-A (RV-A)","Samples with rhinovirus-A","1,883",386,,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,age,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 314","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"CIN regression","CIN non-regression","histology proven CIN2, no regression after 24 months",63,24,,16S,"1,2",Illumina,"Welch's T-Test",0.05,false,,,,,,,,unchanged,increased,Complete,Fatima
"Experiment 3","Study 213","United States of America","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high fiber from BEANS (Q3 and Q4)","low fiber from BEANS (Q1 and Q2)","lower quartiles (Q1 and Q2) of BEAN fiber intake vs control (Q3 and Q4)",76,75,"no ""long term"" antibiotics use",16S,"3,4","Illumina,Roche454",DESeq2,0.05,true,,,"age,body height,body mass index,body weight,race,sex,smoking behavior",,,,,,,Complete,
"Experiment 3","Study 384",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,FSCZ,TSCZ,"first-episode drug naive schizophrenia(FSCZ) diagnosed according to the DSM IV criteria and PANSS having illness duration <=12 months and no treatment with antipsycotic medications before, anti-psycotic treated schizophrenia (TSCZ) having illness duration >12 months and received antipsychotic treatment for at least past 3 months",40,85,"1 month",16S,4,Illumina,DESeq2,0.05,true,,demographics,,,decreased,decreased,,,decreased,Complete,
"Experiment 3","Study 148",China,"Homo sapiens",Feces,UBERON:0001988,"polycystic ovary syndrome",EFO:0000660,IR-PCOS,NIR-PCOS,"diagnosed if two of the following were present: olig-/amenorrhea, clinical and/or biochemical hyperandrogenish, or polycystic ovaries",8,9,"administration of antibiotics",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 3","Study 217",Finland,"Homo sapiens",Feces,UBERON:0001988,age,EFO:0000246,"infant at 6 months","infant at 18 months","infant 18 months of age",34,34,,16S,,"Human Intestinal Tract Chip",ANOVA,0.01,false,,,,,,,,increased,,Complete,
"Experiment 3","Study 328","United States of America","Homo sapiens",Feces,UBERON:0001988,"psoriatic arthritis",EFO:0003778,"skin psoriasis","psoriatic arthiritis","patients fulfilling the criteria of the Classification of Psoriatic arthritis (CASPAR)",15,16,"3 months",16S,"1,2",Roche454,LEfSe,0.2,true,2,"age,ethnic group,sex",,,,,,,,Complete,
"Experiment 3","Study 320","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants (6-weeks) to mothers unexposed to  antibiotic","infants(6-weeks) to mothers exposed to  antibiotics (amoxicillin, penicillin or ampicillin)","vaginally delivered at full-term (>37 weeks of gestation)",179,55,,16S,"4,5",Illumina,PERMANOVA,0.05,false,,,,,unchanged,,unchanged,,,Complete,
"Experiment 3","Study 276",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy control","Multiple Myeloma patient","patient diagnosis with multiple myeloma and no other disease validated to affect intestinal microbial including digestive disease like liver cirrhosis, liver cancer, inflammatory bowel disease, and irritable bowel syndrome; systemic disease like diabetes and hypertension and thyroid disease; no treatment including antibiotics, chemotherapy, plasma exchange or bone marrow transplant; no cold, fever or other infections within 3 months before sampling with administrated antibacterial drugs, gastrointestinal motility drugs or micro-ecological conditioning agents like eating and living habit change 1 week before sampling",17,40,"3 months",16S,"3,4",Illumina,Metastats,0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 330",Finland,"Homo sapiens",Mouth,UBERON:0000165,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ oral sample determined by PCR and genotyped with Multimetrix",26,13,,16S,"3,4",Illumina,LEfSe,0.05,false,3,,,,unchanged,increased,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 404","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","patient with atopic dermatitis","patient age >6 years diagnosed with atopic dermatitis based on the SCORAD scoring system",22,17,"6 months",16S,"1,2",Roche454,"Random Forest Analysis",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 3","Study 142","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"oral squamous cell carcinoma",EFO:0000199,surgery,"chemothrapy radiation and surgery","histopathologically confirmed HNSCC (Head & Neck Squamous Cell Cancer) and had atleast one post-treatment salivary sample",,,,16S,"3,4,5",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Rimsha Azhar"
"Experiment 3","Study 242",China,"Homo sapiens","Dental plaque",UBERON:0016482,"Iron deficiency anemia",HP:0001891,"iron deficiency anemia moderate","iron deficiency anemia severe","iron defiency anemia",16,8,"2 weeks",16S,"3,4",Illumina,LEfSe,0.05,true,3.5,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 290",Netherlands,"Homo sapiens",Mouth,UBERON:0000165,"oral mucositis",EFO:1001904,"one and two weeks after stem cell transplant","pre- and three month after auto stem cell transplant","patient developed uclerative oral mucositis",31,20,,16S,4,RT-qPCR,PERMANOVA,0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 3","Study 202",Spain,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"healthy controls","children with autism mental regression (AMR)","Children between 2-6 years old with an agreed clinical diagnosis of autism per the ICD 10th Edition for ASD and DSM-5 who had development regression during the first two years of life.",57,18,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"atopic no asthma","atopic asthma","atopic asthma",21,42,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 294","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,baseline,"post re-induction therapy","120 weeks of continuation phase with the last 17-20 weeks of reinduction II therapy",112,90,,16S,"1,2,3",Illumina,,0.05,true,,,,,decreased,unchanged,decreased,,,Complete,
"Experiment 3","Study 139","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"squamous cell carcinoma",EFO:0000707,controls,"Pharynx cancer cases","histologically confirmed incident HNSCC including oral cavity, pharynx and larynx. (excluding salivary glands & nasopharynx)",254,30,,16S,"3,4",Roche454,DESeq2,0.1,true,,"ethnic group,sex","age,sex,smoking status",,,,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 167",China,"Homo sapiens",Mouth,UBERON:0000165,"squamous cell carcinoma",EFO:0000707,"healthy controls","Stage 2 & 3","OSCC  confirmed by biopsy and pathological findings",51,66,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,increased,unchanged,unchanged,,,Complete,
"Experiment 3","Study 307",France,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Negative control group (CLT)","DAV132+moxifloxacin treated group (MXF+DAV132)","healthy male and female volunteers aged >18 years",8,14,"3 months",WMS,,"Mass spectrometry","Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,unchanged,Complete,
"Experiment 3","Study 255","United Republic of Tanzania","Homo sapiens","Uterine cervix",UBERON:0000002,"HIV infection",EFO:0000764,HIV-,HIV+,"HIV+ comfirmed by Standard Diagnostics HIV-1/2 3.0 detection kit",95,39,,16S,4,Illumina,LEfSe,0.1,true,,,,,,increased,,,,Complete,"Fatima Zohra"
"Experiment 3","Study 302","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,asthma,MONDO:0004979,"non-exacerbated asthma","exacerbated asthma","physician-diagnosed current asthma presenting with an encounter diagnosis of asthma exacerbation",31,20,,16S,"3,4",Illumina,LEfSe,0.05,true,2,,,,,,,,unchanged,Complete,"Lucy Mellor"
"Experiment 3","Study 419",Denmark,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"individuals with no change in uptake","individuals with decreased F-2-fluoro-2-deoxy-D-glucose (F-FDG) uptake on positron emission tomography (PET)/magnetic resonance imaging (MRI)","Persons with HIV",7,5,"2 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,unchanged,Complete,
"Experiment 3","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy controls","Intravenous drug abuse HIV patients","Intravenous drug abuse patients infected with HIV",35,3,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,3,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 348",Brazil,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean children","obese children","Healthy children with obesity based on z-score of >+2",30,30,"3 months",16S,,RT-qPCR,"Logistic Regression",0.05,false,,,age,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 412","United States of America","Homo sapiens",Rectum,UBERON:0001052,"methamphetamine dependence",EFO:0004701,"MSM who did not test positive on MA urine drug screening","MSM who tested positive on MA urine drug screening","MSM who tested positive for methamphetamine (MA) use in a urine drug screening",329,52,,16S,4,Illumina,,0.1,true,,,"age,alcohol drinking,cannabis use,ethnic group,smoking behavior",,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 3","Study 308","United States of America","Mus musculus",Caecum,UBERON:0001153,"air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,unchanged,unchanged,,,increased,Complete,
"Experiment 3","Study 208",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"infants non-IgE mediated","infants IgE mediated","infant IgE mediated",17,17,"1 month",16S,"1,2,3",Roche454,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 3","Study 298","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute myeloid leukemia",EFO:0000222,"no infection",infection,"acute myeloid leukemia patients that were microbiologically documented with infection during induction chemotherapy before neutrophil recovery",30,15,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,,,,,Complete,
"Experiment 3","Study 346","United States of America","Homo sapiens",Feces,UBERON:0001988,"anxiety disorder",EFO:0006788,"mild anxiety","severe anxiety","psychiatric inpatients diagnosed by DSM-IV Disorders, SCID-I and SCID-II interviews, CSSR-S, SLEQ and GAD-7",,,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 3","Study 231","United Kingdom","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"pink lady apple - at 10 hr",cellulose,"poorly fermentable fiber (cellulose)",3,3,"3 months",16S,"3,4",Illumina,ANOVA,0.05,true,,,,,increased,increased,,,increased,Complete,
"Experiment 3","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic free group (postnatal day 7)","combination of penicillin and moxalactam group (postnatal day 7)","pre-term neonates given a treatment regimen of penicillin (10U kg-1, twice a day) combined with moxalactam (40 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,unchanged,,,,,Complete,Chloe
"Experiment 3","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0-0.5 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,T-Test,0.05,false,,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 3","Study 309","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,CIN1,CIN2+,"patients with CIN2+ confirmed by colposcopy",90,340,,16S,4,Illumina,"Negative Binomial Regression",0.05,true,,,,,unchanged,unchanged,,,,Complete,Fatima
"Experiment 3","Study 424",Israel,"Homo sapiens",Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"NBO PC","BO PC","Bile duct-obstructed pancreatic cancer patients.",16,11,"Individuals who were exposed to antibiotics up to 8 weeks before sampling were excluded from the analysis.",16S,,Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,
"Experiment 3","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Healthy at Low Altitude (LHN)","Tibetan Healthy at High Altitude (HTN)","Tibetan healthy participants living at high altitudes.",35,34,"3 months",16S,"3,4",Illumina,T-Test,0.05,,,"age,sex",,,increased,,,,,Complete,Fatima
"Experiment 3","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"transient HPV+ with LSIL","high-risk HPV transient infection (HPV has regressed within 1 year) with low grade squamus intraepithelial lesion",31,,,16S,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 3","Study 434",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"cervical glandular intraepithelial neoplasia",EFO:1000165,"healthy control",HSIL,"women with high-grade squamous intraepithelial lesions confirmed by biopsy",68,23,"14 days",16S,"3,4",Illumina,LEfSe,0.05,true,4,,,,increased,increased,,,,Complete,
"Experiment 3","Study 428",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Recovered COVID-19 cases","Recovered following negative quantitative reverse transcription PCR (RT-qPCR) tests for SARS-CoV-2 RNA in nasopharyngeal swabs, treated with antibiotics during course of COVID-19",78,14,,WMS,,Illumina,LEfSe,0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 3","Study 441",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"H1N1 patients","COVID-19 patients","viral COVID-19 infections confirmed by real-time reverse-transcription polymerase chain reaction",24,30,"subjects who received antibiotics and/or probiotics within 4 weeks of enrollment were excluded",16S,"3,4",Illumina,LEfSe,0.05,true,3.5,,,,increased,increased,,,,Complete,Fatima
"Experiment 3","Study 453","United States of America","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Non-infected patients with unrelated respiratory medical conditions","Recovered COVID-19 patients",">age 18, more than 2 weeks post-COVID-19 infection that was confirmed by positive PCR for SARS-CoV-2",38,9,,16S,"1,2,3",Illumina,edgeR,0.05,true,,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 3","Study 457",China,"Homo sapiens",Saliva,UBERON:0001836,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals with Type 2 Diabetes; Type 2 Diabetes determined by a fasting blood sugar of > 7.0 mmol/L and an HbA1c concentration of > 7%, as stated by the American Diabetes Association in 201834",27,9,"3 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 3","Study 462",Poland,"Homo sapiens",Feces,UBERON:0001988,"diabetes mellitus",EFO:0000400,"Individuals diagnosed with Type 1 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus in 2012–2015 at the Department of Metabolic Diseases, University Hospital, Krakow, Poland",26,24,"30 days",16S,,Illumina,ANOVA,0.05,true,,,,,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 465",China,"Homo sapiens",Feces,UBERON:0001988,"type II diabetes mellitus",MONDO:0005148,"Healthy controls","Individuals diagnosed with Type 2 Diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes Mellitus; The diagnoses of type 2 diabetes mellitus were established according to the diagnostic criteria of the American Diabetes Association",14,21,"3 months",16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,decreased,unchanged,,,Complete,Claregrieve1
"Experiment 3","Study 468",Turkey,"Homo sapiens",Feces,UBERON:0001988,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","All women in the endometriosis group had moderate to severe (stage 3–4) endometriosis according to
American Fertility Society Revised Classification. Diagnosis of endometriosis was verified through histology.",14,14,"Participants were excluded if they had taken antibiotics within the past 8 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 455",Singapore,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,gingivitis,MONDO:0002508,"pregnant women without gingivitis","pregnant women with gingivitis",,10,10,"6 months",16S,4,Illumina,LEfSe,0.05,true,2,,,,unchanged,unchanged,,unchanged,unchanged,Complete,
"Experiment 3","Study 464",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Suspected COVID-19 cases with one of the following etiological or serological evidence:
(1) Fluorescence RT-PCR detects the positive of the COVID-19 virus nucleic acid.
(2) Viral gene sequencing finds highly homologous to COVID-19 virus",48,24,"Receipt of antibiotics and/or probiotics within 8 weeks prior to enrollment",16S,"3,4,5",Illumina,LEfSe,0.05,false,2,,,,decreased,,decreased,,decreased,Complete,
"Experiment 3","Study 475",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls (Group H)","Community Type II patients","47 COVID-19 patients, 1 healthy control",13,48,,16S,4,Illumina,ANOSIM,0.05,true,,,,increased,,,,,decreased,Complete,
"Experiment 3","Study 477",Spain,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Mild COVID-19 patients","Severe COVID-19 patients","Patients with confirmed COVID-19 infection and severe symptoms who were hospitalized",19,18,,16S,"3,4",Illumina,"Linear Regression",0.25,true,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 3","Study 479",Italy,"Homo sapiens","Nasopharynx,Oropharynx","UBERON:0001729,UBERON:0001728",COVID-19,MONDO:0100096,"Mild-Moderate COVID-19 patients","ICU COVID-19 patients","COVID-19 patients admitted to intensive care unit",11,10,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,decreased,decreased,,,,Complete,
"Experiment 3","Study 480",Brazil,"Homo sapiens",Endometrium,UBERON:0001295,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign conditions","Confirmed endometriosis patients","Patients were assigned to the endometriosis group after endometriosis was confirmed via laparoscopic surgery and histology.",11,10,"within 30 days prior to sample collection",16S,"3,4",Illumina,DESeq2,0,false,,,,,unchanged,,unchanged,,unchanged,Complete,
"Experiment 3","Study 481",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Mild COVID-19 patients","Severe COVID-19 patients","Patients with severe COVID-19",3,3,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 3","Study 483",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Uninfected controls, COVID-19 patients","Pneumonia controls","Patients hospitalized with community-acquired pneumonia",30,6,,WMS,,Illumina,"Linear Regression",0.05,true,,,"age,antibiotic exposure,comorbidity,sex",,,,,,,Complete,Chloe
"Experiment 3","Study 484",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 negative patients with fever and cough","COVID-19 negative patients with fever and cough",7,11,,WMS,,MGISEQ-2000,ANOVA,0.05,false,,,,decreased,decreased,,,,decreased,Complete,Fatima
"Experiment 3","Study 486",India,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Severe COVID-19 patients","COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with severe disease and requiring oxygen support/ventilator",10,10,,16S,"3,4",,LEfSe,0.05,false,2,,,,,,,,,Complete,Fatima
"Experiment 3","Study 487","South Korea","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","Infected COVID-19 samples (respiratory positive)","Samples from symptomatic/mild COVID-19 patients collected on or before positive detection of SARS-CoV-2 RNA from the respiratory tract",36,12,"No history of antibiotics or probiotics",16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,decreased,decreased,,,,unchanged,Complete,
"Experiment 3","Study 489",Italy,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"Pneumonia controls (COVID-negative)","COVID-positive patients admitted to infectious disease ward (w-COVID-19)","COVID-19 patients with nasopharyngeal swab positive for SARS-CoV-2, > 18 years of age admitted in infectious disease ward",8,9,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",DESeq2,0.05,true,,,,,unchanged,unchanged,,,,Complete,Fatima
"Experiment 3","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","estrogen receptor status",EFO:0005512,ER+,ER-,"breast cancer patients with negative Estrogen Receptor status",9,28,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 3","Study 492",India,"Homo sapiens",Feces,UBERON:0001988,"diabetic retinopathy",EFO:0003770,"Individuals diagnosed with type 2 diabetes Mellitus","Individuals diagnosed with Type 2 Diabetes and clinically manifest Diabetic Retinopathy (DR)","Individuals diagnosed with Type 2 Diabetes and clinically manifest Diabetic Retinopathy (DR); Subjects confirmed to having DR based on the fundus examination/photograph followed by fundus fluorescein angiography (FFA) and optical coherence tomography (OCT).",24,28,"3 months",16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,diet,region,sex",,,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 3","Study 493",China,"Homo sapiens","Skin of body",UBERON:0002097,Vitiligo,EFO:0004208,"Lesional skin of Vitiligo patients before irradiation (DF group)","Lesional skin of Vitiligo patients after NBUVB irradiation (DB group)","Lesional skin of Vitiligo patients after NBUVB irradiation (DB group); Vitiligo patients recruited from Weifang Medical University Hospital, Shandong, China, from February 2018 to January 2019.",15,15,"6 months",16S,"3,4",Illumina,T-Test,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 3","Study 478",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","Flu patients","Patients with influenza B",29,31,,WMS,,MGISEQ-2000,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,increased,,,,,Complete,
"Experiment 3","Study 499",Finland,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"IBS patients fulfilled the Rome II criteria. Diarrhea-predominant IBS (IBS-D)",46,25,,16S,,"Human Intestinal Tract Chip",T-Test,0.05,true,,,,,,,,,,Complete,Lwaldron
"Experiment 3","Study 502",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-D,"Fulfilled the Rome III criteria for the diagnosis of IBS. Diarrhea IBS (IBS-D).",24,10,"Exclusion criteria included pregnancy or lactation, chronic intestinal disease (i.e., inflammatory bowel disease or celiac disease) or severe systemic disorders, lactose intolerance or food allergies. Patients who in the 2 mo prior to study entry had taken medication, such as antibiotics, corticosteroids or functional foods containing pre or probiotics, were also excluded from the study.",16S,,HTF-Microbi.Array,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 3","Study 443",India,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Health Control",IBS-D,"Patients with IBS diagnosed using Rome III. Patients were classified into three sub-types
using Rome III criteria: diarrhea predominant IBS (IBS-D).",30,20,"Patients who had prior history of gastrointestinal surgery, inflammatory bowel disease, and celiac disease were excluded. Patients with IBS who used antibiotics, probiotics, or prokinetics within last 4 weeks of inclusion into the study were also excluded.",16S,,RT-qPCR,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,
"Experiment 3","Study 505",Netherlands,"Homo sapiens","Feces,Mucosa of small intestine","UBERON:0001988,UBERON:0001204","irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-A,"IBS patients included in this study fulfilled the Rome II criteria for IBS and were categorized as  alternating IBS subgroup (IBS-A)",26,16,"Subjects taking medication known to influence bacterial composition and gastrointestinal motility, especially antimicrobial medications and/or probiotics were excluded from the study.",,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 3","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,neoplasm,EFO:0000616,"WNH with TNBC normal tissue (second set)","WNH with TNBC normal tissue (second set)","Tumor tissue from white non-hispanic patients with triple negative breast cancer",10,10,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",,false,,,,,increased,increased,,,increased,Complete,Chloe
"Experiment 3","Study 511",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients not treated with antibiotics","Patients with confirmed COVID-19 infection per 2 sequential positive RT-PCR tests who were not treated with antibiotics",44,17,"No antibiotics or probiotics within 8 weeks prior to or during COVID-19 infection (also true for controls)",16S,"3,4",Illumina,"LEfSe,Linear Regression",0.05,true,2,"age,sex",,,,,,,,Complete,Fatima
"Experiment 3","Study 512","United States of America","Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative healthcare workers (controls)","COVID-19 positive patients","Patients positive for SARS-CoV-2",45,68,,16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,decreased,Complete,
"Experiment 3","Study 517",Japan,"Homo sapiens",Ovary,UBERON:0000992,endometriosis,EFO:0001065,"Patients with non-endometrioma cysts","Patients with ovarian endometrioma cysts","Patients with ovarian endometrioma had endometrial cysts in their ovaries. Researchers took samples of the fluid inside these cysts. Ovarian endometrioma is one of the many ways endometriosis manifests in the female reproductive system.",8,8,None,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 522",China,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign tumors","Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",14,36,"Patients were excluded if they had taken antibiotics within 6 months before the study",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 3","Study 535",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic untreated community dwelling subjects","Antibiotic treated community dwelling subjects","community-dwelling subjects treated with antibiotics within 1 month of study",64,9,,16S,4,Roche454,"Chi-Square,Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,true,,age,,,,,,,,Complete,Claregrieve1
"Experiment 3","Study 541",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls","Schizophrenic patients","These new schizophrenic patients were taking antipsychotics.",45,45,,,,,"Mann-Whitney (Wilcoxon)",,,,,,,,,,,,Complete,
"Experiment 3","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"without antibiotic treatment",,,10,,"2 months",16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,unchanged,,,Incomplete,
"Experiment 3","Study 545","United States of America","Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"40 week old (old) mice before antibiotic treatment","40 week old (old) mice 10 days after antibiotic treatments","40-week old mice (old) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.",5,5,"Mice were not previously given antibiotics before the study",16S,,Illumina,DESeq2,0.05,true,,,sex,,,,,,,Complete,
"Experiment 3","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with MSA(multiple system atrophy) disease","Patients diagnosed with synucleinopathy multiple system atrophy (MSA)",113,22,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,increased,,,increased,Complete,
"Experiment 3","Study 438",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Week 4 (treated)","Week 8 (treated)","Had received parenteral antibiotic treatment with a combination of ampicillin and gentamicin within 48 hours of birth",9,9,"excluded if they required oral antibiotics (no time frame given)",16S,4,Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,increased,increased,,,,Complete,Chloe
"Experiment 3","Study 553","United Kingdom","Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"spontaneous abortion",EFO:1001255,"missed miscarriage","complete/incomplete miscarriage","A missed miscarriage is when a baby has died in the womb, but the mother hasn't had any symptoms, such as bleeding or pain.
A complete miscarriage has taken place when all the pregnancy tissue has left your uterus.",61,13,,,,,,,,,,,,,,,,,Complete,Fatima
"Experiment 3","Study 554",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"controls without any form of Parkinson's","patients with Parkinson's disease","Patients who had been diagnosed with PD according to the diagnostic criteria proposed by the International Parkinson Disease and Movement Disorder Society in 2015 (Postuma et al., 2015) in the First Hospital of Jilin University.",48,51,"No antibiotic use for at least 3 months prior to the study. 

Subjects with a history of using medications that have been shown to affect gut microbiota, including COMT inhibitors, anticholinergics, anti-secretory drugs, or cardiological drugs within the 3 months before the start of the study were excluded.",16S,4,Illumina,ANOVA,0.05,,4,age,,,,,,,,Complete,
"Experiment 3","Study 560",Germany,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy men without Parkinson's Disease.","Men with Parkinson's Disease.","Only early stage PD men who were naïve to L-DOPA therapy as diagnosed according to the UK Brain Bank criteria.",28,30,"The use of antibiotics in the past three months in principle was an exclusion criterion. However, we included three PD patients and three controls despite the intake of antibiotics for one to three days in a period of 28–34 days prior to feces sampling as the omission of those cases from the analyses did not change any result",16S,,Illumina,Kruskall-Wallis,0.1,true,,"age,sex",,,,,,,,Complete,
"Experiment 3","Study 568",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","NPD group: patients suffering with PD for less than 1 year and 14 days after treatment.","New Parkinson's disease patients: patients suffering with PD for less than 1 year and samples taken 14 days after treatment.",68,13,"The use of any antibiotics or probiotics within 90 days before collection of the samples.",16S,,Illumina,Metastats,0.05,,,age,,,increased,unchanged,increased,,,Complete,Lwaldron
"Experiment 3","Study 562","Australia,Canada,China,Denmark,Finland,France,Germany,India,Ireland,Israel,Italy,Japan,Luxembourg,Netherlands,South Korea,Spain,Switzerland,United Kingdom,United Republic of Tanzania,United States of America","Homo sapiens",Feces,UBERON:0001988,,,"none - 50% prevalence threshold","feces from healthy adult","non-disease adult participants from curatedMetagenomicData",0,"9,623","no (n=5572), yes (n=276)",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 3","Study 574","Russian Federation","Homo sapiens",Feces,UBERON:0001988,"Antimicrobial agent",CHEBI:33281,"azithromycin treated (day 0)","azithromycin treated (day 60)","administered 10 mg/kg body weight per day of azithromycin, as powder for oral suspension.",42,42,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,age,,,,,,,,Complete,
"Experiment 3","Study 580","United States of America","Homo sapiens",Saliva,UBERON:0001836,"lung function",,"HIV+ patients with normal DLCO","HIV+ patients with reduced DLCO","HIV+ patients with DLCO% predicted <80%",38,37,"5 days",16S,4,Illumina,LEfSe,0.05,false,2,,,,decreased,,,,,Complete,Claregrieve1
"Experiment 3","Study 578","Belgium,Poland","Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"Control (day 1)","Control (day 5-15)","did not receve nitrofurantoin treatment",5,5,,16S,"3,4,5",Roche454,"Linear Regression",0.05,,,,,,,,,,,Complete,
"Experiment 3","Study 607",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Female patients with PD","Male patients with PD","Female/male patients with PD according to United Kingdom Parkinson’s Disease Society Brain Bank Clinical Diagnostic Criteria.",57,105,"Excluded control persons who took dopaminergic medications (n = 5; intake for a different than anti-PD indication) and individuals who reported to have taken antibiotics in the last 6 months (controls: n = 20, PD: n = 13).",16S,"3,4",Illumina,"Linear Regression",0.05,,,,age,,unchanged,,,,increased,Complete,
"Experiment 3","Study 618",Austria,"Homo sapiens",,,,,"control, mild, and severe dementia","moderate dementia","MMSE 10-19: The Mini-Mental State Examination [19] and the clock drawing test [20] were used to quantify cognitive function. We classified cognitive dysfunction according to the German S3-guideline on Dementia 2016 as MMSE 0–9: severe; MMSE 10–19: moderate; MMSE 20–26: mild; MMSE 27–30: no dementia [21].",,,"4 weeks",16S,"1,2",Illumina,LEfSe,0.05,false,,"age,sex",,,,unchanged,unchanged,,,Complete,Lwaldron
"Experiment 3","Study 622",China,"Mus musculus",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"male C57BL/6-APCMin/+: Ctrl, F. nucleatum (Fn), E. coli (Ec); male wild-type C57BL/6): Ctrl, DMH, Fn, Fn+DMH, Ec, Ec+DMH","C57BL/6-APCMin/+: BBR and Fn+BBR; wild-type C57BL/6: BBR, BBR+DMH and BBR+Fn+DMH","DMH was injected subcutaneous at a dose of 20 mg/kg once weekly. BBR was administrated by gavage at a dose of 100 mg/kg two hours after bacterial feeding.

All treatments were performed for 8 weeks to ensure aberrant crypt foci (ACF) formation or 20 weeks to ensure tumor formation.",90,50,None,16S,"1,2,3",Roche454,T-Test,0.05,,,,,,,,,,,Complete,
"Experiment 3","Study 624",Japan,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Healthy Individuals","Patients with advanced CRC","Patients with early colorectal cancer",129,153,"1 Month",16S,"1,2",Illumina,"Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 3","Study 630",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy control (normal and a few polyps)",S0,"stage 0/pTis CRC (S0)",251,73,"None specified",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.005,,,,,,,,,,,Complete,
"Experiment 3","Study 631",Austria,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Advanced Colorectal Adenoma","Colorectal Cancer","colorectal adenoma patients

The study was conducted both in participants of a health screening programme according to national screening recommendations for CRC49 as well as in patients with suspected CRC undergoing colonoscopy as part of the clinical workup at the Department of Internal Medicine,
Oberndorf Hospital.",42,41,"3 months",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,,,,increased,Complete,Fatima
"Experiment 3","Study 566",Italy,"Homo sapiens",Feces,UBERON:0001988,"juvenile idiopathic arthritis",EFO:0002609,"Healthy subjects","JIA-ERA patients","enthesitis-related arthritis (JIA-ERA) patients",29,19,"3 months",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,unchanged,decreased,,,decreased,Complete,Claregrieve1
"Experiment 3","Study 637",China,"Homo sapiens","Oral cavity",UBERON:0000167,"Colorectal cancer",EFO:0005842,CRA,CRC,"Patients with colorectal cancer",34,161,"Not specified",16S,"3,4",Illumina,"Welch's T-Test",0.05,,,,"age,smoking status",,increased,unchanged,increased,,,Complete,
"Experiment 3","Study 642",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"socioeconomic status",,"Malays children (Moderate SES, household income =>RM500)","Orang Asli children (low SES, household income <RM500)","Gut microbiota from fecal samples of 20 Orang Asli children whose household income<RM500.

45% of the households earn < RM500

Note: Poverty line = RM 764($254).",24,20,unspecified,16S,"3,4,5",,PERMANOVA,0.05,true,,,,increased,increased,,,increased,,Complete,
"Experiment 3","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"colorectal adenoma","colorectal cancer","subjects with invasive adenocarcinoma",47,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,unchanged,,,Complete,
"Experiment 3","Study 648","United States of America","Homo sapiens",Feces,UBERON:0001988,"Socioeconomic status",,"Household income (EA & AA) =>$50,000.","Household income (EA & AA) < $50,000.","Gut microbiota of children from low-income households (EA & AA) < $50,000.",30,30,unspecified,16S,"3,4,5",Illumina,PERMANOVA,0.05,true,,,"age,body mass index,education level,ethnic group,sex",,unchanged,,,unchanged,unchanged,Complete,
"Experiment 3","Study 651",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"paracancerous tissue (pa2t)","cancerous tissue (cat)","37-88 years of age, cancerous tissue.

Note: Group 0 = paracancerous tissue 2-5 cm from cancerous tissue",27,27,"1 month",16S,"1,2,3",Sanger,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 3","Study 652",Japan,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,Healthy,"CRA (colorectal adenoma)","Colorectal adenoma, as diagnosed after a complete colonoscopic exampination",10,47,"None Specified",16S,"3,4",Illumina,LEfSe,0.05,,3,,,,increased,,,,,Complete,
"Experiment 3","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Caucasians,"African Americans","African Americans sampled from the American Gut Project (AGP) data set","1,237",13,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,decreased,decreased,decreased,,,Complete,
"Experiment 3","Study 663",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Chinese,Jakun,"Jakun ethnic group living in the  Segamat Malaysian community.",65,54,Unspecified,16S,"3,4",Illumina,"Linear Regression",0.05,true,,,,unchanged,unchanged,,,,,Complete,Fatima
"Experiment 3","Study 673","Colombia,Denmark,France,Japan,South Korea,Spain,United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,"USA data","South Korea data","The Korean dataset consisted of 14 lean and four overweight individuals (six women and 12 men)",54,18,"4 months",16S,"1,2,3",,ANOSIM,0.05,,,,"age,sex,waist circumference",,,,,,,Complete,
"Experiment 3","Study 681","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Colorectal cancer",EFO:0005842,Young,"Old (≥ 65 yrs)","65+, regardless of cancer status",103,87,"None specified",16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 3","Study 682",China,"Homo sapiens","Mucosa of rectum",UBERON:0003346,"small intestine enteropathy",EFO:0009705,IBS.sibo-,IBS.sibo+,"Patients with typical clinical symptoms and normal colonoscopy presentation fulfilling the Rome III diagnostic criteria; with SIBO",33,24,"3 months; also includes probiotics and proton-pump inhibitors",16S,"1,2,3",Roche454,LEfSe,0.05,,2,,,,,decreased,,,,Complete,
"Experiment 3","Study 683",Netherlands,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"non-adenoma group","adenoma group","Patients with a successful polypectomy. A total of 9 patients had advanced adenomas and 10 patients had non-advanced adenoma (NA), with a median size of the largest adenoma being 0.7 cm [IQR 0.5–0.8].
POST polypectomy.",32,32,"3 months prior to study inclusion and 3 months prior to second sample",16S,4,Illumina,LEfSe,0.05,,2,,,,,,,,unchanged,Complete,
"Experiment 3","Study 686",Italy,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,adenomas,CRC,"Patients diagnosed with CRC",27,29,"None specified",WMS,,Illumina,,0.05,,,,,,,,,,,Complete,
"Experiment 4","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,adenoma,EFO:0000232,controls,"Proximal conventional adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,87,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 12","South Korea","Homo sapiens",Uterus,UBERON:0000995,"human papilloma virus infection",EFO:0001668,"HPV presistent and negative","HPV clearance","HPV DNA was detected using the Digene HC2 high-risk DNA test (Qiagen, Gaithersburg, MD, USA) with signal amplification and chemiluminescence for 13 types of HR-HPV scored in RLU/PC. A positive result indicated a concentration of 1 pg/ml or higher than the RLU/cutoff ratio (RLU of the specimen/mean RLU of 2 positive controls).",26,15,,16S,,Roche454,LEfSe,0.05,false,2,,"age,contraception,menopause,smoking behavior",,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 171",China,"Homo sapiens",Saliva,UBERON:0001836,"Colorectal cancer",EFO:0005842,controls,"colorectal cancer patients","patients with colorectal cancer",48,24,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 4","Study 250","United States of America","Homo sapiens",Tongue,UBERON:0001723,"severe aplastic anemia",EFO:0006927,engraftment,"hematopoietic stem cell transplantation 100 days after the transplant","In HSCT patients, The first sample was obtained before transplant conditioning treatment. The second specimen was collected at engraftment, defined as two absolute neutrophil counts of greater than 500 per microliter for at least 2 days. The final specimen collection occurred at the participant’s scheduled clinic visit approximately 100 days following transplant.",4,4,,16S,"3,4,5,6,7,8,9","Ion Torrent",LEfSe,0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"controls at time 7","Cara Cara",,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ confirmed by HPV assay and genotyping",43,90,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 4","Study 97",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"patients prior to Roux-en-Y gastric bypass RYGB0","obese patients 3 moths after Roux-en-Y gastric bypass RYGB3","obese patients had a body mass index (BMI) of >28 kg/m2.",7,3,"3 months",16S,4,"Ion Torrent",Kruskall-Wallis,0.05,false,4,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 75","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,"smoking behavior",EFO:0004318,"left nasopharynx of nonsmokers","left nasopharynx of smokers","Smokers were defined as current smoking of .2 cigarettes daily for more than 6 months, and nonsmokers were defined as less than 100 cigarettes lifetime.",33,29,"3 months",16S,"1,2",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group before procedure","women <46 years old with suspected high grade cervical dysplasia planning for their first Loop Electrosurgical Excision Procedure",48,75,"long-term antibiotic use",16S,,RT-qPCR,"Logistic Regression",0.05,false,,,"age,contraception,marital status,smoking behavior",,,,,,,Complete,Claregrieve1
"Experiment 4","Study 93",Finland,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,no,"Furry pets at home yes",,108,104,"newborns administerated antibiotics during delivery: Cefuroxime (n= 31), penicillin (n= 28), piperacillin-tazobactam (n=2)",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,"antimicrobial agent during labor,delivery procedure,probiotics during pregnancy",,increased,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 352","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia,human papilloma virus infection","EFO:1000165,EFO:0001668","Low risk-HPV","High risk-HPV","High risk-HPV",3,27,"2 months",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,unchanged,Complete,"Fatima Zohra"
"Experiment 4","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low total cholesterol","high total cholesterol","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Spearman Correlation",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 4","Study 263",Canada,"Homo sapiens",Feces,UBERON:0001988,"rheumatoid arthritis",EFO:0000685,"healthy controls",arthiritis,"patients with immune-mediated inflammatory disease (IMID)",23,21,"8 weeks",16S,4,Illumina,Kruskall-Wallis,0.05,true,,,,,decreased,,decreased,,,Complete,Fatima
"Experiment 4","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"obese adult","obese adolescent",,20,25,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 61",Finland,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"infants of normal maternal weight gain mothers at age 6 months","infants of excessive maternal weight gain mothers","Weight gain >16.0 kg in women with BMI (in kg/m2) <25 and >11.5 kg in women with BMI >25 was considered excessive",20,22,,16S,,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low LDL","Bipolar patients with high LDL","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical cancer",MONDO:0002974,HPV-,"invasive cervical carcinoma","invasive cervical carcinoma confirmed by histology of colonoscopy-directed biopsy",20,10,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 4","Study 67",Italy,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"non constipated neurotypical","constipated neurotypical","cases were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition.",29,11,"3 months",16S,"3,4,5",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery at day 150",c-section,"meconium samples were collected at day 1 after delivery",6,4,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,age,EFO:0000246,"2-12 years","18-62 years","adult age 18-62",13,45,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 4","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight men","overweight men","Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m3",80,171,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 85",Congo,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery","seven-day aged babies c-section",,7,8,,16S,3,Roche454,"Linear Regression",0.05,true,,,,,unchanged,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 64",China,"Homo sapiens","Oral gland",UBERON:0010047,periodontitis,EFO:0000649,"No Periodontitis within positive diabetic background only",periodnotitis,"Periodontitis was defined by the following criteria: at least 30% of sites with probing depth and attachment loss, and more than four with probing depth >=4 mm and clinical attachment loss >=2 mm. Subjects with type 2 diabetes had been diagnosed for at least one year with HbA1c >= 6.5%, fasting plasma glucose test >=7.0 mmol/L, or OGTT 2 hour glucose test >=11.1 mmol/L",8,12,"3 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 247","New Zealand","Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"high dietary fiber","low dietary fiber","placebo (control for prebiotic intake - representing lower fiber group)",34,33,"6 months",16S,"3,4",Illumina,ANOVA,0.05,false,,"age,body mass index,sex",,,unchanged,unchanged,,,,Complete,
"Experiment 4","Study 69",China,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight",obese,,261,58,"2 months",16S,"3,4",Illumina,DESeq2,0.05,true,,,,,unchanged,,unchanged,unchanged,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 74",Netherlands,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low C-Reactive Protein","high C-Reactive Protein","obesity: BMI 30.5-60.3 kg/m5",13,15,"6 months",16S,,"Human Intestinal Tract Chip","Spearman Correlation",0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 4","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","Children Neck before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,normal,"gastritis cases","subjects with gastric lesions (gastritis)",7,18,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 4","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"multiple sclerosis",MONDO:0005301,controls,"untreated multiple sclerosis","untreated multiple sclerosis",43,28,"6 months",16S,"3,4,5",Roche454,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 4","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,">20 years participants","20-30 years participants","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",5,15,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 4","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0-0.5 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,LEfSe,0.05,false,4,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 4","Study 202",Spain,"Homo sapiens",Feces,UBERON:0001988,autism,EFO:0003758,"healthy controls","children with autism spectrum disorders (ASD)","Children between 2-6 years old with an agreed clinical diagnosis of autism per the ICD 10th Edition for ASD and DSM-5",57,48,,16S,"3,4",Illumina,Kruskall-Wallis,0.05,true,,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 4","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy controls","infants with persistent atopic dermatitis","infant with persistent atopic dermatitis",84,26,"before sample collection",16S,"1,2,3",Roche454,LEfSe,0.05,false,4,,,,unchanged,,,,unchanged,Complete,
"Experiment 4","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"heterosexual subjects with HIV","homosexual subjects with HIV","homosexual patients infected with HIV",26,4,"4 weeks",16S,4,Illumina,Metastats,0.05,false,3,"age,sex",,,,,,,,Complete,Claregrieve1
"Experiment 4","Study 208",China,"Homo sapiens",Feces,UBERON:0001988,"food allergy",EFO:1001890,"infants non-IgE mediated","infants IgE mediated","infant IgE mediated",17,17,"1 month",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 162",China,"Homo sapiens",Feces,UBERON:0001988,"lung cancer",MONDO:0008903,"healthy controls","CYF group","newly diagnosed lung cancer patients by histopathology and computed tomography",16,30,"1 month",16S,4,Illumina,LEfSe,0.05,false,,,,,decreased,unchanged,decreased,,unchanged,Complete,
"Experiment 4","Study 142","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"oral squamous cell carcinoma",EFO:0000199,surgery,"chemothrapy radiation and surgery","histopathologically confirmed HNSCC (Head & Neck Squamous Cell Cancer) and had atleast one post-treatment salivary sample",,,,16S,"3,4",Roche454,LEfSe,0.05,false,,,,,,,,,,Complete,"Rimsha Azhar"
"Experiment 4","Study 380","United States of America","Homo sapiens",Feces,UBERON:0001988,"response to allogeneic hematopoietic stem cell transplant",EFO:0007044,"post fecal mircobiota day 30","post allogenic hematopoietic cell transplant/ pre Fecal microbiota transplant","patients who received Fecal Microbiome Transplant",5,13,"48 hours",16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,age,"HLA match,acute graft vs. host disease,age,transplant conditioning",,,,,decreased,,Complete,"Rimsha Azhar"
"Experiment 4","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/caucasian infant",721,74,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 4","Study 187","United States of America","Homo sapiens",Vagina,UBERON:0000996,"medroxyprogesterone acetate",CHEBI:6716,"black participants after using depot medroxyprogesterone (visit 3)","white participants after using depot medroxyprogesterone (visit 3)","white participants at visit 3",16,9,"before sample collection",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.2,true,,,,,decreased,unchanged,,,unchanged,Complete,Claregrieve1
"Experiment 4","Study 276",China,"Homo sapiens",Feces,UBERON:0001988,"multiple myeloma",EFO:0001378,"healthy relatives control","Multiple Myeloma patient","patient diagnosis with multiple myeloma and no other disease validated to affect intestinal microbial including digestive disease like liver cirrhosis, liver cancer, inflammatory bowel disease, and irritable bowel syndrome; systemic disease like diabetes and hypertension and thyroid disease; no treatment including antibiotics, chemotherapy, plasma exchange or bone marrow transplant; no cold, fever or other infections within 3 months before sampling with administrated antibacterial drugs, gastrointestinal motility drugs or micro-ecological conditioning agents like eating and living habit change 1 week before sampling",21,21,"3 months",16S,"3,4",RT-qPCR,Metastats,0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 361",Canada,"Mus musculus",Caecum,UBERON:0001153,"Air pollution",ENVO:02500037,control,"mice exposed to smoke","male, female or ovariectomized females mice exposed to smoke",30,28,,16S,4,Illumina,LEfSe,0.05,true,3.5,,,decreased,decreased,,,,decreased,Complete,Claregrieve1
"Experiment 4","Study 284",China,"Homo sapiens",Gingiva,UBERON:0001828,"chronic kidney disease",EFO:0003884,"healthy controls","Chronic kidney disease","chronic kidney disease patients undergoing hemodialysis",30,30,"30 days",16S,"3,4,5,6",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,"age,sex,smoking behavior",,,decreased,decreased,,,decreased,Complete,Claregrieve1
"Experiment 4","Study 392",Italy,"Homo sapiens",Feces,UBERON:0001988,"milk allergic reaction",EFO:0007369,"infant with non-IgE-mediated cow's milk allergy treated with EHCF","infant with non-IgE-mediated cow's milk allergy treated with EHCF+LGG","infant with non-IgE mediated cow's milk allergy treated with EHCF+LGG",9,14,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 4","Study 249","United States of America","Homo sapiens",Blood,UBERON:0000178,"Hepatitis, Alcoholic",EFO:1001345,NAC,SAH,"alcoholic hepatitis",20,19,,16S,"3,4",Illumina,LEfSe,0.05,false,2,,,,unchanged,,,,,Complete,
"Experiment 4","Study 412","United States of America","Homo sapiens",Rectum,UBERON:0001052,"methamphetamine dependence",EFO:0004701,"HIV-positive men who have sex with men who did not test positive in a methamphetamine drug screening","HIV-positive men who have sex with men who tested positive in a methamphetamine drug screening","HIV-positive Men who have sex with men (MSM) who tested positive in a methamphetamine (MA) drug screening",81,21,,16S,4,Illumina,,0.1,true,,,"age,alcohol drinking,cannabis use,ethnic group,smoking behavior",,unchanged,unchanged,unchanged,,unchanged,Complete,Claregrieve1
"Experiment 4","Study 294","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"non-febrile neutropenia","febrile neutropenia","fever as an oral temperature more than 38.0°C persisting for more than 1 hour; neutropenia as an absolute neutrophil count less than or equal to 500 cells per microliter after baseline first sampled",42,122,,16S,"1,2,3",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,,Complete,
"Experiment 4","Study 348",Brazil,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"lean children","overweight children","Healthy children who are considered overweight based on z-score of ≥ +1 and < +2",30,24,"3 months",16S,,RT-qPCR,"Logistic Regression",0.05,false,,,age,,,,,,,Complete,Claregrieve1
"Experiment 4","Study 235","United States of America","Homo sapiens",Feces,UBERON:0001988,age,EFO:0000246,"<7 years","7-18 years","child age 7-18",26,42,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 320","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants (1-year) to mothers unexposed to  antibiotic","infants(1-year) to mothers exposed to  antibiotics (amoxicillin, penicillin or ampicillin)","vaginally delivered at full-term (>37 weeks of gestation)",179,55,,16S,"4,5",Illumina,PERMANOVA,0.05,false,,,,,unchanged,,unchanged,,,Complete,
"Experiment 4","Study 302","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,asthma,MONDO:0004979,"healthy control",asthma,"physician-diagnosed current asthma presenting for routine, non-urgent, asthma followup care or with an encounter diagnosis of asthma exacerbation",21,51,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 4","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,female,males,"Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,,,,,increased,Complete,
"Experiment 4","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,nonresponder,"inhaled corticosteroid responder","inhaled corticosteroid (ICS) responder",10,15,"3 months",16S,4,Illumina,,0.1,true,,,,,,,,,,Complete,
"Experiment 4","Study 262","United States of America","Homo sapiens","Nose,Mouth","UBERON:0000004,UBERON:0000165","atopic asthma",EFO:0010638,"nasal brush specimens","oral wash specimens","oral wash specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,increased,increased,,,,increased,Complete,Claregrieve1
"Experiment 4","Study 282",China,"Homo sapiens",Feces,UBERON:0001988,"graft versus host disease",MONDO:0013730,"no vancomycin antibiotics","vancomycin antibiotics","patients diagnoised with grade II to IV acute graft-versus-host disease (aGVHD) undergoing intense conditioning treated with vancomycin",59,20,,16S,4,Illumina,,0.05,false,,,,,,,,decreased,,Complete,
"Experiment 4","Study 371",France,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"lean subjects","overweight subjects","patients who were overweight by BMI  (BMI>25 and <30 kg m−2)",64,32,"6 months",WMS,,RT-qPCR,Chi-Square,0.05,true,,,,,,,,,,Complete,
"Experiment 4","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"early stage normal","early stage tumor","gastric cancer",112,116,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,unchanged,decreased,unchanged,,,Complete,Claregrieve1
"Experiment 4","Study 314","United States of America","Homo sapiens","Uterine cervix",UBERON:0000002,"cervical glandular intraepithelial neoplasia",EFO:1000165,"CIN regression","CIN non-regression","histology proven CIN2, no regression after 24 months among women with no regression after 12 months",21,14,,16S,"1,2",Illumina,"Welch's T-Test",0.05,false,,,,,,,,unchanged,unchanged,Complete,Fatima
"Experiment 4","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","IAP+postnatal antibiotic group (2-day old infant)","Term, vaginally delivered infants",47,29,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 4","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic free group (postnatal day 7)","piperacillin-tazobactam group (postnatal day 7)","pre-term neonates receiving piperacillin-tazobactam (75 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,unchanged,,,,,Complete,Chloe
"Experiment 4","Study 170",China,"Homo sapiens",Lung,UBERON:0002048,"Lung cancer",MONDO:0008903,"control group with no antibiotics","cancerous site with no antibiotics","patients who have diagnosis of lung cancer established by histological confirmation",8,13,,16S,"3,4",Illumina,LEfSe,0.05,false,3.5,,,,decreased,,increased,,,Complete,
"Experiment 4","Study 376",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before antibiotic exposure","patients that took Ceftriaxone/Azithromycin","took Ceftriaxone/Azithromycin for 7 days",3,3,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,decreased,,,decreased,Complete,
"Experiment 4","Study 139","United States of America","Homo sapiens","Oral gland",UBERON:0010047,"squamous cell carcinoma",EFO:0000707,controls,"Oral cavity cancer cases","histologically confirmed incident HNSCC including oral cavity, pharynx and larynx. (excluding salivary glands & nasopharynx)",254,41,,16S,"3,4",Roche454,DESeq2,0.1,true,,"ethnic group,sex","age,sex,smoking status",,,,,,,Complete,"Fatima Zohra"
"Experiment 4","Study 322",Sweden,"Homo sapiens","Buccal mucosa,Lower lip","UBERON:0006956,UBERON:0001835","oral mucositis",EFO:1001904,"at malignancy diagnosis","during chemotherapy","patients that are newly diagnosed with malignancies that are between ages 4 and 18 years old that are treated with cytostatic drug and has a national population registration number (Sweden) that did not develop oral mucositis (graded by the World Health Organization) during chemotherapy treatment",10,10,,16S,,Roche454,T-Test,0.05,true,,"age,sex",,,,,,,,Complete,
"Experiment 4","Study 290",Netherlands,"Homo sapiens",Mouth,UBERON:0000165,"oral mucositis",EFO:1001904,"low or no fungi load","0.1% or higher fungi load","patient developed uclerative oral mucositis",31,20,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 308","United States of America","Mus musculus",Stomach,UBERON:0000945,"air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,unchanged,unchanged,,,increased,Complete,
"Experiment 4","Study 346","United States of America","Homo sapiens",Feces,UBERON:0001988,"anxiety disorder",EFO:0006788,"mild anxiety","moderate anxiety","psychiatric inpatients diagnosed by DSM-IV Disorders, SCID-I and SCID-II interviews, CSSR-S, SLEQ and GAD-7",,,,16S,4,Illumina,LEfSe,0.05,false,2,,,,,,,,,Complete,
"Experiment 4","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"premature birth",EFO:0003917,"90-day old Full-term infants(born after uncomplicated pregnancy)","90-day old Pre-term","born at gestational ages between 24 and 32 weeks",13,27,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 35","ICR male mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,unchanged,Complete,
"Experiment 4","Study 424",Israel,,Feces,UBERON:0001988,"pancreatic carcinoma",EFO:0002618,"Healthy control","NBO PC","Non-Bile duct-obstructed pancreatic cancer patients.",13,16,"Individuals who were exposed to antibiotics up to 8 weeks before sampling were excluded from the analysis.",16S,,Illumina,LEfSe,0.05,false,3,,,,unchanged,,,,,Complete,
"Experiment 4","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Healthy at Middle Altitude (MHN)","Tibetan Healthy at High Altitude (HTN)","Tibetan healthy participants living at high altitudes.",35,34,"3 months",16S,"3,4",Illumina,T-Test,0.05,false,,"age,sex",,,increased,,,,,Complete,Fatima
"Experiment 4","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"persistent HPV+ with HSIL","high-risk HPV persistent infection with high grade squamus intraepithelial lesion",31,,,16S,,Illumina,ANOVA,0.05,true,,,,,,,,,,Complete,Fatima
"Experiment 4","Study 434",China,"Homo sapiens","Posterior fornix of vagina",UBERON:0016486,"cervical cancer",MONDO:0002974,"healthy control","cervical cancer","women with cervical cancer confirmed by biopsy",68,9,"14 days",16S,"3,4",Illumina,LEfSe,0.05,true,4,,,,increased,increased,,,,Complete,
"Experiment 4","Study 428",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients treated with antibiotics","Laboratory-confirmed SARS-CoV-2 positive by quantitative reverse transcription PCR performed on nasopharyngeal swabs, treated with antibiotics",78,34,,WMS,,Illumina,"Linear Regression",0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 4","Study 453","United States of America","Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Negative for COVID-19 viral RNA in feces","Positive for COVID-19 viral RNA in feces","COVID-19 viral RNA present in feces sample",26,24,,16S,"1,2,3",Illumina,PERMANOVA,0.05,true,,,,,unchanged,,,,unchanged,Complete,Fatima
"Experiment 4","Study 457",China,"Homo sapiens",Saliva,UBERON:0001836,periodontitis,EFO:0000649,"Healthy controls","Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)","Patients with both Periodontitis and Type 2 Diabetes who received metformin for at least 6 months and achieved glycemic control (HbA1c < 6.5%, without any companion diseases), were classified into the Met group",27,20,"patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,unchanged,,,Complete,Claregrieve1
"Experiment 4","Study 475",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls (Group H)","Community Type III patients","10 COVID-19 patients, 1 healthy control",13,11,,16S,4,Illumina,ANOSIM,0.05,true,,,,decreased,,,,,decreased,Complete,
"Experiment 4","Study 441",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 cases","viral COVID-19 infections confirmed by real-time reverse-transcription polymerase chain reaction",30,30,"4 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,"age,body mass index,sex",,,decreased,decreased,,,,Complete,
"Experiment 4","Study 479",Italy,"Homo sapiens","Nasopharynx,Oropharynx","UBERON:0001729,UBERON:0001728",COVID-19,MONDO:0100096,"Patients infected with other human coronaviruses","ICU COVID-19 patients","COVID-19 patients admitted to intensive care unit",8,10,,16S,"2,3,4,5,6,7,8,9","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,decreased,,,,Complete,
"Experiment 4","Study 484",China,"Homo sapiens",Nasopharynx,UBERON:0001728,COVID-19,MONDO:0100096,"COVID-19 negative patients with fever and cough","COVID-19 positive patients","COVID-19 positive patients with fever and cough symptoms",11,11,,WMS,,MGISEQ-2000,LEfSe,0.05,false,,,,decreased,unchanged,,,,unchanged,Complete,
"Experiment 4","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","progesterone receptor status",EFO:0005513,PR+,PR-,"breast cancer patients with negative progesterone receptor status",23,14,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 4","Study 455",Singapore,"Homo sapiens","Subgingival dental plaque",UBERON:0016484,pregnancy,EFO:0002950,"non pregnant women","pregnant women","pregnant women",10,10,"6 months",16S,4,Illumina,LEfSe,0.05,true,2,,,,increased,increased,,decreased,,Complete,
"Experiment 4","Study 464",China,"Homo sapiens",Tongue,UBERON:0001723,COVID-19,MONDO:0100096,"Healthy controls","Suspected COVID-19 patients","Suspected COVID-19 cases without one of the following etiological or serological evidence:
(1) Fluorescence RT-PCR detects the positive of the COVID-19 virus nucleic acid.
(2) Viral gene sequencing finds highly homologous to COVID-19 virus",150,37,"Receipt of antibiotics and/or probiotics within 8 weeks prior to enrollment",16S,"3,4,5",Illumina,LEfSe,0.05,false,2,,,,decreased,,increased,,,Complete,
"Experiment 4","Study 478",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Confirmed COVID-19 cases",28,31,,WMS,,MGISEQ-2000,LEfSe,0.05,true,,,,,,,,,,Complete,
"Experiment 4","Study 499",Finland,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control","IBS (All patients)","IBS patients fulfilled the Rome II criteria. All IBS patients.",46,62,,16S,,"Human Intestinal Tract Chip",T-Test,0.05,true,,,,,,,,,,Complete,Lwaldron
"Experiment 4","Study 502",,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-M,"Fulfilled the Rome III criteria for the diagnosis of IBS. Mixed IBS (IBS-M).",24,5,"Exclusion criteria included pregnancy or lactation, chronic intestinal disease (i.e., inflammatory bowel disease or celiac disease) or severe systemic disorders, lactose intolerance or food allergies. Patients who in the 2 mo prior to study entry had taken medication, such as antibiotics, corticosteroids or functional foods containing pre or probiotics, were also excluded from the study.",16S,,HTF-Microbi.Array,Kruskall-Wallis,0.05,true,,,,,unchanged,,,,unchanged,Complete,
"Experiment 4","Study 443",India,"Homo sapiens",Feces,UBERON:0001988,"irritable bowel syndrome",EFO:0000555,"Health Control",IBS-U,"Patients with IBS diagnosed using Rome III. Patients were classified into three sub-types
using Rome III criteria: un-subtyped (IBS-U).",30,7,"Patients who had prior history of gastrointestinal surgery, inflammatory bowel disease, and celiac disease were excluded. Patients with IBS who used antibiotics, probiotics, or prokinetics within last 4 weeks of inclusion into the study were also excluded.",16S,,RT-qPCR,Kruskall-Wallis,0.05,true,,,,,,,,,,Complete,
"Experiment 4","Study 505",Netherlands,"Homo sapiens","Feces,Mucosa of small intestine","UBERON:0001988,UBERON:0001204","irritable bowel syndrome",EFO:0000555,"Healthy Control",IBS-C,"IBS patients included in this study fulfilled the Rome II criteria for IBS and were categorized as  constipation predominant (IBS-C)",26,11,"Subjects taking medication known to influence bacterial composition and gastrointestinal motility, especially antimicrobial medications and/or probiotics were excluded from the study.",,,RT-qPCR,T-Test,0.05,true,,,,,,,,,,Complete,Chloe
"Experiment 4","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,neoplasm,EFO:0000616,"TPBC normal tissue","TPBC tumor tissue","Tumor tissue from patients with triple positive breast cancer",10,10,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",,false,,,,,,increased,,,,Complete,Chloe
"Experiment 4","Study 511",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients","Patients with confirmed COVID-19 infection per 2 sequential positive RT-PCR tests",32,81,"No antibiotics or probiotics within 8 weeks prior to COVID-19 infection (also true for controls)",16S,"3,4",Illumina,"LEfSe,Linear Regression",0.05,true,2,"age,sex",,,,,,,decreased,Complete,Fatima
"Experiment 4","Study 468",Turkey,"Homo sapiens",Vagina,UBERON:0000996,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","All women in the endometriosis group had moderate to severe (stage 3–4) endometriosis according to American Fertility Society Revised Classification. 

Diagnosis of endometriosis was verified through histology.",14,14,"Participants were excluded if they had taken antibiotics within the past 8 weeks.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 4","Study 522",China,"Homo sapiens",Endometrium,UBERON:0001295,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign tumors","Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",14,36,"Patients were excluded if they had taken antibiotics within 6 months before the study",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 4","Study 535",Ireland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"Antibiotic untreated subjects in long stay facility","Antibiotic treated subjects in long stay facility","subjects in long stay facility who have had antibiotic treatment in the past month",32,16,,16S,4,Roche454,"Chi-Square,Kruskall-Wallis,Mann-Whitney (Wilcoxon)",0.05,true,,age,,,,,,,,Complete,Claregrieve1
"Experiment 4","Study 541",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls","Baseline schizophrenic patients","These schizophrenic patients were selected from the 90 medication-free patients of experiment 1.",81,38,,,,,"Mann-Whitney (Wilcoxon)",0.1,true,,"age,body mass index,diet,sex",,,,,,,,Complete,
"Experiment 4","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"adult household contact for each patient treated with ciprofloxacin",,,10,,"controls received no antibiotics during the study period or 2 months before it.",16S,"3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Incomplete,
"Experiment 4","Study 545","United States of America","Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"40 week old (old) mice before antibiotic treatment","40 week old (old) mice 6 months after antibiotic treatments","40-week old mice (old) administered treated with broad-spectrum antibiotics metronidazole (500 mg/L) and ciprofloxacin (200 mg/L) for 10 days.",5,5,"Mice were not previously given antibiotics before the study",16S,,Illumina,DESeq2,0.05,true,,,sex,,,,,,,Complete,
"Experiment 4","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with PSP(progressive supranuclear palsy) disease","Patients diagnosed with tauopathy progressive supranuclear palsy (PSP)",113,22,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,increased,,,increased,Complete,
"Experiment 4","Study 554",China,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"controls without any form of Parkinson's disease","patients with Parkinson's disease","Patients who had been diagnosed with PD according to the diagnostic criteria proposed by the International Parkinson Disease and Movement Disorder Society in 2015 (Postuma et al., 2015) in the First Hospital of Jilin University.",48,51,"No antibiotic use for at least 3 months prior to the study. 

Subjects with a history of using medications that have been shown to affect gut microbiota, including COMT inhibitors, anticholinergics, anti-secretory drugs, or cardiological drugs within the 3 months before the start of the study were excluded.",16S,4,Illumina,LEfSe,,,4,age,,,,,,,,Incomplete,
"Experiment 4","Study 560",Germany,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"Healthy men without Parkinson's Disease.","Men with Parkinson's Disease.","Only early stage PD men who were naïve to L-DOPA therapy as diagnosed according to the UK Brain Bank criteria.",28,30,"The use of antibiotics in the past three months in principle was an exclusion criterion. However, we included three PD patients and three controls despite the intake of antibiotics for one to three days in a period of 28–34 days prior to feces sampling as the omission of those cases from the analyses did not change any result",16S,,Illumina,Kruskall-Wallis,0.1,true,,"age,sex",,,,,,,,Incomplete,
"Experiment 4","Study 574","Russian Federation","Homo sapiens",Feces,UBERON:0001988,"Antimicrobial agent",CHEBI:33281,"azithromycin treated","azithromycin-lactulose treated","administered a single daily dosage of 10 mg/kg body weight azithromycin in addition with 20 mg/kg body weight lactulose per day, as powder for oral suspension.",42,42,,16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,age,,,increased,,,,unchanged,Complete,
"Experiment 4","Study 562","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,,,"none - 50% prevalence threshold","nasal cavity from healthy adult","non-disease adult participants from curatedMetagenomicData",0,92,Unknown,WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 4","Study 618",Austria,"Homo sapiens",,,,,"control, moderate, and severe dementia","mild dementia","MMSE 20-26: The Mini-Mental State Examination [19] and the clock drawing test [20] were used to quantify cognitive function. We classified cognitive dysfunction according to the German S3-guideline on Dementia 2016 as MMSE 0–9: severe; MMSE 10–19: moderate; MMSE 20–26: mild; MMSE 27–30: no dementia [21].",,,"4 weeks",16S,"1,2",Illumina,LEfSe,0.05,false,,"age,sex",,,,unchanged,unchanged,,,Complete,Lwaldron
"Experiment 4","Study 624",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"Before resection","After resection","Surgical resection of Cohort-1 CRC specimens",380,380,"1 Month",16S,"1,2",Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 4","Study 630",Japan,"Homo sapiens",Feces,UBERON:0001988,"Colorectal cancer",EFO:0005842,"healthy control (normal and a few polyps)",MP,"multiple polypoid adenomas with low- grade dysplasia (MP, more than three adenomas, mostly more than five adenomas)",251,67,"None specified",WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.005,,,,,,,,,,,Complete,
"Experiment 4","Study 566",Italy,"Homo sapiens",Feces,UBERON:0001988,"juvenile idiopathic arthritis",EFO:0002609,"Healthy subjects","JIA-nERA patients","polyarticular arthritis (JIA-ERA) patients",29,10,"3 months",16S,"5,6",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,unchanged,decreased,,,decreased,Complete,Claregrieve1
"Experiment 4","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,carcinoma-adjacent,"colorectal cancer","mucosae from colorectal cancer",52,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 4","Study 648","United States of America","Homo sapiens","Oral opening",UBERON:0000166,"Socioeconomic status",,"Household income (EA & AA) =>$50,000.","Household income (EA & AA) < $50,000.","Oral microbiota of children from low-income households (EA & AA) < $50,000.",30,30,unspecified,16S,"3,4,5",Illumina,PERMANOVA,0.05,true,,,"age,body mass index,education level,ethnic group,sex",,unchanged,,,unchanged,unchanged,Complete,
"Experiment 4","Study 651",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Healthy volunteers (stc)","CRC patients (stp)","37-88 years of age, diagnosed with colorectal cancer (stp = stool sample)",22,21,"1 month",16S,"1,2,3",Sanger,"Mann-Whitney (Wilcoxon)",0.05,,,"age,sex",,,unchanged,unchanged,,,unchanged,Complete,
"Experiment 4","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Caucasians,"Asian Pacific","Asian Pacific sampled from Human Microbiome Project (HMP) data set",211,34,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,decreased,decreased,decreased,,,Complete,
"Experiment 4","Study 663",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,India,Malay,"Malay ethnic group living in the  Segamat Malaysian community.",49,46,,16S,"3,4",Illumina,"Linear Regression",0.05,true,,,"demographics,diet,health,hygiene",unchanged,unchanged,,,,,Complete,Fatima
"Experiment 4","Study 622",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"Healthy Controls","CRC and CRA","Patients with CRC and CRA confirmed by colonoscopy and pathological examination",52,89,"6 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 4","Study 673","Colombia,Denmark,France,Japan,South Korea,Spain,United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,"USA data","Japan data","The Japanese dataset consisted of 454-generated V1 and V2 16S rDNA sequences of 10 lean and one overweight adult (six females and five males) that participated in an intervention with probiotics",54,11,"4 months",16S,"1,2,3",,ANOSIM,0.05,,,,"age,sex,waist circumference",,,,,,,Complete,
"Experiment 4","Study 681","United States of America","Homo sapiens",Saliva,UBERON:0001836,"Colorectal cancer",EFO:0005842,"Non, Ex Smokers","Current Smokers","Current smoker, regardless of cancer status",138,52,"None specified",16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,,,,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 4","Study 682",China,"Homo sapiens",duodenum,UBERON:0002114,"small intestine enteropathy",EFO:0009705,HC.sibo-,HC.sibo+,"Healthy controls (no IBS) with SIBO",12,7,"3 months; also includes probiotics and proton-pump inhibitors",16S,"1,2,3",Roche454,Chi-Square,0.05,,,,,,,unchanged,,,,Complete,
"Experiment 4","Study 683",Netherlands,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"adenoma group pre-polypectomy","adenoma group post-polypectomy","Patients with a successful polypectomy. A total of 9 patients had advanced adenomas and 10 patients had non-advanced adenoma (NA), with a median size of the largest adenoma being 0.7 cm [IQR 0.5–0.8].",32,32,"3 months prior to study inclusion and 3 months prior to second sample",16S,4,Illumina,LEfSe,0.05,,2,,,,,,,,,Complete,
"Experiment 4","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,control,Coli,"Group 1 mice were treated with colistin (2 mg/ml) in sterile drinking water (Coli group).  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",6,7,,WMS,,Illumina,ANOVA,,,,,,,,,,,,Complete,
"Experiment 4","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"colorectal cancer patients perioperative placebo","colorectal cancer patients perioperative probiotics","Patients in the PGT group received an encapsulated probiotics preparation (Shanghai Xinyi Pharmaceutical Co., Ltd., Shanghai, China) containing live combined Bifidobacterium longum, Lactobacillus acidophilus and Enterococcus faecalis (1:1:1) with no less than 1.0x107 CFU/g viable cells, three times/day, with a total daily dose of 6.0x107 CFU for five days",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,LEfSe,,,2,,,,increased,unchanged,increased,,,Complete,
"Experiment 4","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Gegen Qinlian decoction (GQD)",,control,"low-dose GQD (300 mg/kg)","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were orally gavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously into the left axillary region of each mouse and allowed ~1 week to establish tumours.  When the tumours reached a size of 50mm3, the mice were intraperitoneally (i.p.) injected with 250 μg of anti-mouse PD-1 mAb.  The mice in the control group were administered the same volume of PBS. All mice were injected five times at 3-day intervals with antimouse PD-1 mAb or PBS",11,12,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,increased,increased,,,,Complete,
"Experiment 4","Study 692",China,"Homo sapiens",Feces,UBERON:0001988,Nutraceutical,CHEBI:50733,"colorectal cancer patients who didn't take prebiotics (postoperative fecal sample)","colorectal cancer patients who took prebiotics (postoperative fecal sample)","Patients with radiologic and pathologic diagnosis of CRC and underwent surgical resection. Patients in the intervention group (prebiotic group) received a daily oral dose of 30 g prebiotic supplement (Hangzhou Niuqu Biotech Co., Hainengbo, China) containing fructooligosaccharide (25%), xylooligosaccharide (25%), polydextrose (25%), and resistant dextrin (25%) for 7 d from hospitalization to the day before the operation.",20,18,"no treatment with antibiotics within 6 mo before surgery",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,,,,,Complete,
"Experiment 4","Study 687",China,"Homo sapiens",Tissue,UBERON:0000479,"Colorectal adenocarcinoma",EFO:0000365,"colorectal cancer patients without APC mutation","colorectal cancer patients with APC mutation","diagnosed of colorectal cancer by colonoscopy and histopathology",9,30,"No antibiotics for one month prior to surgery (fecal sample was taken the night before surgery)",16S,"3,4",Illumina,LEfSe,0.05,false,4,,,,decreased,,decreased,,,Complete,
"Experiment 5","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,control,Vanc,"Group 1 mice were treated with  vancomycin alone (0.25 mg/ml) in sterile drinking water (Vanc group)  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",6,7,,WMS,,Illumina,ANOVA,,,,,,,,,,,,Complete,
"Experiment 5","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"colorectal cancer patients perioperative placebo","colorectal cancer patients perioperative probiotics","Patients in the PGT group received an encapsulated probiotics preparation (Shanghai Xinyi Pharmaceutical Co., Ltd., Shanghai, China) containing live combined Bifidobacterium longum, Lactobacillus acidophilus and Enterococcus faecalis (1:1:1) with no less than 1.0x107 CFU/g viable cells, three times/day, with a total daily dose of 6.0x107 CFU for five days",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,LEfSe,0.05,,2,,,,,increased,,,,Complete,
"Experiment 5","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Gegen Qinlian decoction (GQD)",,control,"PD-1 group","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were orally gavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously into the left axillary region of each mouse and allowed ~1 week to establish tumours.  When the tumours reached a size of 50mm3, the mice were intraperitoneally (i.p.) injected with 250 μg of anti-mouse PD-1 mAb.  The mice in the control group were administered the same volume of PBS. All mice were injected five times at 3-day intervals with antimouse PD-1 mAb or PBS",11,9,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,unchanged,unchanged,,,,Complete,
"Experiment 5","Study 687",China,"Homo sapiens",Tissue,UBERON:0000479,"Colorectal adenocarcinoma",EFO:0000365,"colorectal cancer patients without PIK3CA mutation","colorectal cancer patients with PIK3CA mutation","diagnosed of colorectal cancer by colonoscopy and histopathology",33,6,"No antibiotics for one month prior to surgery (fecal sample was taken the night before surgery)",16S,"3,4",Illumina,LEfSe,0.05,false,4,,,,decreased,,decreased,,,Complete,
"Experiment 5","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,adenoma,EFO:0000232,controls,"Distal conventional adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,55,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"20-30 years participants","> 30 years participants","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",15,11,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"controls at time 7",Bahia,,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,HPV-,HPV+,"HPV+ determined by the Linear Array HPV Genotyping Tests",20,31,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,"age,body mass index,ethnic group",,,,,,,Complete,"Fatima Zohra"
"Experiment 5","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low TRP","Bipolar patients with high TRP","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","teen underarm before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 64",China,"Homo sapiens","Oral gland",UBERON:0010047,periodontitis,EFO:0000649,"No Periodontitis within both positive and negative diabetic background",periodnotitis,"Periodontitis was defined by the following criteria: at least 30% of sites with probing depth and attachment loss, and more than four with probing depth >=4 mm and clinical attachment loss >=2 mm. Subjects with type 2 diabetes had been diagnosed for at least one year with HbA1c >= 6.5%, fasting plasma glucose test >=7.0 mmol/L, or OGTT 2 hour glucose test >=11.1 mmol/L",13,18,"3 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low HDL-C","high HDL-C","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Spearman Correlation",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 5","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery at day 365",c-section,"meconium samples were collected at day 1 after delivery",5,5,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,unchanged,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control adolescent","obese adolescent",,12,25,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,decreased,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight women","obese women","Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m5",131,72,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 5","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"atopic eczema",EFO:0000274,"non-lesional skin","lesional skin","atopic dermatitis lesional skin",69,69,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 5","Study 308","United States of America","Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,increased,unchanged,,,increased,Complete,
"Experiment 5","Study 412","United States of America","Homo sapiens",Rectum,UBERON:0001052,"methamphetamine dependence",EFO:0004701,"HIV-negative MSM who did not test positive in a MA drug screening","HIV-negative MSM who tested positive in a MA drug screening","HIV-negative Men who have sex with men (MSM) who tested positive in a methamphetamine (MA) drug screening",248,31,,16S,4,Illumina,,0.1,true,,,"age,alcohol drinking,cannabis use,ethnic group,smoking behavior",,unchanged,unchanged,unchanged,,unchanged,Complete,
"Experiment 5","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"Minimal Residual Disease- (positivity) with Allogenic Stem Cell Transplant","Minimal Residual Disease- (negativity) with Allogenic Stem Cell Transplant","Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,,,,,increased,Complete,
"Experiment 5","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"no new acquisition of HPV within a year","new acquisition of HPV within a year","New HPV-type acquisition confirmed by HPV assay and genotyping",109,24,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 5","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"early stage normal","early stage peritumor","gastric cancer",112,118,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,decreased,decreased,unchanged,,,Complete,Claregrieve1
"Experiment 5","Study 171",China,"Homo sapiens",Saliva,UBERON:0001836,"gastric cancer",MONDO:0001056,controls,"gastric cancer patients","patients with gastric cancer",20,10,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,"age,sex",,,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 5","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0.5-1 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,T-Test,0.05,false,,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 5","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 10","ICR female mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 5","Study 302","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,asthma,MONDO:0004979,"healthy control",asthma,"physician-diagnosed current asthma presenting for routine, non-urgent, asthma followup care or with an encounter diagnosis of asthma exacerbation",21,51,,16S,"3,4",RT-qPCR,T-Test,0.05,false,,,,,,,,,,Complete,Fatima
"Experiment 5","Study 320","United States of America","Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"infants (6-weeks) to mothers unexposed to  antibiotic","infants(6-weeks) to mothers exposed to multi-class antibiotics","vaginally delivered at full-term (>37 weeks of gestation)",179,12,,16S,"4,5",Illumina,PERMANOVA,0.05,false,,,,,increased,,unchanged,,,Complete,
"Experiment 5","Study 376",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"before antibiotic exposure","patients that took Ciprofloxacin","took Ciprofloxacin for 7 days",1,1,,16S,4,RT-qPCR,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,decreased,,,decreased,Complete,
"Experiment 5","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"Multiple sclerosis",MONDO:0005301,"untreated multiple sclerosis","treated multiple sclerosis","treated multiple sclerosis",28,32,"6 months",16S,4,Illumina,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 5","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","IAP+postnatal antibiotic group (4-day old infant)","Term, vaginally delivered infants",47,29,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 5","Study 262","United States of America","Homo sapiens","Sputum,Mouth","UBERON:0000165,UBERON:0007311","atopic asthma",EFO:0010638,"induced sputum specimens","oral wash specimens","oral wash specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,unchanged,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 5","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"children who did not experience exacerbation","Children who experienced exacerbation","children who experienced exacerbation of their asthma (physician-prescribed use of systemic corticosteroids for asthma symptoms, hospitalization for asthma, or both)",346,67,,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 5","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"transient atopic dermatitis","infants with persistent atopic dermatitis","infant with persistent atopic dermatitis",22,26,"before sample collection",16S,"1,2,3",Roche454,LEfSe,0.05,false,4,,,,unchanged,,,,unchanged,Complete,
"Experiment 5","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,normal,"subjects with metaplasia","subjects with metaplasia",7,22,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 5","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy control","HAART-treated HIV+ patients","HIV infected patients treated with highly active antiretroviral therapy (HAART)",35,14,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,3,"age,sex",,,decreased,,,,,Complete,Claregrieve1
"Experiment 5","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group 6 months post-procedure","women 6 months after Loop Electrosurgical Excision Procedure",100,77,"long-term antibiotic use",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 5","Study 322",Sweden,"Homo sapiens","Buccal mucosa,Lower lip","UBERON:0006956,UBERON:0001835","oral mucositis",EFO:1001904,"all samples","mucositis lesions","during chemotherapy, samples were taken from 12 (out of 25) patients in mucositis group and 10 (out of 12) patients in no mucositis group, with 5 patients taken samples from twice",97,27,,16S,,Roche454,T-Test,0.05,true,,"age,sex",,,,,,,,Complete,
"Experiment 5","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/female infant, vaginally delivered, breastfed, not exposed to maternal antibiotics",186,21,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 5","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"2-day old full-term neonates not exposed to antibiotics (IAP/postnatal)","2-day old pre-tem neonates exposed to antibiotics (IAP)","antenatal/postnatal antibiotic exposure",14,10,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 5","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,baseline,"post inhaled corticosteroid treatment","inhaled corticosteroid treatment",8,8,"3 months",16S,4,Illumina,,0.1,true,,,,,,,,,,Complete,
"Experiment 5","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Hypertensive at Low Altitude (LHH)","Han Hypertensive at Middle Altitude (MHH)","Han hypertensive participants living at middle altitude.",34,49,"3 months",16S,"3,4",Illumina,T-Test,0.05,,,"age,sex",,,unchanged,,,,,Complete,Fatima
"Experiment 5","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"persistent HPV+ with LSIL","persistent HPV+ with HSIL","persistent HPV+ infection ( same HPV subtype has infected for >12 months) with high grade squamus intraepithelial lesion",,,,16S,,Illumina,LEfSe,,,,,,,,,,,,Complete,Fatima
"Experiment 5","Study 457",China,"Homo sapiens",Saliva,UBERON:0001836,periodontitis,EFO:0000649,"Individuals diagnosed with Periodontitis and Type 2 Diabetes Mellitus (DAP)","Individuals diagnosed with both Periodontitis and Type 2 Diabetes and treated with metformin (Met group)","Patients with both Periodontitis and Type 2 Diabetes who received metformin for at least 6 months and achieved glycemic control (HbA1c < 6.5%, without any companion diseases), were classified into the Met group",46,20,"patients treated with antibiotics within 3 months or those that received periodontal treatment within 6 months",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 5","Study 475",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls (Group H)","Community Type IV patients","4 COVID-19 patients",13,4,,16S,4,Illumina,ANOSIM,0.05,true,,,,decreased,,,,,decreased,Complete,
"Experiment 5","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","breast cancer",MONDO:0007254,"Grade Low (I/II)","Grade High (III)","breast cancer patients with grade high level tumors (Grade III)",14,23,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 5","Study 478",China,"Homo sapiens",Oropharynx,UBERON:0001729,COVID-19,MONDO:0100096,"Healthy controls","Flu patients","Patients with influenza B",28,29,,WMS,,MGISEQ-2000,LEfSe,0.05,true,,,,,,,,,,Complete,
"Experiment 5","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,EFO:0001799,,WNH,BNH,"Normal tissue from black non-hispanic patients with breast cancer",6,7,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,increased,unchanged,increased,,,Complete,Chloe
"Experiment 5","Study 511",China,"Homo sapiens",Feces,UBERON:0001988,COVID-19,MONDO:0100096,"Healthy controls","COVID-19 patients not treated with antibiotics","Patients with confirmed COVID-19 infection per 2 sequential positive RT-PCR tests who were not treated with antibiotics",32,13,"No antibiotics or probiotics within 8 weeks prior to or during COVID-19 infection (also true for controls)",16S,"3,4",Illumina,"LEfSe,Linear Regression",0.05,true,2,"age,sex",,,,,,,,Complete,Fatima
"Experiment 5","Study 468",Turkey,"Homo sapiens","Uterine cervix",UBERON:0000002,endometriosis,EFO:0001065,"Healthy controls","Stage 3/4 endometriosis patients","All women in the endometriosis group had moderate to severe (stage 3–4) endometriosis according to American Fertility Society Revised Classification. Diagnosis of endometriosis was verified through histology.",14,14,"Participants were excluded if they had taken antibiotics within the past 8 weeks",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,unchanged,,,,unchanged,Complete,
"Experiment 5","Study 522",China,"Homo sapiens","Peritoneal fluid",UBERON:0001268,endometriosis,EFO:0001065,"Controls undergoing laparoscopic surgery for benign tumors","Endometriosis patients","Patients were diagnosed with endometriosis via laparoscopic surgery and stages were categorized according to the revised American Society for Reproductive Medicine scoring system (r-ASRM).",14,36,"Patients were excluded if they had taken antibiotics within 6 months before the study",16S,"4,5","Ion Torrent","Mann-Whitney (Wilcoxon)",0.05,false,,,,,,,,,,Complete,
"Experiment 5","Study 541",China,"Homo sapiens",Feces,UBERON:0001988,schizophrenia,MONDO:0005090,"Healthy controls","Baseline schizophrenic patients","38 of the 90 patients had 3-months of treatment (27 with risperidone and 11 with other antipsychotics).",81,38,,,,,"Mann-Whitney (Wilcoxon)",0.1,true,,"age,body mass index,diet,sex",,,,,,,,Complete,
"Experiment 5","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with De-novo Parkinson's disease","Patients with de novo Parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,39,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,,,,,Complete,
"Experiment 5","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,"baseline of the fosfomycin treated","fosfomycin treated","UTI patients treated with fosfomycin, one 3g dose",2,2,"2 months",16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Incomplete,
"Experiment 5","Study 562","Italy,Philippines,United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,,,"none - 50% prevalence threshold","oral cavity from healthy adult","non-disease adult participants from curatedMetagenomicData",0,659,"No (n=16)",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 5","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"piperacillin-tazobactam group (postnatal day 3)","combination of penicillin and moxalactam group (postnatal day 3)","pre-term neonates given a treatment regimen of penicillin (10U kg-1, twice a day) combined with moxalactam (40 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,,,unchanged,,,Complete,Chloe
"Experiment 5","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,adenoma-adjacent,"colorectal cancer","mucosae from colorectal cancer",47,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 5","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"ethnic group",EFO:0001799,Caucasians,Hispanics,"Hispanics sampled from Human Microbiome Project (HMP) data set",211,43,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,increased,increased,increased,,,Complete,
"Experiment 5","Study 663",Malaysia,"Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Jakun,India,"India ethnic group living in the  Segamat Malaysian community.",54,49,,16S,"3,4",Illumina,"Linear Regression",0.05,true,,,"demographics,diet,health,hygiene",unchanged,unchanged,,,,,Complete,Fatima
"Experiment 5","Study 682",China,"Homo sapiens",Feces,UBERON:0001988,"small intestine enteropathy",EFO:0009705,IBS.sibo-,IBS.sibo+,"Patients with typical clinical symptoms and normal colonoscopy presentation fulfilling the Rome III diagnostic criteria; with SIBO",33,24,"3 months; also includes probiotics and proton-pump inhibitors",16S,"1,2,3",Roche454,Chi-Square,0.05,,,,,,,,,,unchanged,Complete,
"Experiment 5","Study 683",Netherlands,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"control group pre-endoscopy","control group post-endoscopy","Patients with a successful endoscopy.",32,32,"3 months prior to study inclusion and 3 months prior to second sample",16S,4,Illumina,LEfSe,0.05,,2,,,,,,,,,Complete,
"Experiment 5","Study 371",France,"Homo sapiens",Feces,UBERON:0001988,Obesity,EFO:0001073,"anorexic, lean, and overweight subjects","obese subjects","patients who were obese by BMI (BMI>30 kg m−2)",111,108,"6 months",WMS,,RT-qPCR,Chi-Square,0.05,true,,,,,,,,,,Complete,
"Experiment 6","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,adenoma,EFO:0000232,controls,"Non-advanced conventional adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,121,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,unchanged,,,,unchanged,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"low grade dysplasia","low grade dysplasia confirmed by histology of colonoscopy-directed biopsy",20,12,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,"age,body mass index,ethnic group",,,,,,,Complete,"Fatima Zohra"
"Experiment 6","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,"atopic eczema",EFO:0000274,"non-lesional skin","lesional skin","atopic dermatitis lesional skin",59,59,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 6","Study 48","South Korea","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"low sensetive C reactive protein","high senstive C reactive protein","body mass index BMI >= 30 kg/m2, or >= 99th BMI percentile",67,67,"1 month",16S,"1,2,3",Roche454,"Spearman Correlation",0.05,false,,,"age,sex",,,,,,,Complete,Fatima
"Experiment 6","Study 36",Italy,"Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"control adult","obese adult",,12,20,"2 months",16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,false,,age,,,unchanged,unchanged,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 68","United States of America","Homo sapiens",Feces,UBERON:0001988,obesity,EFO:0001073,"normal weight women","overweight women","Healthy-weight was defined as BMI ≥ 18.5 and <25 kg/m2, overweight as BMI ≥ 25 and <30 kg/m2, and obese as BMI ≥ 30 kg/m7",131,75,"long term use in NYU study. NA for CDC study",16S,4,Illumina,DESeq2,0.05,true,,,"age,polyp,sex",,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"premature birth",EFO:0003917,"full-term delivery >39 weeks at day 3","late preterm 34-36 weeks","meconium samples were collected at day 1 after delivery",4,5,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,Kruskall-Wallis,0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 39",Philippines,"Homo sapiens","Skin of body",UBERON:0002097,"body odor measurement",EFO:0008386,"after excercise","teen Neck before","Malodor is a phenotype that is well known to arise from specific interactions between host-derived odor precursors and the microbial metabolism that they support",15,15,,WMS,,Illumina,"Mann-Whitney (Wilcoxon)",0.01,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"BMI < 20","BMI >25","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",5,11,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low TBARS level","Bipolar patients with high TBARS level","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,2,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 131",Brazil,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"Bahia at time 7","Cara Cara",,21,21,current,16S,"1,2,3",Roche454,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 6","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"10-day old full-term neonates not exposed to antibiotics (IAP/postnatal)","10-day old pre-tem neonates exposed to antibiotics (IAP)","antenatal/postnatal antibiotic exposure",14,10,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 6","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/caucasian infant, allergies during pregnancy",429,64,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 6","Study 329",Finland,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"control group","IAP+postnatal antibiotic group (6-month old infant)","Term, vaginally delivered infants",47,29,,16S,"4,5","Ion Torrent",Kruskall-Wallis,0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 6","Study 140","United States of America","Homo sapiens",Feces,UBERON:0001988,"Multiple sclerosis",MONDO:0005301,"untreated multiple sclerosis","treated multiple sclerosis","treated multiple sclerosis patients",28,32,"6 months",16S,"3,4,5",Roche454,DESeq2,0.05,true,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 6","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 0.5-1 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,LEfSe,0.05,false,4,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 6","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 21","ICR female mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 6","Study 271","United States of America","Homo sapiens",Feces,UBERON:0001988,"acute lymphoblastic leukemia",EFO:0000220,"Age greater than 65 years old","Age less than 65 years old","Patients with multiple myeloma (MM) who achieve minimal residual disease (MRD) negativity (MRD-) after upfront treatment",18,16,,16S,"4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,2,,,,,,,,increased,Complete,
"Experiment 6","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,baseline,"post placebo treatment","placebo treatment",8,8,"3 months",16S,4,Illumina,,0.1,true,,,,,,,,,,Complete,
"Experiment 6","Study 308","United States of America","Mus musculus","Feces,Stomach,Caecum,Small intestine,Colon","UBERON:0001988,UBERON:0001153,UBERON:0001155,UBERON:0000945,UBERON:0002108","air pollution",ENVO:02500037,"Filtered air group","PM 2.5 air exposed group","Mice exposed to PM2.5 concentrated from ambient air in Chicago 8 hours per day for 5 days a week for three consecutive weeks in a chamber connected to Versatile Aerosol Concentration Enrichment System (VACES)",10,10,,16S,,Roche454,LEfSe,0.05,false,5,,,,increased,increased,,,increased,Complete,
"Experiment 6","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"late stage normal","late stage tumor","gastric cancer",118,113,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,decreased,decreased,unchanged,,,Complete,Claregrieve1
"Experiment 6","Study 262","United States of America","Homo sapiens","Bronchus,Sputum","UBERON:0002185,UBERON:0007311","atopic asthma",EFO:0010638,"bronchial brush specimens","induced sputum specimens","induced sputum specimen type",27,27,"3 months",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,unchanged,increased,,,,increased,Complete,Claregrieve1
"Experiment 6","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"with any HPV type cleared in a year","without any HPV type cleared","No HPV-type cleared confirmed by HPV assay and genotyping",75,15,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 6","Study 227","South Korea","Homo sapiens",Feces,UBERON:0001988,"atopic eczema",EFO:0000274,"healthy control","infant with transient atopic dermatitis","infant with transient atopic dermatitis",84,22,"before sample collection",16S,"1,2,3",Roche454,LEfSe,0.05,false,4,,,,unchanged,,,,unchanged,Complete,
"Experiment 6","Study 349",Norway,"Homo sapiens",Endocervix,UBERON:0000458,"cervical glandular intraepithelial neoplasia",EFO:1000165,normal,"LEEP group 12 months post-procedure","women 12 months after Loop Electrosurgical Excision Procedure",100,72,"long-term antibiotic use",16S,,RT-qPCR,"Fisher's Exact Test",0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 6","Study 223",China,"Homo sapiens",Feces,UBERON:0001988,"HIV infection",EFO:0000764,"healthy control","HAART untreated","HIV infected patients not treated with HAART",35,19,"4 weeks",16S,4,Illumina,LEfSe,0.05,false,3,"age,sex",,,decreased,,,,,Complete,Claregrieve1
"Experiment 6","Study 243",China,"Homo sapiens",Feces,UBERON:0001988,"gastric cancer",MONDO:0001056,"subjects with gastritis","subjects with metaplasia","subjects with metaplasia",18,22,,16S,4,Illumina,"Welch's T-Test",0.05,false,,,,,unchanged,,,,unchanged,Complete,Claregrieve1
"Experiment 6","Study 425",China,"Homo sapiens",Feces,UBERON:0001988,hypertension,EFO:0000537,"Han Healthy at Low Altitude (LHN)","Han Healthy at Middle Altitude (MHN)","Han healthy participants living at middle altitude.",35,35,"3 months",16S,"3,4",Illumina,T-Test,0.05,,,"age,sex",,,unchanged,,,,,Complete,Fatima
"Experiment 6","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"transient HPV+ with HSIL","persistent HPV+ with LSIL","high-risk HPV persistent infection with low grade squamus intraepithelial lesion",,,,16S,,Illumina,LEfSe,,,,,,,,,,,,Complete,Fatima
"Experiment 6","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","breast cancer stage",EFO:0005607,"Stage Low (I/II)","Stage High (III)","Breast cancer patients with high stage progression of breast cancer (Stage III).",22,15,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 6","Study 475",China,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"Group I - High Diversity COVID-19 patients","Group II - Medium Diversity COVID-19 patients","Patients with medium microbial diversity in rectal samples",15,24,,16S,4,Illumina,ANOSIM,0.05,true,,,,unchanged,,,,,decreased,Complete,
"Experiment 6","Study 504","United States of America","Homo sapiens",Breast,UBERON:0000310,"ethnic group,Rapid Amplification of cDNA Ends","EFO:0001799,EFO:0004182",WNH,BNH,"Tumor tissue from black non-hispanic patients with breast cancer",6,7,"Biorepository information revealed that no patients were treated with antibiotics prior to tissue sample collection, however duration window of non-exposure was unidentified.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,false,,,,,decreased,decreased,,,decreased,Complete,Chloe
"Experiment 6","Study 541",,"Mus musculus",,,,,"Saline-treated and Streptococcus thermophilus ST12 - treated mice","Streptococcus vestibularis - treated mice","S. vestibularis ATCC 49124 was transplanted, using oral gavage and drinking water, into C57BL/6 mice after antibiotics-based microbiota depletion.",,,,,,,"ANOVA,Kruskall-Wallis",0.05,true,,,,,,,,,,Incomplete,
"Experiment 6","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's disease","patients with early Parkinson's disease","Patients with early Parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,57,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,,,,,Complete,
"Experiment 6","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,CRL2,CP2,"ciprofloxacin group, between antibiotic treatment",10,10,,16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 6","Study 562",Italy,"Homo sapiens",Milk,UBERON:0001913,,,"none - 50% prevalence threshold","milk from healthy adult","non-disease adult participants from curatedMetagenomicData",0,8,Unknown,WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 6","Study 336",China,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"piperacillin-tazobactam group (postnatal day 7)","combination of penicillin and moxalactam group (postnatal day 7)","pre-term neonates given a treatment regimen of penicillin (10U kg-1, twice a day) combined with moxalactam (40 mg kg-1, twice a day)",12,12,,16S,"3,4",Illumina,"ANOVA,T-Test",0.05,false,,"birth weight,delivery procedure,gestational age,sex",,,,,unchanged,,,Complete,Chloe
"Experiment 6","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,adenoma-adjacent,carcinoma-adjacent,"specimen obtained approximate to colorectal cancer",47,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 6","Study 654","United States of America","Homo sapiens",Feces,UBERON:0001988,"Ethnic group",EFO:0001799,Caucasians,"African Americans","African Americans sampled from Human Microbiome Project (HMP) data set",211,10,NA,16S,"3,4,5",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,body mass index,sex",,decreased,decreased,decreased,,,Complete,
"Experiment 6","Study 695",China,"Mus musculus",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,coli,Vanc,"Group 1 mice were treated with  vancomycin alone (0.25 mg/ml) in sterile drinking water (Vanc group)  Mice (in all groups) were then subcutaneously injected into the right axillary with 0.25 live CT26 tumor cells.",7,7,,WMS,,Illumina,ANOVA,,,,,,,,,,,,Complete,
"Experiment 6","Study 696",China,"Homo sapiens","Intestinal mucosa",UBERON:0001242,Nutraceuticals,,"Healthy controls","colorectal cancer patients perioperative placebo","Patients in the CGT group received encapsulated maltodextrin (Haiyan Liuhe Pharmaceutical Industry Co., Ltd., Jiangsu, China) three times a day. During the study period, no parenteral or enteral nutritional",11,11,"No antibiotics for 3 months preceding surgery",16S,3,Roche454,LEfSe,0.05,,2,,,,decreased,unchanged,decreased,,,Complete,
"Experiment 6","Study 694",China,"Mus musculus",Feces,UBERON:0001988,"Gegen Qinlian decoction (GQD)",,control,"low dose 300 mg/kg GQD + PD-1 group","BALB/c mice (male, ~20 g, aged 5 weeks) were fed adaptively for 1 week under specific pathogen-free conditions with food and water provided ad libitum.  Then the mice were orally gavaged with 300 mg/kg Gegen Qinlian decoction (GQD), a classical traditional Chinese medicine (TCM) formula, once a day for 10 days.  The mouse colorectal carcinoma cell line CT26  (~2.5 × 106 cells/mouse) were transplanted subcutaneously into the left axillary region of each mouse and allowed ~1 week to establish tumours.  When the tumours reached a size of 50mm3, the mice were intraperitoneally (i.p.) injected with 250 μg of anti-mouse PD-1 mAb.  The mice in the control group were administered the same volume of PBS. All mice were injected five times at 3-day intervals with antimouse PD-1 mAb or PBS",11,12,,16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 7","Study 1","United States of America","Homo sapiens",Feces,UBERON:0001988,adenoma,EFO:0000232,controls,"advanced conventional adenoma cases","conventional adenoma cases; those with at least one tubular or tubulovillous adenoma and no other polyps of hyperplastic, SSA, or unclassified histology. HP cases; having at least one HP, with no other polyps of tubular, tubulovillous, SSA, or unclassified histology. SSA cases; having at least one SSA, with or without HP(s), and with no other polyps of tubular, tubulovillous, or unclassified histology. Proximal polyps; polyps located in the cecum, ascending colon, hepatic flexure, transverse colon, or splenic flexure. Distal polyps; polyps located in the descending colon, sigmoid colon, or rectum.",323,22,"NYU included who had not been on long-term antibiotic treatment",16S,4,Illumina,DESeq2,0.1,true,,,"age,body mass index,sex",,decreased,,,,decreased,Complete,"Shaimaa Elsafoury"
"Experiment 7","Study 86",Luxembourg,"Homo sapiens",Feces,UBERON:0001988,"cesarean section",EFO:0009636,"vaginal delivery","overall time point infants samples of c-section","meconium samples were collected at day 1 after delivery",8,7,"11 mothers (6 contols and 5 cases) used antibiotices 12 hours before and after delivery.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 7","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low MDA level","Bipolar patients with high MDA level","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 7","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"BMI <20","BMI 20-25","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",5,15,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 7","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"healthy control","atopic asthma","atopic asthma",21,42,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 7","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 1-2 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,T-Test,0.05,false,,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 7","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"samples with no rhinovirus infection","samples with any rhinovirus infection","samples with rhinovirus infection","1,883","1,239",,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,,,,,,,,Complete,
"Experiment 7","Study 293",China,"Homo sapiens","Uterine cervix",UBERON:0000002,"human papilloma virus infection",EFO:0001668,"no HPV type persisted","at least one HPV type persisted","Any HPV-type persisted confirmed by HPV assay and genotyping",64,29,"2 weeks",16S,4,Illumina,LEfSe,0.05,false,2,,,,unchanged,unchanged,unchanged,,unchanged,Complete,"Fatima Zohra"
"Experiment 7","Study 244","United States of America","Homo sapiens","Skin of body",UBERON:0002097,age,EFO:0000246,"2-12 years","18-62 years","teenager/adult age 13-62",59,69,"1 week (oral antibiotics)",16S,"1,2,3",Illumina,T-Test,0.05,true,,,,,decreased,,,,,Complete,
"Experiment 7","Study 262","United States of America","Homo sapiens","Bronchus,Sputum","UBERON:0002185,UBERON:0007311","atopic asthma",EFO:0010638,"healthy controls","atopic asthma subjects","subjects with atopic asthma",11,22,"3 months",16S,4,Illumina,Chi-Square,0.05,false,,,,,,,,,,Complete,Claregrieve1
"Experiment 7","Study 356",China,"Mus musculus",Colon,UBERON:0001155,"air pollution",ENVO:02500037,"mice dams exposed to filtered blanks PND 35","ICR female mice exposed to PM 2.5","ICR mice exposed to PM 2.5",8,8,,16S,"3,4",Illumina,LEfSe,0.05,false,,,,,,unchanged,unchanged,,increased,Complete,
"Experiment 7","Study 246",Canada,"Homo sapiens",Feces,UBERON:0001988,asthma,MONDO:0004979,"no asthma","maternal asthma","maternal prenatal asthma/caucasian infant, no allergies during pregnancy",278,10,,16S,,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,,,,,,Complete,
"Experiment 7","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"30-day old full-term neonates not exposed to antibiotics (IAP/postnatal)","30-day old pre-tem neonates exposed to antibiotics (IAP)","antenatal/postnatal antibiotic exposure",14,10,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 7","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"high grade dysplasia","high grade dysplasia confirmed by histology of colonoscopy-directed biopsy",20,27,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,"age,body mass index,ethnic group",,,,,,,Complete,"Fatima Zohra"
"Experiment 7","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,"transient HPV+ with LSIL","transient HPV+ with HSIL","high-risk HPV transient infection with high grade squamus intraepithelial lesion",,,,16S,,Illumina,LEfSe,,,,,,,,,,,,Complete,Fatima
"Experiment 7","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907",age,EFO:0000246,"Age 50+","Age ≤50","Breast cancer patients who's age is ≤50 years old.",17,20,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,Kruskall-Wallis,0.001,false,,,"ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 7","Study 475",China,"Homo sapiens",Rectum,UBERON:0001052,COVID-19,MONDO:0100096,"Group I - High Diversity COVID-19 patients","Group III - Low Diversity COVID-19 patients","Patients with low microbial diversity in rectal swab samples",15,24,,16S,4,Illumina,ANOSIM,0.05,true,,,,decreased,,,,,decreased,Complete,
"Experiment 7","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with mid stage Parkinson's","Patients with mid stage Parkinson's disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,53,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,,,,,Complete,
"Experiment 7","Study 538",Switzerland,"Homo sapiens",Feces,UBERON:0001988,"urinary tract infection",EFO:0003103,CRL2,NF2,"nitrofurantoin group between antibiotic treatment",10,10,,16S,"3,4",,"Mann-Whitney (Wilcoxon)",0.05,true,,,,,unchanged,unchanged,unchanged,,,Complete,
"Experiment 7","Study 562","Italy,Luxembourg,United States of America","Homo sapiens",Vagina,UBERON:0000996,healthy,,,"healthy adult vagina 70% up",,,96,No,WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 7","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal adenoma",EFO:0005406,"healthy controls",adenoma-adjacent,"specimen collected adjacent to histology-proven adenoma",61,47,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 8","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"low BMI","Bipolar patients with high BMI","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 8","Study 130",Spain,"Homo sapiens",Feces,UBERON:0001988,diet,EFO:0002755,"BMI 20-25","BMI >25","SEAD: Southern European Atlantic Diet. SEAD adherence was measured using an index of nine food components (fresh fish, cod, red meat and pork products, dairy products, legumes and vegetables, vegetable soup, po- tatoes, wholegrain bread and wine) that ranged from 0 (lowest adherence) to 9 (highest adherence).",15,11,"6 months",16S,,RT-qPCR,ANOVA,0.05,false,,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 8","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"healthy control","atopic no asthma","atopic no asthma",21,21,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 8","Study 342","United States of America","Homo sapiens","Nasal cavity",UBERON:0001707,Asthma,MONDO:0004979,"Rhinovirus-negative samples","Samples with rhinovirus A","Samples with rhinovirus A present","1,883",386,,16S,4,Illumina,"Zero-Inflated Beta Regression",0.15,true,,,,,,,,,,Complete,Claregrieve1
"Experiment 8","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"cervical cancer",MONDO:0002974,HPV-,"invasive cervical carcinoma","invasive cervical carcinoma confirmed by histology of colonoscopy-directed biopsy",20,10,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,"age,body mass index,ethnic group",,,,,,,Complete,"Fatima Zohra"
"Experiment 8","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"late stage normal","late stage peritumor","gastric cancer",118,129,"1 month",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,"age,sex",,decreased,decreased,decreased,,,Complete,Claregrieve1
"Experiment 8","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"90-day old full-term neonates not exposed to antibiotics (IAP/postnatal)","90-day old pre-tem neonates exposed to antibiotics (IAP)","antenatal/postnatal antibiotic exposure",14,10,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 8","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 1-2 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,LEfSe,0.05,false,4,age,,,unchanged,,,,,Complete,Lwaldron
"Experiment 8","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"transient HPV+ with LSIL","high-risk HPV transient infection with low grade squamus intraepithelial lesion",,,,16S,,Illumina,LEfSe,,,,,,,,,,,,Complete,Fatima
"Experiment 8","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907",parous,EFO:0002947,Parous,Nulliparous,"Breast cancer patients who are nulliparous (have had no live births.)",29,8,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,Kruskall-Wallis,0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 8","Study 537",Italy,"Homo sapiens",Feces,UBERON:0001988,"Parkinson's disease",MONDO:0005180,"healthy controls without any form of Parkinson's Disease","patients with advanced stage Parkinson's","Patients with advanced stage Parkinson&#039;s disease with stage diagnosed according to UK Brain Bank Criteria(1996)",113,44,,16S,"3,4",Illumina,"Negative Binomial Regression",0.05,,,"age,geographic area","age,breast feeding,smoking status",,,,,,,Complete,
"Experiment 8","Study 562","China,India,Italy,Malaysia,Singapore,United States of America","Homo sapiens","Skin of body",UBERON:0002097,healthy,,none,"healthy adult skin 70% up",,,362,"All records NA",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 8","Study 86",Luxembourg,"Homo sapiens",Meconium,UBERON:0007109,"cesarean section",EFO:0009636,"vaginal delivery",C-section,,4,6,"11 mothers (6 controls and 5 cases) used antibiotics 12 hours before and after delivery, 3 VD mothers were positive group B Streptococcus screening.",16S,4,Illumina,"Mann-Whitney (Wilcoxon)",0.05,true,,,,unchanged,unchanged,,,,increased,Complete,Lwaldron
"Experiment 8","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"healthy controls",carcinoma-adjacent,"specimen collected from tissue adjacent to adenocarcinoma site",61,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 9","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"no metabolic syndrome","Bipolar patients with metabolic syndrome","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 9","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"normal HP-","normal HP+","normal samples that are H. Pylori positive",64,166,"1 month",16S,"3,4",Illumina,LEfSe,,true,2,,"age,sex",,decreased,decreased,decreased,,,Complete,Claregrieve1
"Experiment 9","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection,cervical cancer","EFO:0001668,MONDO:0002974","abnormal pH","normal pH","HPV+ determined by the Linear Array HPV Genotyping Tests, low grade dysplasia,high grade dysplasia, invasive cervical carcinoma confirmed by histology of colonoscopy-directed biopsy,",20,74,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 9","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 2-3 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,T-Test,0.05,false,,age,,,decreased,,,,,Complete,Lwaldron
"Experiment 9","Study 267","United States of America","Homo sapiens",Bronchus,UBERON:0002185,"atopic asthma",EFO:0010638,"atopic no asthma","atopic asthma","atopic asthma",21,42,"3 months",16S,4,Illumina,,0.1,true,,,,unchanged,unchanged,,,,unchanged,Complete,
"Experiment 9","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"30-day old full-term neonates not exposed to antibiotics (IAP/postnatal)","30-day old pre-tem neonates exposed to antibiotics (IAP)","IAP exposure",5,14,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 9","Study 431",China,"Homo sapiens",Vagina,UBERON:0000996,"cervical glandular intraepithelial neoplasia",EFO:1000165,HPV-,"persistent HPV+ with HSIL","high-risk HPV persistent infection with low grade squamus intraepithelial lesion",,,,16S,,Illumina,LEfSe,,,,,,,,,,,,Complete,Fatima
"Experiment 9","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","body mass index",EFO:0004340,BMI<25,BMI≥25,"Breast cancer patients with a high body mass index (BMI≥25)",9,28,"Antibiotic use one week or more during the month prior to fecal sample collection.",16S,"3,4",Illumina,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,ethnic group,race",,unchanged,unchanged,,,,Complete,
"Experiment 9","Study 562","Australia,Canada,China,Denmark,Finland,France,Germany,India,Ireland,Israel,Italy,Japan,Luxembourg,Netherlands,South Korea,Spain,Switzerland,United Kingdom,United Republic of Tanzania,United States of America","Homo sapiens",Feces,UBERON:0001988,,,"none - 70% prevalence threshold","feces from healthy adult","non-disease adult participants from curatedMetagenomicData",0,"9,623","no (n=5572), yes (n=276)",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 9","Study 644",China,"Homo sapiens",Intestine,UBERON:0000160,"Colorectal cancer",EFO:0005842,"colorectal adenoma",carcinoma-adjacent,"specimens collected from tissue adjacent to adenocarcinoma",47,52,"Not specified",16S,"1,2,3,4",Roche454,"Mann-Whitney (Wilcoxon)",0.05,,,,,,,,,,,Complete,
"Experiment 10","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,"healthier bipolar patients","Bipolar patients with depressive syndrome","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",,,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 10","Study 403",China,"Homo sapiens",Feces,UBERON:0001988,Eczema,HP:0000964,"healthy control","child with eczema","children age 2-3 with eczema diagnosed by pediatrician based on clinical criteria such as dry, desquamation skin, increased temperature on the local skin, and oozing or crusting",123,49,,16S,"3,4",Illumina,LEfSe,0.05,false,4,age,,,decreased,,,,,Complete,Lwaldron
"Experiment 10","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"30-day old pre-term neonates not exposed to antibiotics (IAP/postnatal)","30-day old pre-tem neonates exposed to antibiotics (IAP/postnatal)","pre-term infants and mothers exposed to antibiotics",5,9,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 10","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"peritumor HP-","peritumor HP+","peritumor samples that are H. Pylori positive",65,182,"1 month",16S,"3,4",Illumina,LEfSe,0.05,true,2,,"age,sex",,decreased,unchanged,decreased,,,Complete,Claregrieve1
"Experiment 10","Study 274","United States of America","Homo sapiens",Vagina,UBERON:0000996,"human papilloma virus infection",EFO:0001668,non-Hispanic,Hispanic,"HPV+ determined by the Linear Array HPV Genotyping Tests, low grade dysplasia,high grade dysplasia, invasive cervical carcinoma confirmed by histology of colonoscopy-directed biopsy,",53,47,"3 months",16S,4,Illumina,DESeq2,0.05,true,,,,,,,,,,Complete,"Fatima Zohra"
"Experiment 10","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","body fat percentage",EFO:0007800,TBF≤46%,TBF>46%,"Breast cancer patients with a total body fat percentage ≥46%.",25,12,,,,,"Mann-Whitney (Wilcoxon)",,,,,,,unchanged,decreased,,,,Complete,
"Experiment 10","Study 562","Australia,Canada,China,Denmark,Finland,France,Germany,India,Ireland,Israel,Italy,Japan,Luxembourg,Netherlands,South Korea,Spain,Switzerland,United Kingdom,United Republic of Tanzania,United States of America","Homo sapiens",Feces,UBERON:0001988,,,"none - 0% prevalence threshold","feces from healthy adult","non-disease adult participants from curatedMetagenomicData",0,"9,623","no (n=5572), yes (n=276)",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
"Experiment 11","Study 34",Austria,"Homo sapiens",Feces,UBERON:0001988,"bipolar disorder",MONDO:0004985,Controls,"Bipolar disorder","cases followed the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)21 diagnosis of bipolar I disorder",10,27,"1 month",16S,"1,2","Ion Torrent",LEfSe,0.05,false,3,,,,,,,,,Complete,"Shaimaa Elsafoury"
"Experiment 11","Study 316",Spain,"Homo sapiens",Feces,UBERON:0001988,"antimicrobial agent",CHEBI:33281,"90-day old pre-term neonates not exposed to antibiotics (IAP/postnatal)","90-day old pre-tem neonates exposed to antibiotics (IAP/postnatal)","pre-term infants and mothers exposed to antibiotics",5,9,,16S,"3,4","Ion Torrent",ANOVA,0.05,false,,,,,,,,,,Complete,
"Experiment 11","Study 256",China,"Homo sapiens",Stomach,UBERON:0000945,"gastric cancer",MONDO:0001056,"tumor HP-","tumor HP+","tumor samples that are H. Pylori positive",77,152,"1 month",16S,"3,4",Illumina,LEfSe,0.05,true,2,,"age,sex",,unchanged,unchanged,unchanged,,,Complete,Claregrieve1
"Experiment 11","Study 467","United States of America","Homo sapiens","Digestive system,Digestive tract,Lower digestive tract","UBERON:0001007,UBERON:0001555,UBERON:0004907","physical activity",EFO:0003940,"Yes Physical Activity","No Physical Activity","Breast cancer patients who do not have regular physical activity.",24,13,"Antibiotic use one week or more during the month prior to fecal sample collection.",,,,"Mann-Whitney (Wilcoxon)",0.001,false,,,"age,race",,unchanged,decreased,,,,Complete,
"Experiment 11","Study 562","Australia,Canada,China,Denmark,Finland,France,Germany,India,Ireland,Israel,Italy,Japan,Luxembourg,Netherlands,South Korea,Spain,Switzerland,United Kingdom,United Republic of Tanzania,United States of America","Homo sapiens",Feces,UBERON:0001988,,,"none - 30% prevalence threshold","feces from healthy adult","non-disease adult participants from curatedMetagenomicData",0,"9,623","no (n=5572), yes (n=276)",WMS,,Illumina,,,,,,,,,,,,,Complete,Lwaldron
